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Abstract 
A two-stage qualitative research strategy using semi-structured interviews was 
conducted with a convenience sample of 45 participants who lives with type 2 
diabetes. In Stage One of the research, a qualitative study was conducted using 
semi-structured interviews with a purposive sample of 25 participants. Of these, 
20 participants were diagnosed with type 2 diabetes, two participants were 
primary care physicians, two were ophthalmologists, and one was a retinal 
screener. People with diabetes were purposely recruited to fall into four groups 
with different grades of diabetic retinopathy. The aim of Stage One was to 
explore how people with type 2 diabetes perceive diabetic retinopathy risk, their 
understanding of risk information, and to appraise existing risk communication 
tools that have been used in other clinical settings. The data from Stage One 
was analysed and used to develop a risk communication tool designed to 
provide risk information about diabetic retinopathy and diabetic screening 
results to people with type 2 diabetes, which was then used in Stage Two.  
In Stage Two of this research, a total of twenty people with type 2 diabetes were 
recruited. Participants were divided into two groups based on their grade of 
diabetic retinopathy. Group one: 10 participants with no diabetic retinopathy 
(R0); Group two: 10 participants who had background diabetic retinopathy (R1). 
The aim of Stage Two was to i) appraise a newly developed risk communication 
tool that was developed to communicate risk information about diabetic 
retinopathy to people with type 2 diabetes, ii) to explore the influence of the new 
developed risk tool on risk perception and on diabetes self-care management, 
and iii) to establish a method(s) by which risk information about diabetic 
retinopathy can be effectively communicated to people with type 2 diabetes. All 
interviews were audio recorded and transcribed using a digital recording 
machine. Data was analysed using constructivist grounded theory approach. 
Results 
In Stage One, people with type 2 diabetes appeared to lack knowledge about 
diabetes, diabetic retinopathy and its impact on their sight. Perception of risk 
appeared to be influenced by many factors, such as individual’s knowledge, 
beliefs, understanding and interpretation of risk information, type of diabetes, 
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presence of visible eye complications, and the individual’s past experience. 
There were also differences in risk perception between people with type 2 
diabetes and Health Care Professionals. People with diabetes responded to 
being at risk in different ways, such as being optimistic, pessimistic, or 
underestimating diabetic retinopathy risk as well as having emotional responses 
such as denial, low mood, and depression. 
In Stage Two, the new risk communication tool was reported as useful, easy to 
use, and described as a good visual representation that may improve the 
understanding and interpretation of risk. It was found to facilitate the 
presentation of risk for those who were illiterate or whose their first language 
was not English. 
Conclusion 
The lack of knowledge about diabetes and its complications points to the 
importance of designing educational material that address people with 
diabetes’s educational needs. This study also highlights the importance of how 
we frame the risk messages and that we need to take into consideration the 
differences in perception of risk between people with diabetes and their Health 
Care Professionals.  
This study also demonstrates that risk information should be personalised and 
provided in a clear and attractive style based on level of understanding, 
particularly to the symptomless participants. Health Care Professionals should 
assess patients’ knowledge and understanding of risk when risk message is 
given. Risk communication tools could benefit participants to understand their 
own risk of developing diabetic retinopathy and reduces anxiety level. In 
addition, future quantitative studies should examine the effectiveness of risk 
tools.  
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 Introduction 
1.1. Development of the research idea 
This doctoral thesis is entitled “Communicating risk information about diabetic 
retinopathy to people with type 2 diabetes”. The researcher has been working 
for many years in the field of nursing. For the past seven years, he has worked 
in an ophthalmology department. In the course of his practice as a senior 
ophthalmic nurse, he has been engaged in the education of patients and the 
management of people with diabetes related eye complications. As a result of 
this work, the researcher noticed that a significant number of people with 
diabetes, in particular those from ethnic minority groups, who were invited for 
retinal photography did not always attend hospital appointments and diabetic 
retinopathy screening appointments, and as a result could be putting 
themselves at risk of future blindness (Gray et al., 2009). For example, research 
has shown a relationship between non-attendance at screening and 
subsequent loss of vision (Gray et al., 2009; Zoega et al., 2005). Moreover, the 
lack of uptake in relation to diabetic retinopathy screening  is of concern 
because only when the uptake is above eighty eight per cent will the screening 
service be eighty per cent sensitive to detect sight-threatening diabetic 
retinopathy (Gray et al., 2009). This has been shown in a screening programme 
that investigated sight differences between attenders and non-attenders of 
screening programmes, which found that the non-attenders’ level of diabetic 
retinopathy was higher than those who attended regularly (Gray et al., 2009).  
Lay beliefs about the causes of health problems and the degree of risk people 
perceive they are subject to have long been a feature of research in the field of 
health (Smith et al., 1999). Therefore, it was clear that non-attendance 
regarding diabetic screening could be due to a number of factors including 
people misunderstanding the risk message and their degree of personal risk, 
which could lead the person with diabetes to perceive their diabetes to be mild 
or at low risk of other associated problems. In turn, this may have a negative 
impact on their adherence to hospital and diabetic screening appointments as 
17 
 
well as diabetes self-care management. For example, in relation to diabetes, 
research that has focused on population characteristics has shown that patients 
living in the most deprived areas are less likely to attend for screening and when 
they do present have worse retinopathy (Scanlon et al., 2008).  
At the time of conducting the research, people with diabetes were invited 
annually to have a digital photograph taken of the back of their eye (retinae). 
This is designed to detect problems at an early stage, so they can be treated to 
prevent further vision loss. The English NHS Diabetic Eye Screening 
Programme (NHS DESP) offers annual screening to over two million people, 
with over one and a half million being screened in 2012 (DH, 2014). If diabetic 
retinopathy is diagnosed early it can be effectively treated and the persons’ sight 
can be saved or preserved (Bachmann and Nelson, 1996; Scanlon, 2008). 
Understandably, the maintenance of vision is associated with a better quality of 
life and independent living, particularly in older people (Chia et al., 2004). The 
consequences of non-adherence regarding hospital appointments and diabetic 
screening appointments, as well as whether patients heeded Health Care 
Professionals’ advice, motivated the researcher to explore people’s 
understanding and decision-making processes as a means of ultimately 
preventing blindness within certain groups of patients, given that eighty per cent 
of blindness is preventable (IAPB, 2009). Therefore, the researcher 
commenced his PhD study at the University of Nottingham in 2009 and then 
transferred to the University of Warwick in 2011 where he joined a well-
established research team, who were involved in a research project to identify 
factors leading to low uptake of diabetic retinopathy screening in primary care 
(FLURRI STUDY). 
The original idea for this research (communicating risk information about 
diabetic retinopathy to people with type 2 diabetes) came whilst undertaking the 
FLURRI study. The team were aware of an ongoing discussion in the national 
screening programme about possible extended screening intervals for people 
at low risk of developing diabetic retinopathy. During the FLURRI fieldwork, 
when participants were asked about the views on extended screening intervals, 
many participants seemed concerned at the proposal. Additionally, the FLURRI 
study highlighted issues, such as a lack of communication, for non-concordance 
18 
 
with diabetic eye screening (Lindenmeyer et al., 2014; Hipwell et al., 2014). 
However, the method regarding how risk information about diabetic retinopathy 
is communicated to people with diabetes may impact not only in their level of 
attendance at diabetic screening centres, but also may affect their decisions 
regarding their diabetes self-care management and their anxiety regarding the 
development of complications. 
In addition, type 2 diabetes can be asymptomatic, and people are sometimes 
diagnosed with type 2 diabetes in retrospect when they present with diabetes 
complications such as renal problems or visual problems (Looker et al., 2012). 
Diabetes is viewed as a serious condition leading to many severe 
complications, particularly in South Asian populations (Macaden and Clarke, 
2006). This is despite the fact that a number of educational programmes 
(Ockleford et al., 2008; Carey et al., 2014; Sturt et al., 2008; Davies et al., 2008; 
Deakin et al., 2006) have been designed to provide valuable information to 
people with diabetes. Furthermore, it was noticed that previous research on 
topics like perception of risk had been conducted mainly among western 
populations. As a result, there are very limited studies (Osal et al., 2011; 
O'Sullivan et al., 2009; Duncan et al., 2010; Shrestha et al., 2007; Macaden and 
Clarke, 2006; Macaden and Clarke, 2010) that have sought to address the 
perception of risk among the South Asian populations and among other minor 
ethnic groups living in western countries. Furthermore, the fact that research 
regarding risk perception about diabetic retinopathy and the communication of 
risk information about diabetic retinopathy has not taken place with people with 
diabetes is perhaps surprising given that this population is at risk of developing 
sight-threatening diabetic retinopathy. Issues relating to the perception of risk 
and the communication of risk information can be challenging topics, particularly 
when people with type 2 diabetes need to understand their risk before they 
make informed decisions about their care. Therefore, the researcher was 
interested in this subject area because of his academic and clinical background 
as well as personal interest and motivation to prevent avoidable blindness 
among people with type 2 diabetes.  
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1.2. Background of the researcher 
The researcher is a senior ophthalmic nurse with Master’s Degree in Advanced 
Nursing and has been involved in staff and patients’ education and nursing 
practice for over twenty years in different Middle East and Western countries. 
As in the UK, Middle East countries such as United Arab Emirates and Saudi 
Arabia also have a considerable number of South Asian people with diabetes. 
Recently, the researcher has been working at hospital in the Midlands. This 
hospital has an international standing and reputation and has been a pioneer 
regarding nursing education and practice development within the United 
Kingdom.  
1.3. Background of the research 
Diabetes is a global problem affecting a significant number of people in the 
United Kingdom. Published data shows that 3.5 million people have diabetes in 
England (Diabetes UK, 2015). Of these, approximately 85 per cent have type 2 
diabetes and 15 per cent have type 1 diabetes. Diabetes is costly, both in terms 
of resources and quality of life. People with diabetes are at high risk of 
developing a number of complications. One complication of diabetes is diabetic 
retinopathy, which occurs when diabetes damages the small blood vessels at 
the back of the eye (retinae). Diabetic retinopathy is also often symptomless to 
the patient until in its advanced stages and if left untreated this can result in loss 
of vision and blindness. Diabetic retinopathy was, until recently  (Liew et al., 
2014), the leading cause of visual impairment in people of working age (Bunce 
et al., 2010). However, the introduction of the national NHS diabetic eye 
screening programme in England and Wales (NHS choices, 2013) has resulted 
in more cases being detected at an earlier stage and treated before the diabetic 
retinopathy has progressed. 
The risk of developing diabetic retinopathy and progressing can be reduced by 
maintaining blood glucose as near to normal as possible. In the UK, diabetic 
retinopathy affects nearly all people with type 1 diabetes and almost two thirds 
of people with type 2 diabetes within 20 years of diagnosis (Scanlon, 2008). 
People with diabetes may need to make major changes to their lifestyle, in 
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terms of diet, exercise, and the need to take long term medications to bring their 
blood glucose levels into a target range for reducing diabetic retinopathy risk or 
progression (Garcia-Perez et al., 2013). These changes in lifestyle can lead to 
decrease in quality of life, as people may feel deprived from their favourite 
foods, sweets, and drinks, in addition to having to endure regular finger prick 
checks to monitor their blood glucose level (Macaden and Clarke, 2010). 
Knowledge about people, their values and culture facilitate the delivery of care 
as well as enabling Health Care Professionals to empower patients to make 
informed decisions and for them to feel valued (Pawa, 2003). However, there 
are several challenges in relation to diabetes awareness associated with culture 
and different ethnic groups (Iqbal et al., 2008; Osman and Curzio, 2012; 
Shrestha, et al., 2007; Zeh et al., 2012) in addition to the high cost of delivering 
educational programmes (O’Hare et al., 2004; Greenhalgh et al., 2011). For 
example, a recent review conducted by Osman and Curzio (2012) concluded 
that cultural beliefs play a significant role in attitudes towards diabetes among 
people of South Asian origin and understanding their beliefs can improve the 
care provided to this community. Another systematic review conducted by Zeh 
et al., (2012) reported that structured interventions that were tailored to people 
with diabetes from ethnic minority group and integrated elements of culture, 
language, religion, and health literacy skills, improved patient’s outcomes such 
as HbA1c. However, O’Hare et al., estimated the annual cost per patient at £365 
compared with £264 for treating type 2 diabetes, and Greenhalgh et al. (2011) 
estimated the cost of training a bilingual health care as a facilitator at £1500 and 
£345 to deliver the 12-week-sharing course per person. Ethnicity may impact 
on health care and access to the health services in many ways and at many 
levels such as: variation in service uptake, communication problems, culture 
and attitudes, socio-economic factors, and variations in disease prevalence. 
These variations influence access to services and may act as barriers to good 
health care (Szczepura, 2005). In summary, across diverse populations, the 
complications associated with type 2 diabetes could be prevented with better 
management that includes providing clear risk communication messages to 
people with diabetes. Therefore, this study aims 1) to explore how people with 
type 2 diabetes perceive and experience their diabetic retinopathy risk, 2) to 
develop or modify a risk communication tool and 3) develop a risk 
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communication model to facilitate the presentation of risk messages about 
diabetic retinopathy to people with type 2 diabetes. 
1.4. Definition of diabetes 
The World Health Organization (WHO) defines diabetes as a chronic disease 
that occurs when the pancreas does not produce enough insulin, or when the 
body cannot effectively use the insulin it produces. Hyperglycaemia, or raised 
blood sugar, is a common effect of uncontrolled diabetes and over time leads 
to serious damage to many of the body's systems, especially the nerves and 
blood vessels (WHO, 2009).  
1.5. Types of diabetes 
Diabetes mellitus is divided into two main categories, type 1 diabetes and type 
2 diabetes. There are differences in the causes and treatment for these two 
major forms of diabetes (Diabetes UK, 2014b). Type 1 Diabetes accounts for 
about 15% of all diabetic population; it is most often found in people less than 
40 years of age. Type 2 diabetes accounts for about 85% of all people with 
diabetes. It is more common in over 40 years old in the White population and in 
over 25 years old of the Black and South Asian population (Diabetes UK, 2010). 
The symptoms with type 2 diabetes often appear very slowly and some people 
do not have any symptoms at all. Therefore, people can live with type 2 diabetes 
for up to 10 years before diagnosis (Diabetes UK, 2013).  
1.6. Outline of the thesis 
Chapter one of this thesis has outlined the development of the research idea, 
the researcher’s background, the origin and progression of the research project, 
and the definition and types of diabetes. It concludes with the aims and 
objectives of the study. 
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Chapter two provides a review of the literature on diabetes, diabetic 
retinopathy, prevalence of diabetes and diabetic retinopathy, cost of diabetes, 
and the main complications associated with diabetes. The chapter then 
considers diabetic retinopathy in more detail as the main diabetes related eye 
complication. It covers the modifiable and non-modifiable risk factors of 
developing diabetic retinopathy, its signs and symptoms, the diabetic 
retinopathy classification of progression to proliferative diabetic retinopathy, and 
how people with diabetes construct knowledge and make sense of their 
diabetes. Finally, the chapter provides details about the NHS diabetic eye 
screening programme, its effectiveness and a critique of diabetic eye screening 
as well as examining the screening pathway from invitation to communicating 
the screening results. 
Chapter three examines the literature about perception of risk and risk 
communication among people with type 2 diabetes. The chapter begins by 
exploring the perception of risk before moving on to explore risk communication 
issues and the factors that have been found to influence the exchange of risk 
information about diabetes between Health Care Professionals and their 
patients. This includes a range of risk communication formats, numerical 
knowledge, the interaction between Health Care Professionals and their patient, 
the influence of visual risk communication tools, individual limitations, variations 
in risk interpretation, the use of fear and threatening messages, and framing 
bias. The chapter then considers other issues regarding risk communication 
such as the constraints around effective communication and other ethical issues 
related to risk communication.  
Chapter four begins by stating the aims of the research and how these aims 
guided the research design and how the research was conducted. It discusses 
the philosophical position of the research and gives details of its theoretical and 
methodological perspectives. The chapter sets out the rationale for adopting the 
theoretical fundamentals drawn from social constructionism and interpretivism 
as a methodological and philosophical framework, with aspects of a 
constructivist grounded theory approach employed in relation to data analysis 
(Charmaz, 2006). This approach was adopted based on key issues, such as 
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the methodological limitation of existing research regarding the communication 
of risk information about diabetic retinopathy to people with type 2 diabetes.  
Chapter five discusses the methods used in this study. The chapter then 
proceeds to detail why the study has adopted a two-stage approach, followed 
by discussion regarding the recruitment process, data collection, and data 
analysis process. 
Chapter six presents an analysis of the Stage One interview data and seeks to 
explore how the risks and benefits of diabetic retinopathy screening are 
understood and interpreted by people with diabetes and by Health Care 
Professionals. It also explores the perception of risk information about diabetic 
retinopathy by using numerical and textual formats and the influence of risk 
information on risk perception. It also appraises the existing risk communication 
tools from other clinical settings and develops a new diabetic retinopathy risk 
communication tool that can be used to communicate risk information about 
diabetic retinopathy to people with type 2 diabetes.  
Chapter seven provides an analysis of the Stage Two interview data. This 
seeks to explore the views of people with diabetes regarding a newly developed 
diabetic retinopathy risk communication tool and explores the influence of the 
newly developed risk communication tool on risk perception and diabetes self-
care management. The chapter also explores people’s preference regarding 
the most appropriate methods of communicating risk information about diabetic 
retinopathy and diabetic eye screening results to people with type 2 diabetes.  
Chapter eight draws together the findings of this study that has the perception 
of risk and risk communication as its central concepts. The chapter discusses 
the main factors that have influenced risk perception and the model put forward 
for communicating risk information about diabetic retinopathy and diabetic 
retinopathy screening results. 
Chapter nine provides the concluding comments of the thesis and makes 
recommendations for clinical practice, policy, and research. 
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 Literature Review 
2.1. Introduction  
This literature review aims to examine the research evidence regarding 
diabetes and diabetic retinopathy risk among people with type 2 diabetes. The 
literature reviewed in this chapter is primarily a scientific and medical review 
embedded within a medical context and includes limited work in the field of 
social sciences. This decision was informed by the researcher's clinical 
background and the pragmatic imperative to understand the evidence as it 
relates to, and impacts upon, clinical practice. Scoping reviews identified risk 
communication evidence in the behavioural sciences literature and the 
academic discipline of the primary supervisor as a behavioural scientist 
informed the directional decision of the evidence review. Firstly, the chapter 
explores the scientific and medical literature regarding diabetes, diabetic 
retinopathy, and prevalence of diabetes and diabetic retinopathy. It also 
explores the costs of diabetes and the different types and complications of 
diabetes. The chapter then considers diabetic retinopathy, the main cause of 
diabetes related eye complications, presentation of the modifiable and non-
modifiable risk factors of developing diabetic retinopathy along with a critique of 
the modifiable factors, signs and symptoms, and the diabetic retinopathy 
classification of progression to proliferative diabetic retinopathy. Finally, the 
chapter provides details about the NHS diabetic eye screening programme. In 
so doing, it provides a critique of diabetic eye screening and explores the 
screening pathway from invitation to the communication of the screening 
results. 
2.2. Source of the literature 
The literature search for this study covers several areas because there were 
various components to the study. The main areas that were investigated were 
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perception of risk among people with type 2 diabetes mellitus, risk 
communication, and risk communication tools. A broad search of the clinical 
and behavioural sciences evidence regarding issues related to perception of 
risk, risk communication tools, and risk communication and how these may be 
influenced by health beliefs, knowledge, education, and ethnicity. The literature 
search was performed by the researcher (NA) in October 2010 and updated at 
annual intervals with the final search conducted in December 2017, to identify 
literature on the perceptions and perspectives of people with diabetes on 
diabetes, diabetic retinopathy, risk, and risk communication tools. Boolean 
operators were used for combinations of the following keywords: “risk”, “risk 
communication”, “risk tools”, “risk communication tools”, “visual tools”, 
“diabetes”, diabetic retinopathy”, “diabetes self-care management”, and 
“qualitative research”. Equivalent terms in glossaries or MeSH browsers were 
used wherever possible. Searches were restricted to the English language only. 
A general literature search of the broad topic area was performed in the 
following journals: Diabetic Medicine, Practical Diabetes International, Journal 
of Diabetes Nursing, Health, Risk and Society, Risk Analysis, The Diabetes 
Educator, and Journal of Advanced Nursing. A number of bibliographic 
databases were accessed electronically including MEDLINE, EBSCO EJS, 
Cambridge University Press Journals, Blackwell Publishing of Synergy, Elsevier 
Journals, and Wiley. In addition, an electronic content alerts were set up and 
published journals were reviewed on a regular basis/as they were published in 
order to keep up to date with the current literature. 
Due to the nature of the research and the fact that it has a number of different 
elements it was important to arrange the references in an easy way to facilitate 
the literature review process. Therefore, Endnote X7 was used to manage the 
referencing process. Endnote X7 is a bibliography manager that allows the 
access of bibliographic data from a range of resources such as journals, books, 
and electronic databases, search for entries by title, subject, keyword, or 
authors. Data were exported to bibliographic entries into a Microsoft word 
processor. Data was reformatted in word according to different bibliographic 
style such as author and date, Vancouver, APA 6th, or Harvard style directly 
from online resources (Endnote, 2014). 
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2.3. Prevalence of diabetes 
Diabetes is a global problem affecting over 415 million people worldwide and 
causing about 5% of all deaths globally each year (Diabetes UK, 2015). The 
International Diabetes Federation (IDF) note that the prevalence of diabetes 
had risen to 285 million in 2010, representing 6.4% of the world's adult 
population, with a prediction that by 2040 the number of people with diabetes 
will have risen to 642 million (IDF, 2011). It was reported by the International 
Diabetes Federation (2011) that diabetes is accountable for 4.6 million deaths 
every year worldwide (one death due to diabetes occurs every 7 seconds) and 
that over 75 000 people with diabetes die every year in the UK. Of these, 24 
000 people die earlier than would be expected for their age group (The 
Information Centre for Health and Social Care, 2011). 
The number of people with diabetes in the UK in 1996 was 1.4 million, which 
had risen to 3.5 million by 2015, which equates to one in sixteen adults in the 
United Kingdom now having the condition (Diabetes UK, 2015). It is estimated 
that the prevalence of diabetes will rise to 5 million by 2025 (Diabetes UK, 
2015). The evidence also shows that diabetes can affect certain ethnic groups 
to a far greater extent. For example, rates of diabetes are six times higher for 
individuals within the South Asian ethnic group and up to three times higher for 
individuals within the Afro-Caribbean ethnic group (Diabetes UK, 2014b).  
2.4. Cost of diabetes 
Long term conditions such as diabetes and its complications require a lot of 
planning to enable the NHS to deliver appropriate health care services, 
particularly when it involves people from different cultures and ethnic groups. 
Due to its long-term nature, diabetes is a costly condition. Not only for the 
particular individuals and their families in terms of quality of life, pain, anxiety, 
and complications (WHO, 2009), but also costly for the NHS (Diabetes UK, 
2015). In the United Kingdom, diabetes accounts for around 10 per cent of the 
NHS budget and 80 per cent of these costs are because of complications 
(Diabetes UK, 2014a). It is estimated that diabetes costs the NHS 
approximately £23.7 billion each year (£9.8 billion in direct costs and £13.9 
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billion in indirect costs). The costs for type 1 diabetes mellitus was £1.9 billion 
and for type 2 diabetes was £21.8 billion. By 2035/2036 costs are estimated to 
rise to £39.8 billion (£16.9 billion in direct costs, which includes treatment, 
intervention, and complications and £22.9 in indirect costs, which includes those 
related to increased death and illness and work loss). The cost of type 1 
diabetes is estimated to rise to £4.2 billion and the cost of type 2 diabetes is 
estimated to rise to £35.6 billion (Hex et al., 2012). In addition to the financial 
costs, people with diabetes are twice as likely to be admitted to hospital 
compared with those without diabetes, and one in seven hospital beds is 
occupied by someone who has diabetes (Sampson et al., 2007). Furthermore, 
diabetes leads to other conditions such as depression (Ali et al., 2009), pain, 
anxiety, vision loss and amputations, which also impact on people’s quality of 
life (WHO, 2009).  
2.5. Age of onset 
Type 1 diabetes is more common in children and is sometimes known as 
Juvenile diabetes. It is prevalent in 98% of children with diabetes and 10% of 
adults with diabetes. In contrast, type 2 diabetes is more common in adults. It 
is prevalent in 90% of adults with diabetes and 2% of children with diabetes 
(HSCIC, 2013). Type 2 diabetes generally appears in middle age (Tuomilehto 
et al., 2001). Despite the fact that type 1 diabetes is much more common in 
children, type 2 diabetes is the most common type of diabetes across all ages 
in the UK population (Tuomilehto et al., 2001).  
2.6. Complications of diabetes 
Diabetes is a chronic long-life metabolic disorder marked by hyperglycaemia 
with disturbances of the body’s metabolism resulting from defects of insulin 
section, insulin action, or both (WHO, 2009). People with diabetes are at high 
risk of a number of complications. Diabetes can cause problem with other body 
functions, such as heart, kidneys, nerves, feet, bones, joint disorders, and eyes 
(Wu, 2010). There are also other long-term complications of diabetes include 
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skin problems, digestive problems, sexual dysfunction, and problems with teeth 
and gums (Diabetes UK, 2014b; Wu, 2010).  
Diabetes complications have negative consequences for patient’s quality of life, 
which may precipitate psychological, physiological and social burdens 
(Jeffcoate, 2004), and also results in increased economic costs for 
governments’ and the wider society (McCormack et al., 2008). In this research, 
the researcher concentrates on issues related to diabetic retinopathy, which is 
one of the diabetes-related eye complications that confers a significant burden 
on patients’ quality of life (Jeffcoate, 2004). 
2.7. Diabetes-Related Eye Complications 
As the incidence of diabetes gradually increases there is the possibility that 
more individuals will suffer from eye complications, which if not properly 
managed may lead to permanent eye damage and blindness (Clarke, 2008). 
Sight-threatening diabetic retinopathy is one of the main diabetes related eye 
complication. If diabetes related eye complications are left untreated, they lead 
to the deterioration of vision and, ultimately, sight loss and blindness. Sight-
threatening diabetic retinopathy was until recently (Liew et al., 2014) the leading 
cause of visual impairment in people of working age in the UK and still is in most 
countries (Bunce and Wormald, 2006). As the incidence of diabetes gradually 
increases there is the possibility that more individuals will suffer from eye 
complications which, if not properly managed, may lead to permanent eye 
damage and blindness (Clarke, 2008). The most frequently recorded cause of 
certification for blindness are degeneration of the macula and posterior pole 
(58.6 %), which largely comprises age-related macular degeneration. 
Glaucoma (8.4 %), diabetic retinopathy (6.3 %), optic atrophy (4.2 %), 
hereditary retinal disorders (5.5 %), and cerebrovascular disease/accidents (1.5 
%) are the next most frequently occurring causes of certification for blindness 
(Bunce and Wormald, 2006). These causes account for more than 80 % of 
blindness certifications and the percentage of severely sight impaired 
(blindness) registrations caused by diabetic retinopathy has increased from 
5.9% in 2000 to 6.3% in 2008 (Bunce et al., 2010). 
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2.8. Diabetic Retinopathy 
Diabetic retinopathy is a complication of diabetes mellitus, which can eventually 
lead to blindness. It is an ocular manifestation of systemic disease which affects 
up to 80% of all patients who have had diabetes for 10 or more years (Kertes, 
2005). Diabetic Retinopathy affects the blood vessels supplying the retina. 
Blood vessels in the retina of the eye can become blocked or leaky (Wu, 2010). 
Diabetes can also affect the big blood vessels of the head and neck, but 
pathology of the larger blood vessels does not come under the classification of 
diabetic retinopathy (Scanlon, 2010). Rates of diabetic retinopathy are also 
projected to increase exponentially due to an ageing populations and lifestyle 
changes (IAPB, 2009). People with diabetic retinopathy experience many socio-
emotional problems in addition to sight-related problems (Fenwick et al., 2012). 
It is also associated with incidence of mortality and cardiovascular disease. For 
example, there is almost twice the risk of ischaemic stroke when there is 
diabetic retinopathy and seventy one percent of patients registered blind from 
diabetic retinopathy died within 10 years of registration (Nagi et al., 2009). 
2.8.1 Signs and symptoms of diabetic retinopathy 
Diabetic retinopathy can be a symptomless condition that may lead to 
irreversible eye damage (Wu, 2010). The dilemma that people with type 2 
diabetes have is that they can live for up to 10 years before they are diagnosed 
with diabetes (Diabetes UK, 2010), They sometimes do not present themselves 
until they begin to lose their normal vision and are only seen by their 
ophthalmologist or optician when the disease progresses toward advanced or 
proliferative diabetic retinopathy. However, there are some early signs and 
symptoms of diabetic retinopathy. The most commonly reported signs and 
symptoms prior to treatment are blurred vision, short sightedness, difficulty with 
poor lighting, difficulty with night vision, flickering spots before eyes, distorted 
vision, difficulty identifying how close/far an object is (from them), and loss of 
contrast in vision (Scanlon et al., 2006). There are also signs and symptoms of 
diabetic retinopathy that present at a later stage when the people with type 2 
diabetes are referred to an ophthalmologist. This include retinal changes such 
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as retinal swelling and blood vessels leaking fluids, floaters, spotty, blurry, or 
hazy vision, and difficulty in reading (Wu, 2010). 
2.8.2 Diabetic Retinopathy Classification of Progression to Proliferative 
diabetic retinopathy 
The English diabetic eye screening programme proposed the following Grading 
Classifications that should be used in any grading of diabetic retinopathy. The 
following Table (Table 2.1) shows diabetic retinopathy classification of 
progression to proliferative diabetic retinopathy in the first column that links to 
the features, symptoms, and grading criteria used in the English National 
Screening Programme as the management and screening criteria is affected by 
the progression of the lesion. For example, background diabetic retinopathy 
(R1), the least serious, is unlikely to be sight-threatening and requires no 
treatment other than annual monitoring through the screening programme. 
However, serious conditions such as preproliferative diabetic retinopathy (R2) 
and proliferative diabetic retinopathy (R3) require referral to the patient’s 
hospital ophthalmology team for closer monitoring (R2) or treatment (R3). This 
condition occurs when the retinal cells become stressed by oxygen deprivation, 
and new, weak, blood vessels grow. These blood vessels can leak, break off, 
or bleed, causing potentially sight-threatening damage to the retina (Wu, 2010). 
Most of these serious retinopathies are treated by a specialist, using a laser at 
a hospital outpatient clinic, with patients allowed to return home afterwards (Wu, 
2010). A tiny laser beam is directed on to the abnormal part of the retina and 
then small bursts of laser light are used to seal leaking blood vessels or to treat 
areas of retina that are lacking oxygen. Laser treatment reduces the stimulus 
for the production of abnormal new blood vessels growing in the retina and 
those that have formed will often regress or fibrose after laser treatment. Whilst 
vision that has already been lost is not recoverable, laser treatment can prevent 
further damage from occurring. For some people, however, laser treatment is 
insufficient and surgical intervention may be required (Wu, 2010). 
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Table 2.1: Diabetic retinopathy classification of progression to proliferative diabetic retinopathy 
NSC International Term Symptoms Features Action 
R0 No Diabetic retinopathy None Normal retina.   Grade 0 (US) Aannual 
rescreen 
RI Mild non-proliferative (mild 
pre-proliferative) 
None Haemorrhages & 
microaneurysms, Grade 1 
(US). Very minor IRMAs 
Inform 
diabetes 
team 
R2 Moderate non-proliferative, 
moderate pre-proliferative 
None Previously termed mild pre-
proliferative. Extensive 
Microaneurysm, intraretinal 
haemorrhage, and hard 
exudates   Grade 2 (US) 
Refer 
HES 
 
R2 Severe non-proliferative 
severe pre-proliferative 
None Previously termed severe pre-
proliferative. Venous 
abnormalities, large blot 
haemorrhages, cotton wool 
spots (small infarcts), venous 
beading, venous loop, venous 
reduplication, IRMA,  Grade 3 
(US) 
Urgent 
refer HES 
R3 Proliferative retinopathy Floaters, 
sudden 
visual loss 
New Vessel formation either 
at the Disc (NVD) or New 
Vessel Elsewhere (NVE).  
Grade 4a (US) 
Urgent 
refer HES 
R3 Pre-retinal fibrosis+/- 
tractional retinal detachment 
Floaters, 
central 
loss of 
vision 
Extensive fibrovascular 
proliferation, retinal 
detachment, pre-retinal or 
vitreous haemorrhage, 
glaucoma.   Grade 4b (US). 
Traction and Subhyaloid 
haemorrhage 
Urgent 
refer HES 
 
R3s treated proliferative 
retinopathy (s = stable) 
 
No haemorrhages or 
exudates or new vessels, 
laser ('P' added) 
Annual 
rescreen 
NSC: National screening Committee, IRMA: Intraretinal Microvascular Abnormalities, HES: 
Hospital Eye Services 
 
2.8.3 Prevalence of Diabetic Retinopathy 
In the United Kingdom, the prevalence of diabetic retinopathy in type 2 diabetes 
was present in 39% of men and 35% of women (Kohner et al., 1998). In 2002, 
diabetic retinopathy was present in 45% of type 1 diabetes and 25.3% of type 
2 diabetes (Younis et al., 2002). Cormack et al. (2001) has estimated the 
prevalence and incidence of blindness due to diabetic retinopathy in Fife in 
Scotland where the prevalence of blindness was 0.21% of diabetic population 
and the incidence of blindness due to diabetes was 0.064% (SD: 0.024, 95%CI: 
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0.049-0.079). However, Scanlon (2008) argues that these figures reported by 
Cormack and colleagues are lower than European figures due to the voluntary 
nature of the certification and the criteria for registration in the UK, which is at a 
poorer visual acuity level than the World Health Organization (WHO) definition 
of blindness. Grauslund et al. (2009) reported the incidence of proliferative 
retinopathy among type 1 Danish diabetic patients was 42.9%. Two studies 
(Spijkerman et al., 2003; Bek et al., 2009) have found that, if one screens for 
Type 2 diabetes, the prevalence of diabetic retinopathy in screen positive 
patients (7.6% and 6.8%) is much lower than the prevalence in the known 
population of people with diabetes. The relatively small sample (n=195) in the 
first study may indicate false representation, while differences in health care 
systems could explain the low prevalence rate in the second study. However, 
the fact that these patients have a shorter duration of diabetes than those 
presenting symptomatically is the most likely explanation. The Wisconsin 
Epidemiological Study of Diabetic Retinopathy, a population-based incidence 
study that was conducted in an eleven county areas in Wisconsin, reported the 
prevalence of diabetic retinopathy in the United State of America (Klein et al., 
1992). Proliferative diabetic retinopathy (R3) was prevalent in 23% of people 
aged less than 30 years, and 10% in people older than 30 years. Proliferative 
diabetic retinopathy (R3) occurred in 67% in persons with type 1 diabetes for 
35 or more years. However, the Wisconsin epidemiological study of diabetic 
retinopathy reported the cumulative rate of progression of proliferative diabetic 
retinopathy (R3) after twenty five years period to be 83% and the progression 
of to be 42% (Klein et al., 2008). This reduction in the progression of proliferative 
diabetic retinopathy (R3) could be due to the early detection and treatment of 
diabetic retinopathy. One would therefore expect that nearly half of people with 
type 1 diabetes would need laser treatment for proliferative diabetic retinopathy 
during their lifetime. A recent study conducted by Yau et al. (2012) to examine 
the global prevalence of diabetic retinopathy reported that there are 
approximately 93 million people with diabetic retinopathy (34.6% of the overall 
people with diabetes). Of these, 17 million had proliferative diabetic retinopathy 
(6.96%). 
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2.8.4 Prevalence of diabetic retinopathy among South Asians 
Patients from ethnic minorities have significantly higher rates of sight-
threatening diabetic retinopathy than Caucasians. Raymond et al. (2009) 
conducted a cross-sectional study to compare prevalence and risk factors for 
diabetic retinopathy among UK residents of South Asian or White European 
ethnicity. One thousand and thirty five patients with type 2 diabetes were 
included. Of these, 421 (41%) were South Asians and 614 (59%) were white 
Europeans. Sight-threatening diabetic retinopathy was detected in 142 (14%) 
patients with more sight-threatening diabetic retinopathy in the South Asian 
group. Maculopathy was detected in 105 (10%) patients with a significant 
difference between ethnic groups: 55 South Asian patients (13%) versus 60 
(9%) White European patients. Patients of South Asian ethnicity were 
significantly younger at the point of diagnosis of diabetes (mean age at 
diagnosis of diabetes 53 years vs. 58 years) and had shorter duration of 
diabetes (7.6 years vs. 8.8 years). Cardiovascular risk factors also were found 
to be significantly higher in South Asian patients; systolic blood pressure 144 
vs. 137 mmHg, P<0.0001; diastolic blood pressure 84 vs. 74 mmHg, P < 
0.0001; blood glucose level HbA1c 7.9 vs. 7.5%, P< 0.0001; and cholesterol 
level 4.5 vs. 4.2 mmol/l, P< 0.0001 (Raymond et al., 2009). The above figures 
were similar to the prevalence of diabetic retinopathy among the population of 
people with diabetes living in India. A study conducted by Raman and 
colleagues in 2009 found that the prevalence of diabetic retinopathy among 
people with diabetes was 18% (Raman et al., 2009). However, a more recent 
study (Gadkari, 2014) reported the prevalence of diabetic retinopathy in India 
was 21.7%. 
2.8.5 Medical management of diabetic retinopathy 
The medical management of diabetic retinopathy is based on the proven benefit 
of blood pressure control and blood sugar control (UKPDS, 1998; DCCT, 1993). 
The most effective treatment of diabetic retinopathy requires the management 
of diabetes and its risk factors as well as eye treatment to save vision, alongside 
effective communication between a multi-disciplinary team such as an 
ophthalmologist, diabetologist, GP, and diabetic nurse specialist (Al-Hussainy 
et al., 2008). Recently, this is being  facilitated within both the eye clinic and 
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diabetic clinic by having access to retinal images in both sites (Al-Hussainy et 
al., 2008). The Diabetes Control and Complications Trial in type 1 diabetes 
showed that achieving a 2% reduction in HbA1c resulted in a 76% reduction of 
developing diabetic retinopathy. The UKPDS study in type 2 diabetes showed 
a 37% reduction of microvascular complication for a 1% reduction in HbA1c 
level (DCCT, 1993).   
2.9. Risk factors for developing diabetic retinopathy 
A range of risk factors are associated with the development of diabetic 
retinopathy. These factors can be divided into two main categories; modifiable 
and non-modifiable risk factors (Matthews et al., 2004).  
2.10. Non-modifiable risk factors 
There are a number of non-modifiable risk factors associated with the 
development of diabetic retinopathy, such as duration of diabetes (Stratton et 
al., 2000), age of individual (Stratton et al., 2000), type of diabetes (Stratton et 
al., 2000), genetic disposition (Patel et al., 2008), and ethnicity (Raymond et al., 
2009).  
2.10.1 Duration of diabetes 
Duration of diabetes is the most deterministic non-modifiable risk factor in the 
progression of diabetic retinopathy (Raman et al., 2009). Over 80% of people 
with type 1 diabetes will develop some grade of diabetic retinopathy after 10 
years of having diabetes (Klein et al., 2008). Sixty seven per cent of people with 
type 2 diabetes who are treated with oral hypoglycaemic medication will develop 
some sort of diabetic retinopathy after 10 years of having diabetes. Nearly 80% 
of people with type 2 diabetes who are treated with insulin will develop diabetic 
retinopathy after 10 years of having diabetes (NHS, 2012). This has been well 
established in previous research (Klein et al., 1984; Klein et al., 1989; Kohner 
and Sleightholm, 1986; Stratton et al., 2001; Simmons et al., 2007).  
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Klein et al. (1989) investigated 271 patients with type 1 diabetes diagnosed 
before 30 years of age. After 4 years, 160 patients (59%) developed diabetic 
retinopathy. Stratton et al. (2001) reported the risk factors related to the 
incidence and progression of diabetic retinopathy over 6 years from diagnosis 
of Type 2 (non-insulin dependent) diabetes mellitus. One thousand nine 
hundred and nineteen patients were included in the study, of these, 1216 (63 
%) had no retinopathy at diagnosis. After 6 years, 22 % of these had developed 
retinopathy. In the 703 (37 %) patients with retinopathy at diagnosis, 29 % 
worsened by two scale steps or more. Simmons et al. (2007) found that pre-
proliferative diabetic retinopathy (R2) and proliferative diabetic retinopathy (R3) 
were associated with diabetes duration. 
2.10.2 Age 
Age was first reported as a risk factor in the Wisconsin Epidemiology Study of 
Diabetic Retinopathy (Klein et al., 1984; Klein et al., 2008). The study found that 
3.6% patients who had Type 1 diabetes before the age of 30 years were legally 
blind compared with 1.6% of patients with Type 2 diabetes who had diabetes 
after the age of 30 (Klein et al., 1984; Klein et al., 2008). In the United Kingdom 
Prospective Diabetes Study (UKPDS), Stratton et al. (2001) reported that in 
patients with type 2 diabetes, who already had retinopathy, progression was 
associated with older age. 
2.10.3 Genetic Predisposition 
The Diabetic Control and Complication Trial (DCCT, 2008) suggested that the 
severity of diabetic retinopathy is influenced by familial factors and Patel et 
al.(2008) suggest a genetic contribution to disease development. In the Birinci 
et al. (2002) study, the differences in HLA antigen frequencies between people 
with diabetes with proliferative diabetic retinopathy suggest a genetic 
contribution to diabetic retinopathy. Birinci and colleagues argue that the 
inconsistency may be related to increasing homogeneity of retinopathy and 
diminishing power to detect small differences. It may also reflect the uncertain 
and inconsistent effects of HLA-DR3 or DR4 on the development and 
progression of diabetic retinopathy. 
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2.10.4 Ethnicity 
Ethnicity and race were reported in many studies as a risk factor for the 
development of diabetic retinopathy (Fong et al., 2004; Raymond et al., 2009; 
Simmons et al., 2007). Kempen et al. (2004) found that the differences in the 
prevalence of diabetic retinopathy between ethnic groups in the United States 
were larger than the differences among people with diabetes. Raymond et al. 
(2009) found that people with diabetes of South Asian ethnicity were diagnosed 
at a younger age had higher HbA1c, systolic and diastolic blood pressure, and 
total cholesterol and greater prevalence of diabetic retinopathy and 
maculopathy. Simmons et al. (2007) conducted a study to compare the 
prevalence of diabetic retinopathy in European, Maori and Pacific peoples with 
diabetes. In people with Type 2 diabetes, the prevalence of moderate or more 
severe retinopathy was 4.0% in Europeans, 12.9% in Maori and 15.8% in 
Pacific people (P = 0.003). There was no significant ethnic difference in the 
prevalence of retinopathy overall or in that of macular disease.  
2.11. Modifiable risk factors 
Diabetic retinopathy is also associated with a number of modifiable factors 
including hyperglycaemia (UKPDS, 1998), hypertension (Matthews et al., 2004; 
UKPDS, 1998), serum lipid level (Cusick et al., 2003), smoking (Muhlhauser et 
al., 1996), non-adherence to diabetic retinopathy screening (Gray et al., 2009; 
Zoega et al., 2005) and knowledge about diabetes and complications (Boren et 
al., 2007). Although hyperglycaemia is often deemed as the most important 
modifiable risk factor in diabetes mellitus, in relation to the progression of 
diabetic retinopathy (Yau et al, 2012), hypertension and hyperlipidaemia are 
also very common and can have a significant impact on patient’s vision. 
Furthermore, due to time limitations during outpatient consultations, risk factors 
such as hypertension and hyperlipidaemia are often given less attention than 
hyperglycaemia (Nirmalan et al., 2004). These modifiable risk factors are 
presented and critiqued individually below. Non-attendance at diabetic 
screening is also considered as a modifiable risk factor and is discussed in the 
section on diabetic retinopathy screening (see section 2.12.5). 
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2.11.1 Blood glucose 
People with diabetes have higher risk of developing diabetic retinopathy if their 
level of blood glucose is high. Blood glucose levels are measured with the 
HbA1c test. HbA1c is a type of haemoglobin which holds the oxygen substance 
that is found in red blood cells and has glucose attached to it (NHS, 2012). The 
Diabetes Control and Complications Trial (DCCT, 1993) was a randomised 
controlled clinical trial conducted to assess the relationship between glycaemic 
control and the development and progression of early vascular complications in 
people with insulin dependent diabetes mellitus. The DCCT consisted of two 
similar studies: a primary prevention, which tested whether improvement of 
abnormal metabolic status led to prevention of the complications, and a 
secondary intervention study, where people with type 1 diabetes received 
intensive insulin therapy. Intensive treatment is the means to get glucose control 
to as near normal as possible. The primary outcome in the primary prevention 
was the first appearance and subsequent development of background diabetic 
retinopathy. In the secondary intervention study, the primary outcome was the 
development of pre-existent minimal retinopathy. The Diabetes Control and 
Complications Trial (DCCT, 1993) showed in the primary prevention cohort, that 
the intensive therapy reduced the adjustment mean risk for the development of 
retinopathy in insulin dependent diabetes mellitus by 76% (95 CI, 62 to 85%) as 
compared with conventional therapy. In the secondary intervention cohort, 
intensive therapy showed the progression of diabetic retinopathy by 54% (95 
CI, 39-66%) and reduced the development of proliferative or severe non-
proliferative diabetic retinopathy by 47% (95 CI, 14 to 67%). The United 
Kingdom Perspective Diabetes Study (UKPDS, 1998) found that intensive 
blood glucose control either by sulphonylureas or insulin substantially 
decreased the risk of microvascular complications, but not macrovascular 
disease in patients with type 2 diabetes. The Diabetes Control and 
Complications Trial (Zhang et al., 2001) reported the progress (after 9-year 
follow-up) of a study designed to determine whether improved glucose control 
in patients with newly diagnosed non-insulin dependent diabetes mellitus 
(NIDDM) is effective in reducing the incidence of clinical complications. Among 
the 153 patients within target metabolic control (mean HbA1c≤6.87%), 138 
(90%) remained free of retinopathy. On the other hand, among the 166 patients 
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within out of target metabolic control (mean HbA1c ≥9.49%), the complication 
did not develop in 71 (43%) and did develop in 95 (57%).  
The Diabetes Control and Complications Trial confirmed that retinopathy 
develops in nearly 10% of patients with type 1 diabetes within target metabolic 
control, whereas more than 40% of patients with type 1 diabetes remain free of 
retinopathy despite out of target metabolic control. Whilst these findings confirm 
that HbA1c is the most significant risk factor for developing diabetic retinopathy 
that can be modified, the process of modifying HbA1c for people with diabetes, 
supported by Health Care Professionals, is far from straightforward.  
Taking insulin and oral hypoglycaemic agents is the first line of treatment for 
lowering blood glucose. However, many studies reported that people with 
diabetes are generally not compliant with diabetes medication (Bailey, et al., 
2011, Karter, et al., 2010, Karter, et al., 2009). For example, Bailey and 
colleagues (2011) found less than fifty per cent of people with diabetes adhere 
to the prescribed diabetes medications (Bailey at al., 2011). Adherence to 
prescribed medication is generally regarded as the proportion of patients taking 
at least 80% of their prescribed medication (Caro et al., 2004). A systematic 
review of adherence with oral hypoglycaemic medication reported that only 
between 61% and 85% of diabetes medications prescribed, are taken, whereas 
25.5% level of non-adherence to insulin as people with diabetes never obtained 
a refill (Cramer, 2004). Adverse reactions and side effects can also lead to non-
adherence. For example, some of the current treatments for diabetes are 
associated with weight gain and hypoglycaemia (Yurgin et al., 2008; Donnelly 
et al., 2008). The evidence suggests that resistance to diabetes medication is 
linked to many factors including the number of oral hypoglycaemic medications 
(Thayer et al., 2010), the combination of insulin and oral hypoglycaemic 
medication (Yurgin et al., 2008), age and perception of glycaemic control 
(Donnelly et al., 2008), duration of the disease (Garcia-Perez, et al., 2013), side 
effects (Curtis et al., 2009; Dilla et al., 2008; Donnelly et al., 2009), knowledge 
(Boren et al., 2007), psychological burden (Garcia-Perez, et al., 2013), 
complexity of dosing regimen (Garcia-Perez, et al., 2013), and 
interactions/relationships with Health Care Providers (Ciechanowski et al., 
2001). It is clear from this evidence that controlling glycaemia with medication 
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is not straightforward. Diabetes self-management education and psychological 
intervention both aim to reduce blood glucose and yet systematic reviews of 
both show only marginal gains in HbA1c (Royle et al., 2009; Allam et al 2009; 
Ismail, Winkley, Rabe-Hesketh, 2004; Sturt et al., 2015). The evidence for 
interventions to consistently modify (lower) blood glucose levels over the 
periods of time required to reduce diabetic retinopathy progression is low. 
Whilst individual’s may wish to engage with the life style modifications 
necessary for the management of diabetes, the evidence suggests that it is 
often difficult to achieve these changes, particularly for those who live with a 
partner with high expressed emotion, or that people have periods of relapse 
(Lister et al., 2016). Therefore, it is important that the individual is supported 
during relapse and supported to understand that occasional outside of target 
diabetes control is inevitable with this complex metabolic condition and does 
not indicate permanent failure. Macaden and Clarke (2006) suggest that 
individuals can be supported to cope with relapses through a number of 
strategies such as providing relevant information, access to guidance when 
needed, and modifying health related behaviours through social support. 
According to Listers and colleagues (2014), greater consideration should be 
given to using family-based approaches rather than individual based 
approaches for diabetes management.  
2.11.2 Blood Pressure 
High Blood Pressure is damaging to each aspect of diabetic retinopathy and a 
tight blood pressure control policy of achieving blood pressure of less than 140 
mm Hg systolic and less than 90 mm Hg diastolic (NICE, 2009), using the 
angiotensin converting enzyme inhibitor captopril, 25 mg twice daily increasing 
to 50 mg twice daily (NICE, 2009), has been found to reduce the risk of clinical 
complications from diabetic eye disease (UKPDS, 1998). Control of blood 
pressure can minimise the risk of new onset diabetic retinopathy and can slow 
the progression of the existing diabetic retinopathy (Chase et al., 1990). A study 
carried out by Matthews et al. (2004) sought to establish the relationship 
between blood pressure control and the different aspects of diabetic retinopathy 
in patients with type 2 diabetes mellitus. The study found that there was a highly 
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significant difference in microaneurysm count, with 23.3% in the tight blood 
pressure control group and 33.5% in the less tight blood pressure control group 
(relative risk [RR], 0.70; P=.003). Hard exudates, largely made up of 
extracellular lipid which has leaked from abnormal retinal capillaries, increased 
from a prevalence of 11.2% to 18.3% at 7.5 years after randomization with fewer 
lesions found in the tight blood pressure control group (RR, 0.53; P˂.001). 
Cotton-wool spots increased in both groups, but less so in the tight blood 
pressure control group which had fewer cotton-wool spots at 7.5 years (RR, 
0.53; P˂.001). The study also found that patients allocated to tight blood 
pressure control were less likely to undergo photocoagulation (RR, 0.65; 
P=.03). The cumulative incidence of the end point of blindness (Snellen visual 
acuity, ≥6/60) in one eye was 18/758 for the tight blood pressure control group 
compared with 12/390 for less tight blood pressure control group. Chase et al. 
(1990) found that the existence of high normal blood pressure resulted in a 
prospectively higher occurrence of retinopathy and of progression of pre-
existing retinopathy. A randomised controlled trial (UKPDS, 1998) conducted to 
determine whether tight control of blood pressure prevents macrovascular and 
microvascular complications in people with type 2 diabetes found that tight 
blood pressure control achieves a significant reduction in the risk of death 
related to diabetes, complications related to diabetes, progression of diabetic 
retinopathy, and deterioration in visual acuity. The study included 1148 
hypertensive people with type 2 diabetes. Of these, 758 individuals were 
allocated to achievement of tight control of blood pressure using medication and 
390 individuals were allocated to less tight control with a median follow up of 
8.4 years. Mean blood pressure in the tight blood pressure control was 144/82 
mg Hg compared with the group assigned less tight blood pressure 154/87 mm 
Hg. After nine years of follow-up the group assigned tight blood pressure control 
had a 47% reduction in risk of diabetic retinopathy.  
Prevention of diabetes-related complications commonly includes medications 
for the control of blood pressure (Garcia-Perez, 2013). As mentioned in the 
previous section, adherence to blood pressure treatment also remain low. 
Analysis of data from previous study (Bramley et al., 2006) which included 840 
individuals reported that 629 individuals (75%) had high adherence to blood 
pressure monotherapy and these individuals were 45% more likely to attain 
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blood pressure control than those who were less compliant. Type 2 diabetes is 
a progressive condition (Garcia-Perez, 2013) which means that once diabetes 
is diagnosed people will have to take medication for life and the complexity of 
the medication regimen is likely to increase over time. For instance, a lot of 
people with diabetes may require not only oral hypoglycaemic agents, but also 
insulin and medication to lower their blood pressure and lipids level (NICE, 
2009). This complex treatment for diabetes and related complications can 
involve up to ten different tablets every day (Gaede, et al, 2003), and it is this 
complexity of treatment that may lead to non-adherence (Mateo et al., 2006).  
2.11.3 Lipid Levels 
Data from the Early Treatment Diabetic Retinopathy Study show that high levels 
of serum lipid are associated with an increased risk of retinal hard exudate in 
people with diabetic retinopathy. The data suggest that lipid lowering may also 
decrease the risk of hard exudate formation and associated vision loss in 
patients with diabetic retinopathy (Chew et al., 1996). Cusick et al. (2003) 
conducted a study to describe a regression of retinal hard exudates in 2 patients 
with diabetic maculopathy. Both patients showed a dramatic regression of 
retinal hard exudates after correction of dyslipidaemia. Recent Indian data also 
showed significant correlation between high levels of serum lipids and severity 
of diabetic retinopathy (Agroviya et al., 2013). However, patients’ adherence to 
statin therapy to control lipids is also reported to be poor (Donnelly et al., 2008). 
2.11.4 Smoking 
Smoking may be a risk factor in the progression of diabetic retinopathy in type 
1 diabetes. Muhlhauser et al. (1996) conducted a study to analyse the 
association between cigarette smoking and progression of retinopathy and 
nephropathy, respectively. Six hundred and thirty six people with Type 1 
diabetes were included: 81% of the original cohort of consecutively referred 
patients, aged 15 to 40 years, and free of severe late diabetic complications. All 
patients had participated in a 5-day in-patient group treatment and teaching 
programme for intensification of insulin therapy. Patients were examined at 
recruitment and reviewed after 1, 2, 3 and 6 years including assessment of 
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smoking status, blood pressure, metabolic control, and degree of nephropathy. 
The degree of diabetic retinopathy was assessed by ophthalmoscopy or fundus 
photography at baseline and after 6 years. Although significant associations 
between smoking and retinopathy were found, the relations were variable 
depending on the statistical model used. The results suggest that the factual 
associations between smoking and retinopathy are complex and that more 
research is needed. Karamanos et al. (2000) found that smoking is associated 
with early development of, and late protection from, microvascular 
complications in people with Type I diabetes. In contrast, the UKPDS suggested 
that smoking may be protective for diabetic retinopathy although mortality risks 
are higher (Adler et al., 2002).  
In the UK, the government has funded country-wide programmes and specialist 
clinics that provide help to smokers and most of these services have been found 
to be effective (McAlpine et al., 2015). A systematic review conducted by Stead 
and Lancaster (2016) assessed the effect of combining behavioural support and 
medication to help smoking cessation. The authors reported that interventions 
that combine medications and behavioural support enhance smoking cessation 
achievement compared to a minimal intervention or usual care. Another recent 
systematic review was carried out by Ussher, Taylor, and Faulkner (2014) to 
determine the effect of exercise-based intervention on smoking cessation. The 
authors reported significant benefits for a combined exercise and smoking 
cessation programme compared with brief smoking cessation advice. Han et 
al., (2014) reported a significant improvement in smoking behaviours at one 
month post brief physician counselling sessions. However, the effect was not 
sustained at three month post intervention. Whilst there is strong evidence for 
the effectiveness of intervention for smoking cessation, the behavioural 
requirements to initiate and complete treatment are significant and remain a 
barrier to the modification of smoking in relation to improving vision retention in 
diabetes. 
2.11.5 Knowledge about diabetes and complications 
People’s knowledge about their diabetes and its complications is an important 
part of managing diabetes and avoiding complications (Boren et al., 2007). A 
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number of previous studies (Iqbal et al., 2008; Bowyer et al., 2011; Pace et al., 
2006) have reported a lack of knowledge regarding diabetes. For example, 
Pace et al. (2006) conducted a study of 84 participants in Brazil to assess 
patients' knowledge of diabetes mellitus, and its causes, and complications. 
Only 28% gave correct answers as to “what is diabetes?” and “what are its 
causes?” The authors pointed to aspects that made the learning process more 
difficult, including little knowledge about diabetes, its causes, and symptoms. 
For example, only 8.6% knew the correct answer about the normal blood 
glucose level and just 28% gave the correct answer about the causes of 
diabetes. In the study by Pace and colleagues (2006) 59% of participants had 
not finished their basic education and 74% were retired or defined as 
housewives. Iqbal et al. (2008) conducted a quantitative study of 111 
participants using a questionnaire to examine the impact of improving patient’s 
understanding of HbA1c values and the relevance to their self-care 
management. Of these, 60% were found to be unfamiliar with the term HbA1c 
and people’s knowledge was poor among those who had poor glycaemic 
control.  
Although previous studies suggest that people with diabetes can improve their 
knowledge by attending diabetes education programmes (Hansen and 
Drivsholm, 2002; Iqbal et al., 2008; Sturt et al., 2008), Ockleford et al. (2008) 
argue that education programmes are unlikely to suit all people with diabetes. 
However, they also reported that education programmes can be improved by 
taking the preferences of people with diabetes into account (Ockleford et al., 
2008). Sturt et al. (2008) conducted a study to determine the effect of the 
Diabetes Manual on glycaemic control, diabetes related distress, and 
confidence of self-care management of patients with type 2 diabetes. The 
Diabetes Manual is a one-to-one structured education tool designed for delivery 
by a practice nurse. The study found no significant difference in HbA1c 
measures (difference -0.08%, 95% Confidence Intervals (CI) -0.28. 0.11). 
However, there was slightly lower scores in terms of diabetes-related distress 
(difference -4.5; 95% CI -8.1, -1.0) and higher score of confidence to self-care 
management (11.2 points higher; 95% CI 4.4, 18.0). Reporting on qualitative 
findings, Lindenmeyer et al. (2010) sought to explore how people with type 2 
diabetes self-manage their condition in daily life and how they viewed the impact 
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of the Diabetes Manual programme on their self-care management. Although 
the study was unable to identify differences between how the control group and 
intervention group participants talked about their knowledge and habits 
regarding diet, exercise, and medication, the participant’s experiences suggests 
that the Diabetes Manual programme needs close communication to improve 
individual’s confidence for diabetes self-care management. For example, it was 
not possible for the researchers to verify whether all participants from the 
intervention group received phone calls from nurses (Lindenmeyer et al., 2010). 
In addition to lacking knowledge of diabetes, previous studies (Rosal et al., 
2011; O'Sullivan et al., 2009; Duncan et al., 2010; Shrestha et al., 2007) show 
that people with diabetes lacked knowledge about diabetes complications such 
as diabetic retinopathy. A quantitative study in Ireland conducted by O'Sullivan 
et al. (2009) to assess the awareness of diabetes complications among people 
with diabetes found that only 12% of the participants were aware of diabetic 
retinopathy as a complication of diabetes. Less than half of the participants were 
aware that improvements in diet and exercise could potentially cut their 
cardiovascular risk. Duncan et al. (2010) carried out a standardized survey in 
the United States for adult ophthalmology diabetic patients to investigate basic 
knowledge of the “recommended levels ABCs of Diabetes”. The recommended 
levels were as follows: HbA1c less than 7.0%; blood pressure, lower than 
130/80 mm Hg; and LDL-C levels, less than 100 mg/dL. One hundred and sixty 
one participants were included. Of these, only 7 participants (4%) reported that 
they knew the recommendations for all the three items (HbA1c, blood pressure, 
and LDL level). This rate increased to 38 participants (23%) who knew about 2 
of the 3 recommendations. A cross sectional study was conducted in Nepal by 
Shrestha et al. (2007) with the aim to establish the knowledge of diabetic 
retinopathy among people with diabetes. Three hundred and sixteen 
participants were included. The authors reported that 50% of participants were 
not aware of diabetic retinopathy.  
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2.12. Diabetic Eye Screening Programmes 
Only a few countries in Europe undertake systematic screening for retinopathy. 
For example, Scotland, Wales, Northern Ireland, Ireland, and Iceland have 
systematic screening programmes (Scanlon 2011, personal communication, 
29th September). Denmark screens people with diabetes in regions covering the 
whole country whilst Sweden covers a number of regions, but not the whole 
country. There is some screening in relation to certain indigenous communities, 
such as North American Indians in the USA and Aboriginals in parts of Australia. 
Any other systematic screening that is undertaken is only in small areas around 
the world. According to Scanlon (2011) many of the programmes do not have 
good population coverage and hence are not systematic in the sense that they 
are unaware of the number of people with diabetes in their areas. 
2.12.1 The NHS Diabetic Eye Screening Programme (NHS DESP) 
Diabetic retinopathy screening as a procedure has been available in some 
areas of the UK since late 1980s. However, the English National Screening 
Programme for Diabetic Retinopathy (ENSPDR), which brought screening to all 
areas of England, was not established until 2003 (Scanlon, 2008). The National 
Screening Committee (NSC, 2011) defines screening as: 
“Screening is a public health service in which members of a defined 
population, who do not necessarily perceive they are at risk of, or are 
already affected by a disease or its complication, are asked a question or 
offered a test, to identify those individuals who are more likely to be helped 
than harmed by further tests or treatment to reduce the risk of a disease 
or its complications.” (http://www.nsc.nhs.uk) 
Up until 2003, diabetic retinopathy screening had been opportunistic and ad 
hoc, with people being screened when they attend the diabetic or eye clinic or 
by optometrists and GP’s in the community. The NHS diabetic eye screening 
programme aims to cut the risk of sight loss among people with diabetes, by the 
timely identification, efficient communication, and successful treatment, if 
required, of sight-threatening diabetic retinopathy, at the right stage of the 
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diabetic retinopathy process. All people with diabetes are at risk of developing 
diabetic retinopathy, whether the individual is controlling his/her diabetes with 
insulin, tablets, or diet. At the time of the research, the NHS diabetic eye 
screening programme offers annual diabetic retinopathy screening to 2.4 million 
people with diabetes (type 1 and type 2) from the age of 12 years old. In 
England, 84 local programmes screened 1.9 million people with diabetes 
between February 2012 and February 2013 (NHS England, 2013). Figure 2.1 
(Lindenmeyer et al., 2014) shows details of the NHS DESP process. Patients 
are systematically invited to have their retinae digitally photographed at their 
GP surgery, high street optician, or local hospital, depending on which part of 
the country they live. In some areas of the UK, screening is carried out at high-
street optometrists. For the photograph to be taken properly, mydriasis eye 
drops to dilate the pupils are put into patients’ eyes, affecting their ability to drive 
for a short while afterwards. People who do not attend their screening are 
followed up by letter or telephone call, up to three times, by the regional 
screening teams. Additional screening sessions are held to maximize 
attendance, including at weekends in some areas. The photographs are sent to 
a trained and accredited regional NHS retinal grading teams, who perform a two 
or three-stage image grading process. This identifies any changes that could 
indicate sight-threatening diabetic retinopathy that requires monitoring or 
treatment. The grading teams notify any such indicators and communicate it to 
the patient and the medical team. 
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Figure 2.1 Process of diabetic eye screening, source: Lindenmeyer et al., 2014) 
 
2.12.2 Effectiveness and cost-effectiveness of diabetic retinopathy 
screening 
Screening and early treatment of diabetic retinopathy can stop deterioration and 
loss of sight (Bachmann and Nelson, 1998). The effectiveness of systematic 
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screening for diabetic retinopathy, in terms of sight years preserved compared 
with no screening has been considered in a number of studies (Vijan et al., 
2000; Fong et al., 2001; Jones and Edwards, 2010). Bachmann and Nelson 
(1998) used data from previous screening studies and found that retinal 
photography screening was the most effective form of screening. A systematic 
review conducted by Hutchinson et al. (2000) to determine the most effective 
screening and monitoring tests for diabetic retinopathy concluded that the use 
of mydriatic retinal photography with further use of ophthalmoscopy for cases 
where photographs are ungradable were most effective.  
In terms of cost effectiveness, diabetic retinopathy screening has been 
assessed by the UK National Screening Committee and was the subject of a 
report from the Centre for Health Planning and Management at the University 
of Keele (James et al., 2000). This report concluded that diabetic retinopathy 
screening is a cost-effective strategy for the UK compared with opportunistic 
screening. The report also recommended that the establishment of a diabetic 
register that has high population coverage is a key factor in the implementation 
of a successful screening strategy. A study carried out in the United States 
(Moss et al., 1994) reported rates of ten-year incidences of blindness were 1.8% 
in the younger-onset diabetes (diagnosed before age of 30), 4.0% in older-onset 
(diagnosed after age of 30) taking insulin, and 4.8% in older-onset persons not 
taking insulin. Improvements in the incidence of blindness have been found to 
be impressive where organized screening programmes have been introduced. 
The best reduction of blindness was documented in Iceland (Stefansson et al., 
2000; Zoega et al., 2005) where the prevalence of diabetic retinopathy has 
dropped from 2.4% in 1980 to 0.5 in 2005.  
2.12.3 Critiques of screening 
Screening may create a dilemma between patients and their doctor as it is the 
latter who normally seeks out the patient that is deemed to need help and 
support. Therefore, it is important that the NHS DESP can offer some sort of 
effective support and intervention. The main principles of the NHS DESP were 
derived from the public health paper which is proposed by Wilson and Jungner 
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(1968) as general principles of establishment a screening programme. These 
principles are as follows: 
 The condition for screening is required should be an important health problem. 
 There should be an acceptable treatment for the cases identified. 
 Facilities for diagnosis and treatment should be available. 
 There should be a recognized latent or early symptomatic stage. 
 There should be a suitable test or examination. 
 The test should be acceptable to the population. 
 The natural history of the condition should be understood. 
 There should be an agreed policy on whom to treat as patients. 
 The cost of case findings should be economically balanced in relationship to 
expenditure on medical care as a whole. 
 Case-finding should be a continuing process and not a one-time event. 
 
Due to the high prevalence of diabetic retinopathy that is reported by the UK 
prospective Diabetes Study (UKPDS) (39% of diabetic male and 35% of 
diabetic female), it is evident that diabetic retinopathy is a significant public 
health problem and that diabetic retinopathy screening is a good fit with the 
above criteria. However, whilst support screening programmes may have the 
potential to reduce sight-threatening diabetic retinopathy (Younis et al., 2002) 
others criticize screening programme in general as a possible misuse of limited 
resources (Weltermann et al., 2013) and as a cause of unnecessary anxiety 
(Landstra et al., 2013; Tinmouth et al., 2011; Park et al., 2008). Screening 
appears to have certain psychological costs, mainly for those who receive bad 
news or false positive results (Eborall et al., 2007; Hafslund et al., 2011). 
Although the provision of individualized risk information can encourage and 
promote health, the perception of increased personal risk may also cause or 
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increase anxiety levels, particularly if the level of the risk is very high (Roach 
and Marrero, 2005). A positive result can also result in negative feelings and 
depression (Michie et al., 2004). High levels of anxiety have been reported in 
patients participating in screening programmes, including breast cancer 
screening, cervical screening (Marteau et al., 2001b), and anal cancer 
screening (Tinmouth et al., 2011). A study carried out by Marteau et al. (2001b) 
shows that patients who were falsely diagnosed on routine screening, continued 
to be overwhelmed by questions and uncertainties about their health although 
they knew that the results of subsequent testing were negative. This also 
resulted in people being more likely to attended future screening (Michie et al., 
2004). In addition to the unnecessary stress and anxiety there is also risk when 
communicating information either when risk messages are misunderstood 
(Marteau et al., 2001b) or when false-negative results are communicated 
(Petticrew et al., 2001). Other disadvantages to the diabetic retinopathy 
screening programme as highlighted by Taylor (2007) includes: 1) Poor at 
detecting macular oedema by using photographic screening; 2) Less flexible 
due to constraints of centralized recall system as patients with diabetes are not 
able to be screened if not registered on the database or not referred by their 
general practitioner to diabetic retinopathy screening services; 3) The 
complexity associated with managing large numbers of screening locations in 
an optometrist based scheme; 4) Large number of graders makes quality 
assurance difficult and; 5) Screening is relatively expensive for Primary Care 
Trust to use an optometric model, a diabetic retinopathy screening that carried 
out by optometrists, using slit-lamb biomicroscopy. In addition, Taylor (2007) 
added that poor performance by a screener can cause problems for the 
patients, the screener, and the screening services as missing sight-threatening 
diabetic retinopathy that can lead to loss of visual function or blindness. Also, it 
could lead to legal action and financial loss against the screener and the 
screening services for the damage due to missed sight-threatening diabetic 
retinopathy or anxiety and stress. Furthermore, it could lead to a lack of 
confidence in the service if the problem is exposed to the public. 
There have been reductions in the progression rate of diabetic retinopathy and 
severe visual loss in the past thirty years, probably reflecting improvements in 
diabetes care, screening and early detection of diabetic retinopathy (Klein et al., 
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2008; Wang et al., 2009). Therefore, annual screening may not be required for 
all people with diabetes, which can mean that unnecessary consequences, 
such as anxiety are eliminated. 
2.12.4 How results are communicated 
The standard of the NHS DESP is that results are communicated to all patients 
in writing within 3 weeks after the screening as well as to the Health Care 
Professionals providing their care, such as GPs and Diabetologists (NSC, 
2003). This delay is because the photographs require careful grading, which 
requires time and suitable equipment and lighting, and these are normally not 
available in the screening environment. Furthermore, the images should go 
through a process of internal quality assurance involving more than one grader. 
Images can be seen by patients if they wish to view them and general 
information can be provided about the retina and diabetic retinopathy. The 
screeners must take great care when providing such information not to mislead 
the patients about the outcome of the grading process as it may increase their 
anxiety level or diminish trust (UK NSC, 2009). Individuals are also more likely 
to turn the risk information they receive from their Health Care Providers into 
appropriate behavioural change when they understand their health condition 
and have engaged in treatment decisions (Jacob and Serrano-Gil, 2010). 
2.12.5 Non-adherence to diabetic retinopathy screening 
Early detection and early treatment is key for reducing diabetic retinopathy 
blindness and visual impairment (Bachmann and Nelson, 1996). Unfortunately, 
many people in the at risk population do not have regular and timely eye 
examinations to ensure early diagnosis and treatment (Gray et al., 2009). Non-
adherence to diabetic retinopathy screening is not only a waste of resources, 
but it could have a significant effect on a patient’s sight and is a risk factor for 
poor visual outcome (Zoega et al., 2005). Data from the Insulin Dependent 
Diabetes Trust (IDDT) shows that screening rates consistently fall far below 
recommended levels (IDDT, 2009). Twenty eight per cent of people aged 12 
and over did not receive eye screening between October 2007 and September 
2008, and 13 of the total of 152 Primary Care Trusts failed to screen half of their 
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diabetic population (IDDT, 2009). Almost 66% of service providers were failing 
to meet the government’s 2003 target of screening 80% of the diabetic 
population (IDDT, 2009). The great variation in the provision of diabetic 
retinopathy screening services throughout the UK is believed to be due to the 
variation in screening methods and population coverage and organized 
systematic screening in some units (Grimshaw et al., 1999). Many studies have 
been conducted in the past decade that are designed to improve uptake to 
diabetic screening programmes. A systematic review was conducted by Zhang 
and colleagues in 2007 to assess the effectiveness of interventions intended to 
increase retinal screening among people with diabetes. The review found a 
range of interventions focused on one of the following: people with diabetes, 
Health Care Providers, and health care system infrastructure and processes. 
Zhang et al. (2007) suggested that increasing patients’ awareness of diabetic 
retinopathy can significantly improve diabetic retinopathy screening attendance, 
particularly among diverse and disadvantaged population.  
A recent qualitative study aimed to identify factors contributing to high or low 
patient uptake of diabetic retinopathy screening (Lindenmeyer et al., 2014). A 
purposive sample of nine GP practices in three regional screening programme 
areas were recruited. Practices were sampled to achieve a variety of 
backgrounds according to location, level of deprivation that was identified from 
Index of Multiple Deprivation data (IMD), and screening uptake level from the 
Diabetes Eye Screening Programme. A range of professionals and people with 
diabetes were interviewed in each GP practice, to ensure a broad spectrum of 
views and experiences. Semi-structured interviews were conducted, in a place 
of participants’ choice, to gather information about the diabetic retinopathy 
screening from the perspective of people with diabetes and their Health Care 
Professionals. Lindenmeyer and Colleagues used a comparative case study 
design to identify factors leading to high or low screening uptake. The study 
highlighted many modifiable factors, related to service and staff interactions. 
These include communication issues between General Practice and screening 
programme, people with diabetes and Health Care Professional’s perception, 
contacting and motivating patients, diversity and ethnicity, and language. 
Lindenmeyer et al., (2014) found that practice’s uptake was positively linked to 
communication levels between practice staff and screening services. Practices 
53 
 
with higher uptake had identified their patients who did not attend and called 
them to attend again for diabetic eye screening. Practices with lower levels of 
communication between the practice, the screening service and the patient had 
lower levels of screening uptake. The study also highlighted that good 
communication on the day of mobile in-practice screening, resulted to practice 
staff sharing their knowledge of their patients with screening staff. The study 
also reported the importance of contacting people with diabetes to motivate 
them and to encourage them to attend diabetic screening later in the day or 
provide them with alternative dates. The study also reported staff perception of 
non-attenders, as they described them as a “hard core of difficult to engage” (p: 
488) patients, as they would only attend when symptoms appear to start. This 
has led to a sense of frustration among Health Care Professionals, despite the 
hard efforts and time they spent to motivate people with diabetes. 
2.13. Implications of diabetes 
The prevalence of type 2 diabetes has been affected by changes in patterns of 
living, changes in diet and food consumption, level of physical activities, and 
stress (Naemiratch and Manderson, 2008). Once contracted, it is a chronic 
condition that requires changes in people’s daily living, which are constructed 
around symptom management (Macaden and Clarke, 2006). It also represents 
a loss of reliability when part of the body does not function properly. These 
disruptions to people’s daily activities have social, financial, and medical 
implications as well as symbolic meaning for the person affected, including a 
significant impact on their feelings of self-worth (Bury, 1982). Diabetes is a 
particular problem within the South Asian community as they have higher rates 
of diabetes and greater risk of developing complications (Raymond et al. 2009). 
Bellary et al. (2008) conducted cluster randomised study to investigate the 
effectiveness of a culturally sensitive approach to ease risk factors in diabetes 
among a range of South Asian communities. The authors used an enhanced 
care model with extra time from practice nurses/diabetes nurse specialists and 
support link worker to provide culturally sensitive care and compared this with 
standard care. Bellary et al. (2008) found that the culturally tailored care 
produced significant improvements in diastolic blood pressure and main arterial 
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blood pressure. Previous studies conducted by Choudhury et.al. (2009) and 
Greenhalgh et al. (1998) among Bangladeshi community found that most 
participants were lacking in knowledge about the cause, prevention, and 
management of their diabetes. For example, the participants in Choudhury et 
al., study (2009) often defined their diabetes as being acquired during a visit to 
Bangladesh. Other Bangladeshi participants believed that sugar and western 
diet were the cause of diabetes together with increased physical and 
psychological stress (Greenhalgh, 1998). In contrast, some Bangladeshi 
participants appeared to have better knowledge, which was gleaned from their 
experiences of living with diabetes for longer periods. In other words, it 
appeared that their experience of having diabetes for longer duration thus 
having more contact with Health Care Professionals and others may have 
shaped their knowledge and improved their diabetes management. Lawton et 
al. (2007) argued that people with diabetes from South Asian background 
repeatedly refer to external factors when seeking to explain their diabetes. 
Choudhury et al. (2009) reported that many Bangladeshi participants showed 
awareness about the importance of healthy food and exercise together with a 
cultural concept of body weight. They associated small body sizes with poor 
health while medium or large body sizes with good health, which impacts on 
their decisions regarding diabetes (Choudhury et al. 2009). 
Diabetes has also been found to have negative implications for other family 
members. A recent global study conducted across four continents and within 
seventeen countries including the UK (Joensen et al., 2016) sought to explore 
the effect of household composition on the psychological health of adults with 
diabetes by comparing those who living with other adults including a partner 
with those living with neither. The study surveyed one hundred and twenty two 
family members, five hundred people with diabetes, and two hundred and eighty 
one Health Care Professionals such as nurses, dieticians, general practitioners 
and specialists. The UK results show that fifty four per cent of family members 
were anxious about the likelihood that a family member would develop severe 
complications related to their diabetes. This study also found that twenty five 
per cent of family members reported a negative financial impact on them 
because of their loved ones diabetes. Furthermore, the study also reported that 
seventy nine percent of family members had not attended an educational 
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programme about diabetes and so lacked knowledge regarding the condition. 
Whilst Health Care Professionals provided a lot of information about diabetes 
management through healthy diet and healthy lifestyles, the study found that 
this information was not be absorbed and understood by people with diabetes 
or those around them (Choudhury et al 2009). Thus, in the light of such 
evidence, Joensen et.al (2016) argue that whilst Health Care Professionals 
must prioritise the needs of people with diabetes they also need to understand 
the concerns of those close to them such as their family members and friends, 
particularly as they are often left worried and uncertain about the implication of 
diabetes.  
Taking the incidence, prevalence, and diabetes related complications into 
account, a number of organisations including the Department of Health, 
Diabetes UK, the British Heart Foundation, and the South Asian Health 
Foundation have identified objectives and scheduled strategic plans to tackle 
these challenges (Barnett et al., 2006). These include increasing awareness of 
diabetes and its complications through greater community-based activities; 
providing and promoting more culturally specific risk information for groups at 
higher risk; more partnership with relevant community organisations; and 
funding of community and research projects (Barnett et al., 2006). Barnett and 
colleagues (2006) also highlight the significance to address specific cultural 
structures such as customs, religion, lifestyle, food, and languages. This 
requires a lot of educational interventions to ensure that people with diabetes 
benefit and therefore reduce the risk of diabetes complications.  
2.14. Meanings of diabetes to people with diabetes, 
their family, and professionals 
The ways in which diabetes is constructed by individuals is important to 
consider because it inevitably has different meanings to different people. For 
example, for people with diabetes it can mean a devastating long-term condition 
that imposes disruption causing interruption in social relations and self-identity 
– what is known as ‘biographical disruption’ (Macaden and Clarke, 2006). 
People with diabetes need to make lifestyle changes in order to successfully 
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manage their diabetes. For the family, the daily life of people with diabetes can 
become disrupted. Diabetes also has an emotional impact upon individuals, 
families, and friends, particularly on those with a close relationship to those with 
diabetes. According to Conrad and Baker (2010), some illnesses are embedded 
with cultural meanings — which is not directly derived from the nature of the 
medical condition — that outlines how society reacts to those distressed and 
influences the experience of that illness. People experience an illness not as 
isolated situation, but in the ways it is developed through interactions in a social 
context. Thus, the same condition may hold quite different meanings in different 
times and contexts and for different groups of people (Davey and Seale, 2002). 
For example, eating a diet not appropriate for a condition may make it worse, 
and diet is a factor controlled by society, as certain people eat certain food in a 
certain way of preparing, cooking, and storing. Dietary habits and drinking are 
also influenced by religious beliefs, as well as area of origin (Barnett et al., 
2006). Furthermore, changes in society have led to more inactive lifestyles and 
many occupations necessitating less energy expenditure. These reduced levels 
of physical activity may affect certain populations and ethnicities more than 
others, such as the South Asians groups. For, example, a systematic review 
conducted by Fischbacher, Hunt, and Alexander (2004) included 17 studies to 
assess the level of physical activities among the South Asians population in the 
UK. All the seventeen studies reported lower levels of activities among South 
Asians compared with the general population. This mainly because people of 
South Asian ethnic groups were uncertain what type and level of activity was 
appropriate and safe for them, more difficult to attend gyms, fear of walking in 
public spaces, and lack of appropriate facilities (Fischbacher, Hunt, and 
Alexander, 2004; Sriskantharajah & Kai, 2007). 
In summation, society and culture does not cause diabetes, but may worsen a 
physical illness that already exists. In this sense, the condition and the 
meanings attached to it are, in part, socially constructed and culturally relative, 
and the nature of this construction can profoundly alter the experience of the 
condition for everyone who is affected by it (Davey and Seale, 2002). The next 
section discusses how people may construct their knowledge around diabetes 
through their social interactions. 
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2.15. How knowledge is constructed  
People actively construct their social words and their constructions of selfhood, 
through continuing social interaction with other people (Blumer, 1969). Social 
constructivism refers to the concept that individuals form or construct 
knowledge as they interact with others to share, relate, and dispute their 
interpretations of their social worlds (Applefied et al., 2011). Thus, individuals 
build their knowledge as they participate in a range of social activities (Woolfolk, 
2011) with people developing their own understandings through collaboration 
and interactions with those around them (Applefield, et al., 2011). Personal 
knowledge and development or construction of understanding is therefore 
based upon personal actions and interactions within daily life (Carmichael, 
1990). The ways in which knowledge is created and understood within a social 
constructionist framework is at odds with a more ‘scientific’ or medical model of 
understanding. Within the medical model, for example, diseases are universal 
and invariant to time or place, whereas a more social model of health, the 
meaning and experience of illness is key and is formed by cultural and social 
factors (Conrad and Barker, 2010). Put another way, illness does not simply 
exist in nature, waiting to be discovered by Health Care Professionals. Rather 
knowledge and understanding about illness is key and is constructed when 
individuals interact and interpret their signs and symptoms (Driver et al., 1994). 
Woolfolk (2011) states that the construction of knowledge by individuals is 
based on two main concepts. First, individuals are active in constructing their 
own knowledge through personal experiences. Second, social interactions are 
essential for understanding the construction of knowledge. People with diabetes 
construct their own understanding and knowledge of diabetes through 
experiencing signs and symptoms and reflecting on those experiences. This 
shift in understanding begins to recognise the importance of experience in 
relation to conditions such as diabetes (Macaden and Clarke, 2010) 
2.16. Conclusion 
Diabetes is a global problem affecting over 415 million people worldwide and is 
increasing. The number of people with diabetes in the UK in year 2000 was 1.8 
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million and has risen to 3.5 million in 2015 and expected to rise to 5 million by 
2025. Diabetes mellitus is divided into type 1 diabetes, which accounts for about 
15% of all diabetic population, and type 2 diabetes, which accounts for about 
85% of all people with diabetes. Diabetes can cause problem with major organs 
and systems such as heart, kidneys, nerves, feet, bones, joint disorders, and 
eyes.  
Diabetes is a costly condition for the individuals, their families, and the Health 
Services. Furthermore, diabetes leads to other complaints such as depression, 
pain, anxiety, vision loss, and amputations. Diabetic retinopathy is a 
complication of diabetes mellitus, a potential cause of irreversible vision loss, 
and which can cause a decrease in workplace productivity and a loss of income 
and productivity. There are a number of non-modifiable risk factors associated 
with the development of diabetic retinopathy, such as duration of diabetes, age 
of individual, type of diabetes, genetic disposition, and ethnicity. Diabetic 
retinopathy is also associated with a number of modifiable factors including 
hyperglycaemia, hypertension, serum lipid level, smoking, knowledge about 
diabetes and complications, and non-adherence to diabetic retinopathy 
screening. The NHS diabetic eye screening programme aims to reduce the risk 
of sight loss amongst people with diabetes. It is evident that annual diabetic 
retinopathy screening programmes are effective in terms of screening 
compared with no screening and cost effective at detecting and treating diabetic 
retinopathy. Screening and early treatment of diabetic retinopathy can stop 
considerable disability. The impact of awareness raising of diabetic retinopathy 
and communication between GP practice, the screening service and the person 
with diabetes have been shown to be an important factor related to screening 
uptake. 
Diabetes has also negative implications for other family members. Therefore, 
the ways in which diabetes is constructed by individuals is important to consider 
because it inevitably has different meanings to different people. Some illnesses 
are embedded with cultural meanings, which is not directly consequent from the 
nature of the medical condition. People experience an illness not as isolated 
situation, but in the way it is developed through interactions in a social context. 
People construct their social words and selfhood through continuing social 
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interaction with other people. In the next chapter, the researcher will explore the 
literature regarding risk perception, the risk communication process and how 
people with diabetes understand, interact, make sense of knowledge, and 
respond to risk communication messages.   
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 Literature Review-Risk perception 
and Communication 
3.1. Introduction 
Chapter 2 (section 2.11.5) highlighted that people with diabetes lacked 
knowledge about the risk of diabetes and its complications. Previous studies 
(Boren, 2007; Iqbal et al., 2008; Bowyer et al., 2011; Barnett et al., 2006; 
Lindenmeyer et al, 2014) suggest that this can be improved by good 
communication, patient education about their condition, and through good 
Health Care Professional - Patient interaction. This chapter examines the 
literature regarding perception of risk and risk communication issues among 
people with type 2 diabetes. As with chapter 2, the literature reviewed in this 
chapter is primarily a scientific and medical review embedded within a medical 
context and includes limited work in the field of social sciences. This decision 
was informed by the researcher's clinical background and the pragmatic 
imperative to understand the evidence as it relates to, and impacts upon, clinical 
practice. The chapter explores the factors that influence the exchange of risk 
information about diabetes between Health Care Professionals and their 
patients. This includes perception of risk, risk communication and informed 
decision-making, professional-patient interactions, various risk communication 
formats, numerical knowledge, the effect of visual risk communication tools, 
individual’s limitations, variations in risk interpretation, fear messages, and 
framing bias. The chapter then considers other issues regarding risk 
communication, such as constraints to effective communications and ethical 
issues related to risk communication. 
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3.2. Definitions of risk 
Many terms have been used in relation to communicating risk information to 
people. These include risk, relative risk, residual risk, and absolute risk. The 
word risk was first cited in Oxford English Dictionary (spelled as risque) in 1621 
and was changed to the current spelling as risk in 1655 (Oxford English 
Dictionary). Risk is defined as: “A situation involving exposure to danger.” 
In statistics, the meaning of risk is defined as the expected value of unwanted 
outcome (Lundgren and McMakin, 2009). While risk in a mathematical formula 
is risk = (probability of the accident) x (expected loss). Relative Risk is defined 
as: “The ratio of risk in the exposed and unexposed groups” (Sistrom and 
Garvan, 2004; P: 16). In statistics, relative risk is the ratio of the probability of 
an event occurring or developing a disease in an exposed group to the 
probability of the event occurring in a comparison, non-exposed group. For 
example, a risk of 10 per cent in the control group and a risk of six per cent in 
the intervention group means that the relative risk reduction would be sixty per 
cent. Therefore, one can provide the risk in the control group along with the 
relative risk reduction (e.g. 60% relative risk reduction from a baseline of 10%). 
The absolute risk reduction or risk difference is the difference in risk of a given 
activity or treatment in relation to a control activity or treatment (Sistrom and 
Garvan, 2004). For example, for a risk of ten per cent in the control group and 
a risk of five per cent in the intervention group, the absolute risk reduction would 
be five per cent. 
3.3. Perception of risk 
Risk has become a significant topic in many areas of life including economics, 
medicine, and engineering, and is well studied by social scientists (Macaden 
and Clarke, 2006; French et al., 2013; Schapira et al., 2006). This section 
focuses on the understanding of risk in relation to certain health problems. 
There are many synonyms and meanings to risk such as danger, hazard, and 
threat. Such meanings of risk are generally negative and are associated with 
some kind of threat or loss to the person concerned (Macaden and Clarke, 
2006). The physical outcomes of risk or hazard, such as death or loss of vision 
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are very real. However, perceptions of risk are subjective because they are 
based on people’s attitudes, culture, religion, age, and gender and are 
dependent upon human decisions as well as people’s life experiences 
(Macaden and Clarke, 2006).  
Within the social sciences, the notion of risk is best understood within particular 
social and cultural contexts. For example, Ogden (1995) argues that risk should 
understood as a social construct that is contextualised within the realities of 
people’s lives; i.e. people’s perceptions, interactions, and experiences of risk 
are generated through the ways in which people construct their social world. 
Social constructionism seeks to make sense of the individual in society through 
the meanings individuals assign to phenomena and events via their 
interpretations of their experiences and their interactions with others (Charmaz, 
2006). Therefore, understanding how people construct risk based upon their 
perceptions and experiences can offer a useful means for designing health 
promotion and risk prevention strategies (Adams and Smith, 2001). Given that 
risk is socially constructed based upon interpretation, it then follows that people 
with diabetes and Health Care Professionals may have varied understandings 
and interpretation of diabetes and diabetic retinopathy and the risks related to 
those illnesses. For example, in broader terms, Macaden and Clarke (2006) 
found that Health Care Professionals tend to understand risk mainly in terms of 
probability and occurrence of a related complication, which may also be 
associated with individual’s non-compliance to medical advice. In contrast, 
individuals’ understandings of risk have been associated with personal beliefs, 
past experiences, spirituality, and interactions with family members, friends, and 
other social groups. The evidence also suggests that variations in people’s 
perception and experience of risk as well as their interpretation of risk can lead 
to different reactions (Tate et al., 2003). For example, people have been found 
to underestimate their risk when they associated it with individual behaviour as 
opposed to when risks are associated with external sources (Macaden and 
Clarke, 2006). For example, smoking may be considered by an individual to be 
risky, but individuals can also be as or more worried or anxious about natural 
disasters that they perceive may happen within their environment (Tate et al., 
2003; Shepperd et al., 2002). In terms of Health Care Professionals, Edwards 
et al. (1998b) suggest a standardisation of the language of risk in order to make 
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Health Care Professionals consistent in their perceptions of risk, particularly 
when conveying risk messages to patients. 
Research has also revealed differences in risk perception between men and 
women (Homko et al., 2010). Differences in risk perception have also been 
found in relation to ethnicity and other social divisions. For example, Buster et 
al. (2012) conducted a quantitative study to evaluate skin cancer risk perception 
across race and other demographic factors. Buster and colleagues (2012) 
reported that the black population, the elderly, and people with less education 
perceived themselves as lower risk of developing skin cancer. In terms of 
diabetes, Macaden and Clarke (2006) conducted a qualitative study to report 
perception of risk among older South Asian people in the UK with type 2 
diabetes. Data was collected via focus group interviews with ethnic health 
development workers together with seven individual interviews with Health Care 
Professionals and twenty interviews with participants with type 2 diabetes from 
a South Asian background. The study found that risk perception was influenced 
by a number of issues such as the belief about the cause of diabetes, perceived 
severity of diabetes, food and its social function, religion and beliefs about 
external control, and diabetes management. The study reported that individuals 
were required to make decisions by weighing up different risks. For example, 
participants weighed up the risk when making decisions about dietary 
management where the risk of causing social offence to others had to be taken 
into account together with the risk of less than perfect diabetes management. 
The study only recruited participants of South Asian origin. The author 
conducted more than one interview with each participant in order to cover 
specific issues in detail. Whilst interpreters were involved, the transcripts were 
not reinterpreted or verified by language experts due to financial constraints 
(Macaden and Clarke, 2006).  
3.4. Risk communication and informed decision-
making 
Within clinical environments, counselling patients regarding risk involves the 
presentation of appropriate risk information. For example, the patients’ charter 
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states that patients have a right to be given a clear explanation of the potential 
risks associated with conditions and procedures; i.e. that they are able to make 
informed decisions regarding their health. Marteau et al. (2001a) defines 
informed choice as: 
“One that is based on relevant knowledge, consistent with the decision-
makers’ values and behaviourally implemented” (P: 99). 
The evidence from within primarily medical perspectives suggests that better 
informed patients have been found to make decisions that are deemed to be in 
their best interest, which is usually defined in terms of adherence to treatment 
regimens (Epstein et al., 2004). Conversely, patients who are less well informed 
about the risks associated with certain behaviours and procedures are deemed 
as being more likely to make less appropriate decisions (Epstein et al., 2004). 
Inevitably, when making decisions much depends on a person’s level of 
understanding of the relevant risks presented to them, but also how this 
information corresponds with other beliefs and values they may hold (Michie et 
al., 2005). In order words, whilst people with diabetes have the right to be 
presented with risk information regarding their illness, prognosis, and 
complications this may not correspond with them behaving in ways that are 
deemed to be in their best interests, but in them making decisions they believe 
to be best for them (Sullivan, 2003). Thus, in terms of diabetic screening, 
presenting evidence to patients on the benefits of diabetic eye screening when 
they are defined as low risk may lead people with diabetes to also believe they 
are doing well regarding their diabetes management and for that reason may 
not see the value in attending for annual diabetic eye screening. This in turn 
may lead them to underestimate the importance of controlling their diabetes 
when the evidence suggests that adherence to diabetic eye screening is one 
important factor in the risk of developing sight-threatening diabetic retinopathy.  
The effectiveness of communicating risk information also appears to depend 
not only on people’s understanding and contextualisation of the information 
given to them, but also on the form in which the risk information is presented 
that may influence decision-making processes (Lipkus, 2007; Epstein et al., 
65 
 
2004). For example, factors that can influence the risk communication process 
include understanding and interpretation of numerical information (Schillinger 
et al., 2002; Paasche-Orlow et al., 2005) as well as probabilities and 
percentages (Lipkus, 2007). Other factors include low health literacy and the 
ability to fully engage and be involved in decision-making process about their 
own health (Schillinger et al., 2002; Paasche-Orlow et al., 2005). The evidence 
also demonstrates that Health Care Professionals’ skills and abilities regarding 
the provision of information to also be important (Cokely et al., 2012; Anderson 
and Schulkin, 2014). Furthermore, the risk communication process may also be 
influenced by the amount of information that patients receive form their Health 
Care Providers to provide them with the opportunity to participate in decision-
making around their own health (Heisler et al., 2002; Kinnersley et al., 2008; 
Edwards et al., 2002) as well as the interaction between Health Care 
Professionals and their patients (Epstein et al., 2004). These significant factors 
are discussed in the following sections. 
3.5. Doctor-Patient interaction 
Clearly, interactions between patients and their Health Care Providers are 
central when patients have to make complex decisions about their health care 
(Evans et al., 2004). The interaction between Health Care Providers and their 
patients has been shown to influence the nature of the information that is both 
presented and retained by each of the parties involved  (Evans et al., 2004). 
Therefore, Epstein et al (2004) recommended that Health Care Providers build 
strong relationships with their patients in order to build trust and facilitate the 
transfer of risk information, which also take account of patient’s perspectives. 
According to Epstein et al. (2004) trust building between Health Care Providers 
and patients can be done by the expression of empathy (e.g. “You might feel 
uneasy”); acknowledgment of the complexity or difficulty of the issue and an 
expression of mutual understanding (e.g. “I think I understand…”); increasing 
patient/ family involvement (e.g. “I would like to help you understand...”); and 
promoting and encouraging partnership (e.g. “We need to make this decision 
together”) (Epstein et al., 2004; P:2364). 
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Building trusting relationships between Health Care Professionals and their 
patients also requires good understanding of the patient’s and family members’ 
experience and expectations: 
“Even if the clinician has inquired about the patient’s perspective earlier in 
the visit, it is helpful to delineate the patient’s specific needs, fears, 
expectations, and context specific to this issue. Also, this is the time to 
invite family members to participate when appropriate.” (Epstein et al., 
2004; P: 2363). 
Poor interactions between people with diabetes and their Health Care 
Professionals has also been shown to have a negative impact on the level of 
adherence to oral hypoglycaemic medications, blood glucose monitoring, and 
found to be associated with higher level of HbA1c (Ciechanowski et al., 2001). 
Sinclair et al., (2016) found that patients identified Health Care Professionals’ 
ability to build a relationship with their patients as a core element of doctor-
patient relationships. Most participants stressed the need for Health Care 
Professionals to receive training in the development of interpersonal skills to 
improve communications and patient care. The majority of patients felt that 
understanding the patient as “a fellow human being” (P: 6) was a vital feature 
of patient care. The participants felt that the emphasis within medical education 
on the condition rather than the relationship caused Health Care Professionals 
“to view the patients as a body or disease, rather than a person” (P: 6). Although 
participants recognized that developing biomedical knowledge was important, 
they also pointed out that greater attempt needed to be made in educating 
Health Care Professionals about the holistic needs of their patients, including 
their social, emotional, and spiritual needs. According to Sinclair et al, (2016) 
most participants believed that compassionate care implicated addressing 
people’s medical needs within the larger setting of person, including the 
systematic effect that their illness had on other fields of life. 
However, it is also clear that other factors can influence the nature of the doctor-
patient relationship. For example, the evidence suggests that many South Asian 
people have grown up in a culture with hierarchical relationships based upon 
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class variations in which the physician is often higher placed within the social 
hierarchy (Macaden and Clarke, 2010). In these cases, such patients have often 
been found to listen more to their doctor, which results in more dependent 
behaviour, less independent thinking and higher reliance on others (Macaden 
and Clarke, 2010). Such groups of people tend to perceive Health Care 
Professionals as being in control of their medical condition and so often absolve 
themselves of responsibility for managing their diabetes (Macaden and Clarke, 
2010). In a similar vein, South Asian patients have expectations that their 
physician will be experts in their condition, be able to answer all of their queries, 
and make decisions for them (Kannayiram, 2006; Macaden and Clarke, 2010). 
South Asian patients have also been found to assume more of a passive role 
health care instead of participating in the decision-making process (Macaden 
and Clarke, 2010). Therefore, it appears that many South Asian people prefer 
to be told what to do, and consider the Health Care Professionals as 
incompetent if they did not control and take charge of the medical consultation 
(Kannayiram, 2006). For these reasons, Health Care Professionals are required 
to use different techniques when conveying risk messages to patients as well 
as the amount of information that people with diabetes can understand and 
absorb during a relatively short period of consultation.  
3.6. Amount of risk information required by patients 
during medical consultation 
As mentioned earlier, Health Care Professionals may face challenges when 
providing risk information to people with low numeracy skills or low health 
literacy (Elwyn et al., 2012). In such cases, Health Care Professionals are 
required to use their expertise to provide appropriate levels of information to 
enable their patients to provide informed decisions. However, previous research 
shows that patients frequently do not receive sufficient information from their 
Health Care Professionals to allow them to understand their personal health risk 
and to give them the opportunity to fully participate in the decision-making 
process (Heisler et al., 2002; Kinnersley et al., 2008; Edwards et al., 2002): 
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“Patients often desire more information than currently provided” (Edwards 
et al. 2002; P: 827). 
The amount of information that patients receive from their Health Care Provider 
about their medical condition has also been shown to be critical in shaping the 
level of concordance to medical treatment and treatment outcomes. The 
evidence suggests that most patients understand and remember less than half 
of what they are told during the consultation process (Roter, 2000). Another 
problem that patients may face is that many patients may not  know what 
questions to ask or how to ask questions during consultations (Epstein et al., 
2004). Therefore, Health Care Professionals should anticipate important 
unasked questions and should discuss them with patients. Epstein et al (2004) 
suggest a balanced discussion of uncertainties: 
“Balance is achieved by explaining the limitations of what is known while 
maintaining confidence that this represents the imperfections of medical 
science rather than lack of competence of the practitioner”. (P: 2364). 
Welschen et al. (2012) conducted a randomized control study to investigate the 
effect of a six-step cardio vascular risk communication tool regarding the ten-
year risk of developing cardio vascular disease among people with type 2 
diabetes. The primary outcome measure was the appropriateness of risk 
perception (the difference between the actual cardio vascular disease risk 
calculated by the United Kingdom Perspective Diabetes Study risk engine and 
individuals’ risk perception). The study shows that absolute risk perception 
improved after two weeks of risk communication. However, the effect of risk 
communication disappeared after twelve weeks as patients were not able to 
recall their risk after a few months. Therefore, Welschen et al. (2012) suggested 
that patients should be reminded with the risk information at all patient 
interactions as single risk communications may not be sufficient and should be 
seen as the initial step in a range of additional interventions. Heisler et al. (2002) 
conducted a cross-sectional survey of two thousand patients to assess patients’ 
evaluations of their physicians’ decision-making style and to report 
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understanding of diabetes self-care management. The study found that those 
who understood more had better diabetes self-care management. According to 
Heisler et al. (2002), the cross-sectional design of the study was a limitation and 
that more longitudinal studies are needed to establish the causal relations 
between decision-making and outcomes. The second issue is that all measures 
in the study were self-reported by people with diabetes.  
In addition to the amount of information that patients require in order to make 
informed decisions, the format that Health Care Professionals use to present 
risk information can also influence patients’ understanding of risk. However, 
Health Care Professionals may adopt a particular form of risk communication 
by using simple words or changing the order of the risk information that may 
cause framing bias (Edwards et al., 2002; Paling, 2003; Quick and Bates, 2010). 
As such, they may consider a range of risk communication methods in order to 
facilitate the communication of risk information. These methods are covered in 
the following sections.  
3.7. The use of words and numbers to communicate 
the risk 
Health Care Providers may use different methods to present risk information to 
their patient, which includes the use of words or numbers (Brainerd and Reyna, 
2007). However, patients and Health Care Professionals have been found to 
have differing views and preferences regarding the use of words and numbers 
during medical consultations (Kinnersley et al., 2008). For example, patients 
were found to prefer risk expressed as numbers rather than words during 
genetic counselling for breast and ovarian cancer (Hallowell et al., 1997). In 
contrast, doctors have been found to prefer words rather than numbers in their 
communication, on the basis that words were perceived as easier to process 
(Marteau et al., 2000; Paling, 2003). This is despite the fact that using numbers 
in risk communication has been found to raise awareness of individual risk 
among patients; e.g. pregnant women (Marteau et al., 2000). In addition, 
Marteau et al. (2001b) found that the use of an additional verbal probability 
words such as “low risk” improved patients’ understanding from 52% to 70%, 
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which was not found when adding an absolute or relative risk number. In 
addition, Paling (2003) suggests that Health Care Professionals should avoid 
explaining risk by using pure descriptive words such as “low risk” or “high risk”. 
He preferred the use of estimated numbers and the use of standardized 
descriptive words to minimize any miscommunication. Research has also 
shown that when medical materials are written in plain language this increases 
people’s understanding of the materials (Clement et al., 2009).  
When numbers are used, Paling (2003) found that using a consistent 
denominator minimized the chances of the misinterpretation of probability. For 
example, it is suggested that Health Care Professionals use “two out of ten” and 
“one out of ten” instead of “one in five” and “one in ten”. This is because patients 
were sometimes confused by which is the higher risk as they may interpret “one 
in one hundred” as a greater risk than “one in fifty” (Grimes and Snively, 1999). 
However, the main problem with numbers is that there may be a  lack of 
mathematical knowledge, both among patients and Health Care Professionals 
(Gigerenzer and Edwards, 2003). 
3.8. Numerical knowledge 
The use of numerical information in relation to health is very common  when risk 
information is communicated to patients (Reyna et al., 2009). Two recent 
developments in health care have exacerbated the use of numerical 
information. First, medical decision-making has changed from being led by 
primarily Health Providers to a shared or patient centred model of decision-
making (Apter et al., 2008). This shift has increased the emphasis on people to 
understand health related information, so they can make informed choices 
about their care. Second, there has been an increased use of research results 
to inform evidence-based practice (Nelson et al., 2008). Thus, people are 
increasingly exposed to research findings in relation to health as Health Care 
Professionals are expected to communicate these findings to their patients, 
frequently using numerical information (Brainerd and Reyna, 2007). Many 
statistical formats have been used to present risk communication and risk 
reduction (Gigerenzer and Edwards, 2003). These formats consist of 
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frequencies (one in ten or five in a thousand) and percentages (ten per cent or 
twenty per cent). A study conducted by Gigerenzer and Edwards (2003) found 
that there is a lack of statistical understanding among both Health Care 
Professionals and patients. Therefore, people are required to have fundamental 
numerical skills  to  enable them to make informed decisions (Reyna et al., 
2009). 
A study conducted by Hoffrage and Gigerenzer (1998) sought to examine 
whether doctors’ diagnostic inferences can be improved by communicating 
information using natural frequencies instead of probabilities. A natural 
frequency is the joint frequency of two or more events such as 1) the frequency 
by which a disease occurs 2) the frequency by which a false positive occurs 
and 3) the frequency with which a false positive occurs in diagnosing a disease. 
In contrast to using probabilities communicated in percentages to calculate 
disease prevalence and true/false positives, natural frequencies take 1000 
women and say 10 of these women have will breast cancer, of these 10 women 
9 will test positive in mammography. Of the 990 with no breast cancer, 89 will 
nevertheless test positive to breast cancer in mammography screening. 
Hoffrage and Gigerenzer's (1998) study involved forty eight doctors with an 
average of 14 years’ experience. The doctors were given the following 
information; the prevalence of cancer was 0.3, the sensitivity of the test was 
50% and the false positive rate was 3.0%. The doctors were then asked to 
assess the probability of whether a person who tested positive for cancer did in 
fact have cancer. Only 10% of the doctors were able to provide accurate 
responses when information about cancer was communicated in probabilities. 
However, 46% of the same group of doctors were able to provide accurate 
responses when the information was communicated in natural frequencies. 
These results suggest that natural frequencies, can serve as an effective tool in 
risk communication by increasing the likelihood that people will understand the 
risks (Gigerenzer and Edwards 2003; Gigerenzer 2011). 
Akl et al. (2011) conducted a systematic review to assess the use of different 
statistical presentations of risk and risk reduction in relation to understanding, 
perception, persuasiveness and behaviours amongst patients, Health Care 
Professionals, and policy makers. The review examined 35 studies and 
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reported 83 comparisons. The main results were that patients and Health Care 
Professionals understood natural frequencies better than percentages in the 
context of screening tests. The interventions were perceived by patients to be 
more effective and more persuasive to accept the interventions when exposed 
to Relative Risk Reduction compared to Absolute Risk Reduction and Number 
Needed to Treat. Relative Risk Reduction suggested better understanding than 
Number Needed to Treat. However, Akl et al. (2011) were unsure whether 
presenting relative risk reduction is likely to help patients make decisions 
consistent with their values as the studies reviewed did not evaluate actual 
behaviour in relation to risk communication message regarding patient’s real 
life. In addition to the lack of mathematical skills, studies reported massive 
variation in risk interpretation as well as interpretation of statistical and 
mathematical information (Epstein et al., 2004; Gigerenzer and Edwards, 
2003). The next section considers variation in risk and numbers interpretation. 
3.9. Variation in interpretation 
This chapter has highlighted that interactions between Health Care Providers 
and people with diabetes influence the process of risk communication (Epstein 
et al., 2004). As mentioned earlier, Health Care Professionals and people with 
diabetes may have different preferences in terms of their preferred risk 
communication format. Other issues can also affect and influence the exchange 
of information, such as variations in the interpretation of risk information or 
mathematical information between Health Care Professionals and patients, who 
themselves are not a homogeneous group (Epstein et al., 2004; Gigerenzer and 
Edwards, 2003). For example, Epstein et al. (2004) reported that Health Care 
Professionals did not process probability information in the same way as it was 
processed by patients. It was also found that both patients and Health Care 
Professionals interpreted numbers differently (Epstein et al., 2004; Gigerenzer 
and Edwards, 2003). It has also been found that people with low health literacy 
were unable to fully engage and be involved in decision-making about their own 
health (Schillinger et al., 2002; Paasche-Orlow et al., 2005). Health literacy is 
defined by Roach and Marrero (2005) as: “The degree to which individuals have 
the capacity to obtain, process, and understand basic health information 
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needed to make appropriate health decisions.” This sort of misunderstanding 
was more likely to happen when the patient and the Health Care Providers were 
not of the same ethnic group (Fiscella et al., 2000; Balsa and McGuire, 2003).  
A potential problem of communicating risk information by using probability 
words is the high level of variability in interpretation. For example, Health Care 
Professionals may use terms such as “likely” to represent sixty per cent risk 
while patients may interpret “likely” as eighty per cent (Lipkus, 2007). There 
were also other problems among patients regarding the interpretation of 
numbers. For example, patients believed that a death rate of 1286 in 10,000 
was a greater risk than a death rate of 24.14 in 100 (Yamagishi, 1997). 
Furthermore, such misinterpretation was not exclusively related to the use of 
percentages but also to probability words and numbers. Different groups of 
people have been associated with different meanings when probabilities were 
used (Lipkus, 2007). For example, some people understood “likely” as 
representing a chance of “one in five” while other people  interpreted ‘likely’ as 
representing a chance of “one in two” (Lipkus, 2007). 
In addition, the magnitude of risk, which is the approximate measure of the size, 
severity, or quantity of the risk, may differ between patients and their Health 
Care Professionals. The evidence suggests that Health Care Professionals and 
patients approach risks from different viewpoints and even when the two groups 
agree on the magnitude of the risk, patients may still resist risk management 
due to personal values, beliefs, and experiences. This is the case even when 
Health Care Professionals provide more technical information about the risk 
(Lundgren and McMakin, 2009). 
3.10. Individual’s understanding  
Risk information may be interpreted differently by people with diabetes due to 
differences in age, gender, ethnicity and so forth (Schillinger et al., 2002; 
Paasche-Orlow et al., 2005). Studies show, for example, that patients with lower 
levels of health literacy were less likely to be fully involved in decision-making 
about their own health (Schillinger et al., 2002; Paasche-Orlow et al., 2005). 
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Furthermore, they were more likely not to adhere to prescribed treatment and 
more likely to have poor diabetic control compared with patients with higher 
levels of health literacy (Schillinger et al., 2002; Paasche-Orlow et al., 2005).  
Even when information is given, not all patients may interpret such information 
in the same way because of other factors that impact on these decision-making 
processes, which can be linked to past experiences, perceived levels of 
complexity and urgency together with patients’ tacit and explicit knowledge in 
relation to the topic (Gigerenzer and Edwards, 2003). These interpretations 
apply not only in terms of literacy but also in terms of numeracy, which is also 
related to individuals’ ability to process complex information. These kinds of 
issues affect risk communication efforts and can be a significant challenge to 
Health Care Professionals. Alongside this, there are patients whose cultural 
traditions make it more likely that they lack experience in relation to autonomous 
decisions and so tend to base their decisions on the views of their Health Care 
Professionals (Elwyn et al., 2012). Health Care Professionals, therefore, 
increasingly acknowledge that patients base their interpretations of the 
information provided on a wide range of factors and it is this variation within 
patient interpretation that results in Health Care Professionals not supporting 
the principle of having a standard risk message (Edwards et al., 1998a). 
For example, Edwards et al. (1998a) conducted a qualitative study using six 
semi-structured focus groups to explore current practice regarding the 
communication about risk. Thirty six Primary Care Professionals were recruited 
including general practitioners, practice nurses, district nurses, community 
psychiatric nurses, and health visitors. The sample structure was designed to 
enable a comparison to be made between professionals and to ascertain 
whether there were any differences in their attitudes to risk communication. 
Edwards et al. (1998a) found that although Health Care Professionals 
supported the idea of using standardized communication techniques, because 
they felt it had benefits in making professionals consistent, they did not support 
the idea of standardizing the language of communication because of 
discrepancy in the interpretation of risk data by patients.  
75 
 
It is also important to note that the ways in which individuals interpret the 
information provided is also related to the ways in which Health Care 
Professionals adequately explain health information and not simply the ways in 
which patients interpret or understand such information. A number of studies 
have examined the ways in which variances in the ways in which numeracy is 
used by physicians can impact on this process. For instance, Cokely et al., 
(2012) reported that many physicians did not understand relevant numerical 
information, which decreases their ability to accurately interpret and inform their 
patients about their risk. A systematic review conducted by Anderson and 
Schulkin (2014) shows that 53-75% of physicians’ samples are not able to 
appropriately answer questions about basic probabilities, which limited their 
ability to convert probabilities into frequencies and percentages for their 
patients. In addition, a randomised control trial conducted by Garcia-Retamero 
and colleagues assessed numeracy and risk literacy in a diverse group of 
practicing surgeons, to investigate whether using transparent visual aids 
improved surgeons’ risk comprehension and to investigate changes in 
surgeons’ risk comprehension process. Surgeons were asked to complete a 
two-part computer-based questionnaire. In the first part, they provided 
demographic information. They also completed the Berlin Numeracy Test, a 
validated, psychometric research instrument designed to measure numeracy 
and predict risk literacy in educated samples from diverse countries. In the 
second part of the questionnaire, surgeons were presented with a scenario 
describing the results of a randomised controlled trial testing side effects of new 
type of anaesthesia in patients who underwent surgery. The task involved 
realistic risk information taken from a published study (Davis, et al., 1989) that 
was selected to be representative of the type of information that practicing 
surgeons would routinely encounter and evaluate in due course of continuing 
medical education and professional development. The results show that 50% 
of the surgeons were classified in the first (lowest) level of numeracy, 20% were 
classified in the second level, 14% were classified in the third level, and 16% 
were classified in the fourth (highest) level of numeracy. Despite the fact that 
surgeons from developed countries had higher levels of numeracy, compared 
with surgeons from developing countries, the results showed that 37% of 
surgeons from developed countries had limited numerical skills. Surgeons with 
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limited numeracy skills were unable to correctly interpret the risk without 
additional help. However, visual tools made risks more clearer and eliminated 
differences in understanding between surgeons who had high levels on 
numeracy and those with low levels of numeracy. Therefore, risk tools can be 
an effective tool in improving risk understanding among Health Care 
Professionals with mixed numeracy abilities. 
3.11. Visual risk communication tools 
It is important for Health Care Professionals to design and use different methods 
that facilitate patients’ understanding of risk. Roach and Marrero (2005) suggest 
the use of simple pictures and broadly familiar images to help patients 
understand the disease process and to make it easier for them to absorb their 
degree of risk: 
“For example, a plumbing pipe becoming progressively occluded with rust 
and mineral deposits alongside a diagram of a narrowed blood vessel 
provides a relevant, familiar, and easily understood analogy to describe 
the process that leads to heart attack and stroke” (Roach and Marrero, 
2005; P: 303). 
Such images can strengthen the message about the causes of disease and 
incorporate graphic and symbolic modes of communication to illustrate how the 
patients’ individual characteristics increase their cardiovascular or heart attack 
risk. After providing such important information to patients it is recommended 
that Health Care Professional check patients understanding of the provided risk 
information (Epstein et al., 2004). 
Risk information has also been presented using visual risk communication tools 
(Schapira et al., 2006; Chiu et al., 2009; Schapira et al., 2001; Hawley et al., 
2008). These visual risk communication tools are designed to help convey 
complex risk information and to improve informed decision-making (Fagerlin et 
al., 2011; Edwards et al., 2006b; Chiu et al., 2009). Using a written or visual 
format for discussing risk probabilities was found to be effective and increased 
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the knowledge of Health Care Professionals (Garcia-Retamero et al., 2016) and 
patients and was found to reduce their levels of fear and anxiety (Lee et al., 
2003). Edwards et al. (2002) suggests that the visual presentation of risk 
information is favoured by patients and that the graphical format of information 
boosts the efficiency of risk communication, particularly when visual aids are 
used for probabilities. Visual tools are especially important when 
communicating risk with people who have language barriers or who are not 
familiar with numbers (Edwards et al., 2002). Paling (2003) advocates the use 
of visual aids not only to facilitate the presentation of risk, but also to inform a 
shared “doctor-patient partnership” and increase patient satisfaction. The 
presentation of risk using simple bar charts was found to be favoured by 
patients over the representation of faces or stick figures as a means of 
presenting risk (Paling, 2003). Comparing medical risk with everyday risk was 
also seen as valuable by Edwards et al. (2002); e.g. comparing the risk of stroke 
in atrial fibrillation with the risk associated with road traffic accidents. According 
to Waldron (2007) presenting cardiovascular risk information in percentages or 
frequencies using visual representation was found to be better for achieving risk 
reduction through behaviour change. 
Schapira et al. (2001) conducted a qualitative study using focus groups to 
evaluate the response of women aged 40 to 65 years to various formats used 
for presenting risk information. Participants were randomly recruited from two 
Wisconsin communities. Segmented samples were used to achieve 
homogeneity in relation to age, educational level, and community of residence, 
but they were heterogeneous with respect to race. Each of the focus groups 
met for two hours and were audiotaped and videotaped. Visual aids were used 
to illustrate various graphic formats of risk presentation (Schapira et al, 2001, 
P: 462-463). This study used a graphic of a human figure to demonstrate the 
frequency of numeric format. Figure 3.1 illustrates how highlighted human 
figures were used to present a lifetime risk of breast cancer for a 50 year old 
woman. The lifetime risk of 9% is portrayed in a frequency format with a 
denominator of ten. This tool was presented to explore individual’s perception 
of visual tools. Numeric values (such as 0.9/10 or 9%) were used to tag the 
human figure graphics: 
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Figure 3.1 represents highlighted human figures(Schapira et al., 2001) 
 
A bar graph (Figure 3.2) was also used to demonstrate in a numeric format the 
probability of the lifetime risk of breast cancer for a 50 year old woman. They 
used numeric values such as nine per cent or nine out of ten to mark the bar 
graph.  
 
 
 
 
 
Figure 3.2 represents bar graph format (Schapira et al., 2001) 
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Figure 3.3 represents a vertical bar graph format that was also used to 
communicate comparative lifetime risks for a 50 year old woman including the 
risk of heart disease, osteoporosis, stroke, breast cancer, and endometrial 
cancer: 
 
Figure 3.3 represents vertical bar graph format represents lifetime risks of heart disease, 
osteoporosis, stroke, breast cancer, and endometrial cancer (Schapira et al., 2001) 
 
Figure 3.4 represents a highlighted human figure format that was also used to 
communicate lifetime risk of breast cancer for a 50 year old woman using a 
denominator of 1000 and consecutive highlighting of figures (Schapira et al., 
2001): 
 
Figure 3.4 represents a thousand-consecutive highlighted human figure format (Schapira et 
al., 2001) 
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Figure 3.5 represents the use of human figures to communicate the lifetime risk 
of breast cancer for a 50 year old woman using a denominator of 1000 and 
randomly highlighting of figures: 
 
Figure 3.5 represents a thousand-randomly highlighted human figure formats (Schapira et al., 
2001) 
 
Schapira et al. (2001) performed a content analysis to develop themes from the 
data that informed the findings. Positive characteristics associated with the 
frequency format included simplicity of interpretation and the ability to provide a 
human contextual quality in the graphics. Positive characteristics associated 
with the percentage format included connection with personal risk estimation. 
The study found that human figures were easy to identify with, were clear, and 
provided a meaningful message. The human figures added meaning to the 
numeric information presented because of the illustration of a person, and 
particularly a woman, in the graphics. In contrast, bar graphs were viewed as 
“analytical”, not easy to understand, and as not having such impact. The 
magnitude of risk was viewed to be higher when communicated with human 
figures compared to a bar graph. Graphics with a larger denominator were 
perceived as demonstrating risk of a lower magnitude (Figures 3.1 and 3.4) as 
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more figures were presented without illness (i.e. a thousand figures compared 
to ten figures). However, graphics with a lower denominator had positive 
features associated with “simplicity, directness, and ease of interpretation” 
(Schapira et al., 2001; P: 461). 
A second study conducted by Schapira and colleagues in 2006 examined the 
same graphic formats (Figure 3.1-3.5) used in the first study (Schapira et al., 
2001) in relation to perceptions of risk magnitude and perceived accuracy using 
a vignette of a hypothetical case. Invitation letters were sent to 1,409 
participants, with a response rate of 26% (254 participants responded). A 
written survey was administered face-to-face with a research assistant available 
to answer questions. The survey ascertained socio-demographic factors, breast 
cancer risk factors, numeracy, and perceptions and preferences regarding 
graphic formats. Participants viewed a series of hypothetical risk 
communications regarding the lifetime risk of breast cancer. Identical numeric 
risk information was presented using graphic formats (Figure 3.1-3.5). Risk was 
perceived to be of a lower magnitude when communicated with a bar graph as 
compared with a pictorial display (p < 0.0001). It was also found to be lower with 
consecutively highlighted human figures versus randomly highlighted human 
figures in a pictorial display (p ¼ 0.0001). Data were perceived to be more 
precise when presented as random versus consecutive highlights in a pictorial 
display (p < 0.01). A pictorial display was preferred to a bar graph format for the 
presentation of breast cancer risk estimates alone (p ¼ 0.001). However, when 
considering breast cancer risk in comparison to heart disease, stroke, and 
osteoporosis, bar graphs were preferred to pictorial displays (p < 0.001). 
Other forms of visual risk communication tools used to personalise risk have 
also been found (Chiu et al., 2009; Cates, 2009). For example, Chiu et al. (2009) 
used participatory action research to investigate how the risks and benefits of 
breast and cervical cancer screening programmes are understood by Health 
Care Professionals along with black and minority ethnic groups and low income 
groups. Two hundred and twenty-eight participants evaluated a risk 
communication tool (Figure 3.6) that was designed to present risk information 
for breast and cervical cancer screening programme that personalizes the risk. 
The efficiency of the risk communication tool was tested against the NHS 
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cancer screening programme leaflet “Breast Screening: The Facts”. Chiu et al. 
(2009) reported that the risk tool was found to be more effective than the leaflet 
for passing on knowledge about the main risk factors for breast and cervical 
cancer and cancer screening risks. The risk tool was particularly helpful for 
those participants whose English was not good and who did not gain knowledge 
from the leaflet. 
 
Figure 3.6 represents a breast cancer self-assessment risk tool (Chiu et. al, 2009) 
 
Another visual tool used to communicate risk information has been developed 
in relation to Statin tablets (Cates, 2009) (see Figure 3.7) This tool uses emoji’s 
to demonstrate levels of cardiovascular risk. Thus, 20 patients (red and yellow 
faces) out of 100 patients (green faces) are predicted to have cardiovascular 
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event in the next 10 years. However, if each of the same 100 patients takes a 
statin tablet for the next 10 years, five patients would not have suffered a 
vascular event due to taking a statin tablet (the yellow faces). Eighty patients 
(green faces) would not have had a cardiovascular event, but this group would 
not have had a cardiovascular event even if they had not taken statin tablet. 
Fifteen patients will still have cardiovascular event (red faces) even though they 
had taken statin tablet: 
 
 
Figure 3.7 represents the advantages of taking statin tablet for 10 years, five patients would 
be saved and would not have cardiovascular event (yellow faces) (Cates, 2009) 
 
Hawley et al. (2008) conducted a randomized control study to evaluate the 
ability of graph formats to impart knowledge about treatment risks/benefits to 
people with low and high numeracy. Participants were randomized to receive 
numerical information about risks and benefits of a hypothetical medical 
treatment using one of the six visual formats. All visual formats were perceived 
positively and associated with higher knowledge. The visual formats were more 
effective with those individuals with low numeracy skills. 
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3.12. Effective visual display 
Weinstein and Sandman (1993) have proposed a seven point criteria for use in 
evaluating communications designed to explain the magnitude of a risk. These 
points are: 
1. Comprehension: do patients understand the message of the communication 
content?  
2. Agreement: do patients agree with the interpretations and recommended 
action? 
3. Dose-response consistency: do people who are exposed to a higher level of 
hazard show a higher level of readiness than people who are exposed to a lower 
level of hazard? 
4. Hazard-response consistency: do people perceive a high level of hazard as high 
risk and take extra caution and perceive a low level of hazard as low risk and 
take less precaution? 
5. Uniformity: do patients have the same reaction when exposed to the same risk? 
6. Audience evaluation: do patients evaluate the tool as clear, helpful, and 
effective? 
7. Communication failures: when patients interpret the tool in different way than it 
is intended, is it because these failures are generally of the more acceptable? 
 
These points can be used as a potential guidance to researchers or clinical 
teams in designing a risk communication tool and then may be used as 
evaluation criteria to test the validity and efficiency of the tool in a research study 
or clinical evaluation. 
3.13. Individualized risk information 
The availability of interactive technology presents an opportunity to generate 
individualized risk communications for patients with diabetes, either by video, 
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graphics, animation, or text. The presentation of risk information in these 
formats has been shown to increase involvement in the process of 
understanding when compared with traditional methods (Aspelund et al., 2011). 
It also appears that relevant personal risk data is more valuable to patients than 
providing average population data (Edwards, 2000). Risk can be calculated for 
individuals using data on risk factors such as smoking, age, cholesterol level 
and blood pressure (Wood et al 1999). Many ‘risk calculators’ have been used 
and have been shown to be effective (Hippisley-Cox et al., 2010; Kshirsagar et 
al., 2010; Hippisley-Cox et al., 2009). A risk calculator is an algorithm that has 
been developed by Health Care Professionals and academics and is based on 
regularly collected data from several thousands of GPs (Collins and Altman, 
2010). Risk calculators can be used to work out the risk of having a specific 
condition, such as cardiovascular event or stroke over a given period of time 
such as five or ten years. Most risk calculators have been developed to detect 
and facilitate the risk of cardiovascular disease and diabetes. A study conducted 
by Imms et al. (2010) showed that most general practitioners had used a risk 
calculator and had used it appropriately as a decision-making tool to guide their 
management of cardiovascular disease. Ninety three per cent of the general 
practitioners in Imms study had used a risk calculator to motivate lifestyle 
change and for educational purposes. Sixty six per cent of GPs had used them 
to assist the patient managing their medical condition (Imms et al., 2010). In 
contrast, another study conducted by Holmberg et al. (2011), to assess the use 
of a web-based tool to calculate the five-year risk of developing type 2 diabetes, 
reported that forty per cent of people did not know important values that were 
required to assess their risk such as waist circumference.  
Only one risk calculator has been developed to present risk information about 
diabetic retinopathy (Aspelund et al., 2011). The risk factors for the 
development and progression in diabetic retinopathy are well documented in 
the literature (as mentioned in Chapter 2). These risk factors include age, 
duration of diabetes, type of diabetes, mean blood glucose or HbA1c and blood 
pressure. Based on these risk factors, Aspelund et al. (2011) developed an 
individual risk calculator to provide risk information about diabetic retinopathy. 
This provided information regarding different time periods; twelve months, five 
years, or ten years. The aim of the study was to optimize diabetic screening, 
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while maintaining patient safety, by using information technology and an 
individualized risk assessment to establish screening frequency. This risk 
calculator used a quantitative calculation based on six variables; individual’s 
age, type of diabetes, duration of diabetes, medication, blood pressure, HbA1c, 
and previous diabetic retinopathy screening result. The choice of variables was 
generated by epidemiological data for the prevalence of diabetic retinopathy 
from the Icelandic eye screening database (Kristinsson et al., 1994), and from 
studies on risk factors (Kohner et al., 2001).This makes communicating risk 
information quick and it is easy for patients to understand their risk, which may 
also make screening programmes more efficient.  
The following Table (Table 3.1) shows the differences in diabetic eye screening 
intervals based on risk margin rather than having a standard interval for all 
people with diabetes. For example, Mr. X is 40 years old and has had type 2 
diabetes mellitus for the last 5 years. He has no previous retinopathy (R0), his 
blood pressure is well controlled (120/80 mmHg) and his HbA1c is 7%. He is 
therefore at low risk of developing diabetic retinopathy in the next five years. 
The risk would be medium if blood pressure rose to 150/100 mmHg, with HbA1c 
7%. Mr. X would be high risk of developing diabetic retinopathy within the next 
five years if his with blood pressure was 150/100 mmHg, and his HbA1c 10%.  
Aspelund (2011) did not include smoking as a risk factor because of the effect 
of smoking in terms of lung cancer and cardiovascular diseases, which was felt 
to be more important than the retinopathy risk reduction in terms of morbidity. 
In addition, and due to the nature of the Danish population, ethnicity was not 
included. This may raise questions about the efficacy and accuracy of the 
individualised risk calculator in cities with a diverse population as the prevalence 
rate of diabetes and diabetic retinopathy is higher than in White Europeans 
(Raymond et al., 2009). McGee et al. (2012) argue that the generalisability of 
this risk calculator remains unclear. Furthermore, countries such as Iceland, 
where the risk calculator was developed, have a relatively small population, just 
over 330,000 people (Worldometer, 2017) and a high level of adherence (77%) 
with diabetic eye screening (Zoega et. al, 2005) compared to the England where 
the rate of non-adherence can vary between practices from 5% to 45% 
(Scanlon, 2008). 
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Table 3.1 Diabetic retinopathy risk calculation based on patient individualised risk factors 
Name Ag
e 
Type of 
diabete
s 
Duratio
n of 
diabete
s 
HbA1c Systolic 
blood 
pressur
e 
Diastolic 
blood 
pressur
e 
Previous 
diabetic 
retinopath
y 
Calculated 
risk of 
developin
g STDR 
every year 
Calculated 
risk of 
developing 
STDR in 5 
years 
Level of 
Risk 
Mr. X 40 T2DM 5 years 7% 120 80 No 0.4% 2.2 % Low  
    7% 150 100 No 1.5% 7.7% Medium  
    10% 150 100 No 4.6% 22.2% High  
T2DM: type 2 diabetes mellitus, STDR: sight-threatening diabetic retinopathy, DR: diabetic 
retinopathy 
3.14. Understanding and Agreement 
Regardless of the format used to provide risk information to people with 
diabetes, Health Care Providers need also to ensure that  patients understand 
the provided information (Epstein et al., 2004). Checking patients 
understanding is relatively straightforward and can be used to check whether 
Health Care Professionals continue with their strategy and recommendations. 
For example, it is useful to request that patients summarize what they 
understand, and the reason for that understanding, which may be reflected in 
the level of adherence to Health Care Professionals’ advice. Misunderstanding 
or lack of understanding may also underlie patient’s mistaken belief that their 
diabetes is controlled, and they are doing well and therefore no longer need eye 
screening. Levels of understanding are influenced by many factors including 
whether the Health Care Professional has checked people’s understanding 
during consultation (Campion et al., 2002; Baker et al., 2007), the amount of 
information communicated to people with diabetes (Edwards et al., 2002; Roter, 
2000; Roach and Marrero, 2005), and risk communication formats. Therefore, 
checking patients understanding is an important task during medical 
consultations and a relatively easy way to ensure that people with diabetes have 
understood the information provided (Baker et al., 2007). According to Baker et 
al. (2007), this is a routine aspect of medical consultations. Similar findings are 
also reported by Campion et al. (2002) who found that Health Care 
Professionals do not frequently assess patients’ understanding after medical 
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consultation. Campion et al (2002) carried out an analysis of 2094 videos of 
trainee GPs. This found that only 0.3% of these GPs checked patients’ 
understanding across five consultations and 45% did not check their 
understanding in any consultation. 
3.15. Framing bias 
The previous sections have highlighted that many different factors can influence 
risk communication such as personal factors, doctor-patient interaction, and the 
way that risk information is delivered and interpreted. Edwards et al. (2002) 
highlights a “framing effect” problem where the manipulation of various framing 
factors could affect patients’ decision. Framing means the way that risk 
messages are constructed and communicated to individuals. Framing 
manipulation is an example of bias in which people react to risk information in 
a particular way depending on how it is presented. For example, the use of 
“loss” framing influences screening uptake more than “gain” framing: 
“The potential losses from not having a mammogram” (Edwards, 2002; P: 
324). 
Similar findings were also reported by Yu et al. (2010) who investigated the 
combined effects of messages framed in terms of loss and gain on foetal alcohol 
spectrum disorder. Yu et al. (2010) found that the “gain” frame demonstrates an 
advantage in encouraging perceived efficacy toward foetal alcohol spectrum 
disorder whereas the “loss” frame shows an advantage in increasing prevention 
intention, perceived severity and perceived fear towards foetal alcohol spectrum 
disorder. Another quantitative study supports the use of  “loss” frame messages 
that were found to be more effective for heavy drinkers and underage drinkers, 
whereas those people who perceived health risk to be low would benefit from 
“gain” frame messages (Quick and Bates, 2010). Another form of framing bias 
is when Health Care Professionals provide positive and negative outcomes, 
with the provision of positive outcomes being more acceptable psychologically 
(Paling, 2003). For example, individuals may feel better when Health Care 
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Professionals provide information such as the chances of preserving vision are 
98 out 100, which is perceived to be better than the chances to losing vision are 
2 in 100. 
Although framing bias may be justifiable in screening programmes in terms of 
improving public health, Edwards et al. (2002) argues that presenting 
information with an incomplete picture is not consistent with informed decision-
making. The following section considers other types of framing effects when 
communicating risk messages by using other forms of risk messages, such as 
fear and threatening messages.  
Different forms of framing effects may influence people’s understanding of risk 
and risk information, such as the effect of ways in which risk information has 
been portrayed by the media (Sandell et al., 2013). For example, in general, 
immunization rates are similar in Australia and Sweden. However, during the 
H1N1 pandemic in 2009, the immunization uptake was 60% in Sweden and 
18% in Australia, despite the fact the risk information regarding the H1N1 
pandemic was communicated in the same way in Australia and Sweden. 
Sandell and colleagues found that the perception of risk was largely influenced 
by media, which was reflected in people’s response. Thus, major differences in 
how the media in both countries framed the pandemic risk information was 
defined in terms of “responsibility, self-efficacy, and uncertainty”. For example, 
the Australian media reported responsibility mainly in a negative way, holding a 
range of organizations responsible for a lack of information, whereas Swedish 
media was more transparent in relation to the uncertainties of the pandemic and 
placed responsibility on the community to help protect public health (Sandell et 
al., 2013). 
3.16. The use of fear messages 
The evidence also demonstrates that concentrating on patient’s fears and 
increasing their anxieties have been used as a strategy to attempt to reduce 
certain behaviours (Albarracin et al., 2005; Cohen et al., 2007). In such cases, 
patients must feel adequate worry about the risk to take action, whereas risks 
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that are common and perceived to be low are less likely to prompt that concern 
(Lundgren and McMakin, 2009). However, according to Brown and Smith 
(2007), the frequent use of fear and messages designed to increase anxieties 
can lead to defensive reactions from people that are activated by distress 
associated with perceptions of personal vulnerability (Brown and Locker, 2009; 
Brown and Smith, 2007). Although such messages resulted in defensive 
reaction among smokers (Brown and Smith, 2007) and people with alcohol 
dependency (Brown and Locker, 2009), the use of these messages were 
reported to be well accepted by individuals and Health Care Professionals 
(Albarracin et al., 2005; Cohen et al., 2007). Stephenson and Witte (1998) 
conducted a study to test the effectiveness of fear messages in promoting skin 
cancer. College students received either a plain text message or a text message 
with a graphic photograph. Participants who received the text with a graphic 
photograph reported that they were more likely to take preventative measure 
than those who received the plain message. The results also showed that fear 
messages appear to be effective in prompting people’s behaviours. The higher 
level of threat was more effective as people were more concerned when 
exposed to stronger messages. Therefore, individuals appear to demand more 
information about their condition when the risk information is more threatening 
(French et al., 2006).  
3.17. Constraints to effective risk communication 
Many factors have been found to limit the effectiveness of communicating risk 
information. Therefore, it is vital that Health Care Professionals identify such 
factors in order that they can provide effective risk communication. Lundgren 
and McMakin (2009) have done significant and well-respected work on the 
subject of risk perception within their field. The following sections highlight some 
of their work. Lundgren and McMakin (2009) have divided the potential 
constraints to effective communications into three main domains; organizational 
constraints, emotional constraints, and population constraints. The following 
sections provide an overview of these domains. 
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3.17.1 Organizational constraints 
Despite the fact that it is in the best interest of the organization, such as the 
NHS, that the risk message should be presented and communicated effectively, 
the organization itself may present certain barriers (Lundgren and McMakin, 
2009). These include: 
 Insufficient resources, such as lack of time, funding, and staff to communicate 
the risk information to people effectively.  
 “Management Apathy” or lack of interest. Even when resources are available, 
Health Care Professionals may fail to do their job and fail to provide effective 
risk information due to lack of support from managers and stake holders. 
 Possible role division, as there may be other demands not simply risk 
communication, particularly when the organization perception of this role is to 
adhere to the policies, guidelines, and community expectations. To manage role 
division, Lundgren and McMakin suggest that the Health Care Professionals 
identify the organizational role before the process of risk communication starts. 
 Difficult review and agreement procedures, in particular, when the risk 
communication process is inappropriate or requires a lengthy time to review the 
process of risk communication and approve it. 
 Inadequate information to effectively plan and set schedules. In order to 
establish a strategy for risk communication, a considerable amount of 
information is needed to plan and create this strategy.  
 
In order to communicate risk information appropriately, Health Care 
Professionals should identify the organizational constraints before the process 
of risk communication starts. Insufficient resources, lack of management 
support, inappropriate consultation time, conflicting organizational policies and 
regulations, and inadequate information could lead to incorrect risk 
communication. 
3.17.2 Emotional constraints 
The second type of constraint regarding effective communication is emotional 
constraints. There are three types of emotional constraints highlighted by 
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Lundgren and McMakin (2009). The first constraint is the reluctance in most 
cases to see the community as an equal partner in risk decision-making; i.e. 
decisions about risk should be based on scientific evidence and by Health Care 
Providers who understand the situation, rather than involving the emotions and 
beliefs of the lay population. The second constraint is differences in values; e.g. 
different cultures have different values and may therefore view risk in different 
ways. This can lead the risk communicator to focus their attention on matters 
they feel important without giving attention to the issues that are of importance 
to patients. Health Care Providers must understand their patients thoroughly in 
order to avoid biases in how they frame risk communication messages, as well 
as for the message to be an effective message. Finally, the last emotional 
constraint is the belief that patients cannot understand science. The evidence 
suggests that many Health Care Professionals believe that patients cannot 
understand or absorb scientific terms and information (Lundgren and McMakin, 
2009). 
3.17.3  From patients 
Patients can also bring a whole range of interpretive factors when risk is 
communicated to them. These include hostility, anger, panic, denial, lack of 
concern, mistrust of risk assessment, variation regarding the magnitude of risk, 
lack of confidence in science and institutions, and learning difficulties (Lundgren 
and McMakin, 2009). More details are provided below about these issues. 
3.17.4 Hostility and Anger 
Many patients may interpret risk information with a degree of anger, anxiety, 
and uncertainty about the future. This can particularly be the case when patients 
receive bad news or are involved in ‘crisis’ communications (Eborall et al., 2007; 
Hafslund et al., 2011). In such circumstances, Lundgren and McMakin (2009) 
stress that Health Care Professionals must be aware of these issues as the 
higher the level of anger, the less chance that patients will give attention to the 
risk message and the less chance of effective risk communication. One reason 
that patients may feel angry is when they feel that the risk communicator has 
no credibility; hence, anything the risk communicator says will be viewed with 
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great doubt. Also, patients may feel angry if they perceive their concerns 
regarding a risk have been ignored. Misunderstanding of the risk or 
misunderstanding the process of risk communication may also cause anger 
among patients, especially when technical terms, medical words, or acronyms 
are used (Lundgren and McMakin, 2009). 
3.17.5 Panic and Denial 
Panic happens because patients perceive themselves or those they care for to 
be in imminent, often life-threatening danger that they cannot control (Lundgren 
and McMakin, 2009). Panic is defined as an unexpected overwhelming dread, 
with or without reason, that generates hysterical or unreasonable behaviour, 
and that often extends quickly throughout a group of people (Dictionary.com, 
2012). Panic tends to distort cognitive processing, potentially blocking risk 
messages from being heard, which can make problems worse (Lundgren and 
McMakin, 2009). Denial occurs when the perceived consequence of a risk is so 
shocking that other coping mechanisms break down. Humans tend towards 
denial when they cannot admit the fact that something terrible has happened or 
about to happen (Branstrom et al., 2006). Panic and denial are difficult to deal 
with by most of Health Care Professionals and need skilful and expert risk 
communicators to manage such occasions. Lundgren and McMakin, (2009) 
argue that Health Care Professionals who communicate risk information must 
realize that panic and denial are important part of people’s response to risk 
information, and therefore, a thorough understanding of people’s needs may 
help prevent the introduction of unwanted risk message responses. 
3.18. Ethical issues in risk communication 
Communicating any form of risk information can result in certain ethical 
dilemmas (Johnson, 1999). One of the main reasons for this is that each 
individual has his/her own ethical values that have been shaped by their 
personal experience and beliefs (Lundgren and McMakin, 2009). This individual 
ethical code formulates ethical issues in subjective ways; i.e. what is true for 
one may not be for another and/or what is acceptable for one person may not 
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acceptable for others. In this section, some of the ethical issues faced by those 
who are communicating risk information are discussed. There are many 
important questions in relation to risk communication such as how much 
information should be released, to whom it should be communicated, who 
should provide or communicate this information, and when is the best time to 
do it? Lundgren and McMakin, (2009) highlight additional potential ethical 
issues, such as whether the use of persuasion is acceptable and the 
relationship between public dangers compared with private interests. Lundgren 
and McMakin, (2009) divided the ethical issues in relation to risk communication 
into three main areas: social, organizational, and personal. Social ethics include 
the code of conduct by which society judge certain behaviour and can vary 
between countries and between cultures within same country: 
“Each country and population group may have its own characteristics that 
affect how people perceive and communicate risks. These characteristics 
may include religious beliefs, health and environmental regulations, and 
community traditions, all of which can affect how people perceive and 
respond to risk information.” (Lundgren and McMakin, 2009; P: 330). 
A study in Hong Kong showed that people in Western countries are more likely 
to evaluate unfamiliar or less controllable threats as more frightening than 
others. While Hong Kong Chinese generally evaluate lesser known threats as 
less worrying and something that can be considered with ‘sensible coolness’ 
(Lai and Tao 2003). Another social ethical issue that has been highlighted by 
Lundgren and McMakin (2009) is whether the risk is being explained in the 
same way to all individuals regardless of their ethnic origin. In addition, it was 
also important as to whether the message was clear enough and 
understandable to formulate an informed decision: 
“In any given situation, any message can be misunderstood. No matter 
how much we analyse our audience, there will always be someone within 
it who misinterprets the risk message” (Lundgren and McMakin, 2009; P: 
63). 
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The second ethical issue relates to organizational issues. Lundgren and 
McMakin (2009) refer to organizational ethical issues in terms of how an 
organisation’s code of ethics deals with concerns such as the release of 
information. Health Care Professionals may be more or less restricted in line 
with their organization’s policies and regulations in terms of what kind of risk 
information can be released and to whom should it be communicated.  
The third ethical issue is personal ethics. Although Lundgren and McMakin 
insisted that the risk communicator should consider one’s own personal ethics 
and be aware one’s own beliefs and role as a risk communicator, this may 
create a dilemma due to the massive variation in risk interpretation. In other 
words, risk information may not be processed by all people in the same way as 
it was processed by Health Care Professionals or risk communicators (Epstein 
et al., 2004; Gigerenzer and Edwards, 2003). This highlights the use of 
persuasion, which is one way to communicate and present the risk information 
with the plan of forcing a view on the patient. A convincing method may be used 
to warn the patients and motivate them to action for fear of loss life or loss of 
vision. This is viewed to be justified when time is limited, and risk is high. 
Therefore, risk communicators argue that every effort should be made to 
influence people’s action and get them to do what is good for them (Cohen et. 
al, 2007). However, Edwards et al. (2002) argues that providing information with 
an inaccurate picture is not consistent with informed decision-making. Lundgren 
and McMakin (2009) highlight situations in which persuasion has been justified. 
For example, when a patient is in immediate danger of death or when the 
individual at risk are not the same as individual engaged in the behaviour, such 
as the unborn babies of alcoholic mothers. Another example when persuasion 
is justified is when an individual has specifically asked to be persuaded such as 
when a speaker is involved in lively debate. 
3.19. Conclusion 
Understanding people’s behaviours is vital to the management of their diabetes 
and diabetes complications. Therefore, it becomes crucial to understand the 
various perceptions of risk related to type 2 diabetes and understand perceived 
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susceptibility (or risk) as it is influential in encouraging changes in behaviour. 
Risk is a social construct that is contextualised within the realities of people’s 
lives and experiences and generated through interaction. Previous research 
shows that making an informed decision depends on a persons’ level of 
understanding and interpretation of the evidence of the relevant risks that are 
given to them and the form in which the risk information is presented. Whilst, 
the interactive decision-making approach between patients and their Health 
Care Providers help patients to make complex decisions about their health care, 
poor interactions have shown to have negative impact on people’s adherence 
to medical treatment. Previous studies show that patients prefer risk expressed 
as numbers rather than words. In contrast, doctors prefer to use words rather 
than numbers in their communication, as words are easier to process. Although 
Health Care Professionals are increasingly using numerical information there 
appears to be a lack of numerical understanding among patients and Health 
Care Professionals. Additionally, there are also variations in interpreting the risk 
information and mathematical information between patients and their Health 
Care Professionals. There are also other issues that limit the effectiveness of 
risk communication, such as perception of risk, variation in interpretations of 
medical information, and personal factors such as gender and ethnicity. 
Furthermore, previous studies have highlighted many aspects that influenced 
risk communication, such as framing effect, the way that risk messages are 
constructed and communicated to individuals, and how the manipulation of 
various framing could affect patients’ decision. Framing risk messages were 
found to be effective in terms of increasing prevention intention and perceived 
fear. Concentrating on individual’s fears as a means of reducing certain health-
reducing behaviours has also been found to be accepted by individuals and 
Health Care Professionals. 
This literature review suggests that research about diabetic retinopathy risk has 
tended to focus on potential causal risk factors rather than understanding 
individuals’ perceptions and experiences of risk. Visual risk communication 
tools used in other clinical settings were found to be effective and improved 
patient’s knowledge. None were found that specifically communicate the risk of 
diabetic retinopathy, and previous studies did not explain how visual aids help 
patients to understand the risk. Evidence suggests that risk has socially 
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constructed elements that people with diabetes and Health Care Professionals 
have varied understandings of diabetes and diabetic retinopathy and the risks 
related to those illnesses, and that an explanatory model of risk perception of 
diabetic retinopathy among people with diabetes was not available. 
Consequently, an exploration of how people with type 2 diabetes perceive and 
understand diabetic retinopathy risk is warranted. This study sought to develop 
a risk communication tool to facilitate the presentation of risk messages about 
diabetic retinopathy, and how the risk messages about diabetic retinopathy and 
diabetic retinopathy screening results should be communicated. 
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 Methodology 
4.1. Introduction  
The purpose of this chapter is to provide the theoretical underpinnings of the 
research. The chapter discusses the philosophical position of the research and 
explains its theoretical and methodological perspectives. The chapter sets out 
the rationale for adopting a social constructivism approach that draws upon the 
theoretical fundamentals of interpretivism, as a methodological and 
philosophical framework, along with key aspects of social constructionist 
grounded theory in relation to data analysis (Charmaz, 2006). This choice of 
this approach was based on key issues that included the methodological 
limitations of existing work regarding communicating risk information about 
diabetic retinopathy to people with type 2 diabetes. This decision was also 
based upon the wish to access individual’s meanings and perceptions regarding 
diabetic retinopathy risk, and their experiences and views about retinal 
screening so as to achieve a richer and deeper understanding about diabetes 
complications and how the risks and benefits of diabetic retinopathy screening 
are understood by people with diabetes and by Health Care Professionals. The 
chapter starts by restating the aims of the research and how these aims 
influenced the research methods. 
4.2. Aims of the research: 
The research question to be explored in this thesis is: “How to communicate 
risk information about diabetic retinopathy to people with type 2 diabetes?” The 
aims of the research are to explore how the risks and benefits of diabetic 
retinopathy screening are understood by people with diabetes and Health Care 
Professionals, and then to establish the most appropriate methods by which risk 
information about diabetic retinopathy can be effectively communicated to 
people with type 2 diabetes. 
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4.3. Research objectives: 
1. To explore how the risks and benefits of diabetic retinopathy screening are 
understood by people with type 2 diabetes and Health Care Professionals 
2. To explore how people with type 2 diabetes perceive risk information about 
diabetic retinopathy by using numerical and textual format  
3. To explore the influence of risk information on risk perception 
4. To appraise existing risk communication tools from other clinical settings by 
participants  
5. To develop a new diabetic retinopathy risk communication tool that can be used 
to communicate risk information about diabetic retinopathy to people with type 
2 diabetes 
6. To appraise the views of people with diabetes regarding a newly developed 
diabetic retinopathy risk communication tool  
7. To explore the influence of the new developed risk communication tool on i) risk 
perception, ii) diabetes self-care management 
8. To establish a method(s) by which risk information about diabetic retinopathy 
can be effectively communicated to people with type 2 diabetes to enable 
informed choice 
9. To establish a method by which diabetic retinopathy screening result can be 
effectively communicated to people with type 2 diabetes 
4.4. Quantitative and qualitative research 
The aim of any research is to create new knowledge through systematic enquiry 
governed by scientific principles that vary from one discipline to another 
(Silverman, 2001). Within this context, it is essential to distinguish between the 
terms ‘methodology’ and ‘methods’ (Parahoo, 1997). Research methodology is 
the process of understanding the alternative ways of answering the proposed 
research question/s. Once the relative strengths and weaknesses of the 
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different methods are appraised, it results in a defensible decision regarding the 
proposed research design. Research methods are techniques used to gather 
information relevant to the research questions (Polit, 2001; Parahoo, 1997), 
resulting in a plan that describes how, when and where data are to be collected 
and analysed (Parahoo, 1997). Our understandings of what represents 
knowledge (epistemology), and the nature of being and the way is the world 
viewed (ontology) influence the theoretical position, methods, and methodology 
applied to a study (Schwandt, 2001). Research methodology can be located 
within two main dominant paradigms: qualitative and quantitative methods. 
Qualitative research is defined by Holloway and Wheeler (2013, P: 3) as: 
“A form of social inquiry that focuses on the way people make sense of 
their experiences and the world in which they live. A number of different 
approaches exist within the wider framework of this type of research, and 
many of these share the same aim - to understand, describe and interpret 
social phenomena as perceived by individuals, groups and cultures. 
Researchers use qualitative approaches to explore the behaviour, 
feelings, and experiences of people and what lies at the core of their lives.” 
Thus, qualitative research is associated with naturalistic inquiry and 
emphasizes understanding the human experience as it is lived by collecting and 
analysing narrative and subjective data (Polit et al, 2001; Porter and Carter, 
2000; Creswell, 2003). In contrast, quantitative research tends to understand 
the social world and knowledge as objective that can be accessed and 
measured (Denzin, 2000). The particular approach adopted by the researcher 
depends largely on the nature of the issue investigated and the type of data to 
be generated. In addition, the researcher’s personal philosophy also plays a 
role in choosing the research paradigm, as it is this that informs the research 
problem (McNeill and Chapman, 2005; Polit et al, 2001; Porter and Carter, 
2000; Cormack, 2000). It is also the case that  research studies are increasingly 
combining both quantitative and qualitative approaches on the basis that this 
may yield a more complete analysis, as each research method can access 
different features of the social world and are seen to complement each other 
(Creswell et al., 2004). In selecting a particular research methodology, it is also 
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worth bearing in mind that the chosen approach will inevitably have some 
limitations. It is also the case that members of different disciplines or even within 
the same discipline may approach their research in distinctive ways. As a result, 
they may focus on research questions or research aims and go about answering 
those questions or aims in different ways (Porter, 2000). Therefore, careful 
consideration of research methodology informed the selection of the most 
appropriate methods for this particular study (Porter, 2000). 
4.5. Quantitative research 
Quantitative research is associated with a positivist tradition, which is generally 
portrayed as an objective and systematic process used to collect numeric 
information that is analysed using statistical procedures (Porter and Carter, 
2000; Carter, 2000a; Polit et al, 2001). Quantitative research can be divided into 
experimental and non-experimental designs. Experimental designs tend to 
examine and establish causal links between variables (Parahoo, 1997). Polit et 
al (2001) explain that experiments are the most powerful designs for testing 
hypothesis of cause and effect relationships by using manipulation to control 
and consciously vary the independent variable and then observe its effect on 
the dependent variable. However, experimental designs have some limitations 
that make them difficult to apply. For example, some variables, such as culture, 
are not amenable to manipulation (Polgar and Thomas, 2001; Polit et al, 2001). 
On the other hand, non-experimental designs do not attempt to manipulate the 
independent variable and are mainly descriptive in their nature (Polit et al, 
2001). They can be divided into two kinds of research. The first is correlation 
(ex post facto) research in which the relationships among variables can be 
studied. This type of research is often an efficient and effective means of 
collecting a large amount of data. The second broad class of non-experimental 
research is descriptive research (Carter, 2000a). The aim of descriptive 
research is to discover new facts about people, activities, situations, and events 
or the frequency with which certain events occur (Carter, 2000b). This new 
knowledge can be achieved through systematic collection of information about 
the phenomenon of interest. The data obtained can be used to assess and 
justify current situations and to make plans for improvement (Carter, 2000b). 
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However, the major disadvantage of non-experimental research is its inability 
to conclusively reveal causal relationships. The research question of this 
particular study does not fit into the positivism paradigm of research that 
focuses on theory testing, establishing cause-effect relationship, predicting, 
controlling variables, and generalization (Polit, 2003). 
4.6. Qualitative research 
The central premise of qualitative research is that people actively construct their 
social worlds through on-going social interaction with other people (Blumer, 
1969). Social constructivism refers to the concept that individuals form or 
construct knowledge as they interact with others to share, relate, and dispute 
their interpretations of their social worlds (Applefied et al., 2011). The 
ontological viewpoint of social constructionism is therefore relativist and the 
epistemological viewpoint is subjectivist; i.e. this research methodology denies 
the existence of an objective reality and instead asserts that realities are social 
constructions and, as such, it recognises that a multiplicity of perspectives and 
‘truths’ exist (Charmaz 2006). Thus, individuals build their knowledge as they 
participate in a range of social activities (Woolfolk, 2011) with people developing 
their own understandings through collaboration and interactions with those 
around them (Applefield, et al., 2011). Personal knowledge and development or 
construction of understanding is therefore based upon personal actions and 
interactions within daily life (Carmichael, 1990).  
The ways in which knowledge is created and understood within a social 
constructionist framework is at odds with a more ‘scientific’ or medical model of 
understanding. Within the medical model, for example, diseases are universal 
and invariant to time or place, whereas a more social model of health, the 
meaning and experience of illness is key and is formed by cultural and social 
factors (Conrad and Barker, 2010). Put another way, illness does not simply 
exist in nature, waiting to be discovered by Health Care Professionals. Rather 
knowledge and understanding about illness is key and is constructed when 
individuals interact and interpret their signs and symptoms (Driver et al., 1994). 
Woolfolk (2011) states that the construction of knowledge by individuals is 
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based on two main concepts. First, individuals are active in constructing their 
own knowledge through personal experiences. Second, social interactions are 
essential for understanding the construction of knowledge.  
Therefore, one of the main purposes of qualitative research is for the researcher 
to provide detailed descriptions of the social settings and social interactions that 
they investigate (Bryman, 1988). In other words, the qualitative researcher’s 
concern is to reflect the reality of certain aspects of people’s everyday lives 
(Bryman, 1988). This emphasis on description entails attending to details and 
encourages the researcher to explore issues in depth (Lacy et al., 2004). 
Therefore, qualitative research is acknowledged as a method to collect 
important insights into the meanings and motivations ascribed by individuals to 
social phenomena and for developing knowledge about such phenomena that 
cannot be accessed by quantitative research (Denzin, 2000). Qualitative 
approaches are more concerned with ‘how’ and ‘why’ things happen. Before 
considering the most appropriate research paradigm to choose, the researcher 
should consider the aim of the study and the type of knowledge needed to 
answer the research question.  
At the beginning of the current research the qualitative research paradigm was 
considered most relevant given the research questions and taking into account 
the existing knowledge and research gaps that have been identified in the 
literature review. Defining risk as socially constructed means that understanding 
risk and perceptions of risk requires the researcher to access individual beliefs, 
values and attitudes, as well as their experiences. The researcher is also 
interested in the motivations and capabilities of individuals when making 
choices, which also need to be located within particular cultural and social 
contexts. Therefore, as Sjöberg (2000) argues, risk perception is more 
thoroughly related to the subjective aspects of the social world it is better 
understood using the qualitative approach. 
Field (1985) suggests that there are two main considerations that are central 
for researchers when choosing a research approach. The first element is the 
nature of the phenomenon being explored. The aim of this study is to explore 
how people with type 2 diabetes and Health Care Professionals perceive and 
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experience the risks and benefits of diabetic retinopathy screening. The second 
element is the “maturity” of the concept; this refers to an appraisal of the degree 
to which the concept is identified and understood. There have been many 
studies that have used qualitative methods to explore lived experiences among 
people with diabetes (Macaden and Clarke, 2006; Macaden and Clarke, 2010). 
However, the area of diabetic retinopathy is relatively new, and the perception 
of diabetic retinopathy risk has not been explored via qualitative methods. Thus, 
the use of qualitative methods can achieve insight and depth regarding how 
people understand risk in relation to diabetic retinopathy and can enable us to 
gain more in-depth information about the ways that risk is communicated to 
people with type 2 diabetes. Furthermore, evaluating and appraising the 
existing risk communication tools and exploring patient’s perceptions and 
experiences of other potential tools requires the use of in-depth qualitative 
methods.  
In wider terms, the importance of a qualitative study in this field is evident in 
main  two ways, Firstly, many researchers have noted the need for more 
exploration into the health beliefs of people with diabetes and the factors that 
influence their ability to make lifestyle alterations (Macaden and Clarke, 2010; 
Anderson and Robins, 1998). This study is clearly concerned with exploring the 
broader dimensions of participant’s lives. Secondly, it is suggested that Health 
Care Professionals and people with diabetes have different understanding of 
health, illness and the associated risks and benefits related with non-adherence 
(Macaden and Clarke, 2010). For example, Health Care Professionals tend to 
explain risk generally as the probability of incidence of a related adverse event 
that linked with non-adherence to health advice or if safety measures are not 
taken as requested. However, people’s perceptions of risk are influenced by 
their previous experiences, communications with family members, friends, 
peers, and other colleagues. This is also can be influenced by people’s culture, 
values, and beliefs. Therefore, individuals can overestimate or underestimate 
risks and their decisions as to whether to avoid potential risks or not can be 
conceived as rational decisions associated with perceived individual losses or 
gains (Reyna et al., 2009). Given that the main aim of this study is to understand 
risk perception and it is effect on communicating risk information about diabetic 
retinopathy to people with type 2 diabetes, and then to develop a model of risk 
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communication, it was essential to explore how people with type 2 diabetes 
perceive and experience their risk; to identify the meanings they hold regarding 
diabetes and its complications; to explore how their experiences, values and 
beliefs inform their perceived risk, and the ways in which they handle and 
interpret risk. This study is therefore well positioned to provide better 
understanding of such differences in understanding between Health Care 
Professionals and people with diabetes. 
4.7. Consideration of potential qualitative methods 
In considering the most appropriate methodological approach the researcher 
considered the applicability of implementing either ethnography or 
phenomenology as a research methodology because both are informed by 
social constructionism and the notion that individuals interpret the social worlds 
in which they live (Creswell, 1994). 
4.7.1 Ethnography 
In ethnography, the researcher studies a particular group within their everyday 
setting over a period of time mainly by collecting observational and interview 
data (Creswell, 2003). The goal of ethnography is to provide a deeper, richer 
understanding of the perceptions, social interactions, and behaviours that take 
place within groups, teams, organisations, and communities (Creswell, 2008). 
The primary method of ethnography is fieldwork, which consists of intense 
periods of observing the people who are the focus of the study. Observation is 
important as it enables researchers to both observe and potentially participate 
in daily activities over a period of time (Creswell, 2003). Ethnographers also use 
in-depth conversational interviews alongside the observations during their 
studies to enable them to investigate emerging themes or issues, or to ask 
questions regarding certain behaviours or interactions (Creswell, 2008). As 
such, ethnographers are able to employ methods of triangulation; e.g. check 
out aspects of their observation data, to enable them to offer more 
comprehensive insights into the phenomenon under study. Developing an 
understanding of different cultures in term of social rules, values and interaction 
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approaches can assist Health Care Professionals to work more effectively with 
different groups of people, including people with diabetes from different ethnic 
and cultural backgrounds (Chesnay, 2016). For example, it is increasingly 
recognised that Health Care Professionals should understand different cultures 
and patterns of living as a means of improving patients’ experiences during 
treatments (Chesnay, 2016). 
Thus, ethnography was considered as a potential methodology given that 
culture is one of the main aspects that may influence risk perception. 
Ethnographic research can also lead to a deeper understanding than can be 
achieved by interviews alone, because it provides knowledge of the context in 
which events occur (Hoepfl, 1997). However, as the main aim of the research 
was not to study the culture of this group of participants, but rather to understand 
the different ways of communicating risk information to people with diabetes, 
ethnography was not considered appropriate. There is not a defined setting for 
the researcher to explore; e.g. observing patients in the waiting area would not 
provide valuable information or rich data regarding their views or understand of 
risk. 
4.7.2 Phenomenology 
Phenomenology seeks to explore experiences in relation to a specific 
phenomenon and aims to generate a description of a phenomenon through the 
lived experiences of participants via extensive and prolonged engagement that 
enables the researcher to develop guides and relationships of meaning 
(Creswell, 2003). For some phenomenological research concentrates on 
describing what individuals have in common as they experience a phenomenon 
such as anger, grief, or loss of appetite (Holloway, 2013). However, for others, 
such as Van Manen (1990), phenomenology is not just a description of lived 
experience, but it is also considered as an interpretive process in which the 
researcher makes an interpretation of the meaning of the lived experience. 
Phenomenological philosophy is informed by epistemological questions relating 
to “how we know” and the connection between the individual who knows and 
what can be known (McLeod, 2001). It is also related to the ontological question: 
107 
 
“what is being” and is concerned with the nature of reality and our knowledge 
about it, “how things really are” (Holloway, 2013). 
The phenomenological inquiry starts when the researcher identifies an area of 
interest, concern, or a gap in knowledge about a phenomenon such as non-
attendance to diabetic screening or non-adherence to diabetes medications. 
Data collection starts with the specific and proceeds to the general using in-
depth interviews with the participants (Holloway, 2013). The researcher collects 
data from participants who have experienced the phenomenon and develops a 
combined description of the core of the lived experience for all of the 
participants. Other forms of data collection may include observation and another 
documentary evidence (Moustakas, 1994). The researcher analyses the data 
by going through the interview transcripts to highlight “significant statements” or 
quotes that offer an understanding of how the participants experienced the 
phenomenon, then develop cluster of meaning from these data. These 
important statements and themes are used to write a description about the 
participants experiences (Moustakas, 1994). 
However, whilst phenomenology acknowledges the researcher’s perspective 
and uses open, in-depth qualitative interviews to collect data, there are also 
aspects of phenomenology that are not appropriate to this study. For example, 
phenomenological studies, in general, tend to interview fewer participants 
compared to other qualitative approaches and it tends to ‘divorce’ the participant 
from their social setting (Creswell, 2003). Whilst phenomenology was not 
chosen as the main method for this research, due to the fact that the study 
aimed for more contextualised account of risk, the research has adopted semi-
structured interviews as the main data collection tool (also associated with 
phenomenology) because it is interested in what risk means to people, how they 
perceive it, the way they understand it, and how they use risk information in the 
decision-making.  
4.7.3 Using constructivist grounded theory to analyse data 
This section discusses the choice for using a social constructivist grounded 
theory approach in relation to data analysis. The decision has been based on 
two primary issues: firstly, the aims of the research question and secondly the 
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researcher’s philosophical position. Essential to consideration of the most 
suitable paradigm was the aim of the research and the knowledge needed to 
achieve them. The philosophy underpinning constructivist grounded theory can 
complement other approaches in relation to qualitative data analysis rather than 
stand in opposition to them (Charmaz, 2006). The subjective approach to the 
study of social phenomena concentrates on qualitative analysis, in order to 
construct concepts and theories. Corbin and Strauss (2008, P: 10) state that: 
“Concepts and theories are constructed by researchers, out of the stories 
that are constructed by research participants, who are trying to explain 
and make sense out of their experiences and/or lives, both to the 
researcher and themselves” 
Corbin and Strauss (2008) argue that it is these various constructs, which permit 
researchers to construct knowledge. As themes emerge from the research, 
constructivist design can develop over time to integrate features in a new 
design. This flexibility and the themes that derived from various construct, let 
researchers construct knowledge (Corbin and Strauss, 2008). There are 
several different views of “reality” in terms of what represents “knowledge” 
(Denzin and Lincoln, 2003). In order to access people with diabetes’ and Health 
Care Professionals’ perception of risk an exploratory approach located within 
the constructivist paradigm was judged to be appropriate: 
“Constructivism assumes the relativism of multiple social realities, 
recognises the mutual creation of knowledge by the viewer and the viewed 
and the aims towards interpretive understanding of subjects meanings” 
(Charmaz, 2000, P:510). 
The researcher’s perception of what establishes “knowledge” (epistemology) 
impacts on the theoretical perspective, methodology and methods applied to a 
study (Schwandt, 2001). The researcher’s view of the world and the nature of 
being (Ontology) and the ways in which this may be understood through means 
of enquiry (epistemology) have influenced the study along with the researcher’s 
decision to use constructivist grounded theory in relation to data analysis 
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(Charmaz, 2006). Ontologically, the researcher perceives meaning in the social 
world to be socially constructed, that is to say, there are several realities as 
opposed to a sole “truth” (Charmaz, 2006). It is the researcher’s argument that 
the data collected in this current study will not establish “reality” because true 
knowledge does not exist independently to be discovered but rather is socially 
constructed. 
As part of this approach it is proposed that the researcher’s views and 
experiences be taken into account (Schwandt, 2001). Therefore, Charmaz’s 
(2006) version of ground theory is explicitly located within the constructivist 
paradigm in contrast to other approaches within grounded theory such as 
Strauss and Corbin’s (1998) approach whose philosophical stance has been 
subject to much interpretation (Jeon, 2004). The constructivist version of 
grounded theory therefore takes into account that the researcher is not “neutral” 
in his approach to the study (Charmaz, 2006). That is to say, the researcher 
has selected the topic of risk communication, and brought his interest in people 
with type 2 diabetes. Social process such as risk communications and people 
interactions are likely to involve a range of subjective experiences including 
personal emotions and interactions with others. As Health Care Professionals, 
interact with patients and other Health Care Professionals, the researcher 
believes that access to personal subjective accounts is vital when exploring the 
diverse issues surrounding an illness or complications which may in certain 
cases last for years or even for ever. The researcher’s experiences of people 
with diabetes in both personal and professional life are as results of observing 
others. The constructivist grounded theory approach is perfectly positioned to 
develop areas of enquiry where further exploratory research is necessary. It 
provides a research framework that goes beyond the means of data collection 
to include guidelines for how researchers treat the data and the analytical 
outcomes that stem from the data analysis process. Charmaz (2006, P: 2) 
conceptualises constructivist grounded theory as providing:   
 “Systematic, yet flexible guidelines for collecting and analysing qualitative 
data to construct theories ‘grounded’ in the data themselves.” (Charmaz, 
2006).  
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Thus, researchers study early data and start to divide, sort, and combine these 
data through qualitative coding. Coding refines data, arranges them, and give 
us a handle for making comparisons with other parts of data (Charmaz, 2006). 
Initial codes indicate certain areas to explore further during subsequent data 
collection (Charmaz, 2006; Newby, 2010). Therefore, the researcher would 
compare the events and views that participant talks about, and the codes with 
the next person we talk with, and the next person, and the next. By making and 
coding numerous comparisons, our analytic understanding of the data starts to 
take shape. During this stage, the researcher will write initial analytic notes 
called memos about the codes and comparisons and any other ideas about the 
data that occur to the researcher. Through studying data, comparing them, and 
writing memos, which is a particular type of written note that enclose the product 
of researcher’s analysis (Strauss, 2008), the researcher describes ideas that 
best fit and interpret the data as ‘tentative’ analytic categories (Charmaz, 2006). 
Once predictable questions arise and gaps in the categories come into sight, 
the researcher seeks data that answer these questions and may fill the gaps. 
Researchers may go back to participants to find out more and to strengthen 
these analytic categories. As the process progresses, these categories not only 
combine as the researcher interprets the collected data but also the categories 
develop into more theoretical categories because the researcher engages in 
successive levels of analysis. Based on the aims of the study, it was essential 
that theories regarding risk perception and its effect on risk communication and 
people’s behaviours emerged from the data, which would add to the existing 
knowledge. 
4.7.4 Sampling strategy 
An adequate sampling process and sample size is a key component when 
seeking to answer any research question. According to (Marshall, 1996), an 
adequate sample size for qualitative research is the one that sufficiently 
answers the research question. The total number of participants is determined 
by the progress of the research and recruitment can stop when no new themes 
or categories emerge from data; what is termed ‘data saturation’ (Bryman, 
2008). In this study a convenient sample was used; that is the selection of the 
most accessible subjects (Marshall, 1996). Convenient sampling is the least 
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costly to researchers in terms of effort and time, but it may result in poor 
research quality data and “lack of intellectual credibility” (Marshall, 1996). 
Therefore, it is imperative to describe how the convenience sample is different 
from a perfect sample that was randomly chosen. It is also necessary to explain 
the possible effects of the people who were not selected to the research in order 
to enable the reader to get good idea of the sample that has participated. This 
also enables the reader to assess the differences between the research results 
and the results from the entire population (Explorable.com, 2009). The sampling 
commenced by interviewing participants that were purposively chosen because 
they have good knowledge and experience with the phenomenon being 
explored and who are able to express their experiences. Convenient sample 
was used in order to access those people with diabetes who have different level 
of risk and with different grade of diabetic retinopathy who use to attend diabetic 
screening every year. Furthermore, it was essential to include participants from 
different gender, age, and ethnic back ground.  
4.7.5 Data collection/semi-structured interviews 
Qualitative research from within a social constructionist framework commonly 
employs semi structured interviews to collect data (Charmaz, 2006; Dick, 2005; 
Glaser, 1992). A semi-structured interview  is a flexible way of asking questions 
that can be shaped by the interviewee’s own understanding and researcher’s 
interests (Bryman, 2004). Semi-structured interviews allow the researcher to 
investigate people’s perceptions of risk and risk communication and authentic 
insights can be gained into people’s experiences using open-ended questions 
(Dingwall and Miller, 1997). It allows participants time and space to talk freely 
about their personal thoughts, understandings, and experiences. Semi-
structured interviews have the ability to generate in-depth detail about peoples 
experiences and the meanings of these experiences (Whittaker, 2002), allowing 
insight into their internal reality.  
As the study topic is relatively under-researched, semi-structured interviews 
appeared the most appropriate method for a number of reasons. First, it allows 
the researcher to explore how patients think and talk about diabetes and 
diabetic retinopathy screening. It provides the researcher with the opportunity 
112 
 
to create an environment in which patients feel that they are able to talk as freely 
as possible. Semi-structured interviews (face to face) provide the opportunity 
for flexibility (Dingwall and Miller, 1997) in order to cover a broad range of 
issues. Face to face interviews are practical and feasible within the time and 
cost constraints of the study:  
“When we talk with someone about the world, we take into account who 
the other is, what that other person could be presumed to know, where 
that other is in relation to our self in the world we talk about” (Baker, 
1982:109). 
Dingwall and Miller (1997) argue that the research interview constitutes a 
deliberately created opportunity to talk about something that the researcher is 
interested in and which may or may not be of interest to the respondent. 
However, as (Bryman, 2004) has argued, there exist a wide range of issues that 
are simply not amenable to observation and creating a specific situation in 
which to ask people about different phenomena can be the only viable method 
of researching them. Semi-structured interviews employ a set of topics to inform 
questions in the style of conversation. However, there are a number of 
fundamental constraints which can affect the quality of an interview. These 
factors include variation between interviewee and interviewer (Cohen, 1982) 
such as mutual trust (especially when discussing a sensitive topic such as risk 
of blindness or diabetes self-care management with a minor ethnic group whose 
English is not their first language), social distance between interviewer and 
interviewee, misunderstanding about the use of language, which may be clear 
to one but not to the other. The interviewee may also well adopt avoidance 
tactics by not addressing the question or not saying anything (Cohen, 1982). 
This can be overcome by having follow-up questions or/and probes or by 
rephrasing the questions (Corbin and Strauss, 2008). Therefore, the researcher 
considered the broader picture and was aware of the factors that may have 
influenced the interviews. For example, the researcher considered the place of 
the interview whether it was conducted at the hospital, GP practice, or at 
participant’s home. The second issue considered by the researcher was 
whether the participant was relaxed or anxious during the interview. Another 
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important factor was taken into consideration whether the interview was 
conducted at the same time of retinal screening or after a week or a month to 
explore the effect of the results on participants. Such factors were considered 
in order to minimize researcher’s influence on the reliability of the results 
(Marshall, 1996). 
Other data collection methods were considered such as focus groups and 
structured interviews. Structured interviews mean that participants answer 
questions that are pre-set. It can be used if the focus of the study is narrow and 
the researcher wants to establish a particular fact (Silverman (2001). Focus 
groups usually refer to a group interview with around 10 individuals designed to 
discuss a specific issue or idea. The group are asked a series of questions by 
the researcher or moderator to which they can freely contribute and share their 
opinions and ideas. Kamberelis and Dimitriadis (2013) argue that focus groups 
provide the diversity of responses as well as have other advantages. 
Kamberelis and Dimitriadis (2013) also highlight some problematic issues with 
focus groups, such as protecting individual’s “anonymity”. Researchers are 
expected to respect individuals and therefore protect their integrity including 
their right to be anonymous. This means that focus groups may be beneficial 
when concentrating on public issues rather than individual’s issues, as 
individuals may not feel comfortable when personal issues are discussed in the 
presence of others. Writing (2015) argues that focus groups may not be as in-
depth as individual interviews as they may not wish to expose how they feel. In 
addition, participants may not express honest views and feelings as they may 
hesitate to express their opinions, particularly when their views oppose the 
thoughts of rest of the group. Other important issues with focus groups 
(particularly with novice researchers) is that there is heavy reliance and 
dependence on the researcher’s skills in order to ensure that the opinions of 
each participant is heard (Krueger, 1988). The researcher or moderator 
(intentionally or unconsciously) may also influence the outcome of the focus 
group. McKie (1995) used discussion groups to find out about participation and 
views on screening. Although she states that the use of established groups 
ensured that women felt comfortable with each other and provided important 
support mechanisms, she felt that using this approach can have a reverse 
effect, with women being reluctant to talk about things in front of others that they 
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may have otherwise disclosed. Therefore, in relation to sensitive and upsetting 
topics such as diabetes and blindness participants may feel intimated by the 
presence of others and may open up more in a one to one situation. In addition, 
group discussions of blindness and diabetes especially when participants are 
not adherent to the recommended treatment may cause unnecessary distress 
to patients.  
4.7.6 Case summary 
The principles of constructionist grounded theory, which informed the analysis 
of the data, suggest that after the interview takes place the researcher should 
write a case summary (Charmaz, 2006). These have been shown to help the 
researcher to get some initial thoughts, ideas, and themes regarding the 
interview. This can start with the essentials of the interview; what made it 
interesting, what was special or strange about the case, what was frequent and 
what was different from others. It is essential for the researcher to distinguish 
between their own ideas by drawing circle around these ideas and ideas that 
emerged from the interview. This should include a description of what has 
happened during the interview and not an interpretation of the interview. The 
researcher also may write a reflection after each interview as how the next one 
can be improved  (Corbin and Strauss, 2008).  
4.8. Development of data analysis 
4.8.1 Treatment of literature  
Engaging in any form of grounded theory research requires the researcher to 
address a set of common characteristics such as theoretical sensitivity, 
treatment of the literature, constant comparative analysis, coding, and memo 
writing. The time at which the literature requires to be reassessed or developed 
in the research process in grounded theory is deeply disputed between the 
traditional and evolved forms of grounded theory. Glaser’s suggestion is to hold 
back reviewing literature in the practical area under study (Glaser, 1992) to 
overcome any corruption or weakness with the analytical process (Mills, 2006). 
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This approach also recommends that the data is a separate component from 
both participants and researcher. On the other side, the evolved form of 
grounded theory supports the proactive engagement with the literature from the 
start of the research process (Strauss & Corbin, 1998).  
4.8.2 Theoretical sensitivity 
Theoretical sensitivity is presenting the views of participants and taking the 
position of others during data collection process (Corbin and Strauss, 2008). 
Theoretical sensitivity differs from one researcher to another as it is a skill that 
develops overtime through work with both data and people (Corbin and Strauss, 
2008). Constructivist grounded theory necessitates that the researcher views 
issues and problems from the perspective of participants. According to Corbin 
and Strauss (2008), it is important to see the truth as the participants see it 
rather than the researchers’ perception. A lack of theoretical sensitivity will 
result in a mixture of empirical description with some preconceived conceptual 
description. For this study, theoretical sensitivity was adopted alongside 
reflections in the following ways. First, the researcher’s professional experience 
as an ophthalmology nurse practitioner provided precious insight into every 
stage of the study, such as designing interviews, understanding the background 
and situations of the participants and the creation of codes and categories. The 
researcher also had the chance to join a well-established research team and 
his communication and relation with other members of the team expanded his 
perspectives on the thought of risk, in particular during the theoretical coding 
process. Opportunities to publish scientific posters on risk communication and 
risk tools (Appendix 13) also enhanced his theoretical sensitivity and grip on 
issues around the concept of risk and communication. 
4.8.3 Data coding 
Data coding is a way of attaching a name or description to the text. It helps the 
researcher to handle and organize large amounts of unstructured data and also 
informs additional data collection (Charmaz, 2006). It is the initial stage of the 
analysis process, which begins the process of categorizing and organizing data 
(Charmaz, 2006). Thus, it facilitates the conceptualization of the data, the 
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construction of the theory from the data and in addition establishes the quality 
of the theory that emerges. It is an essential process that links raw data and 
emerging theory so as to provide the theory with explanatory power. There are 
three stages to the coding process (Strauss, 1998). The first stage is “input”; 
the researcher starts searching for the theory from the first line of first interview 
that the researcher codes. This process aims to break the data into conceptual 
elements. It is difficult at this stage to connect the codes together. The second 
stage is the “drugless trip”; in which the data is in the mind of the researcher. At 
this stage many ideas emerge about the theory, but without any lucidity. The 
third stage is “saturation”; the researcher notes down the results from the 
analysis of the data leading to the development of theory. Strauss (1998) also 
highlights three sets of coding used during data analysis. These are open, axial, 
and selective coding. Open coding involves the initial section of data in order to 
explore all possible features about the phenomenon that is being researched. 
This leads to the development of descriptive codes or categories from the 
preliminary data that had been collected. During this aspect of the coding 
process, the researcher is required to search for a “core category” that is central 
to other categories, with the aim being able to produce theory that describes 
changes and dimensions of peoples’ behavioural (Glaser, 2002). The links 
between the codes can be established throughout the axial coding process. 
Axial coding involves the development of a coding paradigm, which identifies a 
central phenomenon, explores causal conditions, specifies actions that result 
from the phenomenon and identifies the context that influences these actions 
and the outcomes of the phenomenon. In this level of coding, the descriptive 
codes are grouped at a more abstract level and linked by relationships that 
emerge from within the codes. The open coding and axial coding described as 
substantive coding which allows conceptualization of “the empirical substance 
of the area of research” (Glaser, 1978: 55). Axial coding consists of a strong 
analysis about one category at a time that helps understanding about 
associations and links between categories and sub-categories (Strauss, 1994). 
This progressively solid conceptualization facilitates the connections to be 
made between different categories. Analysis at this level involves “inductive and 
deductive thinking” and making comparisons within data. Selective coding is the 
third aspect of coding (Charmaz, 2006. This involves the integration of 
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categories from axial coding forming conceptual links that facilitates 
development of the theory. This level of coding seeks to establish a core 
category that establishes connections between itself and other categories 
(Charmaz, 2006). The significant characters at this stage of analysis are the 
theoretical coding and memo writing. This means that the data is viewed 
theoretically rather than descriptively. The core category is that results should 
be solid but complete and should conceptualize the connections between all 
three coding levels (open, axial, and selective) in order to be able to describe 
differences in the categories. 
4.8.4 Memo writing 
Memos are defined as “a specialised type of written records-those that contain 
the products of our analyses” (Corbin and Strauss, 2008: 117). Writing memos 
assists the investigator to become more analytical and it provides opportunities 
to reflect on the situation, which in turn assist in construction of theoretical 
codes. Writing regular memos are a critical element of the formulation and 
improvement of theory in the research. Glaser (2001) argues that researchers 
will not be able to produce a strong theory without writing continuous memos 
from the beginning of the research. Therefore, researchers should have “pacing 
time”, which means that researchers should stop coding in order to allow time 
for writing memos during the whole stages of generating theory. However, 
researchers must keep the process on-going; sorting old memos and writing up 
new memos as it is continuous process that is a fundamental element of 
constant comparative analysis. 
4.8.5 Constant comparative analysis 
As mentioned earlier, within constructivist grounded theory, researchers are 
expected to sustain theoretical sensitivity throughout the research process in 
order to ensure that the generated theory is grounded in the research data 
instead of assumptions or hypothesis (Charmaz, 2006). Constant comparison 
is comparing incident with incident for similarities and differences (Glaser and 
Strauss, 1967). The constant comparative analysis method assists thinking 
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regarding the data, ideas, categories or themes that come out, thus enhancing 
theoretical sensitivity (Jeon, 2004).  
4.8.6 Patient involvement in the development of this study 
The original idea for this research came from the FLURRI study, as the 
participants seemed highly concerned at the proposal of reducing screening 
frequency to patients, who are at low risk (Lindenmeyer et al., 2014; Hipwell et 
al., 2014). The FLURRI team had a Primary Principal Investigator who endorsed 
the decision to develop research questions around this topic. The protocol was 
further developed with the collaboration of members of the Warwick Diabetes 
Research and Education User Group (WDREUG), who reviewed the research 
questions, the interview schedule questions, and the sampling processes. This 
group of approximately 10 people with diabetes have been meeting bi-monthly 
since 2001 to consult with the diabetes research team on the development, 
execution, analysis, and dissemination of the research projects. They have 
been involved in 8 previous publications and contribute to INVOLVE activities. 
A further 10 members were involved via email.  
4.8.7 Reflexivity 
An important aspect of the research was to ensure reflexivity during data 
collection and data analysis processes (Corbin and Strauss, 2008. Reflexivity 
is a self-awareness of researcher’s own influence on research process 
achieved through critical self-consciousness. Researchers may have different 
feelings and emotions, such as being happy, angry, or sad when collecting or 
analysing the data. Such feelings may be conveyed to participants. If this 
happens during the data collection process it may influence the participants’ 
responses and how they react or answer questions. In addition, such emotions 
and feelings may appear during memo writing as a response to certain issue 
(Corbin and Strauss, 2008). As an experienced ophthalmic nurse with an 
interest and active role in diabetes care and blindness prevention the 
researcher may have preconceived ideas about patient education and the role 
it can play in diabetes self-care management and prevention of diabetes related 
eye complications. Recognition of any influence that the researcher may have 
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on the research is, therefore, essential. This is crucial to ensure that the 
research position is separated from clinical position.  
4.8.8 Researcher as clinician 
As the previous section outlined, researchers have a responsibility to reflect 
upon their own position in the research and explain how they believe this may 
influence the study (Creswell, 2003). Therefore, it is important that the 
researcher sets out their personal biography and then reflects upon on how it 
may influence the study. It is important to make a distinction between the 
researcher role and the clinical role. For example, should participants recognise 
the researcher this can influence the research as people may not be as open 
as they should be. Furthermore, it can be difficult for Health Care Professional 
to ignore patients concerns and deny their clinical experience. Therefore, it was 
appropriate to set out before the interview began that should participants have 
any diabetes-related eye questions that these would be answered after the 
interview by Health Care Professionals at the research site. Should participants 
have had any questions or concerns regarding their health care, the protocol 
dictated that they would be referred to their GP practice or local Patient Advice 
Liaison Service (PALS). Interviewing people with diabetes and Health Care 
Professionals who may know the researcher should always be considered as 
this may influence the information given. Therefore, participants were reassured 
that the study was completely separate to their health care. Participants were 
also informed that their identity would be protected throughout the study and 
any information they provided would be confidential. Participants were also 
assured that data protection legislation (Data Protection Act 1998 and 
subsequent amendments) and University of Warwick Research Governance 
procedures would be followed. 
4.9. Ethical issues 
There are fundamental ethical principles that should be considered in health 
research, such as beneficence, non-maleficence, and respect for autonomy 
(Beauchamp and Childress, 2001).  
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4.9.1 Respect for autonomy  
Underpinning the concept of informed consent is the belief that those 
participating in research should not feel forced to do so. Instead, the decision 
should be made voluntarily, with appropriate knowledge of the potential 
implications (Green and Thorogood, 2004). Participants should therefore be 
made aware that they are a crucial element of the research and the researcher 
should make sure that participants understand the purpose of the research. This 
information is normally provided through a participant information sheet. 
Appropriate time should also be considered prior to participation to ensure that 
participants are fully aware of these issues. Informed consent should be sought 
from all participants, including those who do not speak English as their first 
language. Before interviews commence, an opportunity would be provided for 
potential participants to ask questions prior to deciding whether to take part, to 
ensure that fully informed consent is given. In the event that a participant was 
unable to read and write the researcher, through the NHS interpreter, would 
ensure thorough comprehension and the participant’s mark would be obtained 
on the consent form. 
4.9.2 Non-maleficence 
The second ethical principle is known as non-maleficence; i.e. “do no harm” to 
participants (Craig, 2000). The concept of risk and the risk of visual impairment 
could be very sensitive and distressing to people with diabetes. Therefore, 
careful consideration needs to be taken by researchers when such issues are 
discussed. Therefore, relevant contact numbers were provided via participant 
information sheet in order to provide an independent advice to those who may 
potentially be affected. “Do no harm” is also significant to researcher. Previous 
studies suggest that conducting interviews can have an emotional impact on 
the researcher (Craig, 2000; Lalor, 2006). Therefore, guidelines have been 
developed to provide security and maintain safety to researchers (Craig, 2000). 
Communicating risk information is a sensitive issue, however, the aim of the 
study was not to provide risk information but to explore the perception of risk 
and the views that people with diabetes have regarding existing risk 
communication tools as well as the new developed tool. 
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4.9.3 Gate keeping 
The nature of health research itself can be seen as significant to people with 
diabetes due to financial reasons and the impact on their time (Lakerveld et al. 
2008). This has the potential to influence the level of participation that can have 
a significant impact on the external validity of a study (Lakerveld et al., 2008). 
A few issues have to be considered in the health research such as recruitment 
process and involvement of gatekeepers. Health research may use 
gatekeepers to help recruit participants. A gatekeeper is an individual who 
controls the research access such as a manager or individual within a group or 
community who makes the final decision as to whether the researcher gains 
access to carry out the research (Saunders, 2006). In studies where participants 
are being accessed via an established health care context, such as in primary 
care/GP practices or hospital clinics, those who may be invited to participate 
can be easily influenced by the knowledge, motivation, and authority of the 
employees/clinicians in that clinic. This may impact on the recruitment process 
because those people would be making significant decisions regarding the 
recruitment and therefore may pose risks to the validity of the study (Saunders, 
2006). Thus, gate keepers may influence the recruitment process in the 
following ways: 1) by limiting the circumstances of who is entered into the study, 
2) the way they explain the research study to individuals, and 3) restricting 
access to data and participants. These matters were managed by arranging 
meetings with practice managers, clinicians, and receptionists to provide 
consistent information about the study. For example, the literature suggests that 
participants are more likely to participate if they were asked by a doctor rather 
than a receptionist (Symonds et al., 2012). Another issue that could raise a 
potential ethical issue is in cases where participants may have been over 
persuaded to take part as they may have concerns that their health care will be 
compromised. However, this issue can be dealt with when confirming informed 
consent and by gaining assurances that participants are happy to participate in 
the research prior to their interview.  
People with diabetes may face additional barriers in accessing services; e.g. 
due to their ethnic background, and as such these groups may be less likely to 
participate in research. This may also be linked to the non-availability of study 
materials in the appropriate languages. Thus, the researcher may adopt 
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strategies to increase interview participation, such as employing a bilingual 
interviewer, translators, link-workers, practice staff/professionals support. 
Where Primary Care staff identified a particular language need for a specific 
patient, link workers can be contacted by practice staff to facilitate recruitment.  
4.9.4 Adverse events 
The occurrence of adverse events as a result of participation within this 
research was not expected. However, it was envisaged that the interviews may 
have raised issues regarding diabetic screening results, risks, and benefits of 
diabetic eye screening, which could be a sensitive issue to some participants. 
In such cases, if a participant raised a concern then the researcher would 
reiterate the contact numbers of counselling services in the hospital, as well as 
voluntary organizations such as Diabetes UK. In addition, the researcher would 
offer to contact a family member or friend when required. Participants would 
also be reminded in their information letter and before their interview that they 
are in no way obligated to take part in the research and that they may withdraw 
at any time without giving any reason. As mentioned earlier, should participants 
have any questions or concerns regarding their Health Care they would be 
referred to their GP practice or local Patient Advice Liaison Service (PALS). 
Furthermore, the researcher would arrange regular power point presentations 
to Primary and Secondary Care staff ensuring that they are aware of such 
potential issues and to provide support to the participants. 
4.9.5 Risk of recognising the researcher in the clinical setting 
The role of researcher as a clinician can influence the quality of the data 
collected (Creswell, 2003). In such cases, participants may not be as open 
during the interview and may not provide complete answer assuming that the 
researcher knows the answer due to their professional background. The 
concept of power has to be recognised prior to the interviews with Health Care 
Professionals, whereby, participants, particularly if they are senior staff with 
existing experience in diabetes and diabetes eye complications, may influence 
the interview.  
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4.10. Conclusion 
In this chapter, the author sets out the justification for adopting a qualitative 
research methodology that draws upon social constructivist grounded theory in 
relation to the data analysis. To summarise, the choice of a qualitative approach 
placed within social constructivist paradigm has been directed by the explicit 
aims of the current study. Firstly, from philosophical point of view; the emphasis 
on interpretation and meaning is appropriate to the current study because it 
seeks to understand the relationship between the person and society through 
people’s actions and interactions. Second, constructivist grounded theory helps 
with the process of data collection and analysis with the aim of developing 
exploratory work in the field of risk communication. Third, it takes into 
consideration the significance of the role of the researcher in the development 
of theory. In the next chapter, the methods that adopted in the study will be 
presented.  
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 Methods 
5.1. Introduction  
The aim of this chapter is to describe the methods used in this study. The 
chapter details the reasons why the study adopted a two-stage approach, 
followed by the recruitment process, data collection, and the data analysis 
process. 
5.2. Research aims and research methods 
The purpose of this research was to explore how diabetes and diabetic 
retinopathy screening are understood by people with diabetes and Health Care 
Professionals, and to establish the most appropriate methods by which risk 
information about diabetic retinopathy can be effectively communicated to help 
informed choice. Given the research aims, a qualitative approach was identified 
as the most appropriate way of conducting this research. 
5.3. Ethical approval 
An application was made through IRAS (Reference 12/WM/0103). The 
proposed research received National Research Ethics Committee approval and 
subsequent Research and Development approval from the study site (Appendix 
11). Academic and clinical supervision from the University of Warwick as well 
as clinical supervision from the study site has overseen the conduct of the 
research. The researcher was also guided by the ethical and professional codes 
of conduct pertaining to the nursing, studying and research aspect of their work 
(NMC, 2008). Before starting the recruitment process, a substantial amendment 
(101879/340465/13/264/13380) to the final protocol was obtained in order to 
widen the recruitment criteria, adding more recruitment sites and adding more 
people at higher risk in order to understand risk perception (Appendix 12). 
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5.4. Research design 
A two-stage qualitative research strategy (Figure 5.1) using semi-structured 
interviews with people who live with type 2 diabetes was conducted. 
 
Figure 5.1 Research Design 
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5.5. Stage One 
5.5.1 Study setting and population 
Participants were recruited from five GP practices in a Primary Care Trust and 
a specialist eye clinic in a Secondary Care Trust within a large city in the 
Midlands. These Trusts were chosen because they represented populations 
living in different areas of this city, including pockets of deprivation, rural 
locations, and more prosperous locations. People with type 2 diabetes were 
targeted because they would be subject to diabetic eye screening extended 
intervals and because type 2 diabetes accounts for about 85% of all cases of 
people with diabetes (DiabetesUK, 2013). The extension of diabetic eye 
screening intervals is raising the need to understand risk perception in the 
majority population currently accessing screening even though they are at less 
risk of progression to sight-threatening diabetic retinopathy, due to living with it 
for less time compared to those with type 1 diabetes. In addition, the study was 
also informed by significant differences in the prevalence of diabetic retinopathy 
between White Europeans and South Asians  (Raymond et al. (2009) and the 
earlier diagnosis of type 2 diabetes in South Asians meaning that they live with 
it for longer. Therefore, this research includes people of South Asian origin and 
White British with Type 2 diabetes to understand how diabetes and diabetic 
retinopathy screening is perceived and understood by this group. The study also 
wanted to explore whether people’s perceptions of risk impact on their 
behaviours regarding their diabetes self-care management. 
5.5.2 People with diabetes Inclusion/Exclusion Criteria 
The English national screening programme for sight-threatening diabetic 
retinopathy offers a digital photographic screening to all people with diabetes 
over the age of 12 years (Scanlon, 2008). This study focused on adults with 
type 2 diabetes. The inclusion criteria are as follows.  
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5.5.3 People with diabetes Inclusion Criteria 
 Aged 18 years or over 
 Able to give informed consent 
 Has a confirmed diagnosis of type 2 diabetes 
 Has attended at least one diabetic retinopathy screening appointment within the 
last 3 months 
 Speaks English or a language that available interpreters are able to interpret at 
interview and can translate study materials 
 White British or South Asian  
5.5.4 People with diabetes Exclusion Criteria 
 Unable to give informed consent, for example has a learning disability or 
Alzheimer's Disease 
 Unable to be interviewed in a language that can be translated by the researcher 
or available interpreters 
 People with type 1 diabetes 
5.5.5 Study site recruitment 
The researcher worked with the Lead person for the regional Screening 
Programme and Primary Care Research Networks to recruit GP practices and 
patients to this study. The regional screening programme datasets were used 
to identify practices for purposive recruitment according to high and low levels 
of health need and low and high uptake of diabetic retinopathy screening 
services. In addition, the Index of Multiple Deprivation was used to identify 
practices with the highest and lowest levels of deprivation. The Index of Multiple 
Deprivation is based on Census data by postcode/ward and provides a score 
that indicates likely demand for Primary Care services. It considers income, 
unemployment, health deprivation and disability, education and skills, housing 
and services, crime, and the local environment. General Practitioners were 
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sampled from across the different levels of the Index of Multiple Deprivation 
which also identified practices in areas with high and low health need. 
This process identified ten GP practices (two practices from each IMD quintile) 
and one Secondary Care Trust from which potential participants could be 
recruited to the study. The researcher contacted the GP practices and the 
Secondary Care Trust and gave an overview of the study and sought their 
consent to participate. In addition, managers in the potential research sites were 
sent an information pack by post or/and electronically detailing the aims of the 
study and explaining why they were being asked to take part. Each site was 
given at least one week to consider their participation. Of these, five practices 
refused to participate, and five practices and the Secondary Care Trust showed 
an interest in the study. Of these, the one Secondary Care Trust and five GP 
practices were purposively selected as sites of recruitment as these were 
representative of practices across the full range of deprived and more affluent 
areas. The Index of Multiple Deprivation scores for these locations ranged 
between the highest score of 57.46 and the lowest of 9.55, and the screening 
uptake ranged between the highest score of 96% and the lowest score of 57% 
as shown in Table 5.1. Consent to participate in the study was obtained from 
practice managers and the head of the Secondary Care Trust’s research and 
development unit.  
Research sites were provided with copies of the participant information pack 
(invitation letter, consent form and participant information sheet) to be handed 
or posted to potential participants. Research sites were also informed that each 
participant would receive a £20 research incentive to encourage them to 
participate in the study, as well as their travel expenses. Previous studies show 
that incentives increase representation in research (Olsen et al., 2012; 
Thomson et al., 2012). The researcher also visited the research site managers 
to re-assure them that the research protocol would be followed and to provide 
more details about the study. This included the recruitment process, inclusion 
and exclusion criteria, and they were encouraged to discuss any questions or 
concerns they might have, such as interview time, length of the interview, place 
of interview, patients and staff recruitment. For example, one practice manager 
was concerned about patient information and confidentiality, whilst another 
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practice manger raised the possibility of rescheduling the interview in cases 
when the practice was busy or there was a no room available to conduct the 
interview. The researcher showed flexibility with the practice’s and participant’s 
needs such as changing interview date, time, place, and so forth. All research 
sites were also informed that they would be contacted regarding the recruitment 
of participants to Stage Two of the study. 
 
Table 5.1 Practice Characteristics 
 
Practice number IMD score IMD Quintile  Screening uptake  
Practice 1 24.13 Deprived (4th quintile) 68% 
Practice 2 44.99 Most deprived (5th quintile) 57% 
Practice 3 9.72 Above average (2nd quintile) 96% 
Practice 4 9.55 Above average (2nd quintile) 85% 
Practice 5 57.46 Most deprived (5th quintile) 72% 
IMD: Index of Multiple Deprivations 
5.5.6 Recruitment of people with type 2 diabetes 
The regional screening teams used their database to purposively identify a 
number of people with type 2 diabetes from each practice who were stratified 
according to age, gender, ethnicity, length of diagnosis, grade of diabetic 
retinopathy and that they had attended at least one diabetic retinopathy 
screening. Each potential participant also met all aspects of the inclusion 
criteria. The name of each potential participant was then passed to the 
nominated gate keeper (Gallo et al., 2012) who ranged from practice 
receptionists, doctors, nurses, and diabetic screeners and who contacted these 
individuals. The researcher arranged power point presentations to gatekeepers 
in order to provide information about the study, which groups the study was 
asking them to recruit and to answer any questions they may have. The 
recruitment of potential participants was therefore carried out by gatekeepers 
who contacted them to give an overview of the study, posted or emailed a 
participant information pack and explained to the individual that entry into the 
study was entirely voluntary and that their treatment and care would not be 
affected by their decision. In this way the researcher did not receive any 
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participant details prior to informed consent being obtained. Potential 
participants who had a question about the study had the opportunity to ask the 
practice staff or to call the researcher on the phone number that was provided 
in the participant information sheet. Prior to interviews taking place, each 
participant sent their signed consent form to the researcher. 
The use of gatekeepers to recruit participants was considered as a potential 
concern because their decisions about who to recruit may have been influenced 
by their knowledge, and interests in the study, as well as by their negotiation 
skills and the daily pressures associated with a busy practice (Gallo et al., 2012; 
Symonds et al., 2012). In order to ensure that this research is culturally 
competent (Zeh et al., 2012; Papadopoulos, 2004; Papadopoulos, 2006), every 
effort was made within time and budgetary constraints, to facilitate access for 
participants for whom English is not their first language. A detailed translation 
and interpretation protocol that details these procedures can be found in 
Appendix 5. The researcher had access to bilingual link workers provided by 
the researcher’s trust. This allowed potential people with diabetes to be 
contacted in an appropriate language by telephone or directly in person within 
the clinic to encourage recruitment of non-English speakers. Link workers were 
given information about the study and the practices by the researcher. Link 
workers liaised closely with practices to identify the relevant linguistic skills 
needed during recruitment. However, all people with diabetes were English 
speaking and chose to be interviewed in the English language. A link worker 
was available on two occasions as back up but was not required as participants 
preferred to be interviewed in the English language. Assuming a positive 
response rate of approximately thirty per cent, up to fifteen people with type 2 
diabetes within each practice were invited to participate in the research. Thus, 
a total of seventy five people with type 2 diabetes were invited to participate 
over a two month period between September and November 2012. Within the 
first four weeks, fifteen consent forms were signed and returned to the 
researcher. Gatekeepers were asked to follow-up those individuals who did not 
return the consent forms by sending out another pack to all potential 
participants. This also ensured that gate keepers would not be able to identify 
those people who eventually participated in the study. A further five consent 
forms were signed and returned to the researcher eight weeks after the initial 
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pack was sent. A total of twenty consent forms were returned to the researcher 
and each of these participants were contacted by telephone by the researcher 
to arrange an interview appointment at a time and the location of the 
participants’ choice. The study aimed to include equal numbers of participants 
according to their grade of diabetic retinopathy. This decision was made on the 
basis of receiving more consent forms from certain practices than others that 
included more people with certain grades of diabetic retinopathy, which could 
be due to the influence and motivation of gatekeepers during the recruitment 
process (Symonds et al., 2012).  
Twenty participants were recruited to this study. Participants were from different 
grades of diabetic retinopathy to explore the influence of diabetic retinopathy 
grade on perception of risk. These groups included twelve males and eight 
females. Of these, eleven were White British and nine were South Asians. 
Seven participants were females and thirteen were male. Participants were 
divided into four groups (Table 5.2) depending on their most recent screening 
outcome. Group one: seven participants (three White British and four South 
Asians) with no diabetic retinopathy (R0); Group two: six participants (four White 
British and two South Asians) who had background diabetic retinopathy (R1); 
Group three: four participants (one White British and three South Asians) with 
pre-proliferative diabetic retinopathy (R2); and Group four: three participants 
(thee White British and none South Asians) who had proliferative diabetic 
retinopathy (R3). The age of the participants ranged from forty years to eighty 
six years with a mean age of 62 years.  
 
Table 5.2 Sampling Strategy for Stage One 
Group Grade of diabetic retinopathy White 
British 
South 
Asians 
Total 
Group 1 No diabetic retinopathy (R0) 3 4 7 
Group 2 Background retinopathy (R1) 4 2 6 
Group 3 Preproliferative diabetic retinopathy (R2) 1 3 4 
Group 4 Proliferative diabetic retinopathy (R3) 3 0 3 
Total  11 9 20 
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5.5.7 Health Care Professionals 
A range of Health Care Professionals, working with people with type 2 diabetes 
from White British and South Asian backgrounds, were recruited from the same 
research sites used to recruit people with diabetes (see Table 5.3). Practices’ 
managers at these sites were asked to identify a list of staff linked with the 
diabetic screening programme and that each potential Health Care Professional 
met all aspects of the inclusion criteria. The researcher then contacted potential 
Health Care Professionals, with their permission, and a participant information 
pack was sent by post/electronically. Health Care Professionals were given at 
least one week to consider their participation. Health Care Professionals were 
also given the opportunity to contact the researcher and to ask questions about 
the study prior participation using the telephone number provided in the 
participant information pack. In order to ensure that this research is culturally 
competent (Zeh et al., 2012; Papadopoulos, 2004; Papadopoulos, 2006), every 
effort was made to access South Asian Health Care Professionals. All eligible 
practices staff who agreed to participate in the study and who returned their 
consent form to the researcher were then contacted by phone and convenient 
time and place was arranged for them to be interviewed. A total of five Health 
Care Professionals from the five practices were approached over a two month 
period between September and November 2012 and of these two agreed to 
participate in the study. In addition to practice staff, Regional Screening 
Programme lead identified relevant screening staff and provided the researcher 
with contact details. Following the same procedure, one diabetic screener, from 
the Secondary Care Trust, was contacted and agreed to participate. Two 
ophthalmologists were approached directly by the researcher who provided 
participant information pack about the study asking them to participate, giving 
them one week to consider participation. Two ophthalmologists signed and 
returned their consent form. 
Thus, a total of five Health Care Professionals with different roles agreed to 
participate in the study (Table 5.3); two ophthalmologists, one diabetic screener, 
and two General Practitioners. 
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Table 5.3 Health Care Professionals sampling strategy for Stage One 
Ophthalmologist  General practitioners Diabetic screener  Total 
2 2 1 5 
 
5.5.8 Data collection 
A total of twenty five semi-structured interviews were conducted at Stage One 
(twenty people with diabetes and five Health Care Professionals). These 
interviews were conducted by the researcher over a three month period 
(October, 2012 to December, 2012). As mentioned in Chapter Two, current 
practice suggests that diabetic eye screening results should be reported to 
people with diabetes within three weeks of their screening appointment (NSC, 
2003). Therefore, interviews with the people with diabetes were conducted 
within three months of their screening appointments in order to make sure that 
people with diabetes had received their diabetic retinopathy screening 
results. Once the consent form was received by the researcher, each participant 
(twenty people with diabetes and five Health Care Professionals) were 
contacted to arrange the interview at a time and place of their preference. 
5.5.9 Conducting semi-structured interviews with people with diabetes 
Twenty semi-structured face-to-face interviews with people with diabetes were 
conducted at a time and place of their choice. Of these, eleven interviews were 
completed at the hospital (three at diabetic screening and eight at the eye 
clinic), six interviews at their GP surgery, and three interviews at their homes. 
Each interview lasted for approximately 45 to 60 minutes. The researcher 
started each interview by greeting the participant, introducing themselves and 
summarizing the purpose of the study. The researcher also spent time 
explaining the details of the study and ensured that each participant understood 
the information provided in the information sheet. The researcher answered all 
questions that the people with diabetes had concerning their participation in the 
study. Although written consent had been obtained at earlier date, informed 
consent was gained again in relation to the interview and regarding their 
permission to audio-record it. People with diabetes were then reminded of their 
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right that they could withdraw at any time without giving reason or it is affecting 
their treatment. Participants were also made aware (Appendix 1: consent form; 
Appendix 3: participant information sheet) that should they withdraw from the 
study that the data collected to that point would be erased and not included in 
the final analysis. However, no individual asked to leave the study. Should one 
of these participants had lost the capacity to consent during the course of the 
study, the interview would not have been conducted and any data collected 
would have been erased.  
Various issues were explored in the interviews with people with diabetes (see 
Appendix 4 for Interview Schedule) including their experiences of diabetes and 
diabetic retinopathy screening, risk perception, language barriers, and 
communicating risk information. At the beginning of each interview, people with 
diabetes were asked general questions about their type of diabetes, medication, 
diet, duration of diabetes, and how they were managing their diabetes. Then 
they were asked about their experience with diabetes since diagnosis to explore 
their knowledge about diabetes and diabetic retinopathy, beliefs, 
understandings of diabetes, impact of diabetes on their daily life, impact of 
diabetes on sight, knowledge of risk factors of developing diabetic retinopathy, 
and personal perception of risk. People with diabetes were also asked to 
describe their experience regarding the diabetic retinopathy screening 
programme since diagnosis, how many times they had attended to diabetic eye 
screening, how many times they did not attend, who send them the invitation, 
who performed the screening test, how they were notified of the results, their 
understanding of the results, and the impact of the results on their diabetes 
management. People with diabetes were then asked to describe the method of 
communicating the diabetic screening results and possible ways to improve it. 
The researcher was also keen to explore their reactions and suggestions 
regarding the best way of delivering the diabetic retinopathy screening results 
and risk messages about diabetic retinopathy. Data also were collected from 
people with diabetes regarding the kind of risk information that should be 
presented during a consultation for people with diabetes and in the diabetic 
screening results. This was followed by questions about methods of 
communicating risk information about diabetic retinopathy in general by Health 
Care Providers. People with diabetes were also asked about their views of 
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providing risk information by using different format such as numbers, words, 
percentages, and probabilities. Personal perception of risk was further 
investigated by asking people with diabetes how they perceive own risk and by 
estimating the probabilities of their risk based on their understanding of such 
formats and by reflecting on the diabetic retinopathy screening results. This was 
followed by questions to understand the impact of understanding personal risk 
on diabetes self-care management and the influence of personal risk on anxiety.  
As there is currently no risk communication tool used in relation to diabetic 
retinopathy, a set of different risk communication tools currently used in other 
clinical settings (Figure 5.2) were shown to people with diabetes in order that 
they could appraise them and choose the most appropriate and effective tool 
and format for communicating risk message about diabetic retinopathy. People 
with diabetes were asked about their opinions and views regarding the clearest 
and most helpful tool that could be modified and used to communicate risk 
information about diabetic retinopathy. In addition, the researcher collected 
background data about the participants to provide a fuller understanding of their 
social lives. This information was used to explore connections between diabetes 
self-care management and their perception of risk.  
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Figure 5.2 Risk communication tools in clinical settings 
 
In addition to the data collected from the semi-structured interviews, field notes 
were also written during and after the interviews (see Appendix 17). These 
notes included observations on participants’ reactions, facial expressions 
during the interviews, particularly when the people were discussing their own 
137 
 
risk. These also informed new ideas that the researcher needed to consider for 
subsequent interviews (Charmaz, 2006). In the first three interviews, the 
researcher found it difficult to write field notes during the interview as he was 
trying to ensure that the participants were asked all of the questions contained 
within the interview schedule. However, as the researcher became more 
confident regarding the  interview questions it became easier to write field notes 
and also to keep the interview informal and conversational (Charmaz, 2006). 
The latter was achieved by asking well-planned open-ended questions and 
having a series of probes that increased the researcher’s confidence and 
allowed him to concentrate on what the people with diabetes were saying. At 
other times, people with diabetes were very accommodative as they stopped 
talking and provided time for the researcher to write his notes. The researcher 
used different techniques to encourage the people with diabetes to talk more 
about their experiences (Charmaz, 2006). This included asking questions such 
as: “Is this your first time attending a diabetic retinopathy screening?” And using 
open-ended prompts, such as “Could you tell me a little more about you 
experience?” And, “Can you explain what you mean?”  
The anonymity of the participants and individual practice anonymity were 
protected in all documentation relating to the study. The regional screening 
manager knew which practices were eligible to participate but did not know 
which practice or which individual participated. Practices were given a unique 
number and participants were given pseudonym.  
The first step performed by the researcher after each interview was completed 
was to write a case summary (Charmaz, 2006). This started with the essentials 
of the interview; what made it interesting and also identifying what was special 
or peculiar about the case (what was common and what was different from 
others?) This early analysis helped the researcher to generate some initial ideas 
and themes (Charmaz, 2006). The researcher distinguished between what 
happened during the interview and his own ideas by drawing a circle around his 
ideas, which was mainly a description of what has happened during the 
interview and not an interpretation of the interview. The researcher also wrote 
a reflection after each interview as how the next interview could be improved  
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(Corbin and Strauss, 2008). The mp3 files were also downloaded to university 
computer promptly after the interview was finished.  
5.5.10 Semi-structured interviews with Health Care Professionals 
The interviews with Health Care Professionals were conducted at the 
participant’s place of work or at their home at their discretion. Each interview 
was lasted approximately 45 to 60 minutes. The purpose of the Health Care 
Professionals’ interviews was to explore their views regarding how people with 
diabetes perceive diabetic retinopathy risk. These interviews also covered 
issues as how risk message about diabetic retinopathy risk and diabetic 
screening results should be communicated and what information should be 
included. The interviews also covered differences in understanding numerical 
risk information between people with diabetes and Health Care Professionals 
(see appendix 8: Health Care Professional’s interview schedule). Health Care 
Professionals were also asked about their views of using visual risk 
communication tools and to appraise existing risk communication tools that 
have been used in different clinical settings (Figure 5.2). They were also asked 
to about their views of the most appropriate tool that could be modified to 
develop a new diabetic retinopathy tool, which could be used to provide risk 
information about diabetic retinopathy to people with type 2 diabetes. The 
Health Care Professional’s anonymity and the individual practice anonymity 
were protected in all documentation relating to the study. This ensured that 
participants were not able to identify their practice or individual Health Care 
Professionals. Practices were given a unique number and participants were 
given pseudonym.  
5.5.11 Data recording and transcription 
All 25 interviews (20 interviews with anonymity and 5 interviews with Health 
Care Professionals) were audio-recorded and transcribed using a digital 
recording machine. All participants (people with type 2 diabetes and Health 
Care Professionals) were asked to complete and sign consent form giving their 
permission to record the interview. Data was recorded as mp3 folders. Should 
participants have refused to have their interviews recorded the researcher 
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would have taken written notes. The quality of the recording was very clear due 
to the digital recording system and there was no problem encountered with the 
transcription process. A recording test was performed before each interview in 
order to test the machine and minimise data loss. A backup recording machine 
with extra batteries was also available for emergency use. Recording the 
interviews enabled the researcher to maintain more regular eye contact with 
participants and also to concentrate on what they were saying. 
Interviews were transcribed verbatim by the researcher and checked by the 
researcher for any typing errors or missing text. The transcription process 
helped the researcher to engage more with the data and helped with the 
analytical process as the transcription progressed (Macaden and Clarke, 2006). 
NVIVO 10 software (Figure 5.3) was used to manage and organise the data. 
The software strengthens the analytical rigidity by improving simplicity with the 
ability to trace back the original data in an easy retrievable technique. The 
software was downloaded through the university website, and used to facilitate, 
organise, analyse, and structure information. All interviews were imported into 
the software for data management and analysis. The Figures below show the 
special aspect of the software that helped with data management. (Bazeley P., 
2007).   
 
Figure 5.3: NVIVO software 
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5.5.12 Stage One data analysis 
Qualitative data analysis is an iterative process which started with the 
commencement of the research, progressed through the development of the 
research design, and continued through data collection. It was necessary for 
the researcher to engage with the data for the data analysis to be 
comprehensive and accurate concerning the social process that being 
investigated. This engagement involved the collection of data, the transcription 
and coding of data and also the reflection during these stages (Charmaz, 2006). 
Data analysis formed part of the research method used and was consistent with 
the philosophical underpinnings of a constructivist grounded theory approach. 
The results from the study were linked to the data, so that readers can follow 
the data through to the evaluation, clearly seeing how the results have emerged. 
The results in Stage One also led to further research ideas and questions that 
were explored in Stage Two. 
The philosophical assumptions that people construct and interpret their social 
worlds underpinned decisions relating to both data collection and data analysis 
within this study. Evidently, the study was interested in the ways in which 
participants discussed and interpreted their perceptions and experiences in 
relation to diabetes, the ways in which they managed their diabetes and how 
they made sense of the potential complications and risks they associated with 
diabetes. One aspect of this was an interest in the meaning that participants 
attributed to diabetes, which was often framed in terms of their experiences. For 
example, one of the participants perceived his diabetes as “the simplest”, which 
can also be interpreted as the least dangerous signalled by the fact that he only 
used oral medication as a means of control: 
“I think I have the simplest one, or I don’t know what you normally type it 
or write it, but it’s the simplest one, the safe side one, the normal average 
one. … I take tablets only, Glucophage since 2006.” (Bara, 55, South 
Asian, R0) 
It was also clear that when participants considered the risks associated with 
their diabetes that they tended to look outwards and their perceptions and 
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experiences in relation to those around them. The following example illustrates 
how the same participant constructed his knowledge of associated risk through 
the experience of others, with the clear association of vision loss with the taking 
of insulin rather than oral medication: 
 “My mother in law had diabetes, she lost her eyes, and she lost her vision 
completely because of diabetes, she use to have insulin three to four times 
a day.” (Bara, 55, South Asian, R0) 
5.5.13 Treatment of literature 
For this particular study, literature was used from the very beginning of the 
study. As the study was addressing the methods of risk communication, it was 
significant for the researcher to be very familiar with the risk communication 
issues particularly when it involves providing sensitive or depressing 
information. Therefore, the researcher’s knowledge has been expanded about 
the perception of risk and how to communicate risk information. This was very 
helpful in designing the interviews in addition to the purposive sampling that 
was used in the study as discussed earlier. It was important that the researcher 
ensure that the main aspects of risk communication and perception of risk are 
covered and not missed out during the interviews. Utilizing the literature all the 
way through the study process surely enhanced and encouraged the thought 
processes rather than suppressed or inhibited the researcher. It expanded the 
perspectives and possibilities for the data that was inspected more closely 
during the theoretical coding specifically. 
5.5.14 Theoretical sensitivity 
A key principle of social constructivist grounded theory is that the researcher 
adopts a reflective approach and considers their role and contribution to the 
resulting theory (Corbin and Strauss, 2008). Thus, the researcher reflected on 
their involvement and considered their role in the data collection process in 
relation to the interview questions, coding, and analysis. Charmaz (2006) notes 
that researchers are part of the world they study and the data they collect and, 
therefore, construct their theories through their past and present participations 
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and interactions with people, perspectives, and research practices. This was 
evident in this study as the researcher’s role was integral to analysis process 
as the theory that emerged from this study was developed by the researcher. 
Despite the fact that participants were the main data source, the researcher 
integrated with the data by creating and developing the questions and 
identifying the most important areas to be explored. Furthermore, the 
researcher’s academic background and professional job as a nurse working 
with people with diabetes and encountering eye problems shaped the study.  
5.5.15 Validity and reliability 
Validity in data analysis depends on the fair representation of the data, which 
can be completed by making sure that the results are generated from the data 
collected. Two academic supervisors undertook coding alongside the 
researcher in line with good practice (Charmaz, 2006). The widespread 
experience of the secondary coders highlighted further nuances in participants’ 
responses and resulted in constant development of the coding structure and the 
researcher’s understanding. Data was coded consistently from the beginning to 
the end by three different coders (NA, JS, and AD) to minimise the possibility of 
the interpretation bias and to maintain consistency testing. The following 
example shows disagreement between the researcher and the academic 
supervisor, as the following quote was initially coded by the researcher (NA) as 
“REALISTIC”: 
Symptomless participants appeared to be “REALISTIC” as they have had their 
screening test for many years and yet the results were always negative: 
“I am not going to have any complications with diabetic I don't think, it’s 
been stable now for a couple of years 3 years now I mean I just have two 
tablets and I don't have any problem you know so nothing varies with me 
I can as Megan said like she does my blood sugar for me and it’s no 
different to what we had 6 months ago so I am not too concerned really at 
all at the moment” (Nick, 79, R0) 
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However, it was suggested by the academic supervisor JS that people may not 
believe themselves to be at risk because they are bio medically trained but more 
because they are optimistic in light of their experiences. This participant may be 
in this category. Such coding and interpretative discussions were resolved 
through discussion. 
5.5.16 Position of the researcher 
It is essential that the researcher reflects upon his/her position in the research 
and sets out how their  role as a researcher influenced or shaped the study 
(Creswell, 2003). The researcher in this study has a clinical background as an 
ophthalmic nurse with over twenty years of experience in a clinical setting. At 
the point of commencing this research the researcher had worked in the field 
for nearly two decades. He had conducted forty five qualitative interviews with 
people living with type 2 diabetes and their Health Care Providers. At the start 
of the research, the researcher has very limited personal experience as to what 
it was like to live with long term illness and had never experienced receiving 
sensitive risk information from his Health Care Provider. However, during the 
time of conducting this study, he was invited by his general practitioner to attend 
a general cardiovascular check-up. After the examination, the results were 
communicated to him using different formats; probabilities and a visual tool. For 
the first time, he had to consider the methods of communicating risk information 
from a personal perspective. The time that the Health Care Professionals spent 
with him during consultation and way in which risk information was presented 
made him acknowledge his personal experience of communicating risk 
information. The researcher started by considering a few questions such as: 
Who needs to know information about risk perception? Why is understanding 
people’s perception of risk important? And what information about risk 
perception and methods of risk communication is required? The implications of 
this, from a methodological point view, was that the researcher was not only 
interviewing people with type 2 diabetes from a research perspective the 
researcher was also interviewing them with an increasing personal experience 
of perception of risk having received risk information from a Health Care 
Provider. Although this personal experience was relatively limited, the 
researcher believes that this experience guided him to a greater depth of 
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understanding and possibly connection with participants. It was also crucial for 
the researcher to separate his role as a researcher from his professional role 
as an ophthalmic nurse. Therefore, those participants who had any questions 
or concerns regarding their health care were referred to their GP practice or 
local Patient Advice Liaison Service (PALS) as per the research protocol.  
5.5.17 Memo writing 
Writing theoretical memos provided a written record of the data analysis 
process that documents the researcher’s thoughts and ideas on certain issues 
that have emerged during the interviews. This provides information on thought 
progression so this could be reviewed and modified through the data analysis 
process (Corbin and Strauss, 2008). Memo writing was continuous during the 
data gathering process as recording the flow of thoughts assisted the open 
coding analysis and facilitated the process of constant comparison. It is helpful 
at this stage to provide a worked example of memo writing. One participant told 
his story of being diagnosed with type 2 diabetes and at this point in his narrative 
he reflected on the impact of diabetes on his sight and his priorities regarding 
self-care management.  
“I think if the diabetes keeps high that could affect the eye could like go 
blind blindness or something like that. So I’ve got to keep my diet keep 
controlling my diet, and for myself probably try to do exercise and take the 
medicine on time.” (Yazan, 40, South Asian, R0) 
The following exerts are from the memos written by the researcher: 
“Yazan is highlighting the potential impact of diabetes on his sight as it 
could lead to blindness or sight loss if high level of blood sugar continues. 
He is establishing a diabetes self-care management plan to keep his 
diabetes under control by controlling his diet, exercising, and taking 
(diabetes) medication on time. The importance of diabetes self-care 
management is emphasised as he uses verbal confirmation such as I, my 
diet, myself.”   
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This led the researcher to consider whether the prevention of diabetes 
complications was the central focus for people with diabetes who don’t have 
eye complications and, if so, how does prior eye complications influence the 
perception of risk? The direction of the theoretical sampling was guided by the 
following question: in other people with diabetes with different grade of diabetic 
retinopathy or visible eye complications does prevention of complications or 
further deterioration feature the same? The aim of this was not only to expand 
understanding of prevention of diabetic retinopathy, but also to look at how 
diabetes and the absence of eye complications relate to each other. 
5.5.18 Field notes 
In addition, field notes documented important observations and indicated a 
reflexive approach. These reflect the self-awareness of researcher regarding 
their own influence on research process achieved throughout critical self-
consciousness. Field notes were also important to record participant’s reactions 
to particular questions and to compare these with the interview response 
(Charmaz, 2006). Appendix 17 illustrates an example of field note.  
5.5.19 Coding 
As per the principals of Charmaz’s constructivist grounded theory, the process 
of data analysis was rigorous and started at the same point of as the data 
collection process (Charmaz, 2006). Coding has helped the researcher to 
manage unstructured data and directed him to concentrate on further data 
collection. Descriptive codes for textual data were taken from the semi-
structured interviews. This was performed in two main phases: 1) an initial 
phase involving naming each word, line, or section of data and followed by 2) a 
selection of significant frequent codes in order to synthesise and organise the 
large amount of data. During the initial coding, the researcher was flexible to all 
possible theoretical directions indicated by the initial reading of the data. The 
researcher started by making sense of what diabetes meant to people with 
diabetes and to Health Care Professionals. Careful attention was given to 
understand acts, accounts, views, scenes, and silences from participants’ view. 
The researchers then created the codes by defining what he saw in the data. 
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Data analysis in constructionist grounded theory consists of three sets of codes: 
open, axial, and selective coding (Charmaz, 2006). Open coding: implicates the 
primary breaking of data to explore all the possible aspects or information about 
the phenomenon being studied. This results in the progress of descriptive codes 
from the initial data collected. In this study, all the transcripts were subjected to 
open coding by allocating meaningful theme names to each line or paragraph 
of the transcript, as shown in the following figure (Figure 5.4). 
 
Figure 5.4: The process of Open Coding 
 
This was followed by axial coding, known as theoretical coding (Strauss et al., 
1990), which examined the relationship between categories of the phenomenon 
in the data. Axial coding: involved the development of a coding paradigm which 
identified a central phenomenon, explored causal conditions, and identified the 
context that influenced the actions. In this level of coding, the descriptive codes 
were grouped at a more abstract level and linked by relationships that emerged 
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from within the codes. According to Jeon (2004), the stage of open coding and 
axial coding is recognized as substantive coding which enabled 
conceptualisation of “the empirical substance of the area of research”. Axial 
coding enabled links to be made between categories. Furthermore, 
comparisons have been made between codes to enabled links that have been 
made between them and made the emerging analysis solider. The following 
figure (5.5) shows an example of the outcome of axial coding was linking a 
number of codes about people’s knowledge and understanding of diabetes with 
codes about the impact of diabetes on risk perception. These codes were linked 
together as a result of axial coding and the category of personal factors that 
affects perception of risk emerged. 
 
 
Figure 5.5- The process of Axial Coding 
 
Selective coding: involved the integration of categories from axial coding 
forming conceptual links that facilitates the interpretation of the data. This level 
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of coding seeks to establish a core category that establishes connections 
between itself and other categories (Charmaz, 2006). This means that the data 
was viewed theoretically rather than descriptively. The following Figure (Figure 
5.6) illustrates the processes of selective coding: 
 
 
 
Figure 5.6 The Process of Selective Coding 
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5.5.20 Constant comparative analysis 
Thematic analysis of the data was conducted concurrently and following the 
fieldwork phase, by constant comparison of the data. The researcher also 
compared within and between the data from people with diabetes and Health 
Care Professionals’ interviews to gain insight into both sets of participants’ 
views of risk communication and understanding. In addition, constant 
comparison was performed between different ethnicities, gender, and people 
with different grade of diabetic retinopathy. These themes helped produce the 
new risk tool and generate further themes that were explored in the interviews 
with people with diabetes and Health Care Professionals. A potential problem 
with thematic analysis is that the researcher subconsciously has pre-conceived 
ideas regarding themes (Charmaz, 2006), and potentially may failed to spot 
other themes which may be present in the data. This method of comparing and 
raising questions is rooted in the entire research process to sharpen the 
researcher’s thoughts and therefore help understand the content of the data. 
The researcher used the constant comparative method not to describe or verify 
comparisons, but rather to assist in the conceptualization and categorization of 
the data and analysis (Charmaz, 2006). 
The following quotes highlight the constant comparison of data from people with 
diabetes and Health Care Professionals in regard to how they make sense of 
risk messages that are designed to instil anxiety as a means of changing certain 
behaviours: 
“Probably strong messages would be an eye opener, wouldn’t it, to say 
that blindness could actually happen. I think it depends on your consultant 
as well at the hospital and, yes I just think you can’t have a nicely nicely 
approach, you have got to have that with your consultant yes but they do 
need to be more, you know put fear into the patient.” (Claire, 45, White 
British, R3) 
 “I normally say that the diabetes has damaged their retinae with high 
sugars and that this is non-reversible damage, but then we can stop further 
progression with good control” (Andy, Ophthalmologist, White British) 
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5.5.21 Conclusion of Stage One 
In Stage One of the research, a qualitative study was conducted using semi-
structured interviews with a purposive sample of 25 participants. Of these, 20 
participants were diagnosed with type 2 diabetes, two primary care physicians, 
two ophthalmologists, and one retinal screener. People with diabetes were 
purposely recruited to fall into four groups of people with diabetes with different 
grades of diabetic retinopathy. The aim of Stage One was to explore how people 
with type 2 diabetes perceive diabetic retinopathy risk, explore people with 
diabetes’s understanding and interpretation of risk information and different risk 
communication format, and to appraise existing risk communication tools that 
have been used in other clinical settings. Data was analysed and used to 
develop a risk communication tool to provide risk information about diabetic 
retinopathy and diabetic screening results to people with type 2 diabetes to be 
used in Stage Two. 
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5.7. Stage Two 
5.7.1 Introduction  
The rest of the chapter provides information on the methods used in Stage Two 
of the study. The researcher begins by summarizing the aims and objectives of 
this stage and how these influenced the research methods used.  
5.7.2 Aims of Stage Two 
1. To appraise a newly developed risk communication tool that was developed to 
communicate risk information about diabetic retinopathy to people with type 2 
diabetes and risk information about diabetic screening results (Appendix 14) 
2. To explore the influence of the newly developed risk communication tool on risk 
perception 
3. To explore the influence of the new developed risk communication tool on 
diabetes self-care management 
4. To establish a method(s) by which risk information about diabetic retinopathy 
can be effectively communicated to people with type 2 diabetes to help informed 
choice 
 
A qualitative approach enabled the research to engage people with diabetes 
and to focus on the ways in which they appraised a new risk tool and engaged 
with it. Furthermore, it allowed the researcher to explore possible ways of 
communicating risk information about diabetic retinopathy and about diabetic 
retinopathy screening to people with type 2 diabetes. The newly developed 
diabetic retinopathy risk communication tool is aimed at people with type 2 
diabetes who are at low risk of developing diabetic retinopathy and do not 
require annual diabetic retinopathy screening. Therefore, only people with type 
2 diabetes who identified as White British and South Asian and who have either 
no diabetic retinopathy (R0) or background diabetic retinopathy (R1) were 
included at this stage. 
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5.7.3 Stage Two research setting 
Stage Two of the study used the same research sites as in Stage One. This 
included five General Practitioners (GPs) Practices in a large Primary Care 
Trust and one Secondary Care Trust. These sites were chosen because they 
represented populations living in different areas including areas of deprivation 
and more wealthy locations. Due to the high prevalence of diabetic retinopathy 
among people of South Asian background in the United Kingdom (Raymond et 
al., 2009), it was essential to include them at this stage in order to appraise the 
new risk tool and to explore their understandings of it. 
5.7.4 People with diabetes Inclusion/Exclusion Criteria 
 
People with diabetes inclusion criteria 
 Aged 18 years or over 
 Able to give informed consent 
 Has a confirmed diagnosis of type 2 diabetes 
 Has background diabetic retinopathy (R1) or no retinopathy (R0) 
 Has attended at least one diabetic retinopathy screening appointment within the 
last 3 months 
 Speaks English or a language that available interpreters are able to interpret at 
interview and can translate study materials 
 
People with diabetes exclusion criteria 
 Unable to give informed consent, for example has a learning disability or 
Alzheimer's Disease 
 Unable to be interviewed in a language that can be translated by the researcher 
or available interpreters 
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 High risk patients with diabetic retinopathy grade (R2) or (R3) 
 People with type 1 diabetes 
5.7.5 Stage Two practice recruitment 
The same process of research site recruitment used in Stage One was followed 
in Stage Two to ensure consistency in the study. These sites were chosen to 
represent a diverse population with pockets of affluence and deprivation. The 
Index of Multiple Deprivation was used to identify practices with the highest and 
lowest levels of deprivation. GP practices were chosen from the top and the 
bottom levels of the index of multiple deprivations and identified practices in 
areas with high and low deprivation. The Index of Multiple Deprivation score 
varied between the highest score of 57.46 and the lowest of 9.55, and the 
screening uptake level varied between 57% and 96% (Table 5.4). Demographic 
factors such as gender, ethnicity, socio-economic status, and working age, are 
important factors affecting screening uptake (Scanlon et al., 2008; Millett and 
Dodhia, 2006). These factors impact on people’s attitudes, behaviours, 
perception of risk, and as a result, may impact on people’s risk perception and 
their diabetes self-care management. The researcher again contacted the 
research sites and gave an overview of this aspect of the study and again 
sought their consent to take part in the study. Information about the study was 
again sent by post or electronically. The same five practices and Secondary 
Care Trust that participated in Stage One agreed to participate in Stage Two. 
Consent forms were then obtained from practice managers and Secondary 
Care Trust research and development head. The researcher booked an 
appointment with the practice manager and discussed the recruitment process 
and particularly the differences in the inclusion/exclusion criteria, which are 
different from Stage One.  
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Table 5.4 Practice Characteristics  
Practice number IMD score IMD Quintile  Screening uptake  
Practice 1 24.13 Deprived (4th quintile) 68% 
Practice 2 44.99 Most deprived (5th quintile) 57% 
Practice 3 9.72 Above average (2nd quintile) 96% 
Practice 4 9.55 Above average (2nd quintile) 85% 
Practice 5 57.46 Most deprived (5th quintile) 72% 
IMD: Index of Multiple Deprivations 
 
5.7.6 People with diabetes recruitment 
Having identified appropriate GP practices and a Secondary Care Trust, the 
regional screening team again used their database to purposively identify a list 
of people with diabetes according to age, gender, ethnicity that have either 
background diabetic retinopathy (R1) or no diabetic retinopathy (R0) and who 
had attended at least one diabetic retinopathy screening. A list of potential 
people with diabetes was then sent to the identified gate keepers in each 
research site; these included practice staff, GPs, screeners, and nurses. The 
recruitment criteria were again explained to gate keepers, which was the same 
as in Stage One with certain differences in the inclusion criteria.  
The recruitment of people with diabetes was again carried out by the gate 
keepers. The influence of gate keepers on recruitment process was again 
considered and a power point presentation was arranged with gatekeepers to 
facilitate and recruit people with type 2 diabetes according to the inclusion 
criteria. Every effort was made, within time and budgetary limitations to facilitate 
access for people with diabetes for whom English is not their first language 
(Papadopoulos, 2004; Papadopoulos, 2006; Zeh et al., 2012). A detailed 
translation and interpretation protocol that details these procedures can be 
found in Appendix 5. Gate keepers spoke to potential people with diabetes and 
provided an overview of the study, seeking permission to post out or email a 
participant information sheet including consent forms. Gate keepers explained 
to the people with diabetes that entry into the study was entirely voluntary and 
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that their treatment and care would not be affected by their decision. This means 
the researcher did not receive any details of the people with diabetes’s prior to 
informed consent being obtained. Potential participants were again given the 
opportunity to ask questions to the practice staff or to call the researcher on the 
phone number provided in the participant information sheet before considering 
their participation and before sending their consent form to the researcher. 
Bilingual link workers were available to allow potential participants to be 
contacted in an appropriate language by telephone face-to-face at the research 
site in order to encourage the recruitment of non-English speakers. The link 
workers received information about the study from the researcher to identify the 
appropriate linguistic skills required during recruitment.  
As in Stage One up to fifteen people with diabetes per practice were invited to 
participate in the research. A total of sixty nine people with diabetes potential 
participants were invited to join the study over a three month period between 
January 2013 and March 2015. A total of twenty people with type 2 diabetes 
agreed to participate in Stage Two of the research. They sent their signed and 
dated consent form to the researcher using the prepaid envelop that was 
supplied along with the patient information pack. These participants were then 
contacted by the researcher by telephone within a week of receiving their 
consent form to arrange an interview at a time and location of their choice. The 
interviews within each practice were completed within two weeks and 
transcribed in a week. Therefore, the completion of recruitment process and 
data collection was done within 8-10 weeks. The study intended to include equal 
numbers of participants in each ethnic group. However, due to the restrictions 
in time and resources, the first 20 participants to consent to take part were 
included in Stage Two. Of these, nine were White British and eleven were South 
Asians. Nine participants were females and eleven were males.   Participants 
were divided into two groups (Table 5.4) based on their grade of diabetic 
retinopathy. Group one: ten participants (five White British and five South 
Asians) with no diabetic retinopathy (R0); Group two: ten participants (four 
White British and six South Asians) who had background diabetic retinopathy 
(R1). As in Stage One, participants in stage 2 also received a £20 research 
incentive to encourage them to participate in the study. Previous studies show 
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that incentives improve representation in research (Olsen et al., 2012; Thomson 
et al., 2012).  
 
Table 5.5 Sampling Strategy for Stage Two 
Group Grade of diabetic retinopathy White British South Asians Total 
Group 1 No diabetic retinopathy (R0) 5 5 10 
Group 2 Background diabetic retinopathy (R1) 4 6 10 
Total  9 11 20 
 
5.7.7 Data collection 
A total of 20 semi-structured interviews were conducted during Stage Two. The 
data for Stage Two was collected by the researcher (NA) over a three month 
period from February, 2013 to April, 2013. As mentioned in relation to Stage 
One, current practice suggests that diabetic eye screening results should be 
reported to people with diabetes within three weeks of their screening 
appointment (NSC, 2003). Therefore, interviews in Stage Two were also 
conducted within three months of participants screening appointments in order 
to make sure that they had received their diabetic retinopathy screening results. 
As soon as a consent form was received by the researcher, each participant 
was contacted to arrange the interview at a time and place of their preference.  
5.7.8 Stage Two Semi-Structured Interviews 
Twenty semi-structured interviews with people with type 2 diabetes were 
conducted in Stage Two. Each interview lasted for approximately 45 to 60 
minutes. All interviews were conducted at a time and place of the participants’ 
choosing (see Appendix 4 for interview schedule). Thirteen interviews were 
conducted at a hospital, 4 interviews at their GP surgery, and 3 interviews were 
conducted at a screening centre. All people with diabetes were English 
speaking and were able to be interviewed in English language as per their 
preference. A participant information pack which included an invitation letter, 
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consent form and participant information sheet were provided by the 
gatekeepers, either at participants’’ regular visit to their GPs, screening centre 
or sent out by post or email. Consent forms were signed and dated by 
participants before they entered the study. Consent forms were then sent to the 
researcher in a prepaid envelops. One copy of this was be kept by the 
participant and second copy was kept by the researcher.  
The researcher started each interview by greeting the participant and 
summarizing the purpose of Stage Two. The researcher also spent time 
addressing participants’ questions to ensure that they understood the 
information in the participant information sheet and their involvement in the 
study. Although written consent had been obtained at an earlier date and 
participants had appropriate time to consider participation, informed consent 
was gained again to conduct the interview and to audio-record it. Participants 
were reminded of their right to leave the study at any time without giving reason 
or it is affecting their treatment. Interviews in Stage Two of the study asked 
participants to appraise the new risk communication tool. The aim of this stage 
was to appraise the risk tool (Figure 5.7) and provide risk information about 
modifiable risk factors associated diabetic retinopathy. Details about the 
development process of the risk communication tool is discussed in section 7.2. 
Various subjects were explored during Stage Two interviews (see Appendix 4). 
These included their views of the new risk communication tool, perception of 
risk, the influence of the new tool on diabetes self-care management, and its 
impact on anxiety level. However, in order to avoid inducing anxiety to people 
with diabetes, perception of risk was explored using hypothetical blood sugar 
readings. For example, participants were asked how they perceived the risk of 
diabetic retinopathy if someone’s HbA1c was in the green zone (HbA1c below 
7%), in the amber zone (HbA1c between 7% and 9%), or in the red zone (HbA1c 
9% or above) as shown in the Figure 5.6. This information also was used to 
explore the relationship between perception of risk and its impact on diabetes 
self-care management and on anxiety level. However, a few of the people with 
diabetes had performed the self-risk assessment by using their actual HbA1c 
results. This self-risk assessment was followed by questions about diabetes 
self-care management. People with diabetes were asked how they would 
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respond to a different HbA1c results in order to explore the potential impact of 
the risk tool on diabetes self-care management and on anxiety level or distress. 
Background data about people with diabetes, their families and their settings 
was also collected during the interview to provide a fuller understanding of their 
lives and to facilitate the discussion about the new tool. Data was also collected 
from participants to identify what kind of risk information should be presented 
when communicating risk information about diabetic retinopathy to people with 
diabetes. 
 
 
Figure 5.7 Diabetic Eye Risk Communication Tool 
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In Stage Two of the study, the researcher also had the opportunity to ask 
questions that arose after the data analysis of Stage One, particularly about risk 
perception, anxiety, and risk communication, which enabled the researcher to 
fill certain gaps in understanding and to strengthen the analytic categories. 
Along with the predefined interview questions, the researcher was also keen for 
people with diabetes to suggest areas that they regarded as pertinent and 
significant to the research subject. The researcher was open to the idea of 
including these within subsequent interviews. In addition to the semi-structured 
interviews, field notes were again collected relating to patient’s reactions and 
facial expressions during the interviews particularly when they performed self-
risk assessment and when the idea of extending the diabetic retinopathy 
screening intervals was discussed. In addition to the semi-structured interviews, 
field notes (Glaser, 2001) were again collected such as patient’s reactions to 
the new risk tool, understanding of different level of risk, facial expressions 
during the interviews particularly when the people were discussing their own 
risk. At this stage, the researcher found it easier to write field notes during the 
interview than was the case during Stage One. The researcher became more 
confident asking the interview questions, writing field notes at the same time, 
and keeping the interview informal and conversational (Charmaz, 2006).  
The researcher was constantly focused and aware of the research questions by 
asking questions to appraise the new risk tool. The researcher used different 
techniques to encourage the participants to talk more about the new risk tool 
(Charmaz, 2006) starting with simple questions, such as have you used a risk 
communication tool before? And then asking for details using open-ended such 
as, Tell me about your experience with the risk communication tool? The people 
with diabetes were also asked to explain how the tool can impact on their 
diabetes self-care management. 
Writing a case summary as soon as possible after each interview was 
completed was also a feature of Stage Two (Charmaz, 2006). As with the 
interviews in Stage One, this started with the fundamentals of the interview; 
what made it interesting, and also spotting what was unusual or strange about 
the case (what was frequent and what was different from others?) This helped 
the researcher to get some initial ideas and thoughts (Charmaz, 2006).  
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5.7.9 Data analysis 
In Stage Two, twenty interviews with people with diabetes were audio-recorded 
using a digital recording machine. Data was recorded as mp3 folders. The 
recording, transcription process, and data analysis process were identical as in 
Stage One. 
5.8. Ethical issues 
There were a few issues in the study. People with diabetes received a £20 
research incentive in order to encourage them to participate in the study, as well 
as their travel expenses. Research incentives were used because the evidence 
says it improves participation (Thomson et al., 2012; Olsen et al., 2012).  
5.8.1 The role of gatekeepers 
This study used gatekeepers in Stage One and Stage Two to facilitate the 
recruitment process. People with diabetes were accessed via established 
Primary and Secondary Care Trusts, who were invited to participate in the 
study. Gatekeepers used their knowledge and authority and were making 
significant decisions regarding the recruitment. The researcher conducted 
several meetings and carried out power point presentations to the research gate 
keepers to minimise their influence on the recruitment process in the following 
ways: 1) by explaining the importance of the recruitment process, 2) explaining 
the way they explain the research study to individuals, and 3) by providing 
information sheets to ensure that the people with diabetes had appropriate time 
to consider participation. However, this was a potential ethical issue as people 
with diabetes may have been over persuaded to participate or feared that their 
care would have been compromised. The researcher dealt with this issue by 
confirming informed consent at point of interview and confirming that people 
with diabetes had appropriate time to consider participation and they were 
happy to participate in the research prior to the interview. The researcher 
adopted strategies to increase interview participation by employing translators 
and link-workers. 
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5.8.2 Informed consent 
Participation in this study was voluntary. Informed consent was sought from all 
participants, including those who do not speak English as their first language 
(Appendix 1 for Patients Informed Consent form, and Appendix 9 for Health 
Care Professional Informed Consent form). Participants were sent an 
information form detailing the aims of the study and explaining why they were 
being asked to take part, giving them at least one week to consider participation. 
Translation into other languages was considered, in accordance with Bhopal et 
al.’s (2004) and Birbili’s (2000) translation guidance (see Appendix 5). This 
seeks to ensure that conceptual equivalence is achieved, rather than mere 
literal translation, and that an understandable level of language is used (i.e. not 
overly formal or ‘high’). However, all interviews were conducted in English 
language as per participant’s choice. Before interviews commenced, an 
opportunity was provided for all participants to ask questions prior to deciding 
whether to take part, to ensure that fully informed consent was given.  
5.8.3 Risk of recognizing the researcher in the clinical setting 
Some people with diabetes who took part in the study (Stage One and Stage 
Two) knew the identity and professional background of the researcher. In the 
main this occurred when the interview was conducted in the hospital, which was 
the researcher’s place of work. Those who recognized the researcher (Dickson-
Swift, 2007) may have answered differently and may did not provide completed 
answers to the research questions or enough information during the interview 
assuming that the researcher knew such information and has access to it due 
to the professional capacity. In such occasions, the researcher adopted a 
strategy and separated his role as a researcher from his profession. Research 
questions were said differently and asked again at different time during the 
interview. However, as an experienced ophthalmic nurse working with people 
with diabetes and known to some participants, it was difficult to deny 
professional understanding. Therefore, the researcher was able to negotiate 
with people with diabetes that if they had questions related to the research or 
clinical setting that these could be asked at the end of the interview. In addition, 
the researcher considered referring them to their practice or diabetes nurse to 
provide answers. One participant requested more information about the 
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possibility of having diabetes related eye complications during the interview at 
the GP practice. The participant was offered a referral to the practice nurse to 
discuss the issue in more details. However, the participant preferred to discuss 
the issue with the ophthalmologist during their next visit as the participant felt 
that the ophthalmologist was the right person to provide such information.  
The researcher sought to conduct interviews during his study days rather than 
working days to minimise risk of interference with patients and staff. Another 
significant issue was the concept of power and authority (Dickson-Swift, 2007) 
which was recognised prior to the interviews, whereby participants particularly 
the Health Care Professionals had the possibility to influence the proceedings 
(Dickson-Swift, 2007). Some of the Health Care Professionals were senior staff 
with existing experience in diabetes and diabetes eye complications. However, 
the researcher took charge of the interviews and maintained a sense of 
professionalism and kept focused during the interview to address research 
questions and control the timing and length of the interview.  
5.8.4 Adverse events 
The occurrence of adverse events as a result of participation within this study 
was not expected. Although people with diabetes appeared calm and relaxed 
during and after the interview, the interviews did raise issues regarding diabetic 
screening, such as risks and benefits of diabetic eye screening, which was 
sensitive to some people with diabetes. This issue was raised mainly during 
Stage Two after using the new risk tool when the participants began to discuss 
their own risk in relation to the factors presented in the risk communication tool. 
However, this issue did not appear to be significant to participants as the tool 
confirmed that they were low risk participants. The other issue that was raised 
by people with diabetes was regarding the possible change of diabetic 
retinopathy screening intervals. In such cases, where the people with diabetes 
raised a concern or were not very pleased with potential changes that they had 
heard about from their Health Care Providers the researcher made a point of 
reiterating the contact numbers of counselling services in the hospital, as well 
as voluntary organizations such as Diabetes UK. In addition, the researcher did 
offer to contact a family member or friend, when required. People with diabetes 
163 
 
were reminded in their information letter as well as before conducting the 
interview that they are in no way obligated to take part and could withdraw at 
any time without giving any reason. Where people with diabetes had any 
questions or concerns regarding their health care, they were referred to their 
GP practice or local Patient Advice Liaison Service (PALS) as appropriate. 
5.8.5 Identity protection for participants    
Whilst the regional screening teams knew which practices were eligible to 
participate they were not informed as to which practices or 
patients/professionals consented to participate. When the data is presented 
here and in other environments practice and participant’s identities is disguised 
(for example, by number or pseudonym) to protect the identities of all 
participants and the practices.  
5.8.6 Confidentiality 
In order to ensure that confidentiality was maintained during the research 
process, the following points were taken into consideration: 
1. Raw data (e.g. audio tape recordings and field notes) were stored in a locked 
filing cabinet in a private office. 
2. All transcribed data were stored on password protected computer files. 
3. Anonymity was assured by (a) the use of pseudonyms for all participants and 
(b) potentially identifiable information being deleted from transcripts. 
4. No personal data were stored on the same document as the transcripts. 
5. The data was stored in a secure area of the medical school at University of 
Warwick and will be kept for 7 years according to university policy. 
5.8.7 Researcher safety 
The interviews with people with diabetes and Health Care Professionals were 
mainly conducted in NHS premises, where no risks to the researcher were 
anticipated. The researcher had accessed these establishments with 
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permission of the individuals responsible for managing them. However, some 
of the interviews with people with diabetes took place in participants’ homes, 
which raised the issue of ensuring researcher safety. Although it was unlikely 
that there was any threat to the researcher’s safety, the following steps were 
observed to minimize the risk:  
 The researcher advised a member of the supervisory team of any interview that 
is scheduled to take place in a participant’s home; 
 The participants’ name, address and telephone number were given to a 
member of the supervisory team for the purpose of ensuring researcher safety 
and were destroyed when that interview had finished;  
 The researcher provided an estimated time of interview completion, allowing 
between approximately 1 hour and 2 hours;  
 The researcher telephoned the supervisor when the interview was completed, 
to confirm his safety; 
 Should the supervisor have not received the confirmatory phone call within the 
maximum time then they would first telephone the researcher’s mobile number 
and if there was no response, take appropriate action.  
5.9. Conclusion of Stage Two 
In Stage Two of this research, a total of twenty people with type 2 diabetes were 
recruited. Participants were divided into two groups based on their grade of 
diabetic retinopathy. Group one: ten participants (five White British and five 
South Asians) with no diabetic retinopathy (R0); Group two: ten participants 
(four White British and six South Asians) who had background diabetic 
retinopathy (R1). The aims of Stage Two were to appraise a newly developed 
risk communication tool that was developed to communicate risk information 
about diabetic retinopathy to people with type 2 diabetes, to explore the 
influence of the new developed risk tool on risk perception and on diabetes self-
care management, and to establish a method(s) by which risk information about 
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diabetic retinopathy can be effectively communicated to people with type 2 
diabetes. Semi-structured interviews were conducted between February 2013 
and April 2013 and lasted between 45 to 60 minutes. All twenty interviews were 
audio-recorded and transcribed using a digital recording machine. Data was 
analysed using constructivist grounded theory approach.  
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 Stage One results 
6.1. Introduction  
This chapter presents an analysis of the stage one interviews that were 
designed to explore how the risks and benefits of diabetic retinopathy screening 
are understood by people with diabetes and Health Care Professionals. The 
interviews also investigated how people with type 2 diabetes and Health Care 
Professionals perceive risk information about diabetic retinopathy using 
numerical and textual format. In addition, they sought to explore the influence 
of risk information on risk perception and to appraise existing risk 
communication tools. Finally, the interviews were used to develop a new 
diabetic retinopathy risk communication tool that can be used to communicate 
risk information about diabetic retinopathy. The chapter begins by presenting 
people with diabetes’ knowledge and beliefs about diabetes and diabetic 
retinopathy. The chapter then explores the views of people with diabetes 
regarding the influence of knowledge and beliefs on risk perceptions of people 
living with diabetes. And finally, it provides views of the different risk 
communication tools that have been used in other clinical settings in order to 
modify one tool to facilitate communicating risk information about diabetic 
retinopathy to people with diabetes. The chapter will demonstrate that the 
participants understandings and the perceptions of risk was highly subjective, 
premised upon their personal circumstances, constructed in relation to those 
around them and influenced by cultural differences and beliefs. Twenty people 
with type 2 diabetes and five Health Care Professionals participated in stage 
one of the study. Their socio-demographic characteristics are shown in Table 
6.1 and table 6.2. 
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Table 6.1 Stage One socio-demographic characteristics  
Interview participant  
Number 20 People with diabetes 
Range age 
40-86 years 
Mean age 
62yrs 
Gender  
Male  
13 
Female 
7 
Ethnicity  
White British 
11 
South Asian 
9 
Grade of Diabetic Retinopathy   
No diabetic retinopathy (R0) 
7 
Background diabetic retinopathy (R1) 
6 
Pre-proliferative Diabetic Retinopathy (R2) 
4 
Proliferative Diabetic Retinopathy (R3) 
3 
Health Care Professionals  
Ophthalmologist (White British)  
2 
General practitioner (South Asian) 
2 
Diabetic screener (White British) 
1 
Level of education  
Further education (diploma) or Higher education (Masters or PhD) 
9 
Compulsory education (O level or GCSE) or no qualification 
11 
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Table 6.2 Stage One Participants Characteristics                                   
           
WB: White British, SA: south Asian, V/A: Visual Acuity 
 
6.2. Individual’s knowledge and beliefs about diabetes 
and diabetic retinopathy 
6.2.1 Understanding diabetes and diabetic retinopathy 
The start of the interviews with participants was designed to gain an 
understanding of the ways in which they made sense of their diabetes and their 
knowledge and understanding about the condition and the associated risks. It 
was clear that many of the people with diabetes in this study lacked certain 
knowledge regarding their diabetes, including the complications associated with 
it and regarding diabetes self-management. For example, whilst they all knew 
that they were diagnosed with diabetes, many were unable to specify the type 
of diabetes they had. Participants variously described their diabetes in many 
different ways, such as “type b”, “class b”, “second type”, “simplest”, “safest”, 
and the “safe side one”:  
“I suffer from type b diabetes since two years. I take tablets normally.” 
(Younis, 55, South Asian, R2) 
Number Name Reference Age Sex V/A Grade (R, L)Medical historyOccupation Education 
1 Claire WB 45 F 6/6, 1/60 R1, R3 None Sales GCSE
2 John WB 65 M 6/9, 6/24 R3, R3 Kidney Retired NVQ
3 Allen WB 45 M 6/9, 6/6 R0, R0 None Unknown Diploma
4 George WB 70 M 6/6, 6/6 R1, R1 None Retired NVQ
5 Christine WB 67 F 6/6, 6/12 R1, R1 None Retired Diploma
6 Joyce WB 64 F 6/9, 6/9 R1, R1 None Retired Unknown
7 Gareth WB 86 M 6/9, 6/9 R0, R0 None Shop keeper None
8 Jane WB 82 F 6/9, 6/9 R0, R0 None Retired None
9 Harry WB 78 M 6/9, 6/9 R1, R1 None Retired NVQ
10 Keith WB 59 M 6/6, 6/18 R1, R3 None NHS worker Diploma
11 Ronald WB 57 M 6/6, 6/6 R2, R2 unknown Retired None
12 Bara SA 55 M 6/9, 6/9 R0, R0 None Lecturer PhD
13 Samina SA 58 F 6/9, 6/9 R1, R1 BP house wife none 
14 Abdulla SA 47 M 6/9, 6/9 R0, R0 BP Teacher Degree 
15 Gurjit SA 69 F 6/24, 6/12 R2, R2 None None None
16 Yazan SA 40 M 6/9, 6/9 R0, R0 BP, Chol. Shop keeper Degree
17 Younis SA 55 M 6/9, 6/6 R2, R2 None Translator Degree
18 Kumar SA 57 M 6/6, 6/6 R2, R2 None Shop keeper None
19 Kalthoom SA 50 F 6/6, 6/9 R0, R0 None Midwifery Diploma
20 Amit SA 72 M 6/6, 6/9 R1, R1 BP retired Degree
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“I think I have the simplest one, or I don’t know what you normally type it 
or write it, but it’s the simplest one, the safe side one, the normal average 
one. … I take tablets only, Glucophage since 2006.” (Bara, 55, South 
Asian, R0) 
When discussing the perceived cause of their diabetes people with diabetes put 
forward a wide range of various possible causes. For example, many of them 
attributed the cause of their diabetes to stress and certain aspects of negative 
emotions: 
“I was at hospital for a regular check-up in 2006. Accidentally I discovered 
my diabetes, most likely because I get angry, get nervous very quick.” 
(Bara, 55, South Asian, R0) 
A number of the people with diabetes also believed that their diabetes was 
inherited as they had a number of family members with diabetes: 
“I was only 45 when I first had it. …I thought I was too young to have 
diabetes, but my doctor explained it to me as we all have diabetes, the 
whole family, we got it from our father side, me, my sister and young 
brother although he is younger than me he had diabetes longer than me.” 
(Kalthoom, 50, South Asian, R0) 
Moving on, their knowledge and understanding in relation to the potential risk 
factors that might lead to them developing diabetic retinopathy was also wide-
ranging. Although most of them recognized high levels of blood glucose as a 
risk factor, the participants in this study put forward a range of risk factors 
associated with developing diabetic retinopathy: 
“Well, blood pressure will be one, cholesterol will be another one, may be 
the eye condition, glaucoma could be another one, emm, emm, anything 
that could complicate the case.” (Younis, 55, South Asian, R2) 
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Despite the fact that they acknowledged that Health Care Professionals had 
discussed the risk factors of diabetic retinopathy to them, it also appeared that 
they lacked understanding, which was linked to the lack of specific focus on the 
potential problems associated with cholesterol, hypertension, and sugar levels: 
“My doctor did not mention anything about cholesterol level. No, but he did 
ask me if I take any cholesterol tablets and I said yes. He did ask me if I 
have any blood pressure, and I said yes, and he asked me about the 
tablets and I gave him the name and the name of the diabetic tablets as 
well. And he said to me, that you have to control yourself properly to avoid 
any problems any health problems in the future.” (Yazan, 40, South Asian, 
R0) 
“Well from last year it was like if you have too much sugar in your blood 
and it goes up in your eyes and the blood starts problems. It could give 
me a lot of problems with my eyes.  I have also heard not that I have 
experienced it but I also.” (Kumar, 57, South Asian, R2) 
As previously mentioned, type 2 diabetes was generally perceived as the 
“safest type” of diabetes compared to type 1. Across their accounts, people with 
diabetes perceived that those who have type 1 were at higher risk of having 
complications such as vision loss, which was associated with the taking of 
insulin rather than non-adherence with blood glucose control: 
“My mother in law had diabetes, she lost her eyes, and she lost her vision 
completely because of diabetes, she use to have insulin three to four times 
a day” (Bara, 55, South Asian, R0) 
The level of understanding and interpretation of certain medical terms 
associated with diabetes and vision problems, such as “macula” and 
“retinopathy”, varied between the people with diabetes. Although it was clear 
that people had heard these terms before, either from their General Practitioner 
(GP), optician, or ophthalmologist, others appeared to be unfamiliar with them. 
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A number of the people with diabetes stated that they had not heard them before 
and talked more in terms of diabetes as a complication to people’s eyes or 
diabetic eye in more lay terms: 
“I never heard of the term you just mentioned. My doctor did mention 
diabetes complications to eyes, but not what you just said.” (Ronald, 57, 
White British, R2) 
Whilst people with diabetes appeared to understand certain medical terms, the 
majority appeared to have limited understanding of medical abbreviations that 
have experience of being used by health providers:  
“HAB1c and all that I didn’t understand. But blood glucose levels and 
things like that I could understand.” (Gareth, 86, White British, R0) 
The lack of knowledge and understanding among people with type 2 diabetes 
was also recognized by Health Care Professionals who suggested that more 
attention and consideration should be given by other Health Care Professionals 
to explain and provide more details to patients: 
“My experience has been very different in different hospitals that I have 
worked in with different patient populations. I think there is a lot of 
confusion about eye disease and people hear words like glaucoma and 
cataracts and they get it all kind of mixed in together. I still think there is a 
lot of confusion about in what way it affects the eyes and you know what 
can be done about it and how they can try and prevent it. I think that eye 
disease needs to be brought up by the general practitioner and the 
practice nurse and they need to be aware that the retinae and diabetes is 
controlled but I think a lot of patients don’t appreciate that there is that 
relationship between the systemic disease and their eye condition.” (Andy, 
Ophthalmologist, White British)  
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It appeared that Health Care Professionals were aware that some people with 
diabetes have different levels of understanding and, therefore, some tended not 
to use medical terms such as “diabetic retinopathy”: 
“I don’t tend to use the word retinopathy because I think it is a bit of a 
difficult word that people probably don’t understand.” (Andy, 
Ophthalmologist, White British) 
However, it was also clear that some used medical terms such as “macula” that 
may have not been understood by people with diabetes: 
“I would say to him. You have changes in the eye and if you control your 
diabetes, the diabetes will not lead to blindness. If we don’t control it, it will 
be progressive to the degree it involves the macula and once the macula 
is affected you are in trouble.” (Fawzi, GP, South Asian)  
“Some of them don’t know the terms. I think the ones who have been 
diabetic for longer do because obviously they get told when they come to 
screening. Well, they do by me anyway. I think if they are coming to clinic 
the doctor will tell them, but I think if they are quite a new diabetic then 
don’t understand the terms. Again, I feel comfortable telling the patients, 
describing retinopathy and maculopathy, but not all of them know the 
term.” (Kate, Screener, White British)   
However, it also appeared that Health Care Professionals sought to provide 
comprehensive information about diabetes and its complications including long 
term complications and its impact on people with diabetes. For example, in the 
following extract, Abdulla is talking about his General Practitioner: 
“I have type 2 diabetes that I have been diagnosed with since 2005. I was 
diagnosed by my local GP, after having some tests, blood tests, and if not 
mistaken, glucose test. After I was diagnosed with diabetes, emm, my GP 
made an appointment for me to see him, and he explained to me in great 
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details about diabetes and what are the things that could happen to me if 
I don’t look after my diabetes. He told me about many complications like 
kidney failure, in a long term, emm, eye problems, and emm, that probably 
in the late stage, some people may lose some of the limbs.” (Abdulla, 47, 
South Asian, R0) 
6.2.2 Implication of diabetes 
All people with diabetes perceived that their diabetes has or would have some 
sort of effect on their sight. For example, some people with diabetes believed 
that their diabetes may lead to vision loss while others were not sure what would 
be the implications of diabetes on their sight: 
“I think if the diabetes keeps high that could affect the eye could like go 
blind, blindness or something like that. So, I’ve got to keep my diet keep 
controlling my diet, and for myself probably try to do exercise and take the 
medicine on time.” (Yazan, 40, South Asian, R0) 
“I went for a routine blood test. Just really at normal testing with the doctor. 
It must be 5 years plus now.  The doctor said you have the type 2 version. 
He prescribed tablets and advised me to look after what I am eating 
otherwise it could cause blindness and other parts of your body can get 
into trouble with it such as gangrene and things like this. So far it is 
controlled with tablets.” (George, 70, White British, R1) 
Others, such as Samina, believed that diabetes could lead to different 
complications other than in relation to their eyes, such as stroke, hypertension, 
and heart problems, which she believes may result in vision loss: 
“Yes he (Doctor) said to keep controlling blood sugar, you got to look after 
yourself. He mentioned things like you just got to make sure that you got 
to look after yourself right, otherwise you could have problems with things 
like if people don't look after themselves they could have high blood 
pressure, could have stroke, could have heart trouble, there could be other 
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complications. It could make you go blind and stuff like that.  The blood 
pressure could make you blind so can your diabetes can make you blind 
so it’s like important that you look after yourself.” (Samina, 58, South 
Asian, R1) 
Some people with diabetes were unclear about diabetes complications. They 
believed that diabetes could lead to glaucoma and blindness: 
“Probably diabetes can affect my sight I would've thought, gives you 
glaucoma, isn’t it, can send people blind. I know you have to look at your 
feet very well.” (Ronald, 57, White British, R2)  
In comparison, Health Care Professionals seemed divided regarding patient’s 
knowledge of diabetes complications. General Practitioners believed that 
patients are aware of diabetes complications and that individuals were aware 
that diabetes causes blindness when they present with complications: 
“Everyone with diabetes knows that it causes blindness, all of them know.” 
(Fawzi, GP, South Asian) 
However, the ophthalmologists argued that symptomless patients may not be 
aware of the full impact of diabetes, particularly those who have good visual 
acuity: 
“I think the majority understand, particularly those that have had some 
early changes and some visual changes. They then fully understand what 
the implications are. But for those that have perfectly normal vision I am 
not sure some of them understands the impact of the changes are likely 
to permanent once they get them.” (Andy, Ophthalmologist, White British) 
Although it was clear that many people with diabetes were aware that diabetes 
can lead to changes in their eyes, some of them were unaware that these 
changes could lead to permanent vision loss. Furthermore, they tended to 
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believe that their doctor or ophthalmologist would treat any potential eye 
problems and effectively cure them of the problem: 
“Well, I don’t have problems so far. Should things changed, the doctors 
would sort it out for me.” (Younis, 55, South Asian, R2) 
“Perhaps because everything was normal to me even when I had changes 
it was improved after some time. So, there is always a way to get thing 
right for us. You guys are doing a great job in the hospital.” (Joyce, 64, 
White British, R1) 
Despite the varied understanding apparent in the people with diabetes who took 
part in this study, among the Health Care Professionals there was consensus 
that all people with diabetic retinopathy would be informed that this may lead to 
non-reversible damage in the retinae due to high levels of blood glucose. Thus, 
the Health Care Professionals in this study were eager to point out that all 
people with diabetes were told how they may avoid the progression to sight-
threatening diabetic retinopathy by adhering to good diabetes self-
management: 
“I normally say that the diabetes has damaged their retinae with high 
sugars and that this is non-reversible damage, but then we can stop further 
progression with good control. I think they understand that there is 
something going on related to their diabetes I think most of them 
understand that quite clearly, but I am not sure what they understand or 
that they understand what we mean by retinopathy. I think the majority of 
them don’t understand the meaning of it.” (Kate, Screener, White British)   
However, it was also clear that health professionals generally perceived 
“educated people” and those who had regular attendance at their appointments 
at Hospital Eye Services to have better understanding of their own condition. 
As a result, these patients were far more likely to be aware that diabetes affects 
the eye: 
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“I think the more educated people or people that have been coming to 
clinic more often have an understanding that diabetes affects the eyes. I 
think that a lot of them would appreciate that it is kind of at the back of the 
eye rather than at the front of the eye, particularly if they get the hang of 
what dilating diabetic retinopathy drops are for and you know what we do 
when we examined them but I think they have very limited knowledge 
about what actually goes on at the back of the eye.”  (Andy, 
Ophthalmologist, White British) 
However, an individual’s level of education was not necessarily linked to good 
knowledge or understanding of diabetes among the people with diabetes in this 
study. For example, people with diabetes who had a higher degree (masters or 
PhD), or further education (Diploma), provided a range of understanding which 
could be perceived as less knowledgeable that those with compulsory 
education (O Level/GCSE) or no qualifications (see participants characteristics 
in Table 6.2). For example, as mentioned in a previous quote, type 2 diabetes 
was described by Bara, who is a senior lecturer at a university, as the “simplest 
type, safe side one, and normal average one”. Rather than their educational 
background, it appeared that individuals who had existing symptoms or eye 
complications provided explanations that were closer to those provided by a 
range of Health Care Professionals than those who did not have symptoms or 
eye complications: 
“He mentioned complications especially when I had the bleed. I mean that 
was a bit of a shock and with the diabetes that is what usually happens if 
you’re under control. It is the diabetes out of control, too many high blood 
sugars, what happened I was told the blood vessel behind the eye starts 
swelling up and suddenly pops.”  (Keith, 59, White British, R3) 
Health Care Professionals also perceived people with diabetes who have visible 
eye complications or changes in their vision as having better understanding of 
their own eye health status and the risks of disease progression, which was in 
contrast to symptomless patients:  
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“I think the majority understand, particularly those that have had some 
early changes and some visual changes they then fully understand what 
the implications are.” (Andy, Ophthalmologist, White British) 
It was also the case that people with diabetes who had existing eye 
complications or advanced levels of retinopathy believed that everyone with 
diabetes to be at risk. Therefore, perhaps unsurprisingly, they believed that the 
diabetic eye screening programme is beneficial for all people with diabetes 
regardless of their level of risk. This view was inevitably influenced by their past 
experience: 
“I think anyone with diabetes should have eye screening definitely every 
year. I think they are at risk if they have got diabetes anyway, aren’t they, 
everyone with diabetes should be screened.” (Claire, 45, White British, 
R3) 
In contrast, symptomless individuals perceived diabetic eye screening to be 
more effective to those who are high risk because they would be more closely 
monitored: 
“I think the most benefits will be for patients who are at high risk as they 
would be monitored more closely, it would prevent any problem with the 
eye.” (Abdulla, 47, South Asian, R0) 
6.2.3 Causes of diabetes complications 
The role of beliefs about diabetes appeared to influence the knowledge and 
understanding among people with type 2 diabetes, particularly amongst those 
participants of South Asian background, as demonstrated in the quotes below. 
For example, a number of people with diabetes believed that complications may 
happen due to external forces such as God’s will, cold weather, fate, and body 
function, which are all outside of their control. For example, one participant, 
Bara, believed that complications may happen due to external forces such as 
God’s will. In other words, he believed that if something is meant to happen, 
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such as deterioration in his vision or blindness, he can do nothing about it and 
no one can stop it: 
 “It is alright, it did not bother me, I mean, there is nothing you can do if 
something is coming from Allah (God), you have to accept it, whatever you 
do would not stop the will of Allah. There is nothing you can do, you may 
try to do something, but it is something not in your hand, but I tried to do 
my best.” (Bara, 55, South Asian, R0) 
In addition to the previous example, Amit believed that blood glucose may 
become uncontrollable due changes in body function which is believed to be 
outside their control, despite people adhering to medication to the same level 
as they use to do: 
“Sometimes you can’t keep your blood sugar always stable and under 
control. Sometimes it become uncontrollable, you can’t control it all the 
time, your body function changes, may be you are taking your medication 
to the same level and everything is fine, but your body is not the same to 
function like, you know, five years ago. Five years ago I was completely 
different person. I could get up and walk, do exercise, does not matter at 
all, but my health slowly decline. I can walk but with difficulties because 
my knees are painful.” (Amit, 72, South Asian, R1) 
People with diabetes had a range of different beliefs regarding their 
complications and what causes deterioration to their visual acuity. For example, 
Gurjit attributed the deterioration in her sight to cold weather: 
“I feel better down there in India, probably because of the heat. My blood 
sugar was perfect, no high just little bit, 7 or 8. Just wait 6 weeks and see 
my blood sugar will go up, and my eyes get greasy. I think it is all because 
of the cold weather.” (Gurjit, 69, South Asian, R2) 
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In addition, some of these participants attributed the deterioration in their vision 
to their age rather than their diabetes: 
“My eyes are deteriorating now, it is because of my age I suppose, you 
know what I mean, whether diabetes is causing it, I don’t know. ...I think I 
am at low risk, I have not thought much about my eyes in relation to 
diabetes, it is just my age, it is nothing to do with diabetes.” (Harry, 78, 
White British, R1) 
Similar to Harry, Abdulla attributed the deterioration in his sight to age rather 
than diabetes even though he is relatively young: 
“I am 47 this year old, or nearly 47, I don’t think I have any problem in 
relation to diabetes, but I do believe that my sight is getting weaker, every 
year I feel that compare to the previous year, so it seems it is not my 
diabetes is affecting my sight I assume it could be something else, it could 
be age as some people get problems due to their age.” (Abdulla, 47, South 
Asian, R0) 
In addition to cold weather, Gurjit believed that bad luck contributed to her 
diabetes: 
“Why me having diabetes and all these problems, what did I do in my life. 
I think it’s my bad luck having diabetes and these problems.” (Gurjit, 69, 
South Asian, R2) 
These external forces appeared to influence their beliefs to a stage where many 
felt diabetes complications could not be stopped or controlled: 
“I don’t really know my chances of developing complications in my eyes. I 
hope nothing will happen in the next five years, but you know what can I 
do, if it comes it comes, we can’t stop it can we? I think it’s away from our 
control.” (Yazan, 40, South Asian, R0) 
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6.2.4 Severity of risk 
The perceived severity of risk varied between people with type 2 diabetes. For 
example, some of these participants appeared to believe that they were at low 
risk. Others believed that they were at higher risk, while a few perceived that all 
people with diabetes, regardless of their level of risk, have the same chance of 
developing diabetes complications. It appeared that people’s perceived severity 
of risk was influenced by many factors, such as knowledge, experience and 
visible symptoms. For example, Yazan was one of the respondents who 
perceived the risk to be roughly the same for everyone with diabetes:  
“I am not sure, I don't think so I think it’s the same chance, diabetes is 
diabetes, and eye pressure is the eye pressure, it is the same chance with 
everybody, it is more how we deal with it.” (Yazan, 40, South Asian, R0) 
It was also apparent that perception of risk appeared to be understood within a 
wider context of experience and their social interactions with others. People with 
diabetes were influenced by the past experience of seeing or looking after 
people with diabetes. For example, Kalthoom described the case of her mother 
who she defined as careful in terms of controlling her diabetes and who, 
therefore, experienced no problems with her eyesight: 
“You see my mother was a diabetic, but she was on tablets.... She was on 
a very strict diet, and never had problems.” (Kalthoom, 50, South Asian, 
R0) 
In contrast, other people with diabetes were more aware of risk as they 
appeared to have been influenced by caring for or seeing people with 
uncontrolled diabetes and who experienced problems with their vision: 
“It can send people blind. I know you have to look at your feet very well. A 
friend of mine, couple of years ago he had a nasty infection in his toe, he 
ignored it and lost his toe.” (Ronald, 57, White British, R2)  
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Personal experience and their interactions with others could therefore influence 
people’s perceived risk and inform people’s understanding of personal risk. 
However, the potential downplaying of risk can result in vision loss in the future. 
For example, John who has proliferative diabetic retinopathy (R3) and who 
received laser treatment several times in the past appeared aware of the 
perceived severity of his condition. However, it was also clear that he gave 
emphasis to treatment as the most effective way of preventing vision loss: 
“I think it takes 12 months to lose vision if you are at high risk, isn’t it. But 
if your blood vessel could burst you could be blind straight away. It should 
be yeah anytime yeah then you could be blind, that was what I was told. 
But it would be a few years before you go blind if you are low risk, yeah 
few years. Not necessarily if you get the right treatment.” (John, 65, White 
British, R3) 
It was also apparent that those people with diabetes but without existing visible 
symptoms or eye complications were unsure of the time frame in relation to 
them potentially developing sight-threatening diabetic retinopathy. Their sense 
of uncertainty is clearly apparent in the following extract: 
“One thing that diabetes may cause is blindness … how long does it take 
for someone to become completely blind or partially blind, that is what I 
don’t know” (Abdulla, 47, South Asian, R0)  
The notion of uncertainty regarding the progression of diabetic retinopathy was 
also apparent amongst Health Care Professionals accounts. They believed that 
the classification of the patient as low risk or high risk depended not only the on 
grade of retinopathy, but also on the impact of the disease and possible 
effectiveness of treatment and effect on visual acuity, which illustrated their lack 
of uncertainty regarding its progression: 
“Not necessarily the figures of getting it but the impact of that disease 
giving the actual treatment that you can deliver to it.  So something that is 
relatively small percentage but has a severe visual impairment and is 
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untreatable to me it terms a much higher risk overall as opposed to 
somebody that maybe has higher risk of developing but can be treated 
relatively easily and reversed I think I may put at a lower risk.” (Hayley, 
Ophthalmologist, White British) 
However, perhaps not surprisingly, the Health Care Professionals in this study 
often tended to towards more medical notions of associated risk and the 
progression of diabetes. For example, one of the General Practitioners, who 
reflected on his personal experience caring for people with diabetes 
predominantly from Asian background, believed that all people with diabetes 
are at high risk due to the nature of diabetes as “a progressive condition”: 
I don’t believe that there is much at low risk because diabetes is such a 
progressive condition.  If they don’t have high blood pressure this year and 
you consider them as low risk, next year they might have high blood 
pressure. That’s why I am dodgy about clarification more risk and high 
risk. I consider all diabetic patients at high risk, all of them.” (Fawzi, GP, 
South Asian)   
In was also the case that most of the participants with diabetes perceived that 
Asian populations are at higher risk of eye complications associated with 
diabetes compared with white population, due to hereditary factors and 
variations in life style: 
“Well I would probably say Asians are at higher risk, but only from things I 
have read in the paper or when I first had diabetes. These people are more 
at risk of getting diabetes it does mention the black population Asians and 
that sort of people may be due to their lifestyle or perhaps hereditary.” 
(Christine, 67, White British, R1) 
In addition, it also appeared that those people with diabetes who also had co-
morbidities were unable to allocate the symptoms they experienced to the 
specific condition: 
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 “I do a lot of reading, if I was having trouble reading, it was getting blurred 
I would be really worried then … I have got so many things wrong with me. 
I have got coronary heart disease, arthritis and diabetes and eye 
problems, so I don’t know which symptoms apply to which illness.”  
(Gareth, 86, White British, R0) 
According to most Health Care Professionals, people with diabetes who have 
been seen in an eye clinic perceived themselves at higher risk. This was 
particularly the case for those who have significant eye disease, those who have 
undergone laser treatment, or those who have had invasive treatment or eye 
injections. A few people with diabetes perceived that any damage caused by 
diabetes in the retinae as to be treatable by doctors, but it was clear that 
damage may not be reversible: 
“I think people we see tend to have more significant eye disease 
particularly if they start needing laser treatment or surgery or injections or 
whatever, then I think they have obviously appreciated that can be quite 
serious. Once they have got that damage, it’s permanent and established 
and not reversible.” (Andy, Ophthalmologist, White British) 
Importantly, there was a notable variation in perceived severity of risk between 
people with diabetes and Health Care Professionals when risk information was 
communicated to people with diabetes. Health Care Professionals perceived 
that a risk score of five per cent or more as high risk due to the nature of the 
non-reversible damage that could happen to the eye as a result of diabetic 
retinopathy: 
“I would put that down as a high risk.  I think anything higher than 5% I 
would probably quote as high risk particularly I would put into a package 
where most of these are non-reversible.” (Hayley, Ophthalmologist, White 
British) 
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In contrast, people with diabetes perceived themselves to be at low risk of 
developing diabetic retinopathy if their risk score was fifteen per cent or less. 
They only perceived themselves to be at high risk if their risk score increased 
to fifty percent or seventy-five per cent:  
“For me fifteen per cent is low risk, I think the high risk is about fifty per 
cent or seventy-five per cent.” (Samina, 58, South Asian, R1) 
In addition to the significant variation in risk perception between people with 
diabetes and Health Care Professionals, a number of the people with diabetes 
also appeared to have difficulty understanding statistical and mathematical 
information when risk information was communicated to them in this form and 
asked for clearer information to be given: 
“I don’t know, maybe none of them, none of them, because we are not 
understanding in the community. My ethnic group does not understand 
percentages and numbers. We do not understand writing, you can tell us 
this thing is not good, this thing is good, say it direct.” (Gurjit, 69, South 
Asian, R2) 
Health Care Professionals who specialized in diabetes related eye 
complications appeared to perceive low risk patients as those who keep their 
blood glucose under good control and do not have diabetic changes in their eye 
or insignificant changes due to having diabetes: 
“I think low risk is mainly somebody is well controlled, and my definition is 
it would have to be somebody with no diabetic changes and I hope that is 
the category that it comes under.  I mean you could have low risk in 
somebody who has had diabetes for a long time so the duration is longer 
so it will have some diabetic changes at the back of the eyes.” (Kate, 
screener) 
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As previously mentioned, people with diabetes generally perceived those who 
were treated by oral hypoglycaemic medications to be at a lower risk compared 
to those who were treated by insulin injections. For example, in the following 
quote, Allen defines himself as currently at low risk for developing sight-
threatening diabetic retinopathy, but he is also evaluating his risk of developing 
such problems. Currently, he is taking metformin and his disease appears to be 
well controlled and, therefore, he thinks he is at low risk. Whilst he may progress 
to taking insulin, until that occurred he would continue to perceive himself to be 
low risk: 
“Emm, because I am on metformin, I am assuming I am at low risk, 
otherwise I'll be on injections if I was high risk.” (Allen, 45, White British, 
R0) 
Other people with diabetes perceived themselves as low risk for different 
reasons, such as reassurances from their Health Care Provider. For example, 
Kumar experienced some changes in his retinae (R2), but his visual acuity 
remained (6/6) and he considered himself at low risk of developing eye 
complications. Despite the evidence of some change, he appeared to be 
reassured by the message communicated to him by his GP. Kumar described 
how he was told that there was improvement in his results (diabetic screening 
image) which impacted on his perception of risk: 
“Well because of my last result (diabetic retinopathy screening) which was 
like improvement, I now don’t class myself as high risk.” (Kumar, 57, South 
Asian, R2) 
The risk information that was given to people with diabetes such as “slight 
sugar” in the back of the eye without proper explanation appeared to have 
resulted in a misinterpretation of the facts and therefore a misunderstanding of 
the risk message which may lead them to underestimate their risk: 
 “He just said that there was slight sugar in the back of the one eye. I didn’t 
really, I didn’t feel that it was so severe, as it was to be quite honest with 
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you and then when I came to see the consultant it was still ok but then it 
seemed to deteriorate over the next three or four years.” (Claire, 45, White 
British, R3) 
Similarly, risk information that was communicated in such terms as “not big 
changes” also appeared to make people with diabetes feel that they were at low 
risk: 
“You mean the changes in the back of my eyes, oh yes, it’s not a big 
changes as I can’t describe, you know, if it is big changes then I would 
have worried, but sometime you got back in your mind, is it something 
going to spread or blind you, you know thing like that but after seeing 
screening results myself, it appears to me that there are not any concern 
to me unless next time I come if it shows that the patches larger than what 
it is appear this time then I will be probably worried.” (Amit, 72, South 
Asian, R1) 
In addition, many of the people with diabetes stated that because they followed 
their doctor’s advice they perceived themselves to be at low risk:  
“I am not worried too much about it because I manage my diabetes with 
the help of the doctor. If there is problem, my doctor calls me and explains. 
I am happy with my diabetes care I think I am at low risk because I do 
everything as instructed by my doctor, if I did not manage my diabetes I 
would be at higher risk.” (Kalthoom, 50, South Asian, R0) 
 “I feel I am at low risk because I do consciously follow doctor’s advice and 
take my medications when I am supposed to take them, and I do on the 
whole avoid the food that I should be avoiding you know high sugar and 
fat content foods etc.” (Abdulla, 47, South Asian, R0) 
In summary, this section about Individual’s knowledge and beliefs about 
diabetes and diabetic retinopathy indicates that many of the people with 
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diabetes in this study appeared to lack knowledge about their diabetes, and risk 
factors for developing diabetic retinopathy. People with diabetes appeared to 
perceive type 2 diabetes as safer than type 1. They also believed that people 
with type 2 diabetes and who are treated with oral medications are at a lower 
risk than those who treated with insulin. Many participants attributed the cause 
of their diabetes various reasons such as to hereditary factors, stress, and 
certain aspects of negative emotions. Health Care Professionals suggested that 
GPs should provide detailed diabetes education to people with diabetes. 
However, it was evident that GPs provided a wide-ranging information and 
diabetes education. Despite the fact that medical terms, such as retinopathy 
appeared difficult to understand by people with diabetes, it also appeared that 
Health Care Professionals regularly used these terms when risk information 
about diabetic retinopathy or screening’s results were provided. 
These data have illustrated also that the majority of people with diabetes in this 
study appeared to believe that diabetes would have some impact on their sight. 
However, the perceived effects of diabetes were viewed in a diversity of ways. 
Although some people with diabetes appeared to link diabetes with sight loss, 
others were uncertain as to what extent diabetes would impact on their sight. 
Health Care Professionals appeared divided regarding people with diabetes’s 
knowledge about the impact of their diabetes. People with diabetes’s knowledge 
appeared to be influenced by many factors, such as beliefs, past experience, 
and visible eye complications or changes in visual acuity. Health Care 
Professionals perceived “educated people” and those who were seen at 
hospital eye services to have better knowledge of their diabetes condition. 
However, it was evident that level of education was not linked to good 
understanding or better knowledge of diabetes and its complications. People 
with type 2 diabetes used specific ideas about diabetes causation and diabetes 
control and regulation to make sense of their predicament. A number of people 
with diabetes, particularly South Asians, believed that complications may 
happen due to external forces such as God’s will, changes in body function, 
cold weather, age, bad luck and fate. It was perceived by a number of people 
with diabetes that these external forces are outside their control.  
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This section has illustrated also that perceived differences in the severity of 
diabetes was a key theme when people with diabetes discussed the risk 
associated with diabetes. For example, most people with diabetes viewed 
people of South Asian background to be more vulnerable to diabetic retinopathy 
and diabetes complications compared with White British. It seems that people 
with diabetes perceived themselves at high risk if treated with insulin, had a past 
medical history, and were treated in a hospital. Those who perceived 
themselves at low risk tended not to have existing eye complications or visible 
symptoms, were treated with oral medications, were often reassured by Health 
Professionals, and tended to adhere to Health Professional’s advice. Health 
Care Professionals stressed that categorizing peoples’ risk as “high risk” or “low 
risk” should be based on their grade of diabetic retinopathy, the potential impact 
on sight, and the effectiveness of treatment. It was evident that there was 
massive variation in perceived severity of risk between people with diabetes 
and Health Care Professionals and that there were differences between the two 
groups in understanding when numeracy scales, such as percentages or 
probabilities were used. The data did not show any differences in risk perception 
between the different genders or between different participants with different 
grades of diabetic retinopathy. This could be due to the small number of 
participants in each of these different groups. 
6.3. Factors influencing self-reported behaviour 
6.3.1 Doctor-Patient interaction 
This study also found that the relationships between people with diabetes and 
their Health Care Professionals appeared to influence the ways in which people 
with diabetes made sense of their diabetes and the associated risk. For 
example, was aspect of this was the ways in which they received the information 
given to them and how they digested the information: 
“We have had a lot of different consultants at the hospital.  Obviously you 
get on with some and you don’t get on with others. I personally think it 
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depends on how it is put across to me and whether I actually like the 
person, not a good thing but you know. I think you need that relationship 
definitely with either your diabetes nurse or whoever it is.” (Claire, 45, 
White British, R3) 
Older participants appeared to be more concerned regarding their signs and 
symptoms and appeared to count more on their GPs to explain it for them: 
 
“I would take the advice of the doctors.  They know more than I do about 
it.  I have got so many things wrong with me. I have got coronary heart 
disease, arthritis and diabetes so I don’t know which symptoms apply to 
which illness.” (Gareth, 86, White British, R0) 
It was also the case that those people with diabetes who reported having good 
relationships with their GPs suggested that this facilitated access to those 
services involved in their diabetes management: 
“I do think that we have been spoiled really because we have got a good 
relationship with our doctor and the nurse and we have never had any 
problems and if I was worried that my sugar was very high I would ring 
them up and just have a chat with them and they will talk to me and yes I 
think we are very lucky.” (Jane, 82, White British, R0) 
6.3.2 Diabetes education 
People with diabetes who had attended diabetes education courses appeared 
to have changed their attitudes towards their diabetes and had become more 
aware of the risks associated with diabetic complications: 
“Well it’s still there but it is not as bad as it was it somehow seems to have 
retracted naturally because I was going to have laser treatment and it was 
all about the control of my diabetes.  My diabetes was running too high.  I 
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went on a diabetes course and they helped me to control my sugar levels 
a lot better.” (Kumar, 57, South Asian, R2) 
Diabetes education appeared to have encouraged people with diabetes to think 
more about their diabetes management and encouraged people with diabetes 
to control their blood glucose: 
 “He told me straight really, he told me to alter my diet, life style, he said if 
you want to drink, you can have a drink, if you want fish and chips or curry, 
have them but in moderation, if you want chocolate have one but in 
moderation and it seems it did the trick, yea he is really very good GP.” 
(Allen, 45, White British, R0) 
It was also apparent that such health education sessions and receiving 
educational materials appeared to influence people’s understanding of diabetes 
and could lead to improvements in their diabetes self-management: 
“Complications can happen over that one year. Yes we were always told 
that there are complications obviously with the kidneys, with the eyes, we 
were always told that, yes. I think that comes when you read any leaflet 
about diabetes, you know that just comes with diabetes and you have to 
do something about it.” (Claire, 45, White British, R3) 
“I do know a little bit about it.  I have read a little bit.  It causes blindness, 
I would sort of do anything that I was told to do.” (George, 70, White British, 
R1) 
6.3.3 Existence of visible symptoms or eye complications 
There was also evidence that people with diabetes’s experience of diabetes 
complications appeared to influence reported behavioural change: 
“I mean personally I keep a very stringent eye on my diabetes anyway 
especially having so many bleeds at the back of my eye where I have 
191 
 
ended up having laser treatment on it, so I am doing blood tests quite a 
few times during the day just to make sure everything is stable.” (Keith, 
59, White British, R3) 
This was in comparison to some of the symptomless people with diabetes who 
demonstrated less self-motivation regarding making changes to their diabetes 
self-management: 
“If I was diagnosed with it, probably would've changed. We are human 
beings, you know, once I have not been diagnosed with it, probably none 
of us may go and read about it until we have been diagnosed with it.” 
(Abdulla, 47, South Asian, R0) 
These data indicate that there were several factors that appeared to influence 
the perception of risk among people with type 2 diabetes. These included good 
Health Care Professional-patient relationship, diabetes education, and the 
presence of existing visible eye symptoms or eye complications or loss in visual 
acuity. The perceived relationship between people with diabetes and their 
Health Care Professionals appeared to influence the ways in which people with 
diabetes received the information given to them and facilitated the ways in 
which they understand the information. Good relationships with their GPs 
facilitated access to those services involved in their diabetes management. 
Older participants appeared to be more worried regarding their signs and 
symptoms and appeared to depend on their GPs to explain it for them. People 
with diabetes who had attended diabetes education courses appeared to have 
changed their attitudes towards their diabetes and had become more aware of 
the risks associated with diabetic complications. Furthermore, diabetes 
education appeared to encourage people with diabetes to think more about their 
diabetes management and encouraged people with diabetes to control their 
blood glucose. Health education sessions and receiving educational materials 
appeared to influence people’s understanding of diabetes and could lead to 
improvements in their diabetes self-management. There was also evidence that 
diabetes complications appeared to influence reported behavioural change. 
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This was in comparison to some of the symptomless participants who 
demonstrated less self-motivation regarding making changes to their diabetes 
self-management. 
6.4. The use of fear messages during risk 
communication 
6.4.1 People with diabetes’s perception of fear messages 
People with diabetes appeared to understand the need for and therefore accept 
the use of explicit language in relation to sight-threatening diabetic retinopathy 
as this was believed to make people more aware of the risk. This was 
particularly the case for those people who are non-adherent with health 
professional’s advice and at higher risk of developing sight-threatening diabetic 
retinopathy: 
“Probably strong messages would be an eye opener, wouldn’t it, to say 
that blindness could actually happen. I think it depends on your consultant 
as well at the hospital and, yes I just think you can’t have a nicely nicely 
approach, you have got to have that with your consultant yes but they do 
need to be more, you know put fear into the patient.” (Claire, 45, White 
British, R3) 
Although most people with diabetes supported the use of explicit messages a 
few found some words difficult, particularly the word “blindness”. They preferred 
using more “friendly” words, such as eye complications.  Keith, for example, 
who has proliferative diabetic retinopathy with reduced vision, was sensitive to 
the word blindness probably because he feels that it’s going to affect him: 
“Well I think blindness is a bit drastic and could frighten people. The best 
thing is to tell them that they could have complications. I think if you turn 
around and say to somebody you could go blind with diabetes that is going 
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to frighten them if you say complications could occur then I should imagine 
they would start looking after themselves” (Keith, 59, White British, R3) 
One person with diabetes believed that people with diabetes may not accept 
risk messages regardless of how they were presented. However, rather 
contentiously, she also suggested that treatment should be stopped for those 
individuals who are non-adherent: 
“Probably some will take it (fear messages) and some wouldn’t. They 
would probably give you a load abuse, telling you to mind your own 
business but I do think if you don’t listen to what they tell you, you should 
not be able to have treatment.” (Jane, 82, White British, R0) 
6.4.2 Health Care Professional’s perception of fear messages 
Some of the Health Care Professionals appeared to use detailed and 
sometimes explicit information when talking to people with diabetes. Health 
Care Professionals suggested that they used such information in order to get 
patients to fully understand the seriousness of their condition and to improve 
their adherence regarding diabetes self-care management: 
“I normally say that the diabetes has damaged their retinae with high 
sugars and that this is non-reversible damage, but then we can stop further 
progression with good control” (Andy, Ophthalmologist, White British) 
However, Health Care Professionals also stressed that they should also draw 
upon their expertise when delivering such messages to those who are non-
adherent: 
“At the same time you don’t want to really scare your patients because the 
vast majority is not going to develop diabetic retinopathy or not significant 
diabetic retinopathy so, yes it is difficult.  I think certainly for those that are 
not controlled and that are not looking after themselves, not looking after 
their diabetes I think that is certainly good thing to talk about and stress 
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that you know blindness can result if they don’t sort themselves out.” 
(Andy, Ophthalmologist, White British) 
Thus, whilst using the word “blindness” may appear shocking, some health 
professionals justified its use in terms of stimulating people with diabetes to 
become more responsible regarding their diabetes management. However, it 
was also felt that such messages may not be effective with everyone: 
“The word blindness is often quite a shocking word so I think if you really 
want to emphasize something, if you really feel that a patient needs to take 
control themselves then use the word blindness. I think that would make 
them take responsibility. I have used that word before because I felt I had 
got to say it because they are not listening, they are not looking after 
themselves so I have used the word blindness and you know stop you 
working and driving and some people still don’t care.” (Hayley, 
Ophthalmologist, White British) 
6.4.3 The use of fear messages in risk communication to prompt 
behaviour change 
Some people with diabetes reported that they would be more likely to change 
their behaviours if fear messages were used by their Health Care Professionals 
when communicating risk information about diabetic retinopathy or diabetic 
retinopathy’s results. For example, some participants used their personal 
experience to illustrate how they had reacted to such messages by improving 
their diabetes self-care management and life style: 
“People are more likely to change their attitudes once they have been 
threatened. I had my diabetes for many years, I tell you, for years, I abuse 
the situation for a lot of years, I was going away with all sort of things and 
certain ideas, then my doctor told me if you don’t alter your life style you 
will be in load of trouble. So, I have altered my life style, and had lots of 
tablets a day, and he is happy with everything now. I use to be a publican; 
I use to drink quite a lot, but never smoked in my life never smoked never.” 
(Ronald, 57, White British, R2) 
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Thus, it was felt that more explicit messages were more likely to result in 
behavioural changes. Therefore, strong messages were perceived to act as an 
“incentive” in order to save the vision of certain individuals: 
“I think blindness is obviously quite emotive thing, yes so I think if people 
knew that then that might be quite an incentive to look after their diabetes 
than say kidney problem or heart problems or whatever.” (Andy, 
Ophthalmologist, White British) 
It was also apparent that some people with diabetes appeared not to be initially 
too concerned when diabetic retinopathy screening results indicated that they 
had changes in their diabetic retinopathy grade. However, the use of explicit 
language by their Health Care Professionals had appeared to impact on their 
diabetes self-care management and resulted in changes in their lifestyle: 
“I am a shamed to say it that the screening results have not really impacted 
on me but then I was told that if I was not careful I would become blind. 
Perhaps after few weeks I was more careful with what I eat.” (Joyce, 64, 
White British, R1) 
One of the people with diabetes, George, described the use of such language 
as a “shock treatment” and a potential way to get patients’ attention regarding 
the severity of their risk: 
“You have got to tell how is it? Haven’t you. I think I would rather be told. 
I think it would, if somebody perhaps drinks a lot and to be told, look if you 
don’t stop drinking then you will go blind, it’s really up to you. I think the 
shock treatment is probably the best” (George, 70, White British, R1) 
The Health Care Professionals interviewed for this study appeared to believe 
that people with diabetes respond better to strong risk messages. There was 
evidence that they had used such messages when they felt that patients were 
196 
 
not listening to them. However, it was also clear that they preferred not to use 
strong language as they did not want to upset their patients: 
“I think strong message is more effective because they will have a good 
idea about what is going on.  Mild message they will say ok I am alright I 
have no problem at the moment but you have to emphasize on them” 
(Suresh, GP, South Asian) 
In summation, it appeared that most people with diabetes accept the use of 
plain language as this was perceived to make people more aware of the 
consequences of their behaviour. However, a few people with diabetes felt 
some words such as “blindness” were too strong and may scare people. 
Therefore, they preferred the use of more friendly words. Some of the Health 
Care Professionals seemed to advocate the use of fear messages in order to 
get patients to fully understand the seriousness of their condition and to improve 
their adherence regarding diabetes self-care management. In addition, Health 
Care Professionals stressed that they must use their skills and knowledge when 
delivering such messages taking into consideration the seriousness of diabetic 
retinopathy, people with diabetes’s behaviour, and the probabilities of 
developing sight-threatening diabetic retinopathy. It appeared that a number of 
people with diabetes more likely to change their behaviours when fear 
messages were used. They reported responding to such messages by 
improving their diabetes self-care management.  
6.5. Responses to being at risk 
Perhaps unsurprisingly, those people with diabetes who had experienced 
retinal changes tended to interpret their risk in relation to their past experiences. 
For some, their experiences had led them to appear more ‘optimistic’ about their 
diabetes and their chances of developing sight-threatening diabetic retinopathy. 
In contrast, others were more ‘realistic’ about the possibility of developing sight-
threatening diabetic retinopathy in the future. It was also apparent that 
perceiving themselves to be more at risk of developing sight-threatening 
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diabetic retinopathy could also invoke other emotions and responses, such as 
low mood or depression, underestimation of risk, denial, and sarcasm. 
6.5.1 Optimism 
A number of people with retinal changes appeared more optimistic regarding 
their chances of developing further complications. For example, some people 
with diabetes perceived that they were doing better than others and, as such, 
they are less likely to experience complications: 
“I don’t think I will be that one in the next five years. No, because I always 
think positive. You know what I mean, I always think of the good things 
you see, I don’t think of the bad.  Terrible isn’t it.” (Harry, 78, White British, 
R1) 
It was also the case that people with diabetes often perceived their chance of 
developing diabetic retinopathy to be less than others of the same age group 
and who had diabetes for the same duration. Though they often could not 
explain why this was the case:  
“Well my chances of developing diabetic retinopathy are probably less 
may be I don’t know why, I think that but probably less.” (Joyce, 64, White 
British, R1) 
Those people with diabetes who had attended eye screening for some time and 
whose screening results were negative also believed that they were less likely 
to develop eye complications: 
“I have been twice now and had it done and there has been nothing wrong 
you see so personally I think it will probably be the same next time you 
know.” (Samina, 58, South Asian, R1) 
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It was also the case that people with diabetes who perceived that they had good 
control of their diabetes appeared more optimistic regarding their chances of 
developing complications: 
“No No, I would like to think no, I don’t think there will be chance for me to 
be 1 out of 10 (patient laugh) probably this is optimistic no, ah, as far as 
now today at this moment, my diabetes is very well controlled.” (Bara, 55, 
South Asian, R0) 
It was also clear that certain individuals did not believe themselves to be at risk 
because they keep their diabetes under control: 
“I am not going to have any complications with diabetic I don't think. It’s 
been stable now for a couple of years, three years now I mean I just have 
two tablets and I don't have any problem you know so nothing varies with 
me I can as Megan said like she does my blood sugar for me and it’s no 
different to what we had 6 months ago so I am not too concerned really at 
all at the moment.” (Harry, 78, White British, R1) 
People with diabetes who had previously experienced eye problems or who had 
previously experienced episodes of bleeding tended to deem themselves as 
“realistic” regarding their risk of developing future problems. Hence, they were 
less optimistic regarding the future:  
“Well when you say I mean I don’t wish it upon myself to have problems, I 
do try to take care, but I know from the past it was getting bad, it is possible 
that something could happen within like the next 5 years.” (Kaur, 59, South 
Asian, R1) 
Similarly, Christine, who has background diabetic retinopathy, appeared less 
optimistic about her chances of not developing sight-threatening diabetic 
retinopathy. However, she also attributed the possibility of future complications 
due to her getting older rather than her lifestyle: 
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“Yes, I may develop eye complications in the next five years, I would think 
so, it’s possible, not because of my lifestyle, but as I say the ageing 
process.” (Christine, 67, White British, R1) 
6.5.2 Underestimation of diabetic retinopathy risk 
This study also found that some people with diabetes appeared to 
underestimate their risk even though they were having difficulties with their 
diabetes self-management. This appeared to be due to either a lack of 
understanding of the actual risk or due to insufficient information having been 
communicated to them about the condition: 
“I didn’t expect it to be as serious because I did feel that I did keep my 
blood sugars under control, maybe not 100% but as good as anybody else 
would. I didn’t really understand it until I came to the hospital appointment 
and then the consultant just said.  I didn’t feel anxious at that time because 
it wasn’t, when I got to the hospital the consultant just said that she was 
going to just keep an eye on me.  It wasn’t as bad then and then it 
deteriorated over the next few years.” (Claire, 45, White British, R3) 
For example, Amit appeared to underestimate his risk despite the fact that he 
had background diabetic retinopathy (R1). Amit did not appear concerned 
during the interview because he perceived the changes to be small. However, 
he did acknowledge that he would become concerned if he was to be informed 
that his condition was deteriorating: 
“Last time he has done picture as well last year and he said there is some 
sort of abnormalities in the back of my eyes so that is why I came in here, 
but the patches seem to be not that big. It is like aaa it is there very fainted 
way you know, so I am coming back again in 6 months’ time to have my 
eyes pictured again to see whether it’s going to spread or whether it is 
going to stay as is it is. But it’s not affecting me at all you know, at the 
moment I have got eye drops and I can see little bit blurred and I can’t 
read much, otherwise I can read papers with my glasses and I have got 
long distance glasses.” (Amit, 72, South Asian, R1) 
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6.5.3 Emotional responses 
A number of people with diabetes described how their risk of eye problems 
resulted in them feeling a range of emotions such as guilt, low mood or 
depression, and food restriction. For example, some people with diabetes 
expressed feelings of guilt which they related to them having underestimated 
their risk and not taking certain precautions, only to then develop eye 
complications as a result:  
“I did not give any attention at the beginning, I do not feel anxious, I feel 
naughty, yes, I do feel guilty, because emm, you know, I am aware of it is 
my fault, it is not somebody else fault. I feel it is my fault because I am not 
controlling my blood sugar, I’ve been type 2 diabetic for long time, over 
ten years.” (Joyce, 64, R1) 
Other people with diabetes who had underestimated their risk and as a result 
felt guilty also appeared motivated to improve their diabetic self-management: 
“I have started you know putting more effort to keep things under control, 
I start watch what I eat, I joined the gym, started to do exercise, I did lose 
some weight, then I put it back on. I was so angry I thought it is my fault 
that I did not control my diabetes, and that start affecting my eyes.” 
(Kalthoom, 50, South Asian, R0) 
It was also evident that some people with diabetes experienced adjustment 
problem with their diabetes. For example, Kalthoom described how she denied 
her diabetes when first diagnosed as she could not believe that it was possible 
for her to get diabetes because she was young, healthy, and fit. As a result, she 
now believes that she put herself at higher risk by not complying with health 
professional advice and by not taking her medication: 
“I also could not accept my diabetes because I was only 45 when I first 
had it, and I thought I was too young to have diabetes, because I am the 
first female in my generation in our family to have diabetes, it was very 
difficult to accept it, I did accept it but after one year, I did not take 
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medication during that year. I was always very healthy with my diet and 
my exercise, which is why I could not accept it, it very hard to accept it.” 
(Kalthoom, 50, South Asian, R0) 
A number of the people with diabetes appeared to have low mood that they 
associated with being at risk. It was also the case that needle phobia and pain 
due to daily needle breaks contributed to their low mood and led to poor self-
care management as individuals did not keep their blood glucose under control. 
For example, Samina felt that her low mood was impacting on her management 
of diabetes, which put her at risk of worsening sight-threatening diabetic 
retinopathy: 
“I don’t even check my blood sugar (laugh), no chance to break my finger 
to check sugar level. I am scare to death, no way, I don’t check it. If I am 
at home and I feel that my blood sugar dropped down I would have taken 
it, but I don’t have sticks to check it. I just know that it is my diabetes, I just 
know it. I feel down, I am sometimes depressed, I could not go out of bed 
so I eat if I want to eat and if I don’t have anything up there, then I make 
sure that I have biscuits, crackers and any pop and water. I just check my 
blood sugar when I go to the hospital. If I have to test it I just test the urine 
I go to the toilet and test it there but I don’t test the blood. I am scared of 
needles.” (Samina, 58, South Asian, R1) 
In a similar vein, Kaur, who has background diabetic retinopathy (R1), reported 
being scared of having complications. She was particularly down when she 
talked about her mother’s experience as she also had diabetes and experienced 
sight-threatening diabetic retinopathy: 
“I feel very depressed sometimes. My mom also got diabetes, she can't 
see much now, and things got worse, she is really struggling, but I don’t 
know much about my mom because I live here, and she lives in India, I 
ring my mom every day and ask her if everything is alright, or no, 
sometimes she is ok sometime she is miserable, sometimes she is crying 
sometime they don’t want to live anymore, they want to die, they turn 
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heating off and everything, everything turned off and they were sitting like 
that my mom, she is not  happy at all. She is old lady, she is 86 my mom.” 
(Kaur, 59, South Asian, R1)  
In addition, people with diabetes also described how not being able to eat the 
food of their choice could also contribute to their reported depression. For 
example, a number of people with diabetes reported feeling depressed because 
they had stopped eating what they like and had started eating what they had 
been instructed to eat, regardless whether they like it or not. It also appeared 
that the South Asian participants in this study were more affected by this 
because of the limited range of appropriate food in the UK: 
“I have spoken to my GP several times and I know exactly what to do, he 
does to me, I have to eat brown stuff no added sugar, not sugary things, I 
have to eat no cheese, low calorie milk, I eat healthy food all the time, and 
you know, I am not allowed sugary drinks not allowed orange juice, you 
are not allowed these and that.” (Kaur, 59, South Asian, R1) 
It was also apparent that Health Care Professionals recognized that the 
complexity of the disease and fear of complications could   result in patient’s 
being depressed: 
“That’s why they are frightened, what is the cause of depression in their 
diabetes? Fear, they do feel that they might get blind or their kidney fail or 
they have heart attack. They are frightened of the complications because 
when we diagnose diabetes they have no complications except the 
erectile dysfunction.” (Fawzi, GP, South Asian) 
Symptomatic people with diabetes who had advanced diabetic retinopathy (R2 
and R3) and those with low visual acuity tended to believe that they were at 
higher risk of further vision loss and therefore often appeared anxious about the 
future: 
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"I think it (diabetes) would yeah affect my eye in the next few years, I am 
really devastated." (John, 65, White British, R3) 
Individuals with existing complications could also be distressed by sudden 
changes in their condition: 
“It suddenly went blurred, the first time it happened I was outside and it 
was quite a strange sensation and when I looked up I could see what I 
know now was the blood just floating around and it was like a big cobweb. 
It frightened me because I wasn’t sure what was happening.” (Keith, 59, 
White British, R3) 
Certain participants with eye complications not only appeared more anxious 
they also wanted more risk information to enable them to maintain their vision: 
"For me, really anything is high risk even one in million. Yea because 
diabetes is there, I would like to know what is happening to my eyes. I 
have different problems in my eyes and would like to know and they 
usually complicate, different conditions complicate each other, so in my 
case, I have glaucoma, so I need to know, anything just to stay safe." 
(Younis, 55, South Asian, R2) 
These accounts demonstrate how people with diabetes responded in different 
ways to their risk of developing diabetic retinopathy. Some of them placed 
emphasis on positive thinking as a means of coping with the unknown risks 
whilst others were more pessimistic about the possibility of developing the 
condition. Alongside and linked to this were a range of emotional responses that 
included guilt, low mood, fear of developing diabetes complication, anxiety, and 
self-reported depression. These responses were influenced by the age of 
individuals, presence of existing visible symptoms or eye complications, past 
experience, lack of understanding of the actual risk, insufficient information 
having been communicated to them about their condition, family history, 
diabetes self-management, and reduction in visual acuity.  
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6.6. Responses to visual risk tools 
The use of visual risk communication tools (Figure 6.1) appeared to be favoured 
by Health Care Professionals and people with diabetes compared to using 
verbal risk communication as a means of providing risk information about 
diabetic retinopathy to people with diabetes.  
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Figure 6.1 Risk communication tools in clinical settings 
206 
 
The responses of people with diabetes and health professionals varied in 
relation to the different risk communication tools and format presented. Of 
these, some risk communication formats were deemed to be more acceptable 
while others were not found to be useful by people with diabetes for a number 
of different reasons. For example, particular risk communication tools appeared 
to present an understandable risk message, were easy to see, and provided 
risk information about the level of risk without the need for further explanation: 
“Yes I suppose so I mean if you say high risk I think that might jolt them 
into thinking I have got to keep an eye on it. Yes putting it down on paper 
like that it really puts the message over.” (Keith, 59, White British, R3) 
Visual risk communication tools were perceived to provide clearer message and 
it was felt that people with diabetes would be more likely to take notice of the 
risk message communicated through a picture rather than just simply hearing 
the message from their Health Care Professionals:  
“Well I would think it could possibly give you a clearer message to see it 
like that because if somebody said you are sort of fifty per cent, if you saw 
it on there you would think that would be better more explained I think. I 
think so because if you said whatever on there you would take more notice 
of it on a picture; I think that would be better yes.” (Jane, 82, White British, 
R0) 
Health Care Professionals advocated the use of visual tools such as the 
patient’s own retinal image as this was perceived to improve patients 
understanding: 
“There are two types of optometrists some of them are clever they put the 
photograph so I can let the patient have you know and look that will fix in 
their brain some of them just words because the picture will make better 
impression.” (Suresh, GP, South Asian) 
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Health Care Professionals generally supported visual tools for those from ethnic 
minority groups or those who struggle with the main language used: 
“Yes and I think if you have got something visual because obviously a lot 
of wording in diabetes can get quite complicated. I think if you have got 
something visual because obviously not everybody can understand 
languages the same as everybody else because obviously we see a mixed 
race of ethnicities so if you have got something that is quite visual so green 
is good, red is poor then I think it does give a good understanding of how 
their control is.” (Kate, screener, White British) 
A number of the visual risk communication tools were viewed as less 
appropriate by the majority of the people with diabetes and Health Care 
Professional due to different reasons. For example, the highlighted human 
figures (Figures 6.2) was not supported as people with diabetes felt that it could 
give wrong impression that they are at low risk or low probability of developing 
eye complications: 
 
Figure 6.2 represents highlighted human figures 
 
“See, that one (highlighted human figures), like, it says 1 in 10 people, 
would probably think I am not going to get it yet. So I would probably block 
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that one out, that one probably, yes that is really low as well.” (Claire, 45, 
White British, R3) 
Other people with diabetes responded to the highlighted human figures (Figure 
6.2) in other ways:  
“I'd always believe that I am not in that bracket.” (Samina, 58, South Asian, 
R1) 
A number of risk communication tools were not favoured by people with 
diabetes due to their inability to understand scientific materials. Such tools were 
even of concern to a few of them. For example, the bar graph (Figure 6.3) was 
not favoured and described by people with diabetes as “boring” and “too 
technical”: 
 
 
Figure 6.3 represents bar graph format 
 
“The rectangle with one end highlighted looks boring and too technical.” 
(Abdulla, 47, South Asian, R0) 
While Health Care Professionals show their concern as they state that bar graph 
gives wrong risk message particularly to non-educated individuals. Their main 
concern was that people with diabetes, who are at high risk, may not understand 
these risk tools and perceive their risk as low risk. The main concern was that 
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the lack of perceived severity of risk may lead to people underestimate their 
risk, and therefore not prioritise their diabetes care: 
“My personal view is that this actually makes quite a high risk look quite 
low. Yes I think bar graphs sometimes would throw people and I think 
people who are not particularly educated would struggle with a bar graph 
and because you have some people that are professors and some people 
that haven’t finished school so I think you would probably have to gauge it 
according to your patient as you talk to them.” (Hayley, Ophthalmologist, 
White British) 
Similar to single bar graph, the graphic that displays the use of multiple bar 
graphs appeared also not supported by people with diabetes. For example, risk 
tool number four (Figure 6.4), represents a vertical bar graphs format that was 
used to communicate comparative lifetime risks for a 50 year old woman 
including the risk of heart disease, osteoporosis, stroke, breast cancer, and 
endometrial cancer was not supported either by Health Care Professionals or 
by people with diabetes. Claire described it as not attractive tool that stimulate 
people to understand their level of risk: 
 
 
Figure 6.4 represents vertical bar graph format represents lifetime risks of heart disease, osteoporosis, 
stroke, breast cancer, and endometrial cancer 
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“I don’t think that figure (Figure 6.4) comparing different condition is a good 
one, I don’t think that would wake people up”. (Claire, 45, White British, 
R3)  
People with diabetes who had an advanced level of diabetic retinopathy were 
facing a significant challenge in not being able to see the contents of some risk 
communication tools. This was clear in the case of Claire and George who both 
struggled to see the thousand-consecutive highlighted human figures (figure 
6.5): 
 
Figure 6.5 represents a thousand-consecutive highlighted human figure formats 
 
“This one (A thousand figures) made my eyes go funny. It‘s not nice. I think 
the other tools are much better. It looks like a pixellated PC screen.” 
(Claire, 45, White British, R3) 
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“Again I would find that more complicated, it is not easy to see the black 
bits for a start, I would not go for that one either.” (George, 70, White 
British, R1) 
The poor quality of risk communication tools in terms of its visual presentation 
appeared to influence people with diabetes’ decision as not a tool of preference, 
even though they had normal diabetic retinopathy screening photo (R0). For 
example, in the following extracts, Jane and Abdulla are talking about their 
difficulty seeing the human figures (Figure 6.6) and therefore the tool was not 
supported: 
 
Figure 6.6 represents a thousand-randomly highlighted human figure formats 
 
“You can't be serious, that's a joke I can’t even see it.” (Jane, 82, White 
British, R0) 
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“This one didn’t make sense. It is very difficult to see and to be honest with 
you it did not make sense to me. Personally, I don’t like it.” (Abdulla, 47, 
South Asian, R0) 
Although George had good visual acuity, he did not like the consecutive 
highlighted human figures or the bar graph. The human figures, in particular the 
thousand consecutive and randomised figures, were deemed to be difficult for 
those who have low visual acuity: 
“The thousand-random highlighted human figures are not good, I don’t like 
that one. I would find that more complicated, it is not easy to see the black 
bits for a start, I would not go for bar one either.” (George, 70, White British, 
R1) 
Some people with diabetes supported the use of smiley and sad faces (Figure 
6.7): 
 
Figure 6.7 represents the advantages of taking statin tablet for 10 years, five patients would be saved 
and would not have cardiovascular event (yellow faces) 
 
“I think that graph is better (smiley and sad faces). Yes that is the one” 
(Jane, 82, White British, R0) 
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However, the smiley faces were also considered to give the wrong impression 
regarding personal risk as they potentially left individuals   with the impression 
that they are at low risk: 
“Looking at this (smiley and sad faces), I’d assume I am a green low risk.” 
(Abdulla, 47, South Asian, R0)  
Many of people with diabetes and the Health Care Professionals appeared to 
favour the traffic light approach, which was perceived to personalize risk. In 
particular, it was believed to better capture people’s attention because it allowed 
individuals to perform a risk self-assessment: 
“This is also good tool because you have got the three (colours), rather 
you have got more in the middle in the risk factor than around the edge, 
yes definitely. I think if each patient had to fill that in honestly, yes, but they 
need to be explained to as well because they don’t always get explained 
to, it depends obviously on their consultant. I mean if like you just said, 
you have got more in the middle then obviously you need to sort yourself 
out.” (Claire, 45, White British, R3) 
A number of the people with diabetes favoured the traffic light system (Figure 
6.8) that has been used to communicate risk information in cervical cancer 
screening (Chiu, 2009). This was because it included the risk factors associated 
with developing the condition. Abdulla suggested that the cervical cancer risk 
factors should be replaced by diabetic retinopathy risk factors: 
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Figure 6.8 represents a breast cancer self-assessment risk tool 
 
“I think if you change these risk factors, if you replace them with the risk 
factors of diabetic retinopathy, you know like you say family history and 
the type of diabetes the duration and the blood sugar control and the blood 
pressure. It would be amazing” (Abdulla, 47, South Asian, R0) 
This particular tool was also supported by health professionals, as it could be 
modified and include risk factors of developing diabetic retinopathy: 
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“I think this is good it kind of if you include all the factors of diabetes. I think 
most patient would find it helpful to know where they were on the chart.” 
(Kate, screener, White British) 
It was perceived to allow individuals to evaluate their diabetes management in 
a clear and easy style, which was not necessarily the case with written 
information. It was felt that this tool was useful because it drew all of diabetic 
retinopathy risk factors together that could guide health professionals during 
consultation and utilize their time more efficiently: 
 “I think if they can justify what they put down then that would give a nice 
clear representation. It would immediately give you a clearer impact that 
you don’t see necessarily in the written what’s down in the written notes.  
If you can quickly surmise looking at all the 6 or 7 factors that these are all 
well controlled, then it is the evidence that they are then that would put 
patients into the appropriate category to consider longer or shorter 
duration of screening.” (Andy, Ophthalmologist, White British) 
Health Care Professionals felt that the use of a colour coding system facilitated 
risk interpretation. They perceived that people with diabetes would absorb and 
understand the risk information in more appropriate ways and attach different 
colour coding to different level of risk: 
“A green or red traffic light system I think would make people understand 
very easily and they can understand that if everything is looking green 
things are looking good and if things are into red then they have a got 
something that they should be worried about even if they don’t necessarily 
understand why they need to be worried or what the reason for it is.  If you 
have got a colour representation it is very effective.” (Andy, 
Ophthalmologist, White British) 
To summarise, risk communication tools appeared to be favoured by both 
people with diabetes and their Health Care Professionals. It was perceived as 
216 
 
good way to provide a clear message and communicate risk information about 
diabetic retinopathy. Risk communication tools were perceived to be particularly 
helpful to ethnic minority groups and those with literacy issues. However, people 
with diabetes and their Health Care Professionals also raised their concerns 
about the presented risk communication tools for different reasons. One 
concern raised by Health Care Professionals and people with diabetes is that 
some risk communication tools may give the wrong impression in that high risk 
could be viewed as low risk. The majority of people with diabetes, particularly 
those who have existing vision loss symptoms or eye complications, along with 
Health Care Professionals, favoured a tool that personalised risk information. 
These allowed individuals to evaluate their diabetes management in a clear and 
easy style unlike written information. It was favoured by Health Care 
Professionals as it could gather all risk factors in one tool that could guide them 
during consultation and utilize their time more efficiently. 
6.7. Conclusion 
This chapter highlights a few issues in regard to people perception of risk by 
people with diabetes. These included knowledge and beliefs, factors influencing 
self-reported behaviours, the use of fear messages, responses to being at risk, 
and their responses to various risk communication tools. The data has shown 
that the participants understandings and the perceptions of risk was subjective, 
premised upon their personal circumstances, constructed in relation to those 
around them and influenced by cultural differences, beliefs, the individual’s 
knowledge, type of diabetes, presence of visible eye complications, and the 
individual’s past experience. The perceived risk varied between people with 
diabetes. There was difference also in risk perception between people with type 
2 diabetes and Health Care Professionals. Few factors appeared to improve 
behavioural changes such as good relationship between people with diabetes 
and their Health Care Providers and the use of fear messages. People with 
diabetes responded to being at risk in different ways, such as being optimistic, 
underestimating diabetic retinopathy risk, or having emotional responses such 
as denial, low mood and self-reported depression. The lack of knowledge about 
diabetes and its complication points out the importance of designing educational 
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material that address people with diabetes’s educational needs, how to frame 
the risk messages, and takes into consideration the differences in perception of 
risk between people with diabetes and their health professionals. Several 
factors influenced perception of risk such as individual’s knowledge and health 
education, ethnicity, Professional-patient interaction, methods of risk 
communication, and presence of visible symptoms. These factors should be 
considered by Health Care Professionals before providing risk information 
about diabetic retinopathy in addition to grade of diabetic retinopathy, the 
potential impact on sight, and the effectiveness of treatment. People with 
diabetes and Health Care Professionals highlighted their preference in relation 
to framing risk message and the use of fear messages to improve their 
adherence regarding diabetes self-care management. In addition, Health Care 
Professionals stressed that they must use their skills and knowledge when 
delivering such messages taking into consideration the seriousness of diabetic 
retinopathy, people with diabetes’s behaviour, and the probabilities of 
developing sight-threatening diabetic retinopathy. It appeared that a number of 
people with diabetes more likely to change their behaviours when fear 
messages were used. People with diabetes responded to being at risk of 
developing diabetic retinopathy in various ways. Some of them appeared 
optimistic and others appeared more realistic about the possibility of having the 
condition. Other responses were noticed such as underestimation of risk and 
emotional responses that includes guilt feeling, low mood, fear of developing 
diabetes complication, anxiety, and self-reported depression. These responses 
were influenced by the age of individuals, presence of existing visible 
symptoms. Health Care Professional and people with diabetes support the use 
of visual risk communication tools to facilitate inform decision. Most of them 
favour a tool that personalised risk information and allows individuals to 
evaluate own risk in a clear and easy style. 
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 Stage Two Results 
7.1. Introduction 
This chapter presents the findings of the stage two interviews that were 
designed to explore the views of people with diabetes regarding a newly 
developed diabetic retinopathy risk communication tool together with its 
perceived influence on knowledge, risk perception, beliefs, and levels of 
anxiety. Finally, the chapter explores people’s preference of the most 
appropriate methods of communicating risk information about diabetic 
retinopathy and diabetic retinopathy screening results to people with type 2 
diabetes. 
7.2. Development of the new diabetic eye risk 
communication tool 
Existing risk communication tools that have been used in other clinical settings 
have been discussed in Chapter Four. Stage One of the study explored the 
preferences of people with diabetes in relation to risk communication tools that 
personalize risk information (Chiu et al., 2009). From this, a tool was developed 
to provide risk information about diabetic retinopathy to people with type 2 
diabetes. Initially, the new risk communication tool was modified and included 
all the risk factors that contributes to diabetic retinopathy including type of 
diabetes, duration of diabetes, previous retinopathy, blood glucose level, blood 
pressure, lipid level, smoking, and family history (Figure 7.1).  
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Figure 7.1 Diabetic Eye Risk Communication Tool including all risk factors 
 
The tool was presented to Warwick Diabetes Research and Education User 
Group and to the research team. Warwick Diabetes Research and Education 
User Group members felt that the tool was too complicated, when all the risk 
factors are included, and hence requested fewer risk factors be presented and 
include the most significant risk factors only. Based on the available evidence 
as mentioned in chapter two (section 2.11.1), the researcher then decided to 
keep only four risk factors in the final version of the new risk tool (Figure 7.2), 
including blood glucose level as the most significant modifiable risk factor, in 
regards to the progression of diabetic retinopathy (Yau et al., 2012), that 
potentially can motivate people with diabetes to control their blood glucose level 
to remain at low risk of developing diabetic retinopathy. The new risk 
communication tool is divided into four quarters (see figure 7.1). Each quarter 
represents one of the most significant risk factors for developing sight-
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threatening diabetic retinopathy; type of diabetes (Stratton et al., 2001); duration 
of diabetes (Stratton et al., 2001); the most recent HbA1c (UKPDS, 1998) and 
changes in the retina found in the last screening result. These risk factors were 
prioritized in the new diabetic eye risk communication tool based on the 
available evidence to make it “comprehensive”, easy, friendly, and less 
complicated for individual’s to use (Weinstein and Sandman, 1993). Each 
quarter was divided into three parts, and each part was given specific colour. 
The outer part is a green colour that means low risk, the middle part is amber 
indicating medium risk, and the inner part is red indicating high risk. 
 
 
Figure 7.2 Diabetic Eye Risk Communication Tool 
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The new diabetic eye risk communication tool was appraised by twenty people 
with type 2 diabetes (R0 and R1). The socio-demographic characteristics of this 
group are shown below in Table 7.1 and Table 7.2 
 
Table 7.1 Stage Two socio-demographic characteristics 
Interview participant  Number=20 
Range age 40-78 years 
Mean age 61.5 
Gender 
Male  13 
Female 7 
Ethnicity 
White British 9 
South Asian 11 
Level of retinopathy 
R0 10 
R1 10 
R0: No diabetic retinopathy, R1: background diabetic retinopathy 
 
 
Table 7.2 Stage Two Participants Characteristics 
WB: White British, SA: south Asian, V/A: Visual Acuity 
 
Number Name Reference Age Sex V/A Grade (R, L)Medical historyOccupation Education 
1 Nick WB 79 M 6/6, 6/6 R0 Retired None
2 Jack WB 62 M 6/6, 6/6 R0 Mechanic Diploma
3 Doug WB 66 M 6/9, 6/6 R1 Teacher Degree
4 Petty WB 55 F 6/6, 6/6 R0 CABG,BP Shopkeeper None 
5 Joy WB 64 F 6/6, 6/9 R1 None Unknown
6 Geralrd WB 53 M 6/9, 6/9 R1 Unknown Unknown
7 George WB 70 M 6/6, 6/9 R1 Retired NVQ
8 Gareth WB 86 M 6/6, 6/6 R0 Retired Unknown
9 Jean WB 75 F 6/9, 6/9 R0 Pensioner GCSE
10 Lily SA 72 F 6/9, 6/6 R1 Retired Diploma
11 Amy SA 54 F 6/6, 6/6 R1 BP Nurse Degree
12 Salma SA 50 F 6/6, 6/6 R0 Bank Degree
13 Amjad SA 76 M 6/9, 6/9 R0 Retired NVQ
14 Bashar SA 72 M 6/5, 6/6 R0 BP Retired None
15 Amin SA 72 M 6/9, 6/12 R1 Shopkeeper GCSE
16 Hassan SA 62 M 6/6, 1/60 R1 Optic NeuropathyTaxi driver None 
17 Ali SA 73 M 6/6, 6/9 R1 Retired Degree
18 Rehana SA 68 F 6/6, 6/6 R0 Unknown Unknown
19 Sam SA 57 F 6/6, 6/6 R0 Secretary Degree
20 Kaur SA 59 F 6/12, 6/18 R1 Obesity None Diploma
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7.3. Responses to the new diabetic eye risk tool 
The new tool was generally reported to be helpful and easy to use by people 
with diabetes. It was described as a good visual representation that may 
improve the understanding of risk for some people:   
“I think this tool is very helpful. A visual representation for some people is 
the only way they can understand it.” (Nick, 79, R0) 
One positive aspect of the tool was that it enabled people to see how they could 
balance non-modifiable factors (e.g. years with diabetes) with modifiable ones 
(e.g. Blood Glucose levels): 
“This diagram or traffic light system, I think I am in the safe side. Three 
green (quarters) is very good, and this one in the amber shows that I had 
diabetes for longer than five years, but my diabetes sugar level is in the 
green side, because it is well controlled. It is less than seven always and 
I haven’t got any changes in my both eyes, so probably my understanding 
is that I am in the safe side. This is really good way of explaining it to me, 
I can see that I am at low risk.” (Mubarak, 47, South Asian, R0) 
A number of people with diabetes, particularly those who scored four greens in 
the risk tool, appeared to be reassured by using the new risk tool. It provided 
them with information about their level of risk, as well as highlighting areas of 
concern in order to help them keep their diabetes under control: 
“Having four in the green side, I must be at low risk then isn’t it, still I should 
be careful so I don’t go beyond, I have to stay like this and keep myself in 
the green side.” (Jack, 62, R0) 
The new risk communication tool was also perceived as something that could 
be used by a range of Health Care Professionals, such as GPs, practice nurses, 
opticians, or diabetic retinopathy screeners: 
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I guess the best person who should go through it should be health 
professional, I think the doctor himself or practice nurse, or I think the 
optician who does diabetic screening would be good to explain it to 
people.” (Mubarak, 47, South Asian, R0) 
7.4. The influence of the new risk communication tools 
on risk perception 
People with diabetes’ appeared to find the new risk tool useful for making sense 
of their future risk, as most people with diabetes appeared to be aware of the 
different risk categories (high, medium, and low). In short, they could link the 
different risk categories contained within the tool to the probability of them 
developing complications: 
“Low risk means that there is low possibility of me getting complication 
with my eyes, and high risk means there is higher possibility of me getting 
complications with my eyes, if my blood sugar is high that means I am at 
higher risk, and if I had my diabetes for long time that also means that I 
am at high risk which may create problems. I may be at old age probably 
I will classify that I would be at high risk, or when I attend the eye screening 
if I had changes in my eyes or my vision deteriorated, then probably I 
would be at high risk. But now I think I am at low risk.” (Mubarak, 47, South 
Asian, R0) 
A number of people with diabetes also appeared to make a connection between 
their perception of risk and their blood glucose results after using the tool. 
However, it was felt that some people with diabetes, particularly those who 
lacked knowledge, may require more information about the differences in blood 
glucose level at certain times; for example, the ways in which blood glucose 
levels may vary before and after taking medication. The following quote 
highlights the confusion that people with diabetes may have regarding the 
differences between HbA1c and blood glucose level: 
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“I think I am at high risk because of my blood sugar, isn’t it? My blood 
sugar is between seven-to-nine which is amber. But you know sometimes 
when I eat something in the night time and I don’t take medication and I 
eat, then in the morning my blood sugar come to eleven and twelve, before 
medication it is six and seven in the morning but if I eat any food, it goes 
up and up and up, I have to eat, you know, I am diabetic, so yes I am at 
high risk, because when I when I eat, I got sugar in my blood then I am at 
higher risk, because I got no energy, I can’t walk much so I got no energy 
and I can’t do nothing, but if I got low sugar, I have to put sugar in my tea, 
and swallow it and drink it, and I got more energy to walk and thing like 
that so I can do things but then I got sugar high, I don’t know what to do, I 
really don’t know what to do, because if I got no eating sugar, then my 
energy is gone,  I can’t walk much.” (Kaur, 59, South Asian, R1) 
The use of the new risk tool was also tied in with the ways in which people with 
diabetes made sense of their diabetes and diabetic retinopathy. For example, 
Lily scored one red, one green, and two ambers when she used the tool. 
However, whilst she then perceived her risk as high, she attributed her high risk 
to noticeable symptoms such as watery eyes or not wearing sunglasses, as 
opposed to her blood glucose level or other risk factors: 
“I think I am at higher risk, because I am naughty, I keep forgotten my 
glasses, and my eyes keep running water, in the summer it is always 
watery, and people say why are you always crying?” (Lily, 72, R1) 
7.4.1 Knowledge of diabetic retinopathy risk factors 
The new risk communication tool appeared to help individuals understand the 
risk factors associated with developing diabetic retinopathy: 
“This traffic light system is really good way of explaining the risk factors of 
diabetic eye, I was a bit worried but now I can see clearly that I am at low 
risk.” (Hamza, 40, South Asian, R0) 
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Thus, providing risk information in a clear and attractive style was perceived to 
improve patients’ understanding of their own risk and there was also some 
evidence to suggest that people with diabetes may change their diabetes self-
care management as a result: 
“Doing this test, made me think a lot deeper than I did before ... because 
I have 2 reds and 2 greens, I should give more attention to my diabetes to 
keep my eyes safe.” (Alan, 45, R0) 
It was also apparent that the new tool could re-assure those who were at low 
risk. This group described how they felt positive about their diabetes and the 
ways in which they managed it and also noted the potential benefits of 
continuing with their regime: 
“Having scored 4 greens means that I am doing the right thing, so I should 
continue the good work and keep my blood sugar under control and look 
after my diet” (Hamza, 40, South Asian, R0) 
The use of certain colours appeared to help in understanding risk, particularly 
the colour red that is generally associated with danger which in this case was 
associated with high risk of blindness and complications. In addition, the 
universal association of red with danger was found to facilitate the presentation 
of risk for those who could not read or whose their first language was not 
English: 
 “Yes, I can understand this, green is safe, red is more risk of 
complications and blindness may be, yes, red is danger.” (Amy, 54, South 
Asian, R1) 
There was also some evidence to suggest that using the tool could help people 
with diabetes to become more aware of the fact that diabetic retinopathy is 
associated with the duration of diabetes: 
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“Green means less danger and red means more danger. The fact is 
because I had it for long time that means I am at more risk, because the 
longer you have it there are more risks associated with it you know.” 
(Doug, 66, R1) 
The design of the risk tool, which incorporated the traffic light system, also 
appeared to encourage people with diabetes to interpret their own risk by 
comparing their position in relation to conventional use of such colours. In other 
words, they could interpret their own risk easily, because the colour coding 
where green means safe and red means danger is internationally accepted and 
widely used. Therefore, individuals could easily confirm that their risk is low and 
that they were managing their diabetes effectively: 
“This tells me that what I understand is obviously it is traffic light system, 
isn’t it? So green is go. So I am assuming green is giving the perception 
that is I know what I am doing and how to manage my diabetes effectively, 
red is danger I would be worried if I had more in the red zone.” (Alan, 45, 
R0)  
7.4.2 Diabetes Self-Care Management 
The use of the risk communication tool was also perceived as being able to help 
people with diabetes to remember risk factors and to incorporate this knowledge 
into their self-management, particularly in terms of it being something that might 
encourage people to keep their blood glucose levels under control. The 
following quote from Mubarak demonstrates that he perceived the tool would 
help him to retain the information that he was given by his Health Care Provider. 
He scored one red (duration of diabetes) and three greens, which he interpreted 
as not being at risk: 
“This tool tells me, my understanding, having 3 greens, there is high 
possibility of not having diabetes complication in my eyes, obviously, I got 
red one because I have had diabetes for long time, this tells me that I may 
have some complication with my eyes but I think having 3 in the green 
side, so far no changes in the eyes, good glucose control always less than 
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seven, and having type 2 diabetes, so I assume I am in the safe side, I 
understand that I have no control on duration of diabetes or type of 
diabetes, but I can keep my blood sugar under control to keep my eyes 
free of any future changes … well, my doctor did explain thing to me and 
did explain that diabetes could cause blindness, but to be honest, this tool 
helped me a lot to remember such information.” (Mubarak, 47, South 
Asian, R0) 
Many of the people with diabetes viewed diabetic eye screening as a re-
assurance regardless of their level of risk (as discussed in the previous 
chapter): 
“I believe everybody should attend eye screening regularly as told by 
doctor, because you never know, things may happen quickly and 
suddenly. I feel confident now after using this tool, I feel that I am at low 
risk, and that is what the doctor says as well, that I have to keep my blood 
sugar under seven.” (Salma, 50, South Asian, R0) 
The design of the risk tool as traffic light system appeared to improve 
awareness of the importance of diabetes self-care management and could lead 
people with diabetes to re-evaluate their personal care. For example, Salma 
suggested that she would change certain behaviours in relation to her diabetes: 
“The red colour means either I am not looking after myself then I need to 
do something about it, but if it happened not because I am not looking after 
myself then I need to take steps to make sure that does not get worse, or 
whatever the medical outcome will be. If I had something in the amber or 
the red, obviously I need to change my plan, but, if I carry on looking after 
myself I should, emm, I might still be just here (amber), I might not 
progress further.” (Salma, 50, South Asian, R0) 
People with diabetes viewed the risk communication tool as a good means of 
self-assessment and could help people with diabetes control their blood glucose 
228 
 
level. For example, it appeared that the risk tool helped Mubarak to understand 
that his risk would remain low by keeping his blood glucose level within 
recommended parameters. Moreover, this could then protect him from 
developing sight-threatening complications: 
 “I think it is clear and good tool, for people with diabetes to identify 
themselves, if they are in the green or red side, if there is a greater 
possibility for them having complications with their eyes, obviously, again, 
probably this is not hundred per cent perfect, but it helps a lot. I think I 
should maintain my diabetes well controlled below 6.5, so no changes to 
my eyes would happen probably. I should be wise and look after my 
diabetes, watch what I eat and try to keep things under control.”  (Mubarak, 
47, South Asian, R0) 
Thus, it appeared that the new risk tool could help individuals to focus on their 
diabetes care in order to prevent further deterioration: 
“Obviously, if you have things scored in the amber, this means that things 
are not quite right, and things could deteriorate and become more in the 
danger zone.” (Amjad, 76, South Asian, R0) 
Using the risk tool appeared to encourage people with diabetes to think critically 
about their diabetes and the risk factors that could have an effect on their eyes. 
For example, Mubarak became aware that having diabetes for a long time may 
not be a problem as long as he did not experience changes or damage in the 
retina: 
“I think will not be wise of me to think too much about what is going to 
happen in the future because I am in the safe side and all my screening 
tests show that photographs were clear that there is no problem at the 
moment anyway. The number of years I have had diabetes is not many 
years, if I have had changes in one of my eye probably I would be 
concerned about it, and probably I will think that I started to be at risk.” 
(Mubarak, 47, South Asian, R0) 
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7.4.3 The impact of the risk tool on behaviour 
Those people with diabetes who scored four greens with the new tool appeared 
to be reassured and saw this as a sign of ‘reward’ for trying to control their blood 
glucose level: 
“What I found is, by doing this test with what you call it risk tool, this made 
me think to be honest a lot deeper than I did before, I do feel happy now, 
you made me by just doing this exercise alone, think really deeply about it 
more than I have done before, it made me feel happy that I am actually at 
low risk and I need to keep the hard work I am doing. This is really good it 
is fantastic, thank you.” (Petty, 55, R0) 
It was also apparent that using the tool could motivate low risk people with 
diabetes, particularly those with no risk factors, to report that they would 
continue to control their diabetes: 
“Having four greens means to me that I am coping ok with my diabetes, I 
think, because I am controlling it very well. I understand that I need to keep 
my blood sugar down to stay at low risk. I am concentrating on my diet as 
well as my tablets really. Sometimes I go out for a pop meal, and I have a 
pint which has sugar in it. But only I have one pint of drink don’t get me 
wrong I am not a drinker. Sometimes the meal I have can have gamon 
steak, which is a bit high in fat, but I don’t take a lot of it any way. So I think 
although I do it occasionally, this tool tells me that I am still doing well with 
my blood sugar.” (Nick, 79, R0) 
As is apparent in the example below, it was also evident that such emotions 
may change, particularly if his blood glucose level improved. Thus, the traffic 
light system appeared to offer people with diabetes insight into the benefit of 
behavioural changes. For example, the modifiable risk factor (HbA1c) could 
alter from one colour to another based on people’s diabetes self-management. 
Thus, if a person with diabetes scores amber this could change to red colour if 
their diabetes self-care management deteriorated or could change to green 
colour if their diabetes self-care management improved:  
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“Obviously I am in a sort of warning phase where I am not quite ready yet 
which is like you got to take direct and immediate action but you heading 
towards it as I see it from this traffic light system, I have amber and could 
move to red you know, emm, I feel a bit anxious, you know because I 
thought I was doing ok actually but with this traffic light system, you are 
not doing too bad but you could be doing a lot better, but at the same time 
you could be doing a lot worse, but if you don’t pay attention it could be 
costly. Yes that makes very good sense, as I say I can see very well now, 
I do realize that there is direct correlation between diabetes and eye 
complication which I understood anyway, because as I said anyway my 
understanding is that my diabetes is not bad at all really, you know, I 
understand the complications and stuff.” (Alan, 45, R0) 
People with diabetes reported that if they were able to see improvements or 
deteriorations in their risk score when using the tool then that could also 
encourage them to improve their diabetes self-management: 
 “It is good now (blood sugar level), better than before, this morning it was 
seven and a half only, I should keep it always low, you know before, my 
blood sugar was really high, always thirty-five or forty, now it is seven or 
ten sometimes goes up to fifteen but this is very rare. I always try to keep 
it low as much as I can.” (Bashar, 72, South Asian, R0) 
The traffic light system also highlighted the importance of the amber zone 
between high risk and low risk as this prompted people with diabetes to 
recognise the importance of moving towards the green zone: 
“Well still I think I am in the middle, don’t I, I think I need to keep my blood 
sugars level down, yes, I think that is the way to save my vision. I think I 
am at moderate risk now, emm, looking at this, I can’t go back now, and I 
had my diabetes for many years and couldn't be changed. I presume if I 
take my self to the green rather than midway between amber and green, 
which is going to be my hope to secure my sight.” (Joy, 64, R1) 
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However, it was also apparent that the risk tool could increase people’s levels 
of anxiety, particularly if they did not control their blood glucose and were in 
danger of future complications. In contrast, if they were able to control their 
blood glucose they could reduce the risk to their sight: 
“Well, with this traffic light system you know it could be really two ways, 
although it could increase peoples anxiety level, it tells you that you need 
to do a bit more, well actually if I do a bit more to sort of limit sugar intake 
I will be going back to green and if I increase my sugar intake, I will be 
heading towards red, if I don’t pay attention to it I am going to red, and 
towards complications, so I mean it is always going to be anxious because 
you start think, ok, am I doing the right thing am I having too much now, 
or too little because it worries me sometime because I might have low 
blood sugar level you know and I am not sure is that to do with the mood 
because I was diagnosed few years back with clinical depression and I 
was wondering, emm, ok how much is this sort of health based and how 
much is due to psychologically base you know, I agree with you, I should 
keep my sugar intake low, keep it under control.” (Alan, 45, R0) 
7.4.4 The impact of the new risk tool on health beliefs 
This section demonstrates how people with diabetes integrated their score on 
the risk tool with their own health beliefs around diabetes. For example, some 
people with diabetes did not perceive themselves to be at risk despite the fact 
they had diabetes for long time, their blood glucose was uncontrolled, and they 
had changes in the back of their eyes. For example, in the case of Amin, the 
risk tool made him more conscious of his risk though he also sought to remain 
optimistic: 
“For me, the red colour means danger signs (laugh), the yellow is medium 
and green is low risk. …I have one in the green, two in the amber and one 
in the red side, at the moment I am at low risk for me personally, but it 
depends on how people maintain to look after themselves, how they 
control their blood sugar, I am not getting young I am getting old now, I 
think my risk is balanced between the two (high risk and low risk), I would 
232 
 
say I am in between, I could not tell you exactly, I think it is in between” 
(Amin, 72, South Asian, R1) 
Chapter six showed the differences in understanding risk. For example, a five 
per cent risk appeared high to one person with diabetes and low to another 
person. The majority of people with diabetes classified themselves as low risk 
or high risk before they used the tool. This tool appeared to get people with 
diabetes to think about the facts and appraising themselves according to their 
own way of life and own values. Similar to Amin, Hassan avoided using the word 
“high risk” despite the fact that he might be at higher risk, preferring to 
categorize himself as medium risk: 
“I think I am at medium risk, having one item in the red side, one item in 
the amber and two in the green.” (Hassan, 62, South Asian, R1) 
In contrast, Amy, who scored one red, one amber and two greens and, as such, 
may not be perceived to be at high risk, believed that she is at high risk because 
she also had hypertension. Thus, her distress during the interview appeared to 
be related to her more general concerns regarding wider health issues: 
“I think I am high risk now, it is in between actually, but I said it is high risk 
for me because I have other health problems. I have high blood pressure 
also, and I think its related to each other, the blood sugar and blood 
pressure are connected with each other, I know diabetic retinopathy is one 
of the most serious complications of diabetes I know, but the problem is 
because of the high blood pressure, it might cause some other problems 
not only eyes, this is why I said I am at high risk.” (Amy, 54, South Asian, 
R1) 
To summarise, the data in this chapter indicates that the new risk tool was 
reported as helpful and easy to use by people with diabetes. It was described 
as good visual representation that may improve the understanding of risk of 
diabetic retinopathy. It also enabled people to see how they could balance non-
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modifiable factors with more modifiable risk factors. A significant number of 
people with diabetes appeared to be reassured by using the new risk tool, which 
could be due to the fact that the recruited people with diabetes were at low risk. 
The lack of negative comments about the tool may be due to the fact that the 
participants in stage two were at low risk. Most people with diabetes appeared 
to be aware of the different risk categories (high, medium, and low), and 
therefore, they appeared to incorporate their perception into the new risk tool. 
However, a number of people with diabetes also appeared to link their 
perception of risk and their blood glucose results rather than HbA1c results after 
using the tool. Providing risk information in a clear method appeared to provide 
people with a new way of understanding of their own risk and was often linked 
to them discussing how they may change their diabetes self-care management 
as a result of this new way of thinking about and framing the risks associated 
with diabetes. in particular, the new risk tool was found to facilitate the 
presentation of risk for people with poor literacy or whose first language was not 
English. The design of the new risk tool as traffic light system also seemed to 
make people with diabetes understand their own risk by comparing it with the 
usual use of such colours. The risk tool appeared to help people with diabetes 
to remember certain risk factors. Furthermore, people with diabetes were 
critically thinking about the risk factors and its effect on their eyes. It appeared 
that people with diabetes who have scored four greens were pleased as they 
believed that they had been rewarded by controlling their blood glucose. The 
tool appeared to motivate low risk people with diabetes, particularly those with 
no risk factors to keep on controlling their diabetes. In contrast, the tool may 
induce distress in those who believed that they were at high risk. Therefore, 
people with diabetes were able to see improvements or deteriorations in their 
risk score based on their blood glucose results which could also encourage 
them to improve their diabetes management. People with diabetes have used 
their data and incorporated it with their own health belief system. Although the 
majority of the people with diabetes classified themselves as low risk or high 
risk before the tool, this tool appeared to get people with diabetes to think about 
the facts and appraising themselves according to their own way of life and own 
values. The traffic light system highlighted the importance of the amber zone 
between high risk and low risk and people with diabetes could recognize the 
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need to move closer to the green zone (low risk). It may encourage behavioural 
change and save people with diabetes’s sight. 
7.5. Communicating diabetic retinopathy screening 
results 
The chapter now moves on to present the findings from participants in stage 
one and stage two of the study in relation to communicating the results of 
diabetic retinopathy screening. Data is incorporated from the forty people with 
diabetes and the five Health Care Providers to answer the question that 
explores people’s preference of the most appropriate way of communicating 
risk information about diabetic retinopathy and diabetic eye screening results to 
people with type 2 diabetes. Stage 1 and 2 data were combined in order to 
develop a broadly appraised model of communicating risk information about 
diabetic retinopathy disease and communicating diabetic eye screening results. 
As mentioned in chapter two, after diabetic eye screening is performed, the 
photograph of the retinae (the back of the eye) is sent to a trained and 
accredited regional NHS retinal grading teams, who carry out a two- or three-
stage image grading method. This recognizes any changes that could point out 
sight-threatening diabetic retinopathy that necessitates monitoring or treatment. 
The grading teams communicate the results to the people with diabetes and 
their Health Care Providers. Screeners are not expected to give diabetic eye 
screening results at the time of screening for clinical and quality assurance 
reasons. However, despite this, it does appear that there is variability in terms 
of some screeners providing patients with their results. 
7.5.1 Time and place 
Interviews with people with diabetes identified that, despite the English National 
Screening Programme, the communication of the results of diabetic retinopathy 
screening did not appear to be a standardised process across all health 
professionals. For example, diabetic retinopathy screening results appeared to 
be communicated to people with diabetes at different times, places, and by 
different people based on who did the eye screening and where it was done. 
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Although eye screening tests for this sample were mainly carried out either by 
the opticians or by diabetic retinopathy screeners in the hospital, 
communicating the screening results appeared to vary between different 
practices and different professionals. For example, some people with diabetes 
reported that they had received the result at the same time as eye screening: 
“The optician when he does the eye screening, he tells me everything is 
fine.” (Abdulla, 47, South Asian, R0) 
However, it was also clear that diabetic retinopathy screening results may not 
always be communicated to people with diabetes at the time of diabetic 
retinopathy screening: 
“No results were given at the time of eye screening, he said he is going to 
send it to the hospital and they will contact me.” (Ali, 73, South Asian, R1) 
The preferences of the people with diabetes in this study regarding these 
practices were mixed. A number of the people with diabetes did not object to 
receiving the results some period after the eye screening, but most preferred 
that the diabetic eye screening results to be provided at the same time or within 
twenty-four hours. Their main concern was that there could be a chance for the 
results to go unreported or for the results not to reach the patients at their home 
address, which was a clear cause for anxiety: 
“Well if they can’t do the results straight away, if technology is not there to 
give them the results you know if they have to be analysed by another 
doctor then I think within the twenty-four hours you should be notified if 
something is wrong, if you don’t hear from people you assume that 
everything is ok.” (Gerald, 53, R1)  
For example, Salma had not received her diabetic retinopathy screening results. 
Therefore, she believed that her results were normal as a consequence of them 
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not being reported to her and did not question whether the results had simply 
been misplaced: 
“The results were fine, otherwise the doctor would have said something to 
me, and I assume no news is good news.” (Salma, South Asian, 50, R0) 
Perhaps not surprisingly, those people with diabetes who perceived themselves 
as at higher risk tended to be more anxious and preferred the results to be 
communicated to them at the time of the examination, particularly if there are 
was evidence of changes in their eyes. This is apparent in the following quote 
from Younis, who has diabetic retinopathy (R2): 
“I think it should be the optician, there and then, I would like to know. I 
think they should have it yes, they do the tests, and they do know if there 
is anything, I think they should also relate that information to my GP.” 
(Younis, 55, South Asian, R2) 
However, some of the Health Care Professionals interviewed pointed out that 
diabetic eye screeners may not provide such information to avoid providing 
patients with the wrong results. Instead, they described how the results should 
go for grading first: 
“I think it is different with the opticians because they are purely screeners 
so they are only taking pictures so I think they prefer not to tell the patient 
because if the screening grading protocol goes through is that somebody 
may agree with somebody and disagree with somebody else.  So what the 
optician tells the patient may change further along the line because it has 
been graded by other people. So I think that it is better that they don’t.” 
(Kate, White British, Screener) 
(N.B. Kate is referring to the fact that when opticians undertake screening they 
are not part of the quality assurance/grading process unlike the retinal 
screeners who both screen and grade). 
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It was also clear that delays in the communication of diabetic retinopathy results 
could lead to anxiety. For example, Jack, who is fifty five years old and who has 
background diabetic retinopathy (R1), reported being anxious and dissatisfied 
because the screener did not offer him any results, which simply prolonged his 
anxiety.  He was clearly frustrated about not having been given any results from 
the procedure: 
“Well, I got a letter saying they are going to keep me under supervision 
and they will keep looking at my eyes but no reason why I can’t have 
results, I have diabetes for many years. The lady who did the picture says 
I can’t tell you anything because I am not qualified, I can’t give any results, 
and if there is anything the doctor will talk to you about it.”  (Jack, 60, R0) 
7.5.2 Face-to-face communication 
Not all people with diabetes preferred face-to-face to receive diabetic 
retinopathy screening results. Their views were wide-ranging regarding the 
most appropriate method of communicating diabetic retinopathy screening 
results. However, most of the people with diabetes preferred face-to-face 
communication rather than receiving the results via a letter: 
“I suppose I would be happy with word of mouth, somebody (Doctor or 
optician) explaining it to me rather than getting letters.  I think it would 
come better.” (George, 70, R1) 
This appeared to be related to the perceived delay in people with diabetes 
receiving their screening results. For example, a number of the people with 
diabetes were unhappy with the current process of reporting the diabetic 
retinopathy screening results because they associated this with what they 
thought was an unnecessary delay, which could also cause anxiety among 
people with diabetes: 
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 “The hospital sends the results to my GP then my GP tells me the results 
and it could take long time and makes me anxious.” (Rehana, 68, South 
Asian, R0) 
In addition, some people with diabetes appeared to prefer receiving diabetic 
retinopathy screening results face-to-face due to the fact that they have 
experienced problems with reading letters because of to the condition in their 
eyes or because they had literacy problems or language barriers: 
“Well earlier I wasn’t very good at reading, now I am ok, but I would have 
preferred like to talk rather than to have email or letter.” (Kumar, 57, South 
Asian, R2) 
The Health Care Professionals in this study also preferred that screening results 
was communicated face-to-face using risk communication tools or the patient’s 
actual retinal image in order to facilitate patients understanding. As with the 
people with diabetes, the Health Care Professionals also perceived that face-
to-face screening results communication overcame problems people may have 
with not being able to read letters, understand English, or understand the 
medical terminology: 
“I do not think that sending the results to the patient means anything to 
them. I think face to face chat is much better, because they don’t 
understand the medical terminology in the letters and there maybe jargon 
and I think it is better discussed verbally face to face with the picture in 
front of them then they will have a clue.  If they want copy of the picture 
we ask them to make an album, so we can compare one year by year and 
then they will be happy by doing that.” (Suresh, GP, South Asian)  
In addition to the visual risk tools, Health Care Professional also preferred that 
the level of diabetic retinopathy risk was calculated using risk calculators to 
educate the people with diabetes and to improve the understanding of their 
personal risk: 
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“My first response was that this risk calculator could generate great data 
to educate our patients after their diabetic retinopathy screening or their 
regular consultation about the seriousness of their condition, but also 
calculate the benefits of improving their health.” (Hayley, Ophthalmologist) 
It was also the case that a number of people with diabetes preferred that their 
GP provided them with the results of their screening tests as they had a good 
relationship with their GP, and so felt more relaxed. It was also apparent that 
people found it easier to access appointments with their GPs: 
“I would feel more comfortable if my doctor was informed about it first and 
then I would go, or my doctor would call me for an appointment, and I think 
I will be informed, emm, face to face by my doctor, probably I would feel 
more comfortable by my doctor, but I would not like to be informed by 
letter.” (Abdulla, 47, South Asian, R0) 
In contrast, other people with diabetes wanted such screening results 
information to come directly from their optician or their ophthalmologist as they 
believed that they were the experts more so than GPs: 
“The optician I would think or here at the clinic. I know the information gets 
passed on to the GP as he can tell you when he sees you, can’t he?  I’ve 
got to admit the last time the diabetic consultant was informed of the 
results of my eye test and he sent me a copy of the report, which I think 
was quite a good idea.” (Gareth, 86, R0) 
It was clear that a number of the people with diabetes were aware that GPs are 
not eye specialists, which underpinned their preference for their diabetic 
retinopathy screening results to be provided by an ophthalmologist or optician. 
It was these professionals who had the specialist knowledge and, therefore, 
could better answer any concerns that they may have: 
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“I think the eye clinic or optician because they explain more, but the GP is 
not specialized in that area, he is just general doctor, but eye clinic or 
optician can explain it much better.” (Sam, 57, South Asian, R0) 
It was also the case that a number of people with diabetes were satisfied with 
having received a copy of their report or of their retinal screening image as these 
provided a record of the problem and they could discuss issues with their family: 
“I think probably if he puts it down in writing, you know the doctor tells you 
what the problems are if they put it down in black and white  as well you 
see if you are having these problems I mean you know you have got it in 
black and white and you are able or the family knows what’s going on as 
well. You know just like a report on when a patient comes in just give them 
like a bit of a report a written report just what the problems are if any then 
that’s a double check then.” (Harry, 78, R1)  
7.5.3 The use of numerical information and descriptive words 
Individual level of risk is a key component in the communication of health risk 
messages. Therefore, when receiving risk information or diabetic retinopathy 
results, people with diabetes need to know if they are at high risk or low risk of 
developing sight-threatening diabetic retinopathy. In chapter six (section 6.3.4) 
the author discussed the perceived severity of risk and the variation in severity 
of risk between people with diabetes and Health Care Professional particularly 
when numerical data is used. This section discusses the preferences of people 
with diabetes and Health Care Professionals with regards to the use of 
numerical information and descriptive words in order to provide risk information 
about the diabetic retinopathy screening results.  
In this study, people with diabetes were divided in their views as to what was 
the most effective information regarding their level of risk following their diabetic 
eye screening. Some suggested using percentages, such as people having a 
two per cent, five per cent, ten per cent, or twenty-five per cent chance of 
developing diabetic eye complications in the next five years:  
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“It depends on the doctor. They know how to communicate really. 
Personally I think the percentage is the right way to do it.” (Gareth, 86, R0) 
Some people with diabetes suggested that risk information and diabetic eye 
screening results should be communicated using plain words, such as high risk 
or low risk because some patients may not understand probabilities and 
percentages: 
“Not everybody understands what ten per cent means.  If you’ve got an 
older person they might not understand the term you are talking about. So 
you know should be put into something that is plain English and say look 
you know you are at a very high risk, you give the patient, you should tell 
them what is going on.” (Gerald, 53, R1) 
Others preferred using both probabilities and words as it helped them 
understand their risk better as well as their diabetic retinopathy screening result: 
“Sometimes it’s good idea to use numbers sometimes use words, when 
the doctor saw me before to discuss an operation, he told me there is risk 
one in one hundred to lose vision or bleeding, I think it’s better to explain 
it, and to tell you are at high risk so I will be able to know what is my risk 
and what is the end result.” (Sam, 57, South Asian, R0) 
People with diabetes appeared to prefer a simple and clear approach when risk 
information is communicated. In other words, they wanted their Health Care 
Professionals to avoid using medical or unusual terms: 
“You should be told straight, you shouldn’t dress it up in medical terms.  If 
you say to somebody your eyes are getting worse if you don’t change 
whatever you are doing if you don’t change your eating habits or your diet 
then obviously you are going to make yourself worse, so possibility we 
can’t help you anymore.” (Gerald, 53, R1) 
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Some people with diabetes, such as Rehana, did not have a preference in terms 
of whether numerical information or descriptive words were used to convey her 
degree of risk. She wanted to be told in clear terms of her risks though she was 
also aware that not all patients would want to be told in such terms and as such 
was concerned about others, particularly those who may become anxious and 
more worried if risk was communicated in such a way to all patients:  
“I don’t mind what way they use to tell me about diabetes or my risk of 
having complications as long as it’s accurate. For me I think the truth is 
the best, whether it is low or high or if it is damaged, the truth is the best. 
If the patient can take it, if they think they are strong it is best to tell them 
the truth but if the patient is weak they might take it to heart and think a lot 
about it.” (Rehana, 68, South Asian, R0) 
Jean suggested that a family member or carer should escort those who are at 
risk to make sure that the message is understood by people with diabetes: 
“I think they should tell you exactly what the risk is ... because I mean there 
is no point in them telling them for their own good that they have got to 
take care or whatever has got to be done if they I know it sounds silly but 
people have got to listen and if they are not able to do that they have got 
to have an escort with them or something so long as they know the family 
knows what’s going on, it is important.” (Jean, 75, R0) 
Some of the Health Care Professionals felt that involving family members in the 
process of risk communication could benefit people with diabetes as some did 
not appear to understand the message or they experienced language barriers. 
It was also apparent that Health Care Professionals believed that some patients 
found it difficult to retain the information they were given and/or believe that they 
are not at risk and so may not implement the information they are given: 
“We are kidding ourselves once they reach home the wife asks what did 
the doctor say he said well I am alright I am on the borderline I am diet I 
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am this and that, they don’t relay the same message we sent. They take 
the message seriously but they forget.” (Fawzi, GP, South Asian) 
Health professionals could sometimes be frustrated when an interpreter was 
needed to translate risk information to people with diabetes. Kate, for example, 
questioned the credibility of translators, particularly if a translator is a family 
member. The frustration appeared to increase when the same information 
rephrased in different ways several times, but did not appear to register 
because either the translator was not translating well or was translating the 
information in a way designed to reassure the patient rather than 
communicating risk information:  
 “Well obviously one of the things is whether they can actually really 
understand what you are saying, so simple language barrier is obviously 
critical. If you are having to go through an interpreter that can make a 
difference because you don’t know if they are translating exactly what you 
say to the patient. If it is a relative and they sometimes particularly when 
a patient is asking the same question repeatedly and throughout the 
discussion, you do get a feeling then that actually this is not going in or 
thinking it all. Sometimes you know that reinforcing just to check, I need to 
do this, or I don’t need to do this.  When you get the third or fourth occasion 
or so, should I do this or not do this, you know that you are probably not 
communicating well.” (Kate, Screener) 
One of the Health Care Professionals reported that they used plain words with 
“non-educated” people and use scientific language and numbers such as 
percentages and probabilities to more “educated” people. However, it was not 
clear how this Health Care Professional determined or assessed individuals’ 
level of education: 
“I don't like to use numbers; they will forget it when they reach my door.  If 
I said eighty per cent, seventy per cent, forty per cent, thirty per cent then 
once they leave the surgery they forget it does not mean anything to them. 
It has to be words emphasizing, Ok. So either I will put mild or moderate 
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or severe or sometimes I say right it is getting worse but I think percentage 
is for the educated people it is excellent but not for the non-educated 
people. When you do that when you ask them next visit what did I say the 
probability they forget.  If you want a probability you have to type it and 
enforce your words with the written message if you want to get proper 
message.” (Fawzi, GP, South Asian) 
It also appeared that not all Health Care Professionals support the use of 
percentages when communicating screening results. In the case of Kate, for 
example, she appeared to use probabilities for high risk information and to use 
words if the risk to the individual was low: 
“Some patients I don’t think they understand percentages at all. So I 
usually reinforce it if I am using a percentage. If it is 50% I then say that 
means there is one in two chance that you could develop it but when we 
are talking about very small risk factors I tend to use low risk medium risk 
or high risk, that tends to be something they understand or is more relevant 
to them.” (Andy, Ophthalmologist) 
Health Care Professionals used descriptive words in order to provide detailed 
information about signs and symptoms, complications, treatment and 
management when consulting people with diabetes as many of their patients 
don’t understand numerical information. 
“Well, it depends because many of the patients we see in the practice don’t 
understand probabilities and percentages and we have to explain their 
condition to them. We have to tell them your diabetes is progressive and 
it might affect the blood pressure. We have to control your diabetes. Why 
my eyes are getting worse because your diabetes is not controlled.  How 
can I control it I am on insulin we have to review the insulin.  I am on tablet 
we have to review the tablets.  So that’s as much as you can do.  If it is 
extensive of course it has to be the ophthalmologist who deals with the 
results.” (Fawzi, GP, South Asian) 
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To summarise, communicating the results of diabetic retinopathy screening did 
not appear to be standardized among health professionals. It appeared to be 
communicated to people with diabetes in different times, places, and by 
different people based on who did the eye screening and where it was done. 
Most people with diabetes preferred that the diabetic eye screening results to 
be communicated face-to-face and at the same time or within twenty-four hours 
after performing the diabetic retinopathy screening. A number of the people with 
diabetes were unhappy with the current process of reporting the diabetic 
retinopathy screening results. For example, delay in the communication diabetic 
retinopathy results could lead to unnecessary anxiety. The Health Care 
Professionals also preferred face-to-face screening results communication in 
which they could use a range of methods such as risk communication tools, risk 
calculators, and individuals’ retinal images in order to facilitate and improve their 
understanding. Health Care Professionals also felt that involving family 
members in the process could benefit people with diabetes. Some people with 
diabetes preferred that their GP provided them with such screening results 
information as they have had good relationship and found it easy to access 
appointments, while others favoured their optician or ophthalmologist as they 
believed that they were the experts in the field. The data also indicated that 
people with diabetes were divided regarding the most effective risk 
communication format. Some suggested using numerical information 
percentages and some suggested using descriptive words. Others preferred 
using all of them jointly. Health Care Professionals argue that providing 
numbers such as probabilities may benefit the people with diabetes when it’s 
provided with written copy of the results. 
7.6. Conclusion  
The new risk communication tool was reported as useful, easy to use by people 
with diabetes, and described as a good visual representation that may improve 
the understanding of risk. After using the tool, people with diabetes appeared 
to be re-assured, become more aware of risk categories. The use of the new 
risk tool was also tied in with the ways in which people with diabetes made 
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sense of their diabetes and diabetic retinopathy. Furthermore, providing risk 
information in a clear method appeared to encourage behavioural change.  
It was found to facilitate the presentation of risk for those with low literacy, or 
whose their first language was not English. The design of the risk tool as a traffic 
light system also seemed to make people with diabetes interpret their own risk 
by comparing it with the conventional use of such colours where green means 
safe and red means danger. It made them realize that controlling blood glucose 
is in their hand and not their Health Care Professionals.  
The data also showed that communicating the results of diabetic retinopathy 
screening did not appear to be standardized. Most people with diabetes 
preferred that the diabetic eye screening results to be provided face-to-face, at 
the same time or within twenty-four hours to avoid unnecessary anxiety. The 
Health Care Professionals also preferred face-to-face using risk communication 
tools. Health Care Professionals also believed that involving family members 
could benefit people with diabetes. Improving professional-patient relationship 
can improve risk communication. Risk information should be communicated by 
using simple approach and to avoid using medical or unknown terms. Such 
subjective measures are difficult to predict but such professionals need to use 
a standard means of communication. 
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Chapter 8. Discussion 
8.1. Introduction 
This chapter discusses the findings of this study which focuses on the ways in 
which people with diabetes along with Health Care Professionals perceive and 
experience the risks associated with diabetes and the ways in which both 
groups make sense of risk communication as its central focus. The study 
highlights several principle findings regarding people with diabetes’s perception 
of risk such as: 
 This study has shown that peoples’ knowledge of their diabetes and diabetic 
retinopathy is varied.  
 It also shown a range of beliefs about the cause of diabetes and its 
complications, this was evident even though most participants had diabetes for 
longer than five years and were seen regularly by their Health Care 
Professionals.  
 Another aspect of this study is the substantial variation in perception of risk 
between people with diabetes and Health Care Professionals.  
 Diabetes self-care management is influenced by individuals’ lay beliefs and 
knowledge about blood glucose, which also influences people’s diabetes self-
care management.  
 The authority of peer advice influenced individual’s behaviour even though this 
may go against professional advice.  
 Perceived high risk was linked to being older, having type 1 diabetes, being 
treated with insulin injections, being of South Asian origin, having visible 
symptoms or other eye problems, and having co-morbidities, which were all put 
forward for why people were at a higher risk of developing sight-threatening 
diabetic retinopathy. In contrast, low risk was linked with type 2 diabetes, 
treatment with oral hypoglycaemic drugs, reassurance by their Health Care 
Providers, and following Health Care Professionals’ advice.   
 The study identified a number of emotional responses to being at risk such as 
optimism and pessimism.  
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 Another issue that was highlighted by this study was the ways in which of people 
with diabetes often struggled to remember the risk information that was 
provided during their consultations with their Health Care Providers. It was also 
apparent that individuals often interpreted risk information in a variety of ways 
which appeared to be linked to their wider understanding about their health 
literacy as well as there being language barriers.  
 This study found that communicating risk information using visual tools 
appeared to be received positively by people with diabetes, with people 
appearing to understand the information in relation to diabetes and their risk of 
diabetic retinopathy and potentially could lead to better diabetes self-care 
management.  
 Ophthalmologists and opticians were seen as knowledgeable about eye 
conditions more so than general practitioners. 
 
The risk of developing diabetic retinopathy and risk communication tools were 
investigated in this qualitative study among people with type 2 diabetes. In order 
to understand how people with type 2 diabetes perceived the risk of developing 
diabetic retinopathy, it was necessary to explore their level of understanding of 
diabetes itself and from there develop a model for communicating risk 
information about diabetic retinopathy and diabetic retinopathy screening 
results. 
The effectiveness of risk communication depends on people’s understanding of 
the risk information given to them; the form in which the risk information is 
communicated may influence the decision-making process. In this study risk 
communication appeared to have an impact on people’s perception of risk and 
understandings, and therefore, could influence the ways in which they deal with 
their diabetes. The next section discusses the main factors that influenced risk 
perception. 
249 
 
8.2. Knowledge about diabetes and diabetic 
retinopathy 
This study revealed a range of understanding in relation to people’s diabetes 
and risk of diabetic retinopathy. It also revealed a range of beliefs about the 
cause of diabetes and its complications, which was the case even though most 
participants had diabetes for longer than five years and were seen regularly by 
their Health Care Professionals. The participants in this study reported a range 
of knowledge about diabetes, diabetic retinopathy, the causes of the condition, 
medical terms, abbreviations, and the implication of diabetes and diabetic 
retinopathy on their sight. For example, individuals put forward a range of 
names to specify the type of diabetes they have as well as perceived cause of 
their diabetes. This finding was supported by many previous studies in which 
knowledge of diabetes has been found to be varied among people with type 2 
diabetes (Iqbal et al., 2008). For example, Shrestha et al. (2007) found that 
people with diabetes were not aware of common ocular conditions. Alongside 
the fact that many of the people with diabetes had varied knowledge about 
medical terms, this study also found that health professionals often used 
medical terms that were not fully understood by people with type 2 diabetes. 
This appeared to be because health professionals sometimes overestimated or 
underestimated their patients’ recognition of medical terms (Aufseesser et al., 
1995; LeBlanc et al., 2014; Yoshida and Yoshida, 2014). However, this made it 
difficult for these people to take on board risk information they were given, which 
they found difficult to understand and confusing. The use of abbreviations was 
also found confusing by some patients. This study, therefore, highlights that 
Health Care Professionals should pay greater attention during consultations to 
the ways in which they communicate diabetes information generally to their 
patients and specifically risk information about diabetic retinopathy.  
In this study, providing individuals with knowledge about blood glucose 
appeared to result in self-reported change in their diabetes self-care 
management. For example, once people with diabetes recognized that their 
HbA1c level had fallen between 7%-9% (in the amber zone) they appeared to 
be encouraged to improve their daily glucose observation. This echoes the 
findings of highlighted by Pace et al. (2006) regarding individuals’ knowledge of 
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normal values for blood glucose level. A recent study found that people with 
diabetes who hold negative perceptions about their diabetes (individual’s 
knowledge and experiences of their diabetes) were more likely to attend 
diabetes clinics than those participants who had positive perceptions about their 
diabetes (Thongsai, 2015). 
It appeared in this study that a number of people with diabetes did not like risk 
information when it was communicated using percentages or probabilities. 
Similar findings were reported by previous studies (Gigerenzer and Edwards, 
2003; Saver et al., 2014). Saver et al. (2014), for example, argue that providing 
quantitative risk information is unlikely to assist individual patients to understand 
their diabetes related risks. 
Another important issue highlighted by this study is the perception among 
Health Care Professionals that “educated” people have better understandings 
of their medical condition. One significant outcome of this was that they did not 
provide more detailed risk information to patients perceived as “educated” such 
during their consultations. However, this study found that people with diabetes 
who have a degree or higher (e.g. Masters or PhD) or had been in further 
education (e.g. Diploma) did not demonstrate any better understanding than 
those who only had compulsory education (e.g. O level/GCSE) or who had no 
qualifications. Across these education groups, the people with diabetes did not 
always appear to understand the full extent of the complications related to 
diabetes or the implications of diabetes on their vision. Whilst the majority of 
people with diabetes had a general perception that diabetes causes eye 
complications, their knowledge about diabetic retinopathy was often limited, for 
example, the fact that some participants had a perception that any risk or 
damage to the eye can be easily cured by an ophthalmologist or their Health 
Care Provider. Similar findings were reported by Saver and colleagues (2014). 
Another study in South India found that people with type 2 diabetes had 
adequate knowledge regarding the symptoms of hypoglycaemia, but the range 
of complications were only known by one third of the participants (Shriraam et 
al., 2015).  
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This study revealed that diabetic eye screeners may not provide patients with 
relevant information regarding their diabetic screening results because of 
concerns about providing inaccurate information. As such they were following 
procedure in not providing patients with information and sending the results for 
grading first. Therefore, one way forward is to improve patients’ and 
professionals’ education via educational programmes, which was advocated by 
previous studies (Ockleford et al., 2008; Carey et al., 2014). However, there are 
two potential sets of problems with this approach. Firstly, individuals who are 
symptomless may not seek medical advice until they have noticeable symptoms 
or eye complications. This particular group may, therefore, not see such 
educational programmes as relevant to them. A similar finding was reported by 
Pace et al. (2006). Another study also concluded that individuals are more likely 
to take part in structured self-care management education programmes when 
they feel at risk of complications, that they believe diabetes complications are 
serious, and/or they believe that the programme may help them to avoid such 
risks (Ashtarian et al., 2012). Furthermore, other issues that may influence 
participation in education programmes include a lack of personal motivation 
among both patients and Health Care Providers and certain access difficulties 
that were also highlighted by Pace et al. (2006). In addition, a recent study 
(Winkley et al., 2015), conducted to determine why people with type 2 diabetes 
do not attend structured education sessions, highlighted three main reasons for 
non-attendance. These were 1) a lack of information regarding the perceived 
benefits of such education programmes; 2) personal preferences, such as the 
timings of the appointment; and 3) the shame and stigma associated with 
diabetes, which may preclude people from informing others of their diagnosis. 
The second set of problems associated with education programmes are related 
to the variation in risk perception and understanding between patients and 
Health Care Professionals. Interestingly, this study revealed considerable 
variation in the level of risk perception between people with diabetes and Health 
Care Professionals. For example, the people with diabetes in this study 
perceived a ten-to-fifteen percent risk as low or very low because ten is closer 
to zero rather than hundred. Thus, according to people with diabetes, risk was 
only perceived as high if it was fifty per cent or higher. In contrast, Health Care 
Professionals perceived that a ten-to-fifteen per cent risk of developing diabetic 
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retinopathy was serious and a very high risk and would, therefore, be worried if 
they were the patient due to the seriousness of the complication and the 
possibility of visual impairment. This considerable variation in risk perception 
may also help to explain why patents may not conform with health professional’s 
advice because they assume they are at low risk and thus do not need to 
change their behaviour. Therefore, as has been suggested by Vlaar et al. 
(2015), increasing risk perception alone is unlikely to increase attendance at 
diabetes prevention programme. In addition, Edwards and colleagues (1998) 
suggested the standardization of language regarding risk across Health Care 
Professionals would be useful for patients and would help Health Care 
Professionals to become more consistent in their perceptions and definitions of 
risk when communicating with each other and their patients. However, they 
found that the standardization of risk messages between health professionals 
may not be appropriate due to the difference of interpretation of risk messages 
among patients. Edwards et al. (2013) found strong evidence that personalized 
risk information included within risk communication interventions improve 
understanding. This supports the design of the diabetic retinopathy risk tool in 
this study that enables people with diabetes to understand their diabetic 
retinopathy risk when risk information is communicated to them by their Health 
Care Professionals. 
8.3. Lay beliefs about diabetes 
The beliefs of people with diabetes and their knowledge of causes of diabetes 
appeared to impact on risk perception. People with diabetes in this study 
appeared to use certain ideas to make sense of their condition. For example, a 
number of the people with diabetes attributed their diabetes as the 
consequence of external forces, such as God’s will, changes in body function, 
cold weather, bad luck and fate. They believed that these external forces were 
beyond their control, and therefore, they felt that they could do nothing about it. 
In other words, there was a sense of not having control of their diabetes. Similar 
findings were reported by Macaden and Clarke (2010) who investigated the 
influence of locus of control on risk perception among South Asian people with 
type 2 diabetes in the United Kingdom. Locus of control refers to individual’s 
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belief about whether the results of our actions depend on what we do or on 
actions of those (other people/other forces) outside our personal control 
(Wallston et al., 1976). Macaden and Clarke (2010) found that individuals 
attributed their cause of diabetes to external forces such as bad luck and divine 
planning or familial disposition. According to Macaden and Clarke (2010), many 
of these individuals also tended to depend on their Health Care Provider to 
intervene with their diabetes due to low sense of ‘self-autonomy’ and were not 
actively engaged with decision-making regarding their diabetes. A recent 
qualitative study conducted in the UK by Greenhalgh et al. (2015) to investigate 
the influences on the risk behaviour of South Asian women and how these 
influences interact and build over time. The study recruited 45 women of 
Bangladeshi, Indian, Sri Lankan, or Pakistani origin aged between 21 and 45 
years with a history of diabetes in pregnancy. Participants were recruited from 
diabetes and antenatal services in London, UK. Data collections used group 
discussion and individual narrative interviews. The study found that the authority 
of peer advice influenced women’s behaviour even though this may go against 
professional advice. This was found to be due to the fact that peer advice, 
particularly when offered through a storytelling set-up, was perceived to be 
more familiar and meaningful to women. Therefore, Greenhalgh et al. (2015) 
argued that behaviour change interventions aimed at preventing and controlling 
diabetes are more likely to be successful if they address explicit behaviours by 
specific individuals in a particular cultural context. In other words, in order to be 
more successful, diabetes education should concentrate on explanations and 
interventions that are more meaningful to individuals and groups. Lindenmeyer 
et al. (2010) reported that people with type 2 diabetes engage in behaviour 
change interventions in different ways based on a close communication and 
openness in the direction of collaborative approaches to improve their skills and 
confidence for diabetes self-management. Therefore, engaging people with 
type 2 diabetes with the diabetic retinopathy risk tool would benefit them to 
understand their risk and may then lead to improvement in their diabetes self-
care management.  
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8.4. Perceived severity of risk 
This study found that the perceived severity of risk varied between people with 
diabetes. Whilst most people with diabetes perceived themselves to be either 
at high or low risk, few believed that everyone with diabetes is at the same risk 
of developing diabetic related eye complications. In terms of developing sight-
threatening diabetic retinopathy, people with diabetes considered those people 
with diabetes who were older, had type 1 diabetes, were treated with insulin 
injections, were South Asian, had other eye problems, and had co-morbidities 
to be at a higher risk of developing sight-threatening diabetic retinopathy. In 
contrast, people with diabetes considered those who had type 2 diabetes, were 
treated with oral hypoglycaemic drugs, believed that their blood glucose level 
was under control, were reassured by their Health Care Providers, and those 
who were following their Health Care Professionals’ advice all perceived 
themselves to be at low risk. Kesavamoorthy et al. (2015) found that people 
with diabetes perceived their risk of developing diabetic retinopathy to be 
significantly higher if they had co-morbidity factors compared to those without 
co-morbidity factors. Females consider themselves at higher risk more than 
males. Men generally view themselves as less vulnerable to health problems 
compared to women (Dolan, 2014). In relation to diabetes, similar findings were 
reported by previous studies (Homko et al., 2010; Reyes-Velazquez and 
Sealey-Potts, 2015). Homko et al. (2010) found that women with type 2 diabetes 
perceived their risk of developing complications to be significantly higher than 
men although they had the same level of knowledge of diabetes complications. 
More recent study conducted by Reyes-Velazquez and Sealey-Potts (2015) 
also found that women had a higher risk perception than men for diabetes 
onset. Therefore, future research needs to take onboard these findings and 
explore the differences in risk perception between men and women. 
8.5. Factors influence risk perception 
This study revealed that perceived risk was influenced by several factors such 
as knowledge, the presence of existing symptoms or eye complications, family 
history, co-morbidity factors, treatment, type of diabetes, age, and personal 
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experience. Interestingly, the study found that years of education and grade of 
diabetic retinopathy were not linked to better understanding. In particular, the 
study highlighted significant differences between people with diabetes’ 
perceptions of risk and the perceptions of Health Care Professionals. The wider 
evidence also suggests that, low levels of  literacy can limit how people access 
information regarding risk, due to difficulties in reading and writing, or problems 
with communication (Pace et al., 2006). This issue can also affect whether 
individual’s access appropriate learning materials and can minimise the 
opportunities they have for engaging in meaningful risk communication.  
8.5.1 Presence of visible symptoms or eye complications 
This study highlights the importance of educating people about their diabetes, 
particularly those who are asymptomatic. The study found that those people 
with diabetes with existing symptoms or eye complications could talk about this 
in more depth and with more knowledge than symptomless people with 
diabetes. Similar findings have been found in relation to people with diabetic 
foot ulcers who were found to report better  control of diabetes and were more 
likely to follow  professional advice than those people with diabetic retinopathy; 
i.e. the latter may not have been so apparent to the individual (Searle et al., 
2008). However, not experiencing symptoms could eventually lead to a  sight 
loss, particularly if these same  individuals believed that they would eventually 
receive some “warning shots” which would allow them time to change their 
behaviour and improve their diabetes (Saver et al., 2014). Another study found 
a positive correlation between the knowledge demonstrated by individuals 
regarding their diabetic retinopathy and laser treatment, which normally 
happened at advanced retinopathy (Aufseesser et al., 1995; Fenwick et al., 
2013). Another recent study also found that patients had a reasonable 
understanding of the risk factors associated with diabetic retinopathy. However, 
their levels of understanding were potentially attributed to their past history as 
fifty per cent of participants in this study had proliferative diabetic retinopathy 
(R3) and most participants had undergone laser treatment, which may have 
influenced their understanding (Fenwick et al., 2013). 
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Asymptomatic people with diabetes in this study did not appear to value risk 
prevention measures and tended to delay seeking medical care. Not only did 
this have a potential impact on their sight, it may also affect their quality of life. 
Other studies have found that patients with visible complications, such as foot 
ulcers, placed a greater emphasis on the personal control of diabetes (Searle 
et al., 2008). In such cases, it appears that people would benefit from 
understanding the symptomless nature of diabetic retinopathy, at least in the 
early stages of the condition, as a means of encouraging people to control the 
progression of the disease and, as a result, prevent acute complication or sight-
threatening diabetic retinopathy. 
This study also highlighted that the early progression and risk factors of 
developing diabetic retinopathy should be sufficiently well understood by people 
with diabetes to identify disease progression measurement limits. Although 
individuals can control some of the modifiable risk factors such as blood glucose 
level, blood pressure, lipids, and attendance at diabetic screening, the non-
modifiable risk factors such as age, duration of diabetes, type of diabetes, and 
diabetic changes to the eye, should be taken into account (Genuth et al., 2003). 
Identifying risk factors and what form preventive care should take is an 
important part of managing diabetes and thus, preventing the progression of 
retinopathy (Boren et al., 2007). 
8.5.2 Personal experience 
This study found that participants’ perceived severity of risk was best 
understood within the wider context of their personal experience as it was these 
experiences that were seen to increase or decrease the perceived severity of 
risk. For example, individuals were influenced by the experience of seeing 
people with diabetes, such as a family member or friend, who did not manage 
their diabetes and who had complications as a result. This could be contrasted 
with individuals’ experience of seeing people with diabetes who managed their 
diabetes and who experienced no health problems. Thus, the emotional impact 
of witnessing complications with a family member or friend, particularly if these 
complications were severe, appeared to influence their perception of risk. 
Similar findings have been evident in previous studies. For example, Saver et 
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al. (2014) found that nearly sixty per cent of participants reported that such 
experiences had influenced their perception of risk. Walter et al. (2004) reported 
that a member of a family with chronic illness history such as cancer, coronary 
heart disease, or diabetes develop a personal sense of vulnerability. The impact 
of witnessing a family member develop complications has also been found to 
be influenced by the nature and severity of the complication as well as the 
relationship and/or closeness of the participant to the affected person (Walter 
and Emery, 2005). Therefore, engaging asymptomatic people with symptomatic 
ones may influence their risk understanding regarding the development of 
diabetic retinopathy, and consequently may lead to behavioural changes.  
8.6. Psychological response to being at risk 
8.6.1 Optimism vs Pessimism  
The people with diabetes in this study were divided regarding their probability 
of developing diabetic retinopathy. Some of them contextualised their increased 
vulnerability of developing complications in terms of being from a South Asian 
ethnic background or due to their age. In contrast, other participants appeared 
to connect their reduced future likelihood of developing complications with their 
previous experiences, particularly those who attended eye screening and 
whose results were always negative. Therefore, from that, they believed that 
they were unlikely to develop diabetic retinopathy in the future. Such individuals 
appeared to be optimistic about the future and that they would not have 
complications. They generally believed that they were doing well and better than 
others, so were less likely to suffer from complications. This may be explained 
by the Health Belief Model, a psychological model developed by Rosenstock in 
the 1950s (Rosenstock, Strecher, & Becker, 1988). The Health Belief Model 
seeks to understand patient behaviours in relation to self-care and treatment 
concordance and suggests that the willingness of a person to commit to a 
change in behaviour depends on how severe they view their health problem to 
be. As such an  an optimistic stance may reduce anxiety that would ordinarily 
be generated when an individual acknowledges personal susceptibility and 
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increased risk in relation to a disease that is considered serious (Janz and 
Becker, 1984). Optimism may happen when people with diabetes feel confident 
about their chances of having a positive outcome or avoiding negative outcome. 
Self-esteem is also threatened when an individual fails to avoid a potential 
danger, especially if it is perceived that it is possible for an individual to have 
avoided the problem (Shepperd et al., 2002). Thus, individuals who judge their 
own vulnerability as lower compared to others therefore maintain or even 
increase their levels of self-esteem (Branstrom et al., 2006).  
8.6.2 Understanding of diabetic retinopathy risk 
People with diabetes who perceived themselves at low risk appeared to 
diminish their potential risk of experiencing complications for a variety of 
reasons. This included their knowledge about their condition and the ways in 
which they made sense of risk messages they received, being younger, their 
ethnic background, and being treated with oral medications rather than insulin 
injection. Those individuals who tended to perceive themselves to be at lower 
risk of developing sight-threatening diabetic retinopathy were less likely to take 
preventative measure to avoid that outcome. This finding concurs with previous 
studies (Janz and Becker, 1984). According to the Health Belief Model (HBM), 
individuals who perceive themselves to be at lower risk of experiencing a 
negative health outcome will be less likely to take preventative measures (Janz 
and Becker, 1984). Similar beliefs were reported by Saver et al. (2014) where 
people with diabetes tended to downplay or underestimate the associated 
mortality risk. Similarly, Branstrom et al. (2006) reported that people tend to 
underestimate the fact that exposure to sun is a significant risk factor for them 
developing skin cancer, despite the fact that they appeared to be aware of the 
consequences of sun exposure. 
8.6.3 Emotional response to being at risk 
This study found that, in hindsight, a lack of diabetes self-care management 
could subsequently lead to feelings of guilt. The ways in which people with 
diabetes constructed these feelings was clearly influenced by how they now 
made sense of their condition. For example, those who had tended to perceive 
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themselves as relatively at low risk were less likely to express guilt that they had 
failed to self-manage their condition. In contrast, those who deemed themselves 
to have been aware that they were at increased risk but who did not take action 
to improve their self-care management were more likely to express some 
feelings of guilt at not having acted sooner. The main point being is that many 
individuals felt they could have managed their diabetes in a better way and 
possibly have prevented complications from occurring.    
People with diabetes who perceived themselves at higher risk also appeared to 
report lower mood or more depression than those who did not perceive 
themselves in such terms. Those who were symptomatic, who had low visual 
acuity, who had personal experience of someone who developed complications 
were more concerned than others about the possibility of developing 
complications, which was particularly apparent among the South Asian 
participants in this study. Previous studies (Holt et al., 2014b; Williams et al., 
2015; Holt et al., 2014a) also reported a higher prevalence of depressive 
symptoms among South Asian and Black Caribbean groups compared to White 
Europeans. Individuals tended to attribute their low mood or depression to past 
experience of seeing a friend or relative developing complications, food 
deprivation, vulnerability to complications, complexity of disease, and lack of 
communication skills. This low mood was also implicated when they described 
why they did not want to experience the physical discomfort associated with 
checking blood glucose level (finger prick testing), particularly as they were 
symptomless. This may help to explain some of the higher rates of depression 
among South Asians people in previous studies (Holt et al., 2014b; Williams et 
al., 2015; Holt et al., 2014a). 
8.7. Risk communication and informed choice 
Counselling people with type 2 diabetes about diabetic retinopathy and 
presenting them with recommendations about diabetic retinopathy screening 
involves the presentation of risk and benefit information. However, there is a 
lack of evidence as how to guide health professionals about the most effective 
approach when sharing clinical evidence with people with type 2 diabetes 
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(Edwards, 2001; Elwyn, 2012; Fagerlin, 2011; Lipkus, 2007; Schapira, 2006). 
This study found that people with diabetes repeatedly reported that they had 
not received adequate information from their Health Care Providers to help 
them understand their personal risk of developing diabetic eye disease. Michie 
et al. (2004) found that only half of the participants in their study in relation to 
cervical cancer understood that a normal result entailed a residual risk, that is 
the amount of risk left over after natural risk have been reduced by risk controls, 
if results were communicated without an additional explanation regarding this 
risk. However, the understanding of residual risk improved when participants 
were informed that their result indicates a low risk of developing cervical cancer 
in the next five years (Marteau et al., 2001b).  
Another issue found by this study to influence risk communication was the ability 
of people with diabetes to remember the risk information that was provided 
during their consultations with their Health Care Providers. Individuals may also 
experience limitations in relation to their ability to understand risk information 
due to health literacy and language barriers. Previous studies reported that 
South Asian people considered language to be the main and most frequent 
barrier to receiving health education (Brar et al., 2009; Syed et al., 2008). It is 
clear that individuals are more likely to convert risk information from their Health 
Care Providers into appropriate behavioural change when they understand their 
health condition and engage in treatment decisions (Anderson et al., 1995). For 
example, Schillinger et al. (2002) found that poor health literacy was associated 
with worse glycaemic control and higher rates of diabetic retinopathy. 
Therefore, methods that facilitate risk communication and improve patients’ 
understanding of diabetic retinopathy risk, regardless of their literacy condition, 
are required.  
This evidence was the motivation to create a diabetic retinopathy risk 
communication tool that personalises risk and increases Health Care Providers’ 
abilities to communicate risk information in busy clinical settings. The creation 
of this tool was informed by the shift to a model of shared decision-making within 
the consultation process (Edwards, 2006). The shared decision-making model 
is when the preferences of individual patients and the knowledge of their Health 
Care Provider are integrated within the chosen self-care management process. 
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A systematic review conducted by Edwards et al. (2013) found strong evidence 
that personalized forms of risk estimate that are integrated within consultations 
and screening programmes; e.g.in relation to colorectal cancer, lead to more 
informed choices being reported.  
8.8. The influence of visual tools on risk perception 
This study found that communicating risk information using visual tools is 
beneficial for people with diabetes. People with diabetes and Health Care 
Providers advocated the use of visual tools as it was viewed as facilitating risk 
communication, believed to improve people’s knowledge, influenced risk 
perception, and as a result could lead to behavioural change. However, people 
with diabetes had various opinions regarding different visual tools due to the 
nature of the tool and their condition. For example, presenting risk information 
using highlighted human figures (one in ten), bar graph, and smiley faces made 
people underestimate their risk. Other studies have reported similar results (Lee 
and Mehta, 2003; Schapira et al., 2006; Lipkus and Hollands, 1999). Lee and 
Mehta (2003) found that communicating risk information about blood 
transfusions using a written or visual format was effective in improving people’s 
knowledge as well as reducing the perception of risk. Schapira et al. (2006) 
reported that risk was perceived to be lower when risk information was delivered 
using bar graph compared with pictorial display. Furthermore, Schapira and 
colleagues found that presenting risk information with random highlighted 
human figures was more accurate compared to consecutive figures. However, 
the people with diabetes in this study, particularly those with low visual acuity, 
often struggled to see the highlighted human figures (thousand figures), 
whether these were the consecutive highlighted figures or the randomized 
highlighted figures. 
A recent study conducted by Saver et al. (2014) among people with type 2 
diabetes showed that some participants could not understand risk information, 
despite the fact that the risk information was presented via methods 
recommended by previous research (Edwards et al., 2002; Edwards et al., 
2006a; Lipkus, 2007). The current study reports empiric data showing that 
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participants were able to interact with this tool and were able to make sense of 
the information it provided about their own risk. The lack of knowledge of an 
individual’s own risk might explain why, in previous studies, symptomless 
people with diabetes were non-complaint with diabetic eye screening and 
diabetes self-management(Boren et al., 2007; Hipwell et al., 2014; 
Lindenmeyer et al., 2014). 
8.9. Responses to risk communication tools in 
different clinical settings 
This study highlighted the responses of people with diabetes and Health Care 
Providers to different risk communication tools that have been used in other 
clinical settings. In general, most people with diabetes and Health Care 
Professionals advocated the use of risk communication tools when 
communicating risk information about diabetic retinopathy or about diabetic 
screening results. It was perceived that risk communication tools provide clear 
messages and that people with diabetes would take notice of the message 
through a visual tool or a picture rather than simply hearing the message from 
Health Care Professionals. Previous studies (Tait et al., 2010; Lipkus and 
Hollands, 1999; Lipkus, 2007; Ancker et al., 2006; Schapira et al., 2001) 
reported that the use of a visual format was effective when communicating risk 
information to patients. However, many considerations have to be taken into 
account when considering which format is more effective. In this study, Health 
Care Professionals supported the use of visual risk tools for those from an 
ethnic minority group or those who have difficulty with languages. Similar 
findings have been reported by McWhirter and Hoffman-Goetz (2012). 
However, the responses of people with diabetes were diverse regarding each 
risk tool. For example, the use of human highlighted figure (10 figures) was not 
supported because people believed that it would give them the wrong 
impression that they were at low risk of developing diabetic retinopathy. People 
with diabetes described the bar graph as “boring” and “too technical” and 
therefore it was not favoured by them. Health Care Professionals believed that 
the bar graph would give the wrong message for people with diabetes. The 
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human highlighted figure (a thousand figures) was rejected by people with 
diabetes due to the fact that it was difficult to see it, particularly for those with 
low visual acuity or with sight problems. It was described by people with 
diabetes as looking like a pixelated PC screen. The use of smiley faces was 
supported by a few people with diabetes. However, it was also believed to 
provide the wrong impression regarding personal risk as a number of people 
with diabetes thought it would lead them to see themselves as low risk. Lipkus 
and Hollands (1999) reported that people were least accurate when extracting 
information from a bar graph format. The bar graph was perceived as too 
analytical, because it was difficult to understand and hence had less impact 
(Schapira et al., 2001).  Hawley et al. (2008) found that pictographs (using 
human figures) to be more effective than bar graphs at communicating general 
knowledge. Therefore, according to a range of different themes that have been 
identified in the literature and based on the findings in this study it was essential 
to modify/design a new risk communication tool in order to provide risk 
information about diabetic retinopathy to people with diabetes.  
Counselling people about diabetic retinopathy and diabetic retinopathy 
screening involves the presentation of risk and benefit information. In addition, 
the patients’ charter states that patients have a right to be given a clear 
explanation of any treatment proposed, including any risks and alternatives, 
before they decide whether to agree to the treatment. Making an informed 
decision depends on a patient’s level of understanding of the relevant risks that 
are given to them. Informed patients are more likely to make wiser decisions 
and adhere to their treatment (Epstein et al., 2004). Therefore, it is essential 
that risk information is provided in a clear and concise way.  
As has been made clear, no risk communication tool was available in relation 
to diabetic retinopathy. Therefore, the decision was made to talk to people with 
diabetes with regards to existing risk communication tool in other clinical setting. 
This enabled the timely development of a new diabetic retinopathy risk 
communication tool that facilitates the presentation of diabetic retinopathy risk 
to people with diabetes. This appears to be fit for purpose and is timely given a 
recent change in policy regarding the extended screening intervals (NSC, 
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2016). The next section considers the advantages and disadvantages of the 
new diabetic retinopathy has risk communication tool. 
8.10. Advantages and disadvantages of the new 
diabetic retinopathy risk communication tool 
The findings in this study indicate that the new diabetic retinopathy risk 
communication tool was reported as good visual representation that may 
advance the understanding of risk of diabetic retinopathy among people with 
type 2 diabetes. A significant number of participants appeared to be reassured 
by using the new risk tool, which could be due to the fact that the recruited 
people with type 2 diabetes were at low risk. The findings also highlighted that 
most participants appeared to be aware of the different risk categories such as 
high risk and low risk, and therefore, they appeared to integrate their perception 
into the new risk tool. It provided them with risk information in a clear method 
that appeared to improve peoples’ understanding of their own risk and therefore 
may improve diabetes self-care management. The new risk tool was found to 
smooth the progress of the presentation of risk information for those who are 
considered illiterates, or whose first language was not English. The design of 
the new risk tool as a traffic light system too appeared to make people with 
diabetes understand their own risk by comparing it with the conventional use of 
such colours where green means safe and red means danger is internationally 
accepted and widely used. The traffic light system highlighted the importance 
of the amber zone between high risk and low risk and people with diabetes 
could recognize the need to move closer to the low risk zone. 
In contrast, the tool may induce distress to those who believed that they were 
at high risk. Despite the fact that the tool did not include all the risk factors of 
developing diabetic retinopathy, as discussed in chapter 7 (sections 7.2), it 
appeared that it was fit for purpose as people with diabetes were able to see 
improvements or deteriorations in their risk score based on their blood glucose 
results which could also encourage and motivate them to improve their diabetes 
management. Furthermore, the tool may require further modification in order to 
communicate risk information about diabetic retinopathy to people with type 1 
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diabetes. Previous studies that have been conducted with people with cancer 
have found that visual risk tools, were effective at providing risk information 
(Hollands and Spence, 1992; Lee et al., 2003) and were favoured by patients 
(Edwards et al., 2002). 
8.11. The elements of diabetic retinopathy risk 
communication 
This study found that whilst Health Care Professionals preferred to provide 
detailed information about diabetic retinopathy and the results of diabetic 
retinopathy screening, people with diabetes wanted a simple, clear approach. 
They also wanted their condition to be explained to them face-to-face rather 
than receiving the results later or through a letter sent by post. This was 
favoured by people with diabetes for many reasons, including avoiding 
unnecessary anxiety due to the delay in receiving the results, which can take 
up to three weeks. Health Care Professionals also advocated face-to-face 
explanations as they that enabled them to explain the risk of developing diabetic 
retinopathy using either individualized retinal image or/and a risk 
communication tool. Furthermore, people with diabetes appeared more 
comfortable when risk information about diabetic retinopathy was provided by 
an ophthalmologist or optician who they believed have more knowledge about 
eyes rather than their general practitioner.  
This study found that there was no one model that was found to be adequate to 
communicate the risk of diabetic retinopathy to people with diabetes. Therefore, 
the researcher devised a model based upon previous studies (Roach and 
Marrero, 2005; Epstein et al., 2004). This model may work best for people with 
type 2 diabetes. The researcher used the most relevant aspects of previous 
models and developed this new model in order to provide effective 
individualized risk communication about diabetic retinopathy. This can be 
communicated in five common steps as shown below.  Table 8.1 summarises 
these five steps that can provide useful guidance to Health Care Professionals 
to enable them to communicate risk information about diabetic retinopathy to 
people with diabetes.    
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Table 8.1: Elements of diabetic retinopathy risk communication 
Step1 Understand the individuals’ and carers’ knowledge, experience, and 
expectations 
Step 2 Construct partnerships 
Step 3 What is diabetic retinopathy? 
Simple graphic illustration of the eye using plain and simple language 
Retinal image 
Patients testimonials 
Step 4 What is my risk of having diabetic retinopathy? 
Compare HbA1c with recommended targets 
Calculation of individual risk using risk calculator (www.risk.is) 
Visual diabetic retinopathy risk communication tool  
Assign risk severity (high, medium, low) 
Compare individual risk with average risk 
Step 5 How can I reduce my risk? 
Assess motivation for achieving/ maintain normal HbA1c values 
Develop a care plan by shared decision-making 
 
 
Step1: Understand the individual’s knowledge, experience, and 
expectations 
This study has clearly demonstrated that Health Care Professionals need to 
take account of patient’s knowledge, experience and expectations. Good 
evaluation of individual’s knowledge, experience, and expectation, plus their 
ability to read information and ability to absorb and understand risk information 
can help and guide health professionals and facilitate risk communication. 
According to Shrek et al., (2014) assessing and understanding perceived risk 
can provide a framework for individuals to improve their self-care behaviours 
and glycaemic control. Another important issue that was highlighted by Saver 
et al., (2014) is assessing individual’s knowledge of risk factors, which may 
contribute to a treatment plan. 
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Step 2: Construct partnerships 
This study highlighted the significance of relationship between people with 
diabetes and Health Care Professionals. This relationship appeared to 
influence individuals’ perception of risk and improved adherence with health 
professional’s advice. As a result, participants appeared re-assured and 
received risk information with confidence. Flexibility of health professionals 
when offering appointments also enhanced individual’s confidence. Epstein et 
al. (2004) suggests building a partnerships between patients and Health Care 
Professionals to build trust and facilitate the transfer of information by 
expression of empathy, acknowledgment of the complexity or difficulty of the 
issue, an expression of mutual understanding (e.g., “I think I understand,…”), 
increasing patient/ family involvement (e.g., “I would like to help you 
understand”), and fostering partnership (e.g., “We need to make this decision 
together”) 
 
Step 3: What is diabetic retinopathy? 
With consideration to diabetic retinopathy risk, most people with diabetes in this 
study wanted to know 1) what is diabetic retinopathy?  2) Was he/she at risk of 
developing diabetic retinopathy? 3) What can they do to lower or avoid the risk 
or slow disease progression? 
Because the term “diabetic retinopathy” was not fully understood among people 
with diabetes in this study, it seems appropriate to structure the discussion 
about diabetic eye disease. In order to fully understand diabetic retinopathy and 
its implications on sight, relevant information must be provided about what might 
happen? And how might diabetic retinopathy or diabetic eye disease develop?  
This study also revealed that individuals’ risk perception was affected by their 
beliefs in relation to the causes of diabetic retinopathy, whether it is preventable, 
and the consequences of the problem on their sight. To illustrate the causes of 
increased diabetic retinopathy risk, the link between diabetic retinopathy and 
individual’s specific behaviours should be explained in clear and easy plain non-
medical terms (Yoshida and Yoshida, 2014; LeBlanc et al., 2014; Fagerlin et 
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al., 2011). This method was found to be successful in providing patients with 
more precise information regarding their cardiovascular disease risk as a 
means of dampening down excessively optimistic perceptions of individual 
risk(Rothman and Kiviniemi, 1999). For example, if an individual smokes 
cigarette, has uncontrolled blood pressure, uncontrolled blood glucose, a 
simple and clear statement such as “smoking, high blood pressure, and high 
blood glucose all act together to cause damage to blood vessels in the back of 
your eye and this can cause problems to your sight”. This approach appeared 
successful in communicating the increased risk of cardiovascular disease to 
people with diabetes (Roach and Marrero, 2005). However, many individuals 
may have received such information, but did not understand the message, and 
therefore, people with diabetes and Health Care Professionals in this study 
advocate the use of visual risk communication tool to make diabetic retinopathy 
easy to understand, regardless of an individual’s literacy level. This study clearly 
demonstrated that using an individualized retinal image when communicating 
risk information was advocated by health professionals, as it reinforced the risk 
message about the cause of diabetic retinopathy.  
In order to point out the consequences of diabetic retinopathy on an individual’s 
sight, this can be done by using two approaches based on the research findings: 
1) highlight the similarities between the individual and others who have 
experienced similar condition; and 2) graphically show the severity of the 
consequences linked with the event by presenting a similar retinal image. These 
two approaches were found to be effective also in communicating risk 
information about cardiovascular disease among people with diabetes 
(Rothman and Kiviniemi, 1999). Furthumore, people with diabetes and Heath 
Care Professionals in this study pointed out that engaging the individual with 
other people with diabetes who have experienced sight-threatening diabetic 
retinopathy may influence their understanding of risk and therefore, enhanced 
their adherence with diabetes self-care management. Rothman and Kiviniemi 
(1999) suggest providing patients with a brief videotape testimonial from a 
designated individual with diabetes from similar ethnic and age group. The 
significance of diabetic retinopathy and potential sight-threatening nature of 
diabetic retinopathy must be clearly communicated to make sure the individuals 
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are adequately aware of the consequences and to motivate them towards 
behavioural change.   
 
Step 4: What is my risk of having sight-threatening diabetic retinopathy? 
People with diabetes and Health Care Professionals appeared divided about 
the most intuitive approach of risk communication and whether to use plain word 
such as “high, medium, and low risk”; or statistical information such as “a ten 
per cent risk of developing sight-threatening diabetic retinopathy in the next five 
years”; or to use probabilities such as “one in ten chance of developing sight-
threatening diabetic retinopathy in the next five years”. However, Health Care 
Professionals in this study appeared to use different approaches with patients 
based on their level of understanding, education, and ethnic background. 
Therefore, according to Roach and Marrero (2005) an effective risk 
communication approach is to start the risk discussion by describing the 
individual’s statistical risk for their condition. However, due to the massive 
variation in risk perception between patients and Health Care Professionals as 
mentioned earlier, the level of risk must be attached to the risk statement.  For 
example, “you have twenty per cent risk of developing sight-threatening diabetic 
retinopathy or a diabetic eye complication in the next five years, and this is high 
risk or very serious risk”, based on the impact of the retinopathy on an 
individual’s sight. Paling (2003) suggests avoiding using descriptive words such 
as “low risk” or “high risk”, as well as advocating the use of a consistent 
denominator to avoid misinterpretation of risk information. However, when 
communicating a normal diabetic retinopathy result or eye examination results 
to people with diabetes, there are always chances for false negative results, 
therefore, Petticrew et al. (2001) suggests that, when results are 
communicated, individuals should be informed that they have a low risk but 
negligible, and that the risk of developing diabetic retinopathy remains. 
Health Care Professionals in this study advocated the use risk calculators to 
provide individualised risk information. Risk can be calculated by Health Care 
Professionals using a risk calculation tool, which is available online 
(www.risk.is). Experimental testing for safety and efficacy of the risk calculator 
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was done using patient records relating to diabetic retinopathy at Aarhus 
University Hospital, Denmark (Aspelund et al., 2011). For example, Mr. X is 
forty years old, who had type 2 diabetes mellitus for the last five years, he has 
no previous retinopathy (R0), his blood pressure is well controlled (120/80 
mmHg), and with a HbA1c seven per cent he would have a diabetic retinopathy 
screening interval of sixty months. The diabetic retinopathy screening interval 
would be twenty-five months if blood pressure rose to 150/90 mmHg, with 
HbA1c seven per cent. However, Mr. X would require diabetic retinopathy 
screening after twelve months with blood pressure of 150/90 mmHg, and HbA1c 
nine per cent. Mr. X would require screening after six months with blood 
pressure of 160/90 mmHg, and HbA1c twelve per cent. Table 3.2 shows the 
proposed diabetic retinopathy screening interval for Mr. X, based on individual 
risk factors. 
In order to optimize the risk message, Roach and Marrero (2005) recommended 
comparing an individual’s personal risk to an average risk. This can be done by 
using the risk calculator as shown in Table 8.2. Health professionals can 
compare individual’s parameters such as the readings of the third, fourth, and 
fifth row, with the normal “average” values such as in the second row. Such 
comparison was found to be effective in communicating risk information about 
cardiovascular disease among people with diabetes (Rothman and Kiviniemi, 
1999).  
Table 8.2 Diabetic retinopathy screening interval based on patient individualised risk factors 
Name Age Type of 
diabetes 
Duration 
of 
diabetes 
HbA1c Blood 
pressure 
Previous 
diabetic 
retinopathy 
Calculated 
risk of 
developing 
STDR 
every year 
Risk  Screening 
intervals 
Mr X 40 T2DM 5 years 7% 120/80 No 0.4% Low risk 60 months 
    7% 150/90 No 1.5% Medium 
risk 
25 months 
    9% 150/90 No 3.2% High risk 12 months 
    12% 160/90 No 14.5% High risk 6 months 
T2DM: Type 2 Diabetes Mellitus, STDR: Sight-threatening Diabetic Retinopathy  
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The risk calculator can provide the Health Care Professional with individualized 
statistical data that can facilitate communicating the risk information. However, 
as the Health Care Professionals in this study made clear, such information may 
be helpful to guide them about the most effective screening interval, but it may 
not lead to better understanding of risk or to behavioural changes because it 
provides typical risk information only to people with diabetes and it does not 
engage them to improve their diabetes self-care management. Therefore, 
another way of engaging patients and providing risk information is by using risk 
communication tools that facilitate the reception of risk information, improve 
individual’s understanding, and lead to behavioural changes. The new diabetic 
eye risk communication tool was reported as easy to use by participants. For 
example, it enabled them to see how they could balance non-modifiable factors 
(e.g. years with diabetes) with more modifiable ones (e.g. blood glucose levels). 
Therefore, individuals may prioritize improving their diabetes self-care 
management in order to prevent further deterioration. Individuals can interpret 
their risk by comparing it with the colour code. Individuals understood their own 
risk easily, because the colour coding where green means safe and red means 
danger is internationally accepted and widely used (Gil and Le Bigot, 2014). In 
addition, individuals’ perception of future risk also appeared to be incorporated 
into the new risk tool, as most participants appeared to be more aware of risk 
category (high, medium, and low). They appeared to attach the different risk 
categories to probability of them developing complications. Personalized risk 
tools found to increase individuals knowledge, and increase accuracy of risk 
perception (Edwards et al., 2013). 
This study has shown how Health Care Professionals have to decide what sort 
of risk communication language is effective. Based on their initial assessment, 
they have to choose whether gentle language is acceptable particularly for low 
risk patients or whether fear and threatening language is more appropriate, 
particularly for those who appeared non-adherent with medical advice. The 
strength of the fear message should reflect the nature of the condition, severity, 
and impact of the disease. Previous studies suggested using strong language 
as it helps promote people’s behaviours (Stephenson and Witte, 1998). The 
higher level of threat necessities a stronger risk message. According to French 
et al. (2006) individuals request more details when risk information is more 
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threatening. Honey et al. (2014) argues that peoples’ responses to risk 
messages are due to individual’s personal characteristics although it may be 
influenced by the communication style between the individuals and their health 
providers. In contrast, Peters et al. (2013) argue that threatening messages 
rarely result in behaviour change, and the frequent use of fear and threatening 
messages may lead to defensive reactions(Good and Abraham, 2007).  
In diabetic retinopathy screening where the evidence about benefits and harm 
is clear, Health Care Professionals may have recommendation for how to best 
meet patients’ goals. The Health Care Professionals should inform the people 
with diabetes, guided by the diabetic retinopathy risk communication tool and 
risk calculator, why diabetic retinopathy screening is recommended based on 
the clinical evidence, and how that recommendation is generated clearly from 
the patient’s goals and the evidence. 
 
Step 5: How can I reduce my risk? 
Risk reduction recommendations are the last important aspect of risk 
communication. This study has demonstrated that health professionals should 
provide their patient with information that can help them to reduce their risk. 
Understanding the risk without adopting risk reduction strategies would not 
reduce the risk. This can be challenging to Health Care Professionals as it 
involves behavioural change. Health professional must discuss all the risk 
factors associated with developing sight-threatening diabetic retinopathy. 
However, they must also give consideration to the most significant modifiable 
risk factor of developing sight-threatening diabetic retinopathy which is HbA1c, 
and make it clear to individuals that by controlling HbA1c, risk of developing 
sight-threatening diabetic retinopathy will remain low. 
At this stage, the diabetic eye risk communication tool can be used and explain 
to the individual that his/her HbA1c value should remain in the green colour and 
not move to amber or red. Getting patients engaged with the risk tool would 
establish that they are part of decision-making process that will increase their 
chances to adhere to health professional’s recommendations (Roach and 
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Marrero, 2005). The diabetic eye risk communication tool can guide health 
professionals to recommend an appropriate screening interval for people with 
type 2 diabetes, not only for those who have four greens, but also others who 
have had diabetes for a long time but their HbA1c remain under control.  
Furthermore, health professionals expressed the importance of providing 
written information to patients. This could be a personal copy of an individual’s 
retinal image, a copy of the diabetic eye risk tool, and information about 
medications despite the problem of medication non-adherence (Haynes et al., 
2002). Furthermore, the introduction of “passport for care”,  where patients 
records their medications and appointment, was found to be useful in a clinical 
setting as it improves adherence to medication (Barber et al., 2014; Jubraj 
andBlair, 2015), improves follow-up (Poplack et al., 2014), assists Health Care 
Professionals in decision-making (Newell et al., 2014), and enhances healthy 
life-style choices (Vaczy et al., 2011).  
Another important aspect is Involving a family member as it was favoured by 
health professionals and some participants such as the elderly and those who 
have language barriers, as they may not fully understand the risk message, or 
forgotten it at the next visit. A randomised controlled trial among people with 
diabetes found that more accurate risk perception is noticed two weeks after 
communicating risk information and the information about risk perception had 
been forgotten and disappeared by twelve weeks (Welschen et al., 2012). The 
frame of the risk message influenced an individuals’ decision. For example the 
word “loss” was found to influence screening uptake more than the word “gain” 
(Edwards et al., 2002). Therefore, health professionals can use it when 
recommending diabetic retinopathy screening by saying:  
“The potential loss from not having diabetic eye screening is....”  
Such “framing bias” is considered justifiable according to Edwards and 
colleagues (2002).At the end of the consultation, it’s recommended that health 
professionals check that an individual understands the risk information by 
asking them to summarise what they understand, although this is not routinely 
done (Campion et al., 2002). 
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To summarise, risk information about diabetic retinopathy can be 
communicated to people with type 2 diabetes in five common steps as shown 
above in table 8.1. The findings clearly demonstrated that Health Care 
Professionals should first understand patients’ knowledge, experience, 
expectations, and their ability to understand risk information. Second, the 
findings also highlighted the importance of constructing good relationship with 
patients as this appeared to influence individuals’ perception of risk and 
improved adherence with health professional’s advice. Third, most people with 
diabetes wanted to know what diabetic retinopathy is. It seems appropriate to 
structure the discussion about diabetic eye disease because the term “diabetic 
retinopathy” was not fully understood among people with diabetes in this study. 
The forth step is to provide an individualised level of risk using probabilities and 
attaching the level of risk to the risk statement. This can be achieved by using 
risk calculators and engaging them using the diabetic retinopathy risk 
communication tool to help them understand own risk. The last step is to provide 
people with diabetes with information that can help them to reduce their risk. 
Health Care Professional must explain all the risk factors associated with 
developing sight-threatening diabetic retinopathy. However, they must also give 
consideration to the most significant modifiable risk factor of developing sight-
threatening diabetic retinopathy which is HbA1c, and make it clear to individuals 
that by controlling HbA1c, risk of developing sight-threatening diabetic 
retinopathy will remain low. 
8.12. Study strengths and limitations 
The strength of this study is that it provides primary research that explored 
participants’ experience of risk communication as well as the perception of 
diabetic retinopathy risk among people with type 2 diabetes and Health Care 
Professionals. 
8.12.1 Insider researcher 
The insider position of the researcher was a particular strength of this research. 
As a long-established and senior ophthalmic nurse, the researcher had 
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credibility with the participants and this helped to enhance dedication to the 
study. Wide-ranging experience of ophthalmology improved the understanding 
of the research issues. Employment of reflective and reflexive practice assisted 
critical engagement and challenging of obstacles. The researcher had a good 
relationship and power within the ophthalmology department and this helped to 
work against the potentially negative impact of the study association with 
achievement of a higher degree and gained support for the study from the 
senior ophthalmic management team. 
8.12.2 Patient and public involvement 
The involvement of service users was an essential part of this research and 
central to its success. The protocol was further developed with the collaboration 
of members of the Warwick Diabetes Research and Education User Group, who 
reviewed the research questions, the interview schedule questions, and the 
sampling processes. 
8.12.3 Limitation of the literature review 
This section reflects on the process of conducting this study and the most 
important lessons learned, that is to say study limitations. These include: 
limitations of the literature review, the clinician-researcher role, and ethical 
issues arising in the study such as the role of gatekeepers and the 
researcher/clinician role. The purpose of conducting a literature review was: 1) 
to provide a review of the literature on diabetes, and the main complications 
associated with diabetes. The author considers diabetic retinopathy in more 
detail as the main diabetes related eye complication and 2) to examine the 
literature about perception of risk and risk communication among people with 
type 2 diabetes.   
Advocates of systematic reviews argue that they are more liable to produce a 
wide-ranging and fair presentation of the literature (Bryman, 2008). However, 
qualitative research methodology does not fit with usual systematic review 
criteria (Bryman, 2008). In order to understand how and why phenomena of 
interest are important, qualitative research has a great deal to contribute. This 
is particularly evident in complex intervention studies. Sturt et al (2006) argues 
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there is a need to incorporate complex intervention research into systematic 
review.  One would argue why some parts of the study are designed as a 
literature review and not a systematic review such as in section 2.14.5, 
interventions to increase attendance to diabetic screening. There is already a 
systematic review on this topic and therefore there was no need to repeat one. 
Systematic reviews focus on a single question whilst a literature review is more 
comprehensive to various degrees and does not necessarily focus on a single 
question (Bettany-Saltikov, 2010). Conducting a systematic review of risk 
communication tools would have been a legitimate exercise and would have 
highlighted the different risk communication tools. Though this is not really a 
true limitation, as the aim was not to examine the effectiveness of the risk tools 
but rather to modify a risk tool in order to facilitate the presentation of diabetic 
retinopathy risk.  In terms of usefulness, it would have produced limited results 
and possibly cause more confusion to participants. In contrast, the wide-ranging 
search strategy guiding the literature review established the existing knowledge 
and highlighted gaps in data. The literature review ensured the research 
investigated a gap in our knowledge base.  
Furthermore, the literature review offered the benefit of being an on-going 
component of this study. Corbin and Strauss (2008) support the proactive 
engagement with the literature from the start of the research process. Although 
the study investigated the impact of risk communication and risk tools on risk 
perception, the author was not very familiar with the risk communication 
literature, particularly when it involves providing sensitive or potentially 
upsetting information. Therefore, he had to expand his knowledge about the 
perception of risk and how to communicate risk information. This was very 
helpful in designing the interviews and the decision to employ purposive 
sampling that was used in the study. The author ensured that the main aspects 
of risk communication and perception of risk were covered and not missed out 
during the interviews. Utilizing the literature all the way through the study 
enhanced and encouraged the thought processes. It also expanded the 
possibilities for the data to be inspected more closely during theoretical coding. 
Regular updating of the literature review highlighted new risk communication 
studies related research that continued to inform the development of the study.  
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8.12.4 The role of gate keepers 
Gate keepers role have a significant impact on the external validity of a study 
(Lakerveld et al., 2008). In this study where participants have been accessed 
via an established health care context, such as GP practices and hospital 
clinics, those who have been invited to participate have been influenced by the 
knowledge, motivation and authority of the employees and clinicians in that 
clinic. This may impact on the recruitment process because those people would 
be making significant decisions regarding the recruitment and therefore may 
cause risks to the validity of the study. These issues have been managed by 
arranging meetings with practice managers, clinicians, and receptionists 
providing them with information about the study and involving doctors and 
nurses in the recruitment process. As the literature suggests, participants are 
more likely to participate if they were asked by a doctor rather than a receptionist 
(Symonds et al., 2012). Another issue that was taken into consideration was in 
those cases where participants may have been over persuaded to take part 
because they were concerns that their health care will be compromised. 
However, this matter was dealt with when confirming informed consent and by 
gaining assurances that participants were happy to participate in the research 
prior to their interview.  It was also recognised that a number of people with 
diabetes have faced additional barriers in accessing services due to their ethnic 
background and language barriers. Thus, the researcher adopted strategies to 
increase interview participation, such as employing a bilingual interviewer and 
translators. 
8.12.5 The clinician-researcher role 
A number of people with diabetes who took part in the study knew the identity 
and professional background of the researcher when the interview was 
conducted in the hospital, which was the researcher’s place of work. Those who 
recognize the researcher may have answered differently during the interview 
assuming that the researcher knew such information and has access to it due 
to the professional capacity. Therefore, the researcher adopted strategies to 
encourage the participants to expand on his/her answer by having follow-up 
questions or/and probes or by rephrasing the questions. 
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8.13. PhD journey and interruption of studies 
My PhD journey started in 2008 at the University of Nottingham. In my first year, 
I attended courses such as quantitative methods and analysis, qualitative 
research methods, and philosophy of health science module. In addition, I 
attended courses to improve my research skills such as being an effective 
researcher and research methods during 2008 and 2009 as well as attended 
relevant conferences. I then developed my literature review and methodology 
chapter to answer the following research question: “why people with diabetes 
do not attend diabetic retinopathy screening?” 
At the time when I applied for ethical approval at the end of 2010, I was informed 
by a member of the research ethics committee that ethical approval had been 
granted for similar research and I should get in touch with the FLURRI research 
team at the University of Warwick. I was very frustrated at that point as I had 
spent two years at the University of Nottingham conducting the literature review 
and applying for ethical approval. A few days later I had several meetings with 
my supervisors and then there was few email exchanges between the 
researcher and the FLURRI team at the University of Warwick. This ended with 
the researcher transferring his PhD to the University of Warwick in July 2011 
and joining the FLURRI team. As a result, the researcher had to address a 
different research question regarding communicating risk information about 
diabetic retinopathy to people with diabetes. Joining a well-established research 
team (FLURRI) was very beneficial to me as my previous supervisors at the 
University of Nottingham did not have a good connection with the diabetic 
retinopathy screening programme. Therefore, they strongly recommend that I 
join the FLURRI team because of their strong connections with the English 
diabetic retinopathy screening programme. Since then I have then undertaken 
more courses to improve my research skills and knowledge as well as attending 
national and international conferences, which have impacted positively on my 
PhD journey. Furthermore, I have presented three posters and one oral 
presentation at international conferences.  
However, transferring to the University of Warwick caused further delays as a 
result of changing the research question. This meant that the researcher had to 
conduct a second literature review and reapply to another research ethics 
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committee. It would have been ideal to complete the PhD study without further 
interruptions. However, being a part time clinician, a partially funded PhD 
student, and a father of four boys in the school, whom some were undertaking 
University, GCSE and A level examination, also proved to be considerable 
challenges. Following completion of the data collection, in order to provide 
financial resource to be able to continue supporting my family as well as 
complete my PhD study, I had a break from the University to work abroad 
between 2013-2015.  The duration of PhD registration has meant that over the 
period supervisors have moved to other posts and institutions and I have had a 
succession of supervisors, which have impacted positively and negatively on 
the personal and professional development as a researcher. For example, I 
have gained a wide-ranged experience from my supervisors in terms of 
knowledge, research methodologies, and personal and professional 
development. In contrast, changing supervisors caused delays as I had to re-
shape my research questions several times to reflect on the research focus. 
Joining a well-established research team had positive impact significantly on 
the researcher’s knowledge and experience. This helped the researcher in 
many ways such as designing the study, data collection, data, analysis, and 
improved his skills in applying for research ethical approval. Despite the severe 
delay in my PhD study, I do not regret transferring my study to the University of 
Warwick and joining the FLURRI team.  
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 Thesis conclusion 
In conclusion, this qualitative study has explored how diabetes and the risk of 
diabetic retinopathy is understood by people with type 2 diabetes and Health 
Care Professionals. The original idea for this research (communicating risk 
information about diabetic retinopathy to people with type 2 diabetes) came 
whilst undertaking the FLURRI study. The team were aware of an ongoing 
discussion in the national screening programme about possible extended 
screening intervals for people at low risk of developing diabetic retinopathy. 
During FLURRI fieldwork, when participants were asked about the views on 
extended screening intervals, many participants seemed concerned at the 
proposal. Additionally, the FLURRI study highlighted issues such as lack of 
communication as reasons for non-concordance with diabetic eye screening 
(Lindenmeyer et al., 2014; Hipwell et al., 2014).  
 
This study adds to the field of research in several ways: 
1. It provides insight into people with type 2 diabetes’ knowledge and beliefs 
relating to diabetes and diabetic retinopathy; 
2. It explores the impact of risk communication on perception of risk; 
3. It explores the impact of risk communication tools on peoples’ understanding of 
risk; 
4. A model is proposed for communicating risk information about diabetic 
retinopathy to people with type 2 diabetes.   
9.1. Implication for practice 
 Education programmes in relation to diabetes should include more information 
about the risk of diabetic retinopathy. Education programmes should 
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concentrate on explanations and interventions that are more meaningful to 
individuals and groups and the ways in which diabetes is constructed and 
interpreted in everyday life. 
 Health Care Professionals should assess individual’s knowledge and beliefs 
about their condition before communicating risk information and then check the 
level of understanding after providing risk information. 
 Risk information should be personalised and provided in a clear and attractive 
style based on level of understanding, particularly to the symptomless 
participants. 
 Health Care Professionals must be aware that individual’s will interpret the 
evidence in different ways when providing risk information using numerical data. 
Furthermore, Health Care Professionals should not assume that individuals 
understand the information with their patients without checking for themselves 
regardless of other markers such as social class, ethnicity, or gender. 
 Engaging people with type 2 diabetes with a peer group may benefit them in 
making sense of their risk and may then lead to changes in their diabetes self-
care management. Engaging family members may also help individuals change 
their diabetes self-care management particularly those non-English speaking or 
with language barriers. 
 A number of factors such as type of diabetes, individual’s age, ethnicity, type of 
medical treatment, co-morbidity factors, and the presence of visible symptoms 
or eye complication must be considered when risk information about diabetic 
retinopathy is provided.  
 Health Care Professionals must give more attention when risk information about 
diabetic retinopathy is communicated to make sure that those who may 
underestimate their risk have understood the message. In contrast, those who 
may be more pessimistic about their probability of developing diabetic 
retinopathy must be re-assured and provided with information that can help 
them to stop disease progression. 
282 
 
 Those individuals who underestimated their risk of developing sight-threatening 
diabetic retinopathy were less likely to take preventative measure to avoid 
complications. Therefore, one way forward is to engage those individuals by 
asking them to perform self-risk assessment using the diabetic retinopathy risk 
communication tool. Good explanation about individual risk and the probability 
of future complication may help them balancing unseen risk with their personal 
discomfort such as pricking their figure when checking blood glucose. 
 Providing people with diabetes with a copy of diabetic retinopathy screening 
photo, a copy of the diabetic retinopathy risk tool, and written risk information 
may help individuals remember their risk once they go home.  
 Diabetes related eye complications risk information is better communicated 
using personalised visual risk communication tool as it helps individuals to 
interact with the tool, it provides them with risk information in a clear method 
and makes people with diabetes more aware of the different risk categories 
such as high risk and low risk. 
 The study also suggests that risk information about diabetic retinopathy should 
be provided in a simple way, clear approach and face-to-face rather than 
receiving the results later or through a letter sent by post. This approach 
reduces anxiety. 
 People with type 2 diabetes and Health Care Professionals reported that risk 
information about diabetic retinopathy is better communicated using the five 
steps as detailed in section 8.10 
9.2. Implication for policy 
The study took a qualitative approach to explore the perceptions and 
experiences diabetes and diabetic retinopathy risk among people with type 2 
diabetes alongside Health Care Professionals. This enabled the production of 
diabetic retinopathy risk communication tool. Following a review of the 
evidence, the UK National Screening Committee recommended that the 
diabetic retinopathy screening intervals should be changed for people with type 
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2 at low risk of sight-threatening diabetic retinopathy from one year to two years 
(NSC, 2016). This recommendation to change the screening intervals from one 
year to two-year screening intervals is based on the evidence from a large 
observational study, which showed that it was safe to extend the screening 
intervals in low risk people with type 2 diabetes. In contrast, people at high risk 
of developing sight-threatening diabetic retinopathy will remain annually. The 
development of the diabetic retinopathy risk communication tool is timely with 
regard to the policy change. Using the risk communication tool may help people 
with type 2 diabetes to feel more comfortable with extended intervals, due to 
low risk status, when they have been used to annual screening. The findings 
appear to indicate that low risk people felt reassured by the new risk tool so that 
indicates that it is fit for purpose in supporting people with diabetes’ adjustment 
to extended intervals.  
9.3. Implication for research 
 Future quantitative studies should examine how a range of service users 
interpret specific risk tools associated with different conditions 
 Future research is needed to evaluate the new diabetic retinopathy risk 
communication tool for improving patient treatment satisfaction with extended 
screening intervals and improving self-management behaviours to ensure 
maintenance of low risk. 
 More research is needed to evaluate the tool for reductions in modifiable risk 
factors in people with type 1 and type 2 with different stages of diabetic eye 
disease. 
 Future research is needed to evaluate the newly developed risk tool for use by 
different Health Care Professionals related to diabetes (e.g. ophthalmologists, 
practice nurses, eye screeners, optometrists, pharmacists, GPs, and other 
members of the diabetes team). 
 More research is needed to explore the perceptions and experiences of risk 
among people with type 1 diabetes. 
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 Future research is needed to modify the risk tool in order to facilitate 
communicating risk information about diabetic retinopathy to people with type 1 
diabetes.  
 More qualitative studies are needed to explore risk perception differences 
between symptomatic and asymptomatic people with diabetes  
9.4. Implementation of the newly developed risk tool 
It is anticipated that 2 papers will be submitted for publication on 1) patient’s 
perception of risk of diabetic eye disease and 2) the development of the risk 
communication tool. The Director of the English National Diabetic Retinopathy 
Screening programme is one of the supervisors which will facilitate access to 
implementation of the risk communication tool into clinical practice. Discussion 
are underway to assess the validity and reliability of the tool across broader 
populations prior to implementation. These further studies will incorporate 
evaluation of the processes for successful implementation alongside validity 
and reliability evaluations. This will enable the identification of training and 
support needs for health professionals using the risk communication tool in 
routine clinical practice. 
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APPENDIX 1:  Declaration of Informed Consent  
(Patients; v1) 
Participant ID number…………… 
Please tick  
1. I have read and understand the ‘Patient Information Sheet (v1)’.   
 
□ 
2. I understand that taking part in this study will involve me being interviewed, 
providing some personal information, and two short surveys. 
 
□ 
3. I understand that the discussion will be recorded and that the recording will 
be destroyed at the end of the study.   
 
□ 
4. I understand that there are no known expected discomforts or risks 
involved in my participation in this study. 
 
□ 
5. I understand that I am free to withdraw from the study at any time prior to 
the end of the study, without giving a reason, by contacting the e-mail 
address or telephone number below. This will not affect my care. 
 
□ 
6. I give my permission for my GP practice to provide access to my diabetes 
records and that this will be used for the purposes of this research only. 
□ 
 
 
If you would prefer to be interviewed in a language other than English, this can be arranged.  
Please state the language you wish to use in an 
interview:………………………………………….. 
 
I give my informed consent to take part in this study.  I understand that although a 
record will be kept of my participation in the study, my data will be identified by a 
number or an alternative name (pseudonym) only.   
 
Signed …………………………………………  Dated 
………………….………… 
Name (please print in full) ........................................................  
Phone number(s) ..................................................................................................................... 
Email address: .................................................................................................................. 
Address:.......................................................................................................................................
.............................................................................................................................Post code: 
............................... (We will only use this information to contact you about the study) 
 
 
In case of any query, please contact the lead researcher: Nidal Al-Athamneh 07426883070 or n.al-
athamneh@warwick.ac.uk   In case of complaint, please contact Nicola Owen 024 7652 2785  or  
Nicola.Owen@warwick.ac.uk
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APPENDIX 2:  Patients Demographic Data Collection 
(Patients; v1) 
IN CONFIDENCE 
Participant ID number…………… 
This sheet will be stored separately from all other information, to protect  
your identity 
 
 
Date of birth (please write in):  Date ........  Month…………..……….  Year……….….   
 
1. Sex (please circle one): Male/Female   
 
2. What type of diabetes do you have?  (Please tick one): 
 Type 1 Diabetes  □ Type 2 Diabetes □  
3. Do you have any other long term conditions? (Please tick one):  Yes/No 
If yes, please state what these are: .................................................................... 
............................................................................................................................ 
 
4. Which of the following groups do you consider that you belong to? 
(Pease tick one)    
White 
British □ 
White Irish 
□ 
White other 
□ 
Black 
African □ 
Black 
Caribbean 
□ 
Black other 
□ 
Indian □ Pakistani □ Bangladeshi □ 
Chinese 
□ 
Other 
□  Please 
state.............................. 
 
5. What type of work do/did you do? 
................................................................... 
.......................................................................................................................
....... 
6. What is the highest level of qualification you have? ....................................  
............................................................................................................................ 
   
Thank you for your help! 
 
In case of any query, please contact the lead researcher Nidal Al-Athamneh 07426883070 or n.al-
athamneh@warwick.ac.uk; In case of complaint, please contact Nicola Owen 024 7652 2785  or  
Nicola.Owen@warwick.ac.uk  
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APPENDIX 3:  Patients Information Sheet 
(v1) 
 
Study Title: Communicating risk information about diabetic 
retinopathy to people with diabetes 
 
Invitation: 
You are invited to take part in a research study that is being conducted as part of 
educational study at the University of Warwick.  Before you decide whether to take part 
or not, you should understand why the research is being done and what it will involve.  
Please take time to read the following information and discuss it with others if you wish.  
Ask us if anything is unclear or if you would like more details.  Our contact details are 
at the bottom of every page and in sections 12 and 13.  Thank you for reading this 
information sheet. 
 
What is the purpose of this study? 
People with diabetes sometimes develop problems with their eyes that can lead to 
vision loss and blindness.  This damage to the eye is known as Diabetic Retinopathy 
and can be detected early through screening, which involves patients having digital 
photographs taken of their eyes.  These photographs can identify early signs of 
damage caused by diabetes, before the patient becomes aware of any symptoms.  
Research has shown that people who attend the Diabetic Retinopathy Screening 
Programme are less likely to suffer loss of vision or blindness, compared with people 
who don't attend, because they receive their treatment sooner when less damage has 
occurred.  For more information, please see the enclosed leaflet. This research aims to 
find out how the risks and benefits of diabetic retinopathy screening programme are 
understood, and to establish the methods by which risk information can be effectively 
communicated. 
 
The results will be given to the Diabetic Retinopathy Screening Programme 
managers and General Practitioners, so that they are aware of the issues that have 
been raised. You will not be identifiable as we will keep your personal details 
confidential and protect your identity. 
  
Why have I been chosen? 
You may have offered to take part after hearing about the study in the local media, or 
at your GP practice. You are eligible to take part because you have been diagnosed 
with diabetes, and have previously been asked to have photographs taken of the back 
of your eyes.  Your experiences of this process may help us to understand what 
influences people's decisions whether or not to go to the screening, or whether they 
understand the result once it has been communicated to them by their GP, optometrist, 
or diabetic screening staff. We are asking for the views of people with diabetes who 
have previously attended their diabetic eye screening, and will also be asking the views 
of health professionals involved in the screening programme.    
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Do I have to take part? 
It is entirely up to you to decide if you want to take part or not.  If you do decide to take 
part, you will be given this information sheet to keep and asked to sign a form, 
enclosed, saying that you agree to take part (consent form).  You will be free to 
withdraw from the study at any time before the end of the study (estimated at August 
2013), without giving a reason – this will not make any difference to the treatment that 
you receive.  A decision to withdraw or not to take part will not be passed on to your 
medical team.  If we have already collected information from you and you choose to 
withdraw, we will destroy all the information we hold for you and not use it in the study.  
 
What will I have to do? 
You are being asked to take part in a research interview, which will last approximately 
45 minutes to an hour.  This will probably take place at your GP practice, or other venue 
of your choice (to be confirmed), or by telephone.  We will be able to pay your travelling 
expenses and you will receive a £20 gift voucher.  You will be asked about your 
experiences of living with diabetes, your perception and view of risks and benefits of 
diabetic retinopathy screening, and how risk information about diabetic retinopathy 
should be communicated to people with diabetes. 
 
Before you start talking to the researcher, you will be given a form to fill in with your 
personal details; the researcher can help you with this if necessary.  You will also be 
asked to fill in two short surveys, which will ask you a few questions about diabetes 
self-care management, and aspects of living with diabetes that you find difficult; the 
researcher can help you with this if necessary. These forms take no more than 15 
minutes to complete.  Patients come from lots of different backgrounds, so have very 
different experiences that can affect their diabetes and lead to different views about 
diabetic eye screening, which we are interested in.  We will also ask your GP practice 
to send us the result of you most recent blood glucose test. 
 
You will be asked to agree to the discussion being audio recorded (the recording will 
be destroyed at the end of the study).  The recording will then be put into writing and 
your views will be carefully considered, along with the other participants’ views.  Any 
paperwork that is produced as a result of this research study (for example, for the 
Diabetic Retinopathy Screening Programme management) will refer to you by an ID 
number only (e.g. ‘participant number 10’), or an alternative name (pseudonym).   
 
What are the possible disadvantages of taking part 
The only disadvantage is likely to be the time that it takes for you to participate in the 
interview. No other disadvantages are expected. 
 
What are the possible advantages of taking part? 
The views of everyone who talks to us will be considered carefully.  These views will be used 
to suggest improvements to the Diabetic Retinopathy Screening Programme organisers (we 
will refer to you by an ID number or an alternative name only).  The information we get from 
this study may help other people in future. You may learn more about your diabetes and eyes 
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and this may help your health.  We will give you a £20 voucher at the end of the research 
interview. 
 
Will anyone else know I have done this? 
Only the lead researcher/interviewer and the member of staff at your GP surgery who 
sent you this information pack will know exactly who has been invited to take part.  Your 
name or details will not be given to anyone else – you will only be referred to by 
participant ID number or an alternative name (pseudonym) in any paperwork.  So the 
Diabetic Retinopathy Screening Programme management, hospital specialist etc. will 
not know that you have done this.  No-one else will be told exactly who has taken part.  
All information will be treated confidentially.  Only the research team will have access 
to your personal details, the audio recording and the written copy of our conversation, 
which will be kept in locked filing cabinets.  The recordings will be password protected 
and erased at the end of the study (estimated at December 2013).  The Data Protection 
Act (1998) will be followed at all times. The only circumstance, in which we might have 
to pass your details to another person, is if you disclose illegal behaviour.  In this case, 
we will be obliged to inform the authorities, to deal with the matter appropriately.  
However, such a disclosure will not be shared with anyone else if this not necessary. 
 
Who is organising and funding the research? 
This research is being organised by Queen Elizabeth Hospital Birmingham and Warwick 
Medical School at the University of Warwick.  It is self-funded study.  
 
  What happens to the results of the study? 
A summary of the results of the research will be sent to all participants later in the project.  
The research findings will be passed to the team who organise the English National Diabetic 
Retinopathy Screening Programme, so that they can see what needs to be done to help more 
people with diabetes to understand risks and benefits of their eye photography.  The results 
will also be distributed at relevant professional conferences, so other people can benefit from 
your views (you will be identified by an ID number or pseudonym only).   
 
  I have some questions. Whom can I ask? 
If you have any questions, now or at any point in the research, please contact the 
principal researcher,  
Nidal Al-Athamneh 07426883070 or n.al-athamneh@warwick.ac.uk 
 
 
What if something goes wrong? 
If you are unhappy about any aspect of this study, you may complain to the University 
of Warwick.  The University has comprehensive public liability insurance.  Any 
complaint should be addressed to In case of complaint, please contact Nicola Owen 
024 7652 2785 or Nicola.Owen@warwick.ac.uk  
 
  What do I do now? 
If you want to take part in this research, please sign both copies of the Declaration of 
Informed Consent.  Keep one for your records and return the other in the envelope 
provided (it does not need a stamp).   
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Thank you for reading this! 
 
If you want to take part in the research, please sign the 
enclosed Consent Form, and return it in the envelope provided 
 
In case of any query, please contact the lead researcher: Nidal Al-Athamneh 07426883070 or n.al-
athamneh@warwick.ac.uk   In case of complaint, please contact Nicola Owen 024 7652 2785  or  
Nicola.Owen@warwick.ac.uk 
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APPENDIX 4:  Patients Provisional Interview Schedule 
(v1) 
 
Questions for patients 
Stage 1 
 
1. What do you know about DRS, how often needs to be done? 
2. How do you feel about changing the screening intervals from once a year to once 
every 2 or 3 years for people with diabetes who are at low risk? Does it concern you? 
Or relieve you as no need to come every year? (any benefits or risks) 
3. What is the most effective interval of DRS? Every year, 2 years 3 years 5 years etc. 
4. Should the policy changed, how would you cope/adapt yourself? What are your 
alternatives? More visits to optician, eye clinic, GP, etc. 
5. What kind of message will the patients receive when their doctor advice them to 
attend once every 2 years as they are at low risk of developing DR?  Will that affect 
their personal diabetic control, as they may think that they are doing well, and no need 
to take medicine, or change their diet control? 
6. How do you think is the best way to inform patients about their risk of developing 
DR? (by GP, DRS, eye clinic, diabetic clinic, etc  and why? 
7. What it is the best method of presenting risk information to patients? (using umbers, 
percentages, probability, words, figure, combinations or all  (present the tools), which 
is more valuable: individual risk or average, fear messages or positive messages).  
8. When a GP, DRS staff, etc presents to someone the risk of developing DR as 10-15% 
in the next 5 years, how do you interpret this? Low risk, high risk? 
9. Are there any changes to the service that you could suggest - from invitation to 
screening, receiving results/treatments options etc. that would make the screening 
process better for you? (E.g. link with opticians at annual eye test)  
10. How serious would it be to get DR in the next 5 years? 
11. Is there anything you’d like to add that we haven’t covered in the interview?  
12. If I tell you that there is chance 1 in 1000 for someone to develop DR in the next 5 
years, what is your chance to be that person? 
13. How likely do you think you will develop DR in the next 5 years? 
14. How likely you think you will develop DR in the next 5 years compare to others 
(gender, ethnicity, age group) are you more likely, less likely, to get DR and why? 
 
 
Stage 2  
Questions for patients  
1. Can you tell me about diabetic retinopathy and screening programme? 
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(how did you hear about it, why it is being done, how often do you need to go for 
screening, when do you stop going for screening, why important to attend, what are 
the benefits and risks of DRS) 
2. Can you tell me about your most recent retinal screening experience? 
When, where, what they found, who told them what, what do they understand about 
the implication of what they were told, how will you cope, what would you do to keep 
your diabetes under control 
3. After receiving the risk information (result that you have received from DRS, GP, eye 
clinic, etc) how likely would it be to develop DR in the next 5 years?  
4. How did the results impact on your diabetes management? 
 
For patients with no retinopathy (R0) 
5. My understanding from your GP is that you have no signs or retinopathy at present.  
How does that fit with your understanding? 
For patients with background retinopathy (R1) 
6. My understanding from your GP is that you have early signs of retinopathy 
(background).  How does that fit with your understanding? 
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APPENDIX 5:  Translation and Interpreting Protocol 
(v1) 
 
A5.1 Study Materials Translation   
The language(s) that study materials will need to be translated into is not yet confirmed.  
As the cost of having all materials professionally translated is prohibitive, the following 
has been adapted from Bhopal et al. (2004) principles for adapting written research 
materials into different languages and Birbili’s (2000) translating guidance: 
 
 A bilingual person who understands the target language and culture will translate the 
study’s materials into the target language, ensuring conceptual equivalence (not 
simple literal translation) is achieved; 
   
 As the bilingual person may not be representative of the target population because of 
education, age, sex etc., if possible, a representative of the target population will 
assess meaning and acceptability of the translated materials and modifications will be 
suggested; 
 The bilingual person will amend materials as appropriate, comparing translations with 
the original English-language materials, to ensure conceptual equivalence is 
maintained; 
 A second bilingual person who understands the target language and culture will 
validate the materials using the target language and English materials; 
 The two bilingual people and the principal researcher will meet (if possible) to discuss 
the back-translations, negotiating a “best fit” to ensure conceptual equivalence is 
maintained; 
The resultant materials will be piloted with at least two monolingual members of the 
target population (if possible) to check face and content validity, with further changes 
suggested if necessary; 
 The bilingual people and the principal researcher will again discuss the suggested 
modifications and amend materials as appropriate, comparing translations with the 
original English-language materials, to ensure conceptual equivalence is maintained. 
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A5.2 Non-English-language data-collection 
It is anticipated that some potential participants will want to be interviewed in a 
language other than English, and they are asked to indicate their language of choice 
on the consent form, before returning it.  Funding exists to cover the cost of interpreters 
for interviews.  A three-way interview with NA (interviewer), the participant and an 
interpreter will allow detailed data-collection to be undertaken in accordance with 
ethical guidelines. 
 
A5.3 Data validation process 
Full back translation will be too time and resource inefficient for the current study, 
therefore an acceptable method of validating the interpreter's work, used by Hipwell 
(2009), will be used.  Following verbatim transcription of the English-language sections 
of the interviews, a research-trained, fluent speaker of the target language(s) will be 
employed to validate the accuracy of the translated transcripts, using the audio files 
and the English transcripts.  The ‘track changes’ function of Microsoft Word will be used 
by the validator to highlight any areas where discrepancies may have occurred, to alert 
the researchers conducting the analysis.  The interpreter and validator will both be paid 
the appropriate hourly professional rate for this work.  
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APPENDIX 6:  Health Professionals Demographic Data Collection 
(V1) 
 
IN CONFIDENCE 
Participant ID number…………… 
 
 
1. Date of birth:  Month…………..……….  Year……….….   
 
2. Sex (please circle one): Male/Female   
 
3. What is your role with the English National Diabetic Retinopathy Screening 
Programme? 
 
Screening only  □ Grading only  □ Screening & grading □ 
Trainer  □ Programme manager  □ Optometrist  □ 
GP  □ 
Health Care Asst  □     
Specialist nurse  □ 
Other  (please state) □  
 
 
Practice manager □  
 
...........……………….…… 
4. How long have you been working with diabetic retinopathy patients in this 
role? (Please tick one):  
 
Less than one year  □ One to three years  □ More than three years  □ 
   
 
Thank you for your help! 
 
This sheet will be stored separately from all other information, to protect  
your identity 
 
 
 
 
In case of any query, please contact the lead researcher: Nidal Al-Athamneh 07426883070 or 
n.al-athamneh@warwick.ac.uk 
In case of complaint, please contact Nicola Owen 024 7652 2785  or  Nicola.Owen@warwick.ac.uk 
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APPENDIX 7:  Health Professionals Information Sheet 
(Health professionals v1) 
 
1. Study Title:  
Communicating risk information about diabetic retinopathy to 
people with diabetes  
 
2. Invitation:   
You are invited to take part in a research study that is being conducted as part of 
educational study at the University of Warwick.  Ask us if anything is unclear or if you 
would like more details.  Our contact details are at the bottom of every page and in 
sections 12 and 13.  Thank you for reading this information sheet. 
 
3. What is the purpose of this study? 
As you will be aware, people with diabetes can develop sight-threatening diabetic 
retinopathy (DR).  Retinopathy screening can identify early signs of damage whilst 
patients are asymptomatic of DR. Research has shown that people who attend the 
Diabetic Retinopathy Screening Programme are less likely to suffer loss of vision or 
blindness, compared with people who don't attend (Gray, 2009).  However, DR 
screening uptake varies across different GP and optometry practices across the 
country.  This research aims to explore how the risks and benefits of diabetic 
retinopathy screening programme are understood by people with diabetes and health 
care professionals, and to establish the methods by which risk information can be 
effectively communicated to help informed choice. 
The results will be given to the DR Screening Programme managers, so that they are 
aware of the issues that have been raised.  
 
4. Why have I been chosen? 
You have been chosen because you have been identified as a health professional who 
works with patients diagnosed with diabetes and the DR screening programme.  Your 
experiences of this process may help us to understand how risk information is been 
communicated to people who attended for screening.  We are also asking for the views 
of people with diabetes who always attend their diabetic eye screening, and other 
health professionals involved in the screening programme.    
 
5. Do I have to take part? 
Participation in this research is entirely voluntary.  If you do decide to take part, you will 
be given this information sheet to keep and asked to sign a consent form.  You will be 
free to withdraw from the study at any time prior to the end of the study without giving 
a reason. If you do not wish to participate, or if you choose to withdraw from the study 
at a later date, it will have no detrimental effect on your employment.  If we have already 
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collected information from you and you choose to withdraw, we will destroy all the 
information we hold for you and not use it in the study. 
 
6. What will I have to do? 
You are being asked to take part in a research interview, which will last around half an 
hour.  This will probably take place at your workplace, or other venue of your choice 
(to be confirmed).   You will be asked about your experiences of dealing with patients 
who have diabetes, how risk information about diabetic retinopathy is communicated, 
and how risks and benefits of screening programme is presented.   
 
Before you start talking to the researcher, you will be given a form to fill in with your 
personal details.  Health professionals have many different experiences and might 
have different views about diabetic eye screening.  You will be asked to agree to the 
discussion being recorded.  The recording will then be put into writing and carefully 
considered, along with the other participants’ views.  Any paperwork that is produced 
as a result of this research study (for example, for the Diabetic Retinopathy Screening 
Programme management) will refer to you by an ID number only (e.g. ‘participant 
number 10’), or an alternative name (pseudonym).   
 
7. What are the possible disadvantages of taking part 
The only disadvantage is likely to be the time that it takes for you to participate in the 
interview. No other disadvantages are expected. 
 
 
8. What are the possible advantages of taking part? 
The views of everyone who talks to us will be considered carefully.  These views will be used 
to suggest improvements to Diabetic Retinopathy Screening Programme organisers, and 
methods of risk communication (we will refer to you by an ID number or pseudonym only).  
The information we get from this study may help other people in future. 
 
9. Will anyone else know I have done this? 
Only the principal researcher/interviewer will know exactly who has taken part.  Your name or 
details will not be given to anyone else.  So neither the Diabetic Retinopathy Screening 
Programme organisers, nor your PCT management or Commissioners, will know who has 
participated in this.  No-one else will be told who has taken part.  All information will be treated 
confidentially.  Only the principal researcher will have access to your personal details and the 
recording, and only the principal researcher, study director and the data analyst will have 
access to the anonymised written copy of our conversation, which will be kept in a locked 
filing cabinet.  The digital recordings will be password protected and erased at the end of the 
study (estimated at December 2012).  The Data Protection Act (1998) will be followed at all 
times. 
 
The only circumstances, in which we might have to pass your details to another person, are if 
you disclose either unprofessional or illegal behaviour.  In these cases, we will be obliged to 
inform your employing organisation, to be dealt with be dealt with appropriately.  However, 
such a disclosure will not be shared with your peers or managers if this not necessary. 
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10. What happens to the results of the study? 
A summary of the results of this phase of the research will be sent to all participants later in 
the project.  The research findings will be passed to the team who organise the English 
National Diabetic Retinopathy Screening Programme, so that they can see what needs to be 
done to help more people with diabetes to attend their eye photography, and improves 
methods of risk communication.  The results will also be distributed at relevant professional 
conferences, so other people can benefit from your views (you will be identified by an ID 
number or pseudonym only).   
 
 
11. I have some questions. Whom can I ask? 
In case of any query, please contact the lead researcher: Nidal Al-Athamneh 
07426883070 or 
n.al-athamneh@warwick.ac.uk; In case of complaint, please contact Nicola Owen 
024 7652 2785  or  Nicola.Owen@warwick.ac.uk 
 
12. Who is organising and funding the research? 
This research is being organised by Queen Elizabeth Hospital Birmingham and Warwick 
Medical School at the University of Warwick.  It is self-funded study.  
 
13. What if something goes wrong? 
If you are unhappy about any aspect of this study, you may complain to the University 
of Warwick.  The University has comprehensive public liability insurance.  Any 
complaint should be addressed to the study director, Dr Jackie Sturt by telephone 024 
765 73753 or email jackie.sturt@warwick.ac.uk. 
 
14.  What do I do now? 
If you want to take part in this research, please sign both copies of the Declaration of 
Informed Consent.  Please keep one for your records and return the other in the 
envelope provided (it does not need a stamp).   
 
 
 
Thank you for reading this! 
 
 
If you want to take part in the research, please sign the 
enclosed Consent Form, and return it in the envelope provided 
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APPENDIX 8:  Health Professionals Provisional Interview Schedule 
(v1) 
1. How do you feel about changing the screening intervals from once a year to 
once every 2 or 3 years for people with diabetes who are at low risk? Does it 
concern you? Or relieve you as no need for patients at low risk to have DRS 
every year? (any benefits or risks) 
2. What is the most effective interval of DRS? Every year, 2 years 3 years 5 
years etc. 
3. Should the policy changed, how would it impact on your service? What are 
your alternatives? More visits to optician, eye clinic, GP, etc. 
4. What kind of message should the patients receive when their doctor advises 
them to attend once every 2 years as they are at low risk of developing DR?  
Will that affect their personal diabetic control, as they may think that they are 
doing well, and no need to take medicine, or change their diet control? 
5. How do you think is the best way to inform patients about their risk of 
developing DR? (by GP, DRS, eye clinic, diabetic clinic, etc  and why? 
6. What it is the best method of presenting risk information to patients? (using 
umbers, percentages, probability, words, figure, combinations or all  (present 
the tools), which is more valuable: individual risk or average, fear messages or 
positive messages).  
7. When a GP, DRS staff, etc presents to someone the risk of developing DR as 
10-15% in the next 5 years, how do you interpret this? Low risk, high risk? 
8. Are there any changes to the service that you could suggest - from invitation 
to screening, receiving results/treatments options etc. that would make the 
screening process better for you? (E.g. link with opticians at annual eye test)  
9. Is there anything you’d like to add that we haven’t covered in the interview?  
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APPENDIX 9:  Declaration of Informed Consent 
(Professionals; v1) 
Participant ID number…………… 
 
Please tick  
1. I have read and understand the ‘Professionals Information Sheet (v1)’.   
 
□ 
2. I understand that taking part in this study will involve me being interviewed 
and providing some personal demographic information. 
 
□ 
3. I understand that the discussion will be recorded and that the recording will 
be destroyed at the end of the study.   
 
□ 
4. I understand that there are no known expected discomforts or risks 
involved in my participation in this study. 
 
□ 
5. I understand that I am free to withdraw from the study at any time prior to 
the study's end, without giving a reason, by contacting the e-mail address 
or telephone number below. 
 
□ 
   
 
 
I give my informed consent to take part in this study.  I understand that although a 
record will be kept of my participation in the study, my data will be identified by a 
number or an alternative name (pseudonym) only.   
 
 
Signed …………………………………………  Dated 
………………….………… 
Name (please print in full) ........................................................  
Phone number(s) ..................................................................................................................... 
Email address: .................................................................................................................. 
Address:.......................................................................................................................................
.............................................................................................................................Post code: 
............................... (We will only use this information to contact you about the study) 
 
Please sign this form & return it in the envelope provided 
 
 
In case of any query, please contact the lead researcher: Nidal Al-Athamneh 07426883070 or 
n.al-athamneh@warwick.ac.uk 
In case of complaint, please contact Nicola Owen 024 7652 2785  or  Nicola.Owen@warwick.ac.uk  
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APPENDIX 10: Letter to GP 
 
 Date 
GP name 
Surgery name 
Street name 
Town  
County 
Post code 
 
Dear GP name, 
Re: Patient name, Risk Communication Study 
I wish to inform you that your patient, above, has participated in the FLURRI study 
(Communicating risk Information about Diabetic Retinopathy to people with diabetes). 
Please see the enclosed information for further details. 
 
Yours sincerely, 
 
Nidal Al-Athamneh 
PhD Student, 
Warwick Medical School 
 
(Encs: Patient Information Sheet, Demographic data-collection, PAID & DSCAQ, Informed 
consent). 
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 APPENDIX 11:  Risk Communication Tools 
          
1. Figure 1 represents highlighted human figures used to present a lifetime risk of 
breast cancer for a 50 year old woman, the lifetime risk of 9% is portrayed in a frequency 
format with a denominator of 10 (Schapira et al., 2006): 
 
2. Figure 2 represents bar graph format used to communicate lifetime risk of breast 
cancer for a 50 year old woman (Schapira et al., 2006): 
 
3. Figure 3 represents vertical bar graph format used to communicate comparative 
lifetime risks for a 50 year old woman including the risk of heart disease, osteoporosis, 
stroke, breast cancer, and endometrial cancer (Schapira et al., 2006): 
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4. Figure 4 represents a highlighted human figure format used to communicate lifetime 
risk of breast cancer for a 50 year old woman using a denominator of 1000 and consecutive 
highlighting of figures (Schapira et al., 2006): 
 
 
 
5. Figure 5 represents human figures to communicate lifetime risks of breast cancer for 
a 50 year old woman using a denominator of 1000 and randomly highlighting of figures 
(Schapira et al., 2006): 
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6. Figure 6 represents 80 out of 100 patients (green faces) treated with statin who 
would not have suffered a vascular event anyway and 15 red faces still suffer an event in 
spite of the statin, but 5 yellow faces are saved from having a vascular event (Cates, 2009): 
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7. Figure 7 represents a breast cancer self-assessment risk tool (Chiu, 2009). This tool 
includes breast cancer risk factors and personalizes the risk: 
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8. Figure 8 represents an example of risk tool during modification process 
 
 
 
                               
 
 
 
 
 
 
1/2
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9. Figure 9 represents the final version of the risk tool after modification process 
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              APPENDIX 12: Research Committee ethical approval    
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APPENDIX 13: Substantial Amendment 
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APPENDIX 14: Diabetes UK poster Manchester 2013  
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 APPENDIX 15: EASDec 2013 Poster Barcelona Spain 
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APPENDIX 16: EASDec 2014 Oral presentation abstract, Padova Italy 
 
Title: Risk perception of diabetic retinopathy among people with type 2 diabetes  
Authors 
Al-Athamneh, N.; Sturt, J.; Dolan, A.; Lindenmeyer, A.; Stratton, I.M.; Scanlon, 
P.H.  
Aim 
To explore how the risk of Diabetic Retinopathy (DR) is understood by people 
with diabetes and Health Care Professionals (HCPs). 
Methods 
A qualitative study was conducted using semi-structured interviews with a 
convenience sample of 25 participants. Of these, 20 participants were 
diagnosed with type 2 diabetes (11 White British and 9 South Asians), and 2 
primary care physicians, 2 ophthalmologists, and 1 retinal screener. 
Participants were purposely recruited to fall into 5 groups of 5 participants each. 
1) No DR; 2): background DR; 3) preproliferative DR; 4) proliferative DR; 5) 
HCPs. Risk information about DR was routinely provided to participants by 
HCPs after annual diabetic screening. 
 Results 
Participants with diabetes were unfamiliar with the term retinopathy, however 
they were aware that diabetes could lead to changes in their sight or to Sight 
Threatening Diabetic Retinopathy (STDR). They were unaware that these 
changes could lead to permanent vision loss. Participants were optimistic about 
their chance of developing STDR. They perceived the seriousness of risk based 
on noticeable symptoms and scores of visual acuity rather than grade of 
retinopathy. Knowledge of risk was even less with the symptomless 
participants.  
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There was a huge difference in the risk perception between participants and 
HCPs; when HCPs communicated risk message as high risk of developing 
STDR (such as: the chance of developing STDR is 10 in 100 or 10%), 
participants perceived it as low or very low risk. 
Conclusion 
Risk information should be personalised, and provided in a clear and attractive 
style based on level of understanding, particularly to the symptomless 
participants. HCPs should assess patients’ knowledge and understanding of 
risk when risk message is given. 
Risk communication tools could benefit participants to understand their own risk 
of developing DR, and reduces anxiety level. More quantitative study should 
target the effectiveness of risk tools. 
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APPENDIX 17: An example of field note 
 
 
